{
    "640f857d201352f04a00002b_0001": [
        {
            "start_logit": 1.481508493423462,
            "end_logit": 1.8815433979034424,
            "text": "CHecklist for critical Appraisal and data extraction for systematic Reviews of prediction Modelling Studies (CHARMS).",
            "probability": 0.26793813705444336
        },
        {
            "start_logit": 1.2491726875305176,
            "end_logit": 1.8815433979034424,
            "text": "critical Appraisal and data extraction for systematic Reviews of prediction Modelling Studies (CHARMS).",
            "probability": 0.21238915622234344
        },
        {
            "start_logit": 1.481508493423462,
            "end_logit": 1.0880391597747803,
            "text": "CHecklist for critical Appraisal and data extraction for systematic Reviews of prediction Modelling Studies (CHARMS)",
            "probability": 0.12117694318294525
        },
        {
            "start_logit": 1.2491726875305176,
            "end_logit": 1.0880391597747803,
            "text": "critical Appraisal and data extraction for systematic Reviews of prediction Modelling Studies (CHARMS)",
            "probability": 0.09605452418327332
        },
        {
            "start_logit": 0.30099186301231384,
            "end_logit": 1.8815433979034424,
            "text": "systematic Reviews of prediction Modelling Studies (CHARMS).",
            "probability": 0.08228916674852371
        },
        {
            "start_logit": 1.481508493423462,
            "end_logit": -0.006087899208068848,
            "text": "CHecklist",
            "probability": 0.04057389125227928
        },
        {
            "start_logit": 0.30099186301231384,
            "end_logit": 1.0880391597747803,
            "text": "systematic Reviews of prediction Modelling Studies (CHARMS)",
            "probability": 0.03721586987376213
        },
        {
            "start_logit": 1.481508493423462,
            "end_logit": -0.15556541085243225,
            "text": "CHecklist for critical Appraisal and data extraction for systematic Reviews of prediction Modelling Studies",
            "probability": 0.03494052216410637
        },
        {
            "start_logit": 1.2491726875305176,
            "end_logit": -0.15556541085243225,
            "text": "critical Appraisal and data extraction for systematic Reviews of prediction Modelling Studies",
            "probability": 0.027696654200553894
        },
        {
            "start_logit": 1.481508493423462,
            "end_logit": -1.0466140508651733,
            "text": "CHecklist for critical Appraisal and data extraction for systematic Reviews",
            "probability": 0.014333490282297134
        },
        {
            "start_logit": 1.481508493423462,
            "end_logit": -1.2593451738357544,
            "text": "CHecklist for critical Appraisal and data extraction",
            "probability": 0.0115868104621768
        },
        {
            "start_logit": 1.2491726875305176,
            "end_logit": -1.0466140508651733,
            "text": "critical Appraisal and data extraction for systematic Reviews",
            "probability": 0.011361867189407349
        },
        {
            "start_logit": 0.30099186301231384,
            "end_logit": -0.15556541085243225,
            "text": "systematic Reviews of prediction Modelling Studies",
            "probability": 0.010730935260653496
        },
        {
            "start_logit": 1.2491726875305176,
            "end_logit": -1.2593451738357544,
            "text": "critical Appraisal and data extraction",
            "probability": 0.009184633381664753
        },
        {
            "start_logit": -2.5640928745269775,
            "end_logit": 1.8815433979034424,
            "text": "data extraction for systematic Reviews of prediction Modelling Studies (CHARMS).",
            "probability": 0.004688697401434183
        },
        {
            "start_logit": 0.30099186301231384,
            "end_logit": -1.0466140508651733,
            "text": "systematic Reviews",
            "probability": 0.004402101505547762
        },
        {
            "start_logit": 1.481508493423462,
            "end_logit": -2.364741802215576,
            "text": "CHecklist for critical Appraisal and data extraction for systematic Reviews of prediction Modelling Studies (",
            "probability": 0.0038361551705747843
        },
        {
            "start_logit": 1.481508493423462,
            "end_logit": -2.492420196533203,
            "text": "CHecklist for critical Appraisal",
            "probability": 0.003376341424882412
        },
        {
            "start_logit": -2.9536304473876953,
            "end_logit": 1.8815433979034424,
            "text": "prediction Modelling Studies (CHARMS).",
            "probability": 0.003175983438268304
        },
        {
            "start_logit": 1.481508493423462,
            "end_logit": -2.594677448272705,
            "text": "CHecklist for critical Appraisal and data extraction for systematic Reviews of prediction Modelling Studies (CHARMS",
            "probability": 0.003048150334507227
        }
    ],
    "640f857d201352f04a00002b_0002": [
        {
            "start_logit": -0.3895568549633026,
            "end_logit": 0.7547733187675476,
            "text": "Systematic Reviews of Prediction Modeling Studies (CHARMS)",
            "probability": 0.2791290581226349
        },
        {
            "start_logit": -0.8709908127784729,
            "end_logit": 0.7547733187675476,
            "text": "Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modeling Studies (CHARMS)",
            "probability": 0.17247293889522552
        },
        {
            "start_logit": -0.3895568549633026,
            "end_logit": -0.049265533685684204,
            "text": "Systematic Reviews of Prediction Modeling Studies",
            "probability": 0.1249152347445488
        },
        {
            "start_logit": -0.3895568549633026,
            "end_logit": -0.06469897925853729,
            "text": "Systematic Reviews of Prediction Modeling Studies (CHARMS),",
            "probability": 0.12300215661525726
        },
        {
            "start_logit": -0.8709908127784729,
            "end_logit": -0.049265533685684204,
            "text": "Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modeling Studies",
            "probability": 0.07718470692634583
        },
        {
            "start_logit": -0.8709908127784729,
            "end_logit": -0.06469897925853729,
            "text": "Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modeling Studies (CHARMS),",
            "probability": 0.07600262761116028
        },
        {
            "start_logit": -2.850274085998535,
            "end_logit": 0.7547733187675476,
            "text": "Checklist for\u00a0Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modeling Studies (CHARMS)",
            "probability": 0.02383028157055378
        },
        {
            "start_logit": -0.3895568549633026,
            "end_logit": -1.892787218093872,
            "text": "Systematic Reviews",
            "probability": 0.0197689738124609
        },
        {
            "start_logit": -3.3071279525756836,
            "end_logit": 0.7547733187675476,
            "text": "Prediction Modeling Studies (CHARMS)",
            "probability": 0.015091069042682648
        },
        {
            "start_logit": -0.8709908127784729,
            "end_logit": -1.892787218093872,
            "text": "Critical Appraisal and Data Extraction for Systematic Reviews",
            "probability": 0.012215184979140759
        },
        {
            "start_logit": -2.850274085998535,
            "end_logit": -0.049265533685684204,
            "text": "Checklist for\u00a0Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modeling Studies",
            "probability": 0.010664473287761211
        },
        {
            "start_logit": -2.850274085998535,
            "end_logit": -0.06469897925853729,
            "text": "Checklist for\u00a0Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modeling Studies (CHARMS),",
            "probability": 0.010501149110496044
        },
        {
            "start_logit": -3.8146071434020996,
            "end_logit": 0.7547733187675476,
            "text": "We will extract data based on the Checklist for\u00a0Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modeling Studies (CHARMS)",
            "probability": 0.009084993042051792
        },
        {
            "start_logit": -0.3895568549633026,
            "end_logit": -2.8614554405212402,
            "text": "Systematic Reviews of Prediction Modeling Studies (",
            "probability": 0.007504069246351719
        },
        {
            "start_logit": -3.3071279525756836,
            "end_logit": -0.049265533685684204,
            "text": "Prediction Modeling Studies",
            "probability": 0.0067535219714045525
        },
        {
            "start_logit": -0.8709908127784729,
            "end_logit": -2.499436616897583,
            "text": "Critical Appraisal",
            "probability": 0.006659406237304211
        },
        {
            "start_logit": -3.3071279525756836,
            "end_logit": -0.06469897925853729,
            "text": "Prediction Modeling Studies (CHARMS),",
            "probability": 0.006650093477219343
        },
        {
            "start_logit": -0.8709908127784729,
            "end_logit": -2.541567325592041,
            "text": "Critical Appraisal and Data Extraction",
            "probability": 0.006384668871760368
        },
        {
            "start_logit": -0.3895568549633026,
            "end_logit": -3.043245315551758,
            "text": "Systematic Reviews of Prediction Modeling Studies (CHARMS",
            "probability": 0.006256716325879097
        },
        {
            "start_logit": -4.241440773010254,
            "end_logit": 0.7547733187675476,
            "text": "data based on the Checklist for\u00a0Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modeling Studies (CHARMS)",
            "probability": 0.005928613245487213
        }
    ],
    "640f857d201352f04a00002b_0003": [
        {
            "start_logit": 2.2259554862976074,
            "end_logit": 2.144922971725464,
            "text": "Checklist for Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modeling Studies (CHARMS-PF)",
            "probability": 0.20065797865390778
        },
        {
            "start_logit": 2.2259554862976074,
            "end_logit": 1.8530747890472412,
            "text": "Checklist for Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modeling Studies (CHARMS-PF).",
            "probability": 0.14986781775951385
        },
        {
            "start_logit": 1.8643419742584229,
            "end_logit": 2.144922971725464,
            "text": "Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modeling Studies (CHARMS-PF)",
            "probability": 0.13976866006851196
        },
        {
            "start_logit": 2.2259554862976074,
            "end_logit": 1.4961504936218262,
            "text": "Checklist for Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modeling Studies (CHARMS-PF",
            "probability": 0.10488134622573853
        },
        {
            "start_logit": 1.8643419742584229,
            "end_logit": 1.8530747890472412,
            "text": "Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modeling Studies (CHARMS-PF).",
            "probability": 0.10439066588878632
        },
        {
            "start_logit": 1.8643419742584229,
            "end_logit": 1.4961504936218262,
            "text": "Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modeling Studies (CHARMS-PF",
            "probability": 0.07305525243282318
        },
        {
            "start_logit": 2.2259554862976074,
            "end_logit": 0.5139864087104797,
            "text": "Checklist for Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modeling Studies",
            "probability": 0.03927803412079811
        },
        {
            "start_logit": 0.5553070306777954,
            "end_logit": 2.144922971725464,
            "text": "Systematic Reviews of Prediction Modeling Studies (CHARMS-PF)",
            "probability": 0.0377487987279892
        },
        {
            "start_logit": 0.5553070306777954,
            "end_logit": 1.8530747890472412,
            "text": "Systematic Reviews of Prediction Modeling Studies (CHARMS-PF).",
            "probability": 0.028193898499011993
        },
        {
            "start_logit": 1.8643419742584229,
            "end_logit": 0.5139864087104797,
            "text": "Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modeling Studies",
            "probability": 0.02735917642712593
        },
        {
            "start_logit": 2.2259554862976074,
            "end_logit": 0.11221525073051453,
            "text": "Checklist",
            "probability": 0.026282265782356262
        },
        {
            "start_logit": 0.5553070306777954,
            "end_logit": 1.4961504936218262,
            "text": "Systematic Reviews of Prediction Modeling Studies (CHARMS-PF",
            "probability": 0.01973080448806286
        },
        {
            "start_logit": 2.2259554862976074,
            "end_logit": -1.0239568948745728,
            "text": "Checklist for Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modeling Studies (",
            "probability": 0.008437806740403175
        },
        {
            "start_logit": 2.2259554862976074,
            "end_logit": -1.0592002868652344,
            "text": "Checklist for Critical Appraisal and Data Extraction",
            "probability": 0.008145608007907867
        },
        {
            "start_logit": 0.5553070306777954,
            "end_logit": 0.5139864087104797,
            "text": "Systematic Reviews of Prediction Modeling Studies",
            "probability": 0.007389182690531015
        },
        {
            "start_logit": 2.2259554862976074,
            "end_logit": -1.3293482065200806,
            "text": "Checklist for Critical Appraisal and Data Extraction for Systematic Reviews",
            "probability": 0.006217271089553833
        },
        {
            "start_logit": 1.8643419742584229,
            "end_logit": -1.0239568948745728,
            "text": "Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modeling Studies (",
            "probability": 0.0058773658238351345
        },
        {
            "start_logit": 1.8643419742584229,
            "end_logit": -1.0592002868652344,
            "text": "Critical Appraisal and Data Extraction",
            "probability": 0.0056738355197012424
        },
        {
            "start_logit": 1.8643419742584229,
            "end_logit": -1.3293482065200806,
            "text": "Critical Appraisal and Data Extraction for Systematic Reviews",
            "probability": 0.004330648574978113
        },
        {
            "start_logit": 2.2259554862976074,
            "end_logit": -2.158402681350708,
            "text": "Checklist for Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modeling Studies (CHARMS",
            "probability": 0.002713599940761924
        }
    ],
    "640f857d201352f04a00002b_0004": [
        {
            "start_logit": 1.4746122360229492,
            "end_logit": 2.2897377014160156,
            "text": "Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modeling Studies (CHARMS)",
            "probability": 0.7854538559913635
        },
        {
            "start_logit": -0.6396734118461609,
            "end_logit": 2.2897377014160156,
            "text": "Systematic Reviews of Prediction Modeling Studies (CHARMS)",
            "probability": 0.0948195829987526
        },
        {
            "start_logit": 1.4746122360229492,
            "end_logit": -0.4919964075088501,
            "text": "Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modeling Studies",
            "probability": 0.048643965274095535
        },
        {
            "start_logit": 1.4746122360229492,
            "end_logit": -1.5088613033294678,
            "text": "Critical Appraisal and Data Extraction for Systematic Reviews",
            "probability": 0.017595844343304634
        },
        {
            "start_logit": 1.4746122360229492,
            "end_logit": -2.088331460952759,
            "text": "Critical Appraisal and Data Extraction",
            "probability": 0.009857107885181904
        },
        {
            "start_logit": 1.4746122360229492,
            "end_logit": -2.3856918811798096,
            "text": "Critical Appraisal",
            "probability": 0.007321625482290983
        },
        {
            "start_logit": -3.2620816230773926,
            "end_logit": 2.2897377014160156,
            "text": "Prediction Modeling Studies (CHARMS)",
            "probability": 0.006886533927172422
        },
        {
            "start_logit": -0.6396734118461609,
            "end_logit": -0.4919964075088501,
            "text": "Systematic Reviews of Prediction Modeling Studies",
            "probability": 0.00587227288633585
        },
        {
            "start_logit": 1.4746122360229492,
            "end_logit": -2.82757830619812,
            "text": "Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modeling Studies (",
            "probability": 0.004706504289060831
        },
        {
            "start_logit": -3.7671103477478027,
            "end_logit": 2.2897377014160156,
            "text": "Data Extraction for Systematic Reviews of Prediction Modeling Studies (CHARMS)",
            "probability": 0.004155942238867283
        },
        {
            "start_logit": 1.4746122360229492,
            "end_logit": -3.083993911743164,
            "text": "Critical Appraisal and Data Extraction for",
            "probability": 0.0036419895477592945
        },
        {
            "start_logit": 1.4746122360229492,
            "end_logit": -3.353346824645996,
            "text": "Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modeling Studies (CHARMS",
            "probability": 0.00278201955370605
        },
        {
            "start_logit": 1.4746122360229492,
            "end_logit": -3.5563971996307373,
            "text": "Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modeling",
            "probability": 0.0022707872558385134
        },
        {
            "start_logit": -0.6396734118461609,
            "end_logit": -1.5088613033294678,
            "text": "Systematic Reviews",
            "probability": 0.0021241612266749144
        },
        {
            "start_logit": -5.410963535308838,
            "end_logit": 2.2897377014160156,
            "text": "Appraisal and Data Extraction for Systematic Reviews of Prediction Modeling Studies (CHARMS)",
            "probability": 0.0008030695025809109
        },
        {
            "start_logit": -5.488480091094971,
            "end_logit": 2.2897377014160156,
            "text": "Reviews of Prediction Modeling Studies (CHARMS)",
            "probability": 0.0007431699195876718
        },
        {
            "start_logit": 1.4746122360229492,
            "end_logit": -4.817151069641113,
            "text": "Critical Appraisal and",
            "probability": 0.0006436327239498496
        },
        {
            "start_logit": -0.6396734118461609,
            "end_logit": -2.82757830619812,
            "text": "Systematic Reviews of Prediction Modeling Studies (",
            "probability": 0.0005681668990291655
        },
        {
            "start_logit": -5.761471748352051,
            "end_logit": 2.2897377014160156,
            "text": "CHARMS)",
            "probability": 0.0005656259600073099
        },
        {
            "start_logit": 1.4746122360229492,
            "end_logit": -4.985067367553711,
            "text": "Critical Appraisal and Data Extraction for Systematic Reviews of",
            "probability": 0.000544142909348011
        }
    ],
    "6410eb95201352f04a00002e_0001": [
        {
            "start_logit": -2.5541863441467285,
            "end_logit": -1.795396089553833,
            "text": "brain and heart.",
            "probability": 0.19656261801719666
        },
        {
            "start_logit": -2.5541863441467285,
            "end_logit": -2.1766583919525146,
            "text": "brain",
            "probability": 0.13425208628177643
        },
        {
            "start_logit": -2.5541863441467285,
            "end_logit": -2.4918136596679688,
            "text": "brain and heart",
            "probability": 0.0979604423046112
        },
        {
            "start_logit": -3.281968116760254,
            "end_logit": -1.795396089553833,
            "text": "heart.",
            "probability": 0.09493569284677505
        },
        {
            "start_logit": -3.716221332550049,
            "end_logit": -1.795396089553833,
            "text": "gene expression levels and AS is fundamental to organ development, especially for the brain and heart.",
            "probability": 0.06149439513683319
        },
        {
            "start_logit": -3.837399959564209,
            "end_logit": -1.795396089553833,
            "text": "programs controlling gene expression levels and AS is fundamental to organ development, especially for the brain and heart.",
            "probability": 0.05447639524936676
        },
        {
            "start_logit": -3.281968116760254,
            "end_logit": -2.4918136596679688,
            "text": "heart",
            "probability": 0.04731285199522972
        },
        {
            "start_logit": -3.716221332550049,
            "end_logit": -2.1766583919525146,
            "text": "gene expression levels and AS is fundamental to organ development, especially for the brain",
            "probability": 0.04200061410665512
        },
        {
            "start_logit": -3.837399959564209,
            "end_logit": -2.1766583919525146,
            "text": "programs controlling gene expression levels and AS is fundamental to organ development, especially for the brain",
            "probability": 0.03720732033252716
        },
        {
            "start_logit": -4.235818862915039,
            "end_logit": -1.795396089553833,
            "text": "AS is fundamental to organ development, especially for the brain and heart.",
            "probability": 0.03657441586256027
        },
        {
            "start_logit": -3.716221332550049,
            "end_logit": -2.4918136596679688,
            "text": "gene expression levels and AS is fundamental to organ development, especially for the brain and heart",
            "probability": 0.03064681775867939
        },
        {
            "start_logit": -3.837399959564209,
            "end_logit": -2.4918136596679688,
            "text": "programs controlling gene expression levels and AS is fundamental to organ development, especially for the brain and heart",
            "probability": 0.027149269357323647
        },
        {
            "start_logit": -4.235818862915039,
            "end_logit": -2.1766583919525146,
            "text": "AS is fundamental to organ development, especially for the brain",
            "probability": 0.024980267509818077
        },
        {
            "start_logit": -3.716221332550049,
            "end_logit": -2.8806064128875732,
            "text": "gene expression levels",
            "probability": 0.020774707198143005
        },
        {
            "start_logit": -3.837399959564209,
            "end_logit": -2.8806064128875732,
            "text": "programs controlling gene expression levels",
            "probability": 0.018403807654976845
        },
        {
            "start_logit": -4.235818862915039,
            "end_logit": -2.4918136596679688,
            "text": "AS is fundamental to organ development, especially for the brain and heart",
            "probability": 0.01822749525308609
        },
        {
            "start_logit": -4.962646961212158,
            "end_logit": -1.795396089553833,
            "text": "expression levels and AS is fundamental to organ development, especially for the brain and heart.",
            "probability": 0.017681527882814407
        },
        {
            "start_logit": -5.144196033477783,
            "end_logit": -1.795396089553833,
            "text": "organ development, especially for the brain and heart.",
            "probability": 0.014745993539690971
        },
        {
            "start_logit": -3.716221332550049,
            "end_logit": -3.3970601558685303,
            "text": "gene expression levels and AS",
            "probability": 0.012394866906106472
        },
        {
            "start_logit": -5.332220077514648,
            "end_logit": -1.795396089553833,
            "text": "interplay of programs controlling gene expression levels and AS is fundamental to organ development, especially for the brain and heart.",
            "probability": 0.012218458577990532
        }
    ],
    "6410eb95201352f04a00002e_0002": [
        {
            "start_logit": 6.7814555168151855,
            "end_logit": 6.690443992614746,
            "text": "Srrm4 and Nova1",
            "probability": 0.33696073293685913
        },
        {
            "start_logit": 6.7814555168151855,
            "end_logit": 6.673311233520508,
            "text": "Srrm4",
            "probability": 0.33123716711997986
        },
        {
            "start_logit": 6.7461323738098145,
            "end_logit": 6.690443992614746,
            "text": "Nova1",
            "probability": 0.3252662718296051
        },
        {
            "start_logit": 1.8367202281951904,
            "end_logit": 6.690443992614746,
            "text": "tissue-specific splicing factors Srrm4 and Nova1",
            "probability": 0.002399431774392724
        },
        {
            "start_logit": 1.8367202281951904,
            "end_logit": 6.673311233520508,
            "text": "tissue-specific splicing factors Srrm4",
            "probability": 0.002358672907575965
        },
        {
            "start_logit": -0.21607406437397003,
            "end_logit": 6.690443992614746,
            "text": "splicing factors Srrm4 and Nova1",
            "probability": 0.0003080286260228604
        },
        {
            "start_logit": -0.21607406437397003,
            "end_logit": 6.673311233520508,
            "text": "splicing factors Srrm4",
            "probability": 0.0003027961647603661
        },
        {
            "start_logit": -0.872942328453064,
            "end_logit": 6.690443992614746,
            "text": "4 and Nova1",
            "probability": 0.0001597043446963653
        },
        {
            "start_logit": -0.872942328453064,
            "end_logit": 6.673311233520508,
            "text": "4",
            "probability": 0.00015699147479608655
        },
        {
            "start_logit": -0.9627596139907837,
            "end_logit": 6.690443992614746,
            "text": "1",
            "probability": 0.00014598548295907676
        },
        {
            "start_logit": 6.7814555168151855,
            "end_logit": -1.2797491550445557,
            "text": "S",
            "probability": 0.00011645776248769835
        },
        {
            "start_logit": 6.7814555168151855,
            "end_logit": -1.292604923248291,
            "text": "Srrm4 and No",
            "probability": 0.00011497022933326662
        },
        {
            "start_logit": 6.7461323738098145,
            "end_logit": -1.292604923248291,
            "text": "No",
            "probability": 0.00011098001414211467
        },
        {
            "start_logit": 6.7814555168151855,
            "end_logit": -1.5499677658081055,
            "text": "Srrm4 and Nova",
            "probability": 8.888202864909545e-05
        },
        {
            "start_logit": 6.7461323738098145,
            "end_logit": -1.5499677658081055,
            "text": "Nova",
            "probability": 8.579732093494385e-05
        },
        {
            "start_logit": 6.7814555168151855,
            "end_logit": -1.7243512868881226,
            "text": "Srrm",
            "probability": 7.465868111466989e-05
        },
        {
            "start_logit": 6.7461323738098145,
            "end_logit": -2.026427745819092,
            "text": "Nova1 as likely upstream regulators of the observed splicing changes in the PLN-R14del cardiomyocytes.",
            "probability": 5.3278199629858136e-05
        },
        {
            "start_logit": 6.7814555168151855,
            "end_logit": -3.0428500175476074,
            "text": "Srr",
            "probability": 1.997393337660469e-05
        },
        {
            "start_logit": -2.967087507247925,
            "end_logit": 6.690443992614746,
            "text": "specific splicing factors Srrm4 and Nova1",
            "probability": 1.9671657355502248e-05
        },
        {
            "start_logit": -2.9742774963378906,
            "end_logit": 6.690443992614746,
            "text": "Bioinformatical analysis pointed to the tissue-specific splicing factors Srrm4 and Nova1",
            "probability": 1.9530731151462533e-05
        }
    ],
    "64162fb0690f196b5100001a_0001": [
        {
            "start_logit": 6.7276411056518555,
            "end_logit": 6.519691467285156,
            "text": "point mutations",
            "probability": 0.16042864322662354
        },
        {
            "start_logit": 6.686692237854004,
            "end_logit": 6.519691467285156,
            "text": "deletions, 18% duplications and 18% point mutations",
            "probability": 0.1539919674396515
        },
        {
            "start_logit": 6.686692237854004,
            "end_logit": 6.391116619110107,
            "text": "deletions, 18% duplications",
            "probability": 0.13541242480278015
        },
        {
            "start_logit": 6.531416416168213,
            "end_logit": 6.519691467285156,
            "text": "duplications and 18% point mutations",
            "probability": 0.13184460997581482
        },
        {
            "start_logit": 6.686692237854004,
            "end_logit": 6.3366169929504395,
            "text": "deletions",
            "probability": 0.12823010981082916
        },
        {
            "start_logit": 6.531416416168213,
            "end_logit": 6.391116619110107,
            "text": "duplications",
            "probability": 0.11593731492757797
        },
        {
            "start_logit": 5.175426959991455,
            "end_logit": 6.519691467285156,
            "text": "18% duplications and 18% point mutations",
            "probability": 0.033975329250097275
        },
        {
            "start_logit": 5.175426959991455,
            "end_logit": 6.391116619110107,
            "text": "18% duplications",
            "probability": 0.029876144602894783
        },
        {
            "start_logit": 4.934197902679443,
            "end_logit": 6.519691467285156,
            "text": "18% point mutations",
            "probability": 0.026693139225244522
        },
        {
            "start_logit": 4.755446434020996,
            "end_logit": 6.519691467285156,
            "text": "64% deletions, 18% duplications and 18% point mutations",
            "probability": 0.02232382632791996
        },
        {
            "start_logit": 4.755446434020996,
            "end_logit": 6.391116619110107,
            "text": "64% deletions, 18% duplications",
            "probability": 0.019630398601293564
        },
        {
            "start_logit": 4.755446434020996,
            "end_logit": 6.3366169929504395,
            "text": "64% deletions",
            "probability": 0.018589196726679802
        },
        {
            "start_logit": 6.686692237854004,
            "end_logit": 3.2203030586242676,
            "text": "deletions, 18% duplication",
            "probability": 0.005683188792318106
        },
        {
            "start_logit": 6.531416416168213,
            "end_logit": 3.2203030586242676,
            "text": "duplication",
            "probability": 0.004865824710577726
        },
        {
            "start_logit": 6.7276411056518555,
            "end_logit": 2.484684467315674,
            "text": "point mutations.",
            "probability": 0.0028372714295983315
        },
        {
            "start_logit": 6.686692237854004,
            "end_logit": 2.484684467315674,
            "text": "deletions, 18% duplications and 18% point mutations.",
            "probability": 0.0027234347071498632
        },
        {
            "start_logit": 6.531416416168213,
            "end_logit": 2.484684467315674,
            "text": "duplications and 18% point mutations.",
            "probability": 0.0023317462764680386
        },
        {
            "start_logit": 6.686692237854004,
            "end_logit": 2.1976094245910645,
            "text": "deletions, 18%",
            "probability": 0.0020438162609934807
        },
        {
            "start_logit": 6.686692237854004,
            "end_logit": 1.7662343978881836,
            "text": "deleti",
            "probability": 0.0013276936952024698
        },
        {
            "start_logit": 5.175426959991455,
            "end_logit": 3.2203030586242676,
            "text": "18% duplication",
            "probability": 0.0012538848677650094
        }
    ],
    "64162fb0690f196b5100001a_0002": [
        {
            "start_logit": 6.173972129821777,
            "end_logit": 6.001638412475586,
            "text": "exonic deletions",
            "probability": 0.12695232033729553
        },
        {
            "start_logit": 6.173972129821777,
            "end_logit": 5.836054801940918,
            "text": "exonic deletions, 64 (11.1%) were exonic duplications",
            "probability": 0.10757926851511002
        },
        {
            "start_logit": 6.074739456176758,
            "end_logit": 5.88972282409668,
            "text": "nonsense/frameshift types",
            "probability": 0.10278744995594025
        },
        {
            "start_logit": 5.993344306945801,
            "end_logit": 5.88972282409668,
            "text": "Small mutations were identified in 105 cases (18.2%), most being nonsense/frameshift types",
            "probability": 0.09475249797105789
        },
        {
            "start_logit": 5.860105037689209,
            "end_logit": 5.836054801940918,
            "text": "exonic duplications",
            "probability": 0.07859911024570465
        },
        {
            "start_logit": 5.993344306945801,
            "end_logit": 5.64430570602417,
            "text": "Small mutations",
            "probability": 0.07413224875926971
        },
        {
            "start_logit": 5.860105037689209,
            "end_logit": 5.64430570602417,
            "text": "exonic duplications, and one was a deletion/duplication complex rearrangement (0.2%). Small mutations",
            "probability": 0.06488469243049622
        },
        {
            "start_logit": 5.850976943969727,
            "end_logit": 5.64430570602417,
            "text": "deletion/duplication complex rearrangement (0.2%). Small mutations",
            "probability": 0.06429515033960342
        },
        {
            "start_logit": 5.860105037689209,
            "end_logit": 5.4760332107543945,
            "text": "exonic duplications, and one was a deletion/duplication complex rearrangement",
            "probability": 0.05483555048704147
        },
        {
            "start_logit": 5.850976943969727,
            "end_logit": 5.4760332107543945,
            "text": "deletion/duplication complex rearrangement",
            "probability": 0.05433731526136398
        },
        {
            "start_logit": 6.074739456176758,
            "end_logit": 4.762213230133057,
            "text": "nonsense/frameshift types (75.2%). Mutations in splice sites",
            "probability": 0.03328654542565346
        },
        {
            "start_logit": 4.729495525360107,
            "end_logit": 6.001638412475586,
            "text": "deletions",
            "probability": 0.029944192618131638
        },
        {
            "start_logit": 4.729495525360107,
            "end_logit": 5.836054801940918,
            "text": "deletions, 64 (11.1%) were exonic duplications",
            "probability": 0.025374654680490494
        },
        {
            "start_logit": 6.074739456176758,
            "end_logit": 4.362905979156494,
            "text": "nonsense/frameshift",
            "probability": 0.022328101098537445
        },
        {
            "start_logit": 5.993344306945801,
            "end_logit": 4.362905979156494,
            "text": "Small mutations were identified in 105 cases (18.2%), most being nonsense/frameshift",
            "probability": 0.020582718774676323
        },
        {
            "start_logit": 5.506034851074219,
            "end_logit": 4.762213230133057,
            "text": "Mutations in splice sites",
            "probability": 0.018848787993192673
        },
        {
            "start_logit": 6.173972129821777,
            "end_logit": 3.534273624420166,
            "text": "exonic deletions, 64 (11.1%) were exonic duplication",
            "probability": 0.010766583494842052
        },
        {
            "start_logit": 5.860105037689209,
            "end_logit": 3.534273624420166,
            "text": "exonic duplication",
            "probability": 0.007866235449910164
        },
        {
            "start_logit": 5.860105037689209,
            "end_logit": 2.8431739807128906,
            "text": "exonic duplications, and one was a deletion/duplication complex rearrangement (0.2%)",
            "probability": 0.00394118158146739
        },
        {
            "start_logit": 5.850976943969727,
            "end_logit": 2.8431739807128906,
            "text": "deletion/duplication complex rearrangement (0.2%)",
            "probability": 0.0039053678046911955
        }
    ],
    "64162fb0690f196b5100001a_0003": [
        {
            "start_logit": 4.05470085144043,
            "end_logit": 3.1760735511779785,
            "text": "gene duplication",
            "probability": 0.26303744316101074
        },
        {
            "start_logit": 3.8803553581237793,
            "end_logit": 3.1760735511779785,
            "text": "gene deletion rate was 54.3% (391/720), and gene duplication",
            "probability": 0.22095319628715515
        },
        {
            "start_logit": 3.8803553581237793,
            "end_logit": 3.148716926574707,
            "text": "gene deletion",
            "probability": 0.21499060094356537
        },
        {
            "start_logit": 3.8803553581237793,
            "end_logit": 2.1376054286956787,
            "text": "gene deletion rate was 54.3%",
            "probability": 0.07821664959192276
        },
        {
            "start_logit": 1.9778671264648438,
            "end_logit": 3.1760735511779785,
            "text": "deletion rate was 54.3% (391/720), and gene duplication",
            "probability": 0.032965537160634995
        },
        {
            "start_logit": 1.9778671264648438,
            "end_logit": 3.148716926574707,
            "text": "deletion",
            "probability": 0.03207593411207199
        },
        {
            "start_logit": 4.05470085144043,
            "end_logit": 0.8894597887992859,
            "text": "gene duplication rate was 10.6%",
            "probability": 0.02672721818089485
        },
        {
            "start_logit": 3.8803553581237793,
            "end_logit": 0.8894597887992859,
            "text": "gene deletion rate was 54.3% (391/720), and gene duplication rate was 10.6%",
            "probability": 0.022451039403676987
        },
        {
            "start_logit": 4.05470085144043,
            "end_logit": 0.5471731424331665,
            "text": "gene duplication rate",
            "probability": 0.01898019202053547
        },
        {
            "start_logit": 3.8803553581237793,
            "end_logit": 0.651139497756958,
            "text": "gene deletion rate",
            "probability": 0.01769031211733818
        },
        {
            "start_logit": 3.8803553581237793,
            "end_logit": 0.5471731424331665,
            "text": "gene deletion rate was 54.3% (391/720), and gene duplication rate",
            "probability": 0.015943486243486404
        },
        {
            "start_logit": 4.05470085144043,
            "end_logit": 0.2712838053703308,
            "text": "gene duplication rate was 10.6% (76/720)",
            "probability": 0.014404007233679295
        },
        {
            "start_logit": 1.9778671264648438,
            "end_logit": 2.1376054286956787,
            "text": "deletion rate was 54.3%",
            "probability": 0.011669687926769257
        },
        {
            "start_logit": 0.5965202450752258,
            "end_logit": 3.1760735511779785,
            "text": "duplication",
            "probability": 0.008282259106636047
        },
        {
            "start_logit": 3.8803553581237793,
            "end_logit": -0.47591644525527954,
            "text": "gene deletion rate was 54.3% (391/720)",
            "probability": 0.0057314070872962475
        },
        {
            "start_logit": 0.19602981209754944,
            "end_logit": 3.1760735511779785,
            "text": "54.3% (391/720), and gene duplication",
            "probability": 0.005549042951315641
        },
        {
            "start_logit": 1.9778671264648438,
            "end_logit": 0.8894597887992859,
            "text": "deletion rate was 54.3% (391/720), and gene duplication rate was 10.6%",
            "probability": 0.0033496273681521416
        },
        {
            "start_logit": 1.9778671264648438,
            "end_logit": 0.651139497756958,
            "text": "deletion rate",
            "probability": 0.0026393397711217403
        },
        {
            "start_logit": 1.9778671264648438,
            "end_logit": 0.5471731424331665,
            "text": "deletion rate was 54.3% (391/720), and gene duplication rate",
            "probability": 0.002378718927502632
        },
        {
            "start_logit": 0.19602981209754944,
            "end_logit": 2.1376054286956787,
            "text": "54.3%",
            "probability": 0.001964341849088669
        }
    ],
    "64162fb0690f196b5100001a_0004": [
        {
            "start_logit": 5.681460380554199,
            "end_logit": 4.646107196807861,
            "text": "deletion mutant",
            "probability": 0.6570361852645874
        },
        {
            "start_logit": 5.681460380554199,
            "end_logit": 3.156613349914551,
            "text": "deletion",
            "probability": 0.1481529027223587
        },
        {
            "start_logit": 4.918763160705566,
            "end_logit": 3.9110100269317627,
            "text": "gene duplication",
            "probability": 0.14692819118499756
        },
        {
            "start_logit": 5.681460380554199,
            "end_logit": 1.2051975727081299,
            "text": "deletion mutant occurred in Exon 45-54 was 71.9% (281/391) in all gene deletion",
            "probability": 0.021048489958047867
        },
        {
            "start_logit": 5.681460380554199,
            "end_logit": -0.320055216550827,
            "text": "deletion mutant occurred in Exon 45-54",
            "probability": 0.004579438827931881
        },
        {
            "start_logit": 5.681460380554199,
            "end_logit": -0.34065282344818115,
            "text": "deletion mutant occurred in Exon 45-54 was 71.9%",
            "probability": 0.004486076533794403
        },
        {
            "start_logit": 4.918763160705566,
            "end_logit": 0.33192765712738037,
            "text": "gene duplication occurred in Exon 1-40 was 82.9% (63/76) in all gene duplication",
            "probability": 0.004099487327039242
        },
        {
            "start_logit": 1.074112057685852,
            "end_logit": 3.9110100269317627,
            "text": "gene deletion patients; meanwhile, the rate of gene duplication",
            "probability": 0.0031433631666004658
        },
        {
            "start_logit": 5.681460380554199,
            "end_logit": -0.7947637438774109,
            "text": "deletion mutant occurred in Exon 45-54 was 71.9% (281/391) in all gene deletion patients",
            "probability": 0.002848714357241988
        },
        {
            "start_logit": 5.681460380554199,
            "end_logit": -1.832172155380249,
            "text": "deletion mutant occurred in Exon 45-54 was 71.9% (281/391) in all gene",
            "probability": 0.0010095039615407586
        },
        {
            "start_logit": 5.681460380554199,
            "end_logit": -1.8708083629608154,
            "text": "deletion mutant occurred in Exon 45-54 was 71.9% (281/391)",
            "probability": 0.0009712442988529801
        },
        {
            "start_logit": 5.681460380554199,
            "end_logit": -1.9466466903686523,
            "text": "del",
            "probability": 0.0009003108134493232
        },
        {
            "start_logit": 4.918763160705566,
            "end_logit": -1.2115278244018555,
            "text": "gene duplication occurred in Exon 1-40",
            "probability": 0.0008758209296502173
        },
        {
            "start_logit": 5.681460380554199,
            "end_logit": -2.1263046264648438,
            "text": "deletion mutant occurred",
            "probability": 0.0007522600353695452
        },
        {
            "start_logit": -0.47622960805892944,
            "end_logit": 3.9110100269317627,
            "text": "71.9% (281/391) in all gene deletion patients; meanwhile, the rate of gene duplication",
            "probability": 0.0006669442518614233
        },
        {
            "start_logit": 5.681460380554199,
            "end_logit": -2.329545021057129,
            "text": "deletion mutant occurred in Exon 45-54 was 71.9% (281/391) in all gene deletion patients;",
            "probability": 0.00061390595510602
        },
        {
            "start_logit": 4.918763160705566,
            "end_logit": -1.6508156061172485,
            "text": "gene duplication occurred in Exon 1-40 was 82.9%",
            "probability": 0.0005644625634886324
        },
        {
            "start_logit": 5.681460380554199,
            "end_logit": -2.4253745079040527,
            "text": "deleti",
            "probability": 0.0005578065756708384
        },
        {
            "start_logit": 4.918763160705566,
            "end_logit": -1.6681249141693115,
            "text": "gene duplication occurred in Exon 1-40 was 82.9% (63/76) in all gene duplication ones.",
            "probability": 0.0005547759938053787
        },
        {
            "start_logit": 1.074112057685852,
            "end_logit": 1.2051975727081299,
            "text": "gene deletion",
            "probability": 0.00021002710855100304
        }
    ],
    "64162fb0690f196b5100001a_0005": [
        {
            "start_logit": 5.807859420776367,
            "end_logit": 5.511174201965332,
            "text": "DMD and IMD",
            "probability": 0.1182599663734436
        },
        {
            "start_logit": 5.807859420776367,
            "end_logit": 5.491614818572998,
            "text": "DMD",
            "probability": 0.11596941202878952
        },
        {
            "start_logit": 5.9357099533081055,
            "end_logit": 5.347966194152832,
            "text": "BMD",
            "probability": 0.11415165662765503
        },
        {
            "start_logit": 5.807859420776367,
            "end_logit": 5.347966194152832,
            "text": "DMD and IMD was 90.6% (423/467), and BMD",
            "probability": 0.10045173019170761
        },
        {
            "start_logit": 5.4480366706848145,
            "end_logit": 5.511174201965332,
            "text": "IMD",
            "probability": 0.08252184092998505
        },
        {
            "start_logit": 5.4480366706848145,
            "end_logit": 5.347966194152832,
            "text": "IMD was 90.6% (423/467), and BMD",
            "probability": 0.0700952559709549
        },
        {
            "start_logit": 4.821780681610107,
            "end_logit": 5.511174201965332,
            "text": "deletion and duplication, the rate of DMD and IMD",
            "probability": 0.044115278869867325
        },
        {
            "start_logit": 4.821780681610107,
            "end_logit": 5.491614818572998,
            "text": "deletion and duplication, the rate of DMD",
            "probability": 0.043260809034109116
        },
        {
            "start_logit": 4.775283336639404,
            "end_logit": 5.511174201965332,
            "text": "gene deletion and duplication, the rate of DMD and IMD",
            "probability": 0.04211098700761795
        },
        {
            "start_logit": 4.775283336639404,
            "end_logit": 5.491614818572998,
            "text": "gene deletion and duplication, the rate of DMD",
            "probability": 0.04129534959793091
        },
        {
            "start_logit": 4.5742669105529785,
            "end_logit": 5.511174201965332,
            "text": "duplication, the rate of DMD and IMD",
            "probability": 0.03444257006049156
        },
        {
            "start_logit": 4.5742669105529785,
            "end_logit": 5.491614818572998,
            "text": "duplication, the rate of DMD",
            "probability": 0.03377541899681091
        },
        {
            "start_logit": 4.5742669105529785,
            "end_logit": 5.347966194152832,
            "text": "duplication, the rate of DMD and IMD was 90.6% (423/467), and BMD",
            "probability": 0.02925601601600647
        },
        {
            "start_logit": 4.821780681610107,
            "end_logit": 5.088744640350342,
            "text": "deletion",
            "probability": 0.02891547791659832
        },
        {
            "start_logit": 4.775283336639404,
            "end_logit": 5.088744640350342,
            "text": "gene deletion",
            "probability": 0.027601763606071472
        },
        {
            "start_logit": 4.821780681610107,
            "end_logit": 4.993434429168701,
            "text": "deletion and duplication",
            "probability": 0.026286795735359192
        },
        {
            "start_logit": 4.775283336639404,
            "end_logit": 4.993434429168701,
            "text": "gene deletion and duplication",
            "probability": 0.025092510506510735
        },
        {
            "start_logit": 4.5742669105529785,
            "end_logit": 4.993434429168701,
            "text": "duplication",
            "probability": 0.02052314020693302
        },
        {
            "start_logit": 1.4070262908935547,
            "end_logit": 5.347966194152832,
            "text": "90.6% (423/467), and BMD",
            "probability": 0.0012322529219090939
        },
        {
            "start_logit": 5.807859420776367,
            "end_logit": 0.2946513593196869,
            "text": "DMD and IMD was 90.6%",
            "probability": 0.0006416980177164078
        }
    ],
    "64162fb0690f196b5100001a_0006": [
        {
            "start_logit": 5.92138147354126,
            "end_logit": 5.706860542297363,
            "text": "point mutations",
            "probability": 0.13828714191913605
        },
        {
            "start_logit": 5.877699851989746,
            "end_logit": 5.706860542297363,
            "text": "deletions, about 7% duplications, about 26% point mutations",
            "probability": 0.1323765069246292
        },
        {
            "start_logit": 5.877699851989746,
            "end_logit": 5.489188194274902,
            "text": "deletions",
            "probability": 0.10648220777511597
        },
        {
            "start_logit": 5.877699851989746,
            "end_logit": 5.450681686401367,
            "text": "deletions, about 7% duplications",
            "probability": 0.1024598777294159
        },
        {
            "start_logit": 5.92138147354126,
            "end_logit": 5.36232852935791,
            "text": "point mutations and about 2% unknown mutations",
            "probability": 0.09798360615968704
        },
        {
            "start_logit": 5.877699851989746,
            "end_logit": 5.36232852935791,
            "text": "deletions, about 7% duplications, about 26% point mutations and about 2% unknown mutations",
            "probability": 0.09379562735557556
        },
        {
            "start_logit": 5.343229293823242,
            "end_logit": 5.706860542297363,
            "text": "duplications, about 26% point mutations",
            "probability": 0.07756991684436798
        },
        {
            "start_logit": 5.343229293823242,
            "end_logit": 5.450681686401367,
            "text": "duplications",
            "probability": 0.06003938615322113
        },
        {
            "start_logit": 5.375950813293457,
            "end_logit": 5.36232852935791,
            "text": "unknown mutations",
            "probability": 0.05679050460457802
        },
        {
            "start_logit": 5.343229293823242,
            "end_logit": 5.36232852935791,
            "text": "duplications, about 26% point mutations and about 2% unknown mutations",
            "probability": 0.05496230721473694
        },
        {
            "start_logit": 3.6389997005462646,
            "end_logit": 5.706860542297363,
            "text": "26% point mutations",
            "probability": 0.014110938645899296
        },
        {
            "start_logit": 3.328402042388916,
            "end_logit": 5.706860542297363,
            "text": "7% duplications, about 26% point mutations",
            "probability": 0.010343443602323532
        },
        {
            "start_logit": 3.6389997005462646,
            "end_logit": 5.36232852935791,
            "text": "26% point mutations and about 2% unknown mutations",
            "probability": 0.009998331777751446
        },
        {
            "start_logit": 3.328402042388916,
            "end_logit": 5.450681686401367,
            "text": "7% duplications",
            "probability": 0.008005854673683643
        },
        {
            "start_logit": 3.047957420349121,
            "end_logit": 5.706860542297363,
            "text": "65% deletions, about 7% duplications, about 26% point mutations",
            "probability": 0.00781392864882946
        },
        {
            "start_logit": 3.328402042388916,
            "end_logit": 5.36232852935791,
            "text": "7% duplications, about 26% point mutations and about 2% unknown mutations",
            "probability": 0.007328866049647331
        },
        {
            "start_logit": 3.047957420349121,
            "end_logit": 5.489188194274902,
            "text": "65% deletions",
            "probability": 0.006285436917096376
        },
        {
            "start_logit": 3.047957420349121,
            "end_logit": 5.450681686401367,
            "text": "65% deletions, about 7% duplications",
            "probability": 0.006048007868230343
        },
        {
            "start_logit": 3.047957420349121,
            "end_logit": 5.36232852935791,
            "text": "65% deletions, about 7% duplications, about 26% point mutations and about 2% unknown mutations",
            "probability": 0.0055365730077028275
        },
        {
            "start_logit": 5.92138147354126,
            "end_logit": 2.107656955718994,
            "text": "point mutations and about 2% unknown mutations)",
            "probability": 0.0037815282121300697
        }
    ],
    "63eef3ebf36125a42600000a_0001": [
        {
            "start_logit": 8.114133834838867,
            "end_logit": 8.204361915588379,
            "text": "BDCA2",
            "probability": 0.999414324760437
        },
        {
            "start_logit": 8.114133834838867,
            "end_logit": -0.03744560480117798,
            "text": "BDCA2 Antibody Litifilimab for Cutaneous Lupus Erythematosus",
            "probability": 0.00026325308135710657
        },
        {
            "start_logit": 8.114133834838867,
            "end_logit": -0.5976765751838684,
            "text": "BDCA2 Antibody Litifilimab for Cutaneous Lupus Erythematosus.",
            "probability": 0.00015033777162898332
        },
        {
            "start_logit": 8.114133834838867,
            "end_logit": -1.3696868419647217,
            "text": "B",
            "probability": 6.946859502932057e-05
        },
        {
            "start_logit": -2.0599589347839355,
            "end_logit": 8.204361915588379,
            "text": "2",
            "probability": 3.812351860688068e-05
        },
        {
            "start_logit": 8.114133834838867,
            "end_logit": -2.471090316772461,
            "text": "BDCA2 Antibody",
            "probability": 2.3091659386409447e-05
        },
        {
            "start_logit": 8.114133834838867,
            "end_logit": -3.264718532562256,
            "text": "BDCA2 Antibody Litifilimab for Cutaneous Lupus",
            "probability": 1.0442069651617203e-05
        },
        {
            "start_logit": -4.021468639373779,
            "end_logit": 8.204361915588379,
            "text": "DCA2",
            "probability": 5.361918283597333e-06
        },
        {
            "start_logit": 8.114133834838867,
            "end_logit": -4.14021635055542,
            "text": "BDCA2 Antibody Litifilimab for Cutaneous Lup",
            "probability": 4.350735707703279e-06
        },
        {
            "start_logit": -4.366430282592773,
            "end_logit": 8.204361915588379,
            "text": "Anti-BDCA2",
            "probability": 3.7975630675646244e-06
        },
        {
            "start_logit": 8.114133834838867,
            "end_logit": -4.413905143737793,
            "text": "BDCA2 Antibody Litifilimab for Cutaneous Lupus Eryt",
            "probability": 3.30903526446491e-06
        },
        {
            "start_logit": -4.506747722625732,
            "end_logit": 8.204361915588379,
            "text": "CA2",
            "probability": 3.300396883787471e-06
        },
        {
            "start_logit": 8.114133834838867,
            "end_logit": -4.508763313293457,
            "text": "BDCA2 Antibody Litifilimab for Cutaneous Lupus Erythemato",
            "probability": 3.009573674717103e-06
        },
        {
            "start_logit": 8.114133834838867,
            "end_logit": -4.771273612976074,
            "text": "BDCA2 Antibody Litifilimab for Cutaneous Lupus Erythem",
            "probability": 2.314718813067884e-06
        },
        {
            "start_logit": 8.114133834838867,
            "end_logit": -5.113674640655518,
            "text": "BDCA2 Antibody Litifilimab for Cutaneous",
            "probability": 1.6435978977824561e-06
        },
        {
            "start_logit": 8.114133834838867,
            "end_logit": -5.36630392074585,
            "text": "BDCA2 Antibody Litifilimab for Cutaneous Lupus Er",
            "probability": 1.2766730606017518e-06
        },
        {
            "start_logit": 8.114133834838867,
            "end_logit": -5.375980854034424,
            "text": "BDCA",
            "probability": 1.2643794207178871e-06
        },
        {
            "start_logit": 8.114133834838867,
            "end_logit": -5.932584762573242,
            "text": "BDCA2 Antibody Litifilimab",
            "probability": 7.246815698636055e-07
        },
        {
            "start_logit": -6.729168891906738,
            "end_logit": 8.204361915588379,
            "text": "-BDCA2",
            "probability": 3.575861455828999e-07
        },
        {
            "start_logit": -7.054830074310303,
            "end_logit": 8.204361915588379,
            "text": "Trial of Anti-BDCA2",
            "probability": 2.5819511506597337e-07
        }
    ],
    "63eef3ebf36125a42600000a_0002": [
        {
            "start_logit": 7.052419185638428,
            "end_logit": 7.916204929351807,
            "text": "BDCA2",
            "probability": 0.9997929930686951
        },
        {
            "start_logit": -2.4873504638671875,
            "end_logit": 7.916204929351807,
            "text": "2",
            "probability": 7.191848999354988e-05
        },
        {
            "start_logit": 7.052419185638428,
            "end_logit": -2.334820508956909,
            "text": "BDCA2, would be efficacious in reducing disease activity in patients with cutaneous lupus erythematosus",
            "probability": 3.531395850586705e-05
        },
        {
            "start_logit": 7.052419185638428,
            "end_logit": -2.7377448081970215,
            "text": "B",
            "probability": 2.3602526198374107e-05
        },
        {
            "start_logit": -3.6027379035949707,
            "end_logit": 7.916204929351807,
            "text": "CA2",
            "probability": 2.357404628128279e-05
        },
        {
            "start_logit": -4.308955669403076,
            "end_logit": 7.916204929351807,
            "text": "DCA2",
            "probability": 1.1633961548795924e-05
        },
        {
            "start_logit": -4.753390312194824,
            "end_logit": 7.916204929351807,
            "text": "monoclonal antibody against BDCA2",
            "probability": 7.459545486199204e-06
        },
        {
            "start_logit": 7.052419185638428,
            "end_logit": -4.426316261291504,
            "text": "BDCA",
            "probability": 4.361350420367671e-06
        },
        {
            "start_logit": 7.052419185638428,
            "end_logit": -4.439781188964844,
            "text": "BDCA2, would be efficacious in reducing disease activity in patients with cutaneous lup",
            "probability": 4.303023160900921e-06
        },
        {
            "start_logit": -5.3150434494018555,
            "end_logit": 7.916204929351807,
            "text": "litifilimab, a humanized monoclonal antibody against BDCA2",
            "probability": 4.253921815688955e-06
        },
        {
            "start_logit": 7.052419185638428,
            "end_logit": -4.650674343109131,
            "text": "BDCA2, would be efficacious in reducing disease activity in patients with cutaneous lupus",
            "probability": 3.4848474115278805e-06
        },
        {
            "start_logit": -5.701343536376953,
            "end_logit": 7.916204929351807,
            "text": "humanized monoclonal antibody against BDCA2",
            "probability": 2.8908202693855856e-06
        },
        {
            "start_logit": 7.052419185638428,
            "end_logit": -4.954461097717285,
            "text": "BDCA2, would be efficacious in reducing disease activity in patients with cutaneous lupus eryt",
            "probability": 2.5718798042362323e-06
        },
        {
            "start_logit": 7.052419185638428,
            "end_logit": -5.13454532623291,
            "text": "BDCA2, would be efficacious in reducing disease activity in patients with cutaneous lupus erythemato",
            "probability": 2.1480336727108806e-06
        },
        {
            "start_logit": 7.052419185638428,
            "end_logit": -5.267273902893066,
            "text": "BDCA2, would be efficacious in reducing disease activity",
            "probability": 1.881038656392775e-06
        },
        {
            "start_logit": 7.052419185638428,
            "end_logit": -5.358273983001709,
            "text": "BD",
            "probability": 1.7174223785332288e-06
        },
        {
            "start_logit": -6.26456880569458,
            "end_logit": 7.916204929351807,
            "text": "Whether treatment with litifilimab, a humanized monoclonal antibody against BDCA2",
            "probability": 1.6459463267892716e-06
        },
        {
            "start_logit": 7.052419185638428,
            "end_logit": -5.452639102935791,
            "text": "BDCA2, would be efficacious in reducing disease activity in patients with cutaneous lupus erythem",
            "probability": 1.5627693983333302e-06
        },
        {
            "start_logit": 7.052419185638428,
            "end_logit": -5.500532150268555,
            "text": "BDCA2, would be efficacious in reducing disease activity in patients with cutaneous",
            "probability": 1.4896883158144192e-06
        },
        {
            "start_logit": -6.534969806671143,
            "end_logit": 7.916204929351807,
            "text": "treatment with litifilimab, a humanized monoclonal antibody against BDCA2",
            "probability": 1.2559779634102597e-06
        }
    ],
    "63eef3ebf36125a42600000a_0003": [
        {
            "start_logit": 8.135600090026855,
            "end_logit": 8.207880020141602,
            "text": "BDCA2",
            "probability": 0.9995686411857605
        },
        {
            "start_logit": 8.135600090026855,
            "end_logit": -0.6109828352928162,
            "text": "BDCA2 Antibody Litifilimab for Systemic Lupus Erythematosus.",
            "probability": 0.0001478527847211808
        },
        {
            "start_logit": 8.135600090026855,
            "end_logit": -0.8545889854431152,
            "text": "BDCA2 Antibody Litifilimab for Systemic Lupus Erythematosus",
            "probability": 0.0001158865270554088
        },
        {
            "start_logit": 8.135600090026855,
            "end_logit": -1.329780101776123,
            "text": "B",
            "probability": 7.205432484624907e-05
        },
        {
            "start_logit": -2.061448574066162,
            "end_logit": 8.207880020141602,
            "text": "2",
            "probability": 3.7264118873281404e-05
        },
        {
            "start_logit": 8.135600090026855,
            "end_logit": -2.409724235534668,
            "text": "BDCA2 Antibody",
            "probability": 2.4470682546962053e-05
        },
        {
            "start_logit": 8.135600090026855,
            "end_logit": -3.6999166011810303,
            "text": "BDCA2 Antibody Litifilimab for Systemic Lupus",
            "probability": 6.734766884619603e-06
        },
        {
            "start_logit": -4.059420108795166,
            "end_logit": 8.207880020141602,
            "text": "DCA2",
            "probability": 5.053395398135763e-06
        },
        {
            "start_logit": 8.135600090026855,
            "end_logit": -4.152220726013184,
            "text": "BDCA2 Antibody Litifilimab for Systemic Lup",
            "probability": 4.284394435671857e-06
        },
        {
            "start_logit": -4.306389808654785,
            "end_logit": 8.207880020141602,
            "text": "Anti-BDCA2",
            "probability": 3.94753078580834e-06
        },
        {
            "start_logit": -4.615170955657959,
            "end_logit": 8.207880020141602,
            "text": "CA2",
            "probability": 2.898833827202907e-06
        },
        {
            "start_logit": 8.135600090026855,
            "end_logit": -4.596277236938477,
            "text": "BDCA2 Antibody Litifilimab for Systemic Lupus Eryt",
            "probability": 2.748135784713668e-06
        },
        {
            "start_logit": 8.135600090026855,
            "end_logit": -4.702252388000488,
            "text": "BDCA2 Antibody Litifilimab for Systemic Lupus Erythemato",
            "probability": 2.4718026452319464e-06
        },
        {
            "start_logit": 8.135600090026855,
            "end_logit": -4.953193664550781,
            "text": "BDCA2 Antibody Litifilimab for Systemic Lupus Erythem",
            "probability": 1.9232306840422098e-06
        },
        {
            "start_logit": 8.135600090026855,
            "end_logit": -5.339569091796875,
            "text": "BDCA",
            "probability": 1.306864646721806e-06
        },
        {
            "start_logit": 8.135600090026855,
            "end_logit": -5.578460216522217,
            "text": "BDCA2 Antibody Litifilimab for Systemic Lupus Er",
            "probability": 1.0291572607457056e-06
        },
        {
            "start_logit": 8.135600090026855,
            "end_logit": -5.917154312133789,
            "text": "BDCA2 Antibody Litifilimab",
            "probability": 7.334804763559077e-07
        },
        {
            "start_logit": -6.760860919952393,
            "end_logit": 8.207880020141602,
            "text": "-BDCA2",
            "probability": 3.3912704111571657e-07
        },
        {
            "start_logit": -7.109764099121094,
            "end_logit": 8.207880020141602,
            "text": "Trial of Anti-BDCA2",
            "probability": 2.3924096126393124e-07
        },
        {
            "start_logit": -2.061448574066162,
            "end_logit": -0.6109828352928162,
            "text": "2 Antibody Litifilimab for Systemic Lupus Erythematosus.",
            "probability": 5.511976208794067e-09
        }
    ],
    "63eef3ebf36125a42600000a_0004": [
        {
            "start_logit": 7.011911392211914,
            "end_logit": 7.945633888244629,
            "text": "BDCA2",
            "probability": 0.9997031092643738
        },
        {
            "start_logit": -2.2999558448791504,
            "end_logit": 7.945633888244629,
            "text": "CA2",
            "probability": 9.031891386257485e-05
        },
        {
            "start_logit": -2.338275909423828,
            "end_logit": 7.945633888244629,
            "text": "2",
            "probability": 8.69233044795692e-05
        },
        {
            "start_logit": 7.011911392211914,
            "end_logit": -2.539759635925293,
            "text": "BDCA2, in patients with SLE have not been extensively studied.",
            "probability": 2.7933316232520156e-05
        },
        {
            "start_logit": -3.499124765396118,
            "end_logit": 7.945633888244629,
            "text": "DCA2",
            "probability": 2.7226144084124826e-05
        },
        {
            "start_logit": 7.011911392211914,
            "end_logit": -2.8058061599731445,
            "text": "B",
            "probability": 2.1408190150395967e-05
        },
        {
            "start_logit": 7.011911392211914,
            "end_logit": -3.861837863922119,
            "text": "BDCA2, in patients with SLE",
            "probability": 7.446479685313534e-06
        },
        {
            "start_logit": -5.081275939941406,
            "end_logit": 7.945633888244629,
            "text": "The safety and efficacy of subcutaneous litifilimab, a humanized monoclonal antibody that binds to BDCA2",
            "probability": 5.595855782303261e-06
        },
        {
            "start_logit": -5.125471115112305,
            "end_logit": 7.945633888244629,
            "text": "litifilimab, a humanized monoclonal antibody that binds to BDCA2",
            "probability": 5.353931555873714e-06
        },
        {
            "start_logit": -5.405506610870361,
            "end_logit": 7.945633888244629,
            "text": "monoclonal antibody that binds to BDCA2",
            "probability": 4.046272806590423e-06
        },
        {
            "start_logit": 7.011911392211914,
            "end_logit": -4.482268333435059,
            "text": "BDCA",
            "probability": 4.004069978691405e-06
        },
        {
            "start_logit": -5.479894638061523,
            "end_logit": 7.945633888244629,
            "text": "humanized monoclonal antibody that binds to BDCA2",
            "probability": 3.756199021154316e-06
        },
        {
            "start_logit": -5.606684684753418,
            "end_logit": 7.945633888244629,
            "text": "subcutaneous litifilimab, a humanized monoclonal antibody that binds to BDCA2",
            "probability": 3.308905888843583e-06
        },
        {
            "start_logit": -5.77847957611084,
            "end_logit": 7.945633888244629,
            "text": "binds to BDCA2",
            "probability": 2.7866012715094257e-06
        },
        {
            "start_logit": 7.011911392211914,
            "end_logit": -5.287205696105957,
            "text": "BD",
            "probability": 1.7902835907079861e-06
        },
        {
            "start_logit": 7.011911392211914,
            "end_logit": -5.434617042541504,
            "text": "BDCA2,",
            "probability": 1.5449055581484572e-06
        },
        {
            "start_logit": -6.8014373779296875,
            "end_logit": 7.945633888244629,
            "text": "oclonal antibody that binds to BDCA2",
            "probability": 1.001866621663794e-06
        },
        {
            "start_logit": -6.89152717590332,
            "end_logit": 7.945633888244629,
            "text": "cutaneous litifilimab, a humanized monoclonal antibody that binds to BDCA2",
            "probability": 9.155549491879356e-07
        },
        {
            "start_logit": -7.079646587371826,
            "end_logit": 7.945633888244629,
            "text": "ilimab, a humanized monoclonal antibody that binds to BDCA2",
            "probability": 7.58551323087886e-07
        },
        {
            "start_logit": -7.110574722290039,
            "end_logit": 7.945633888244629,
            "text": "a humanized monoclonal antibody that binds to BDCA2",
            "probability": 7.354502145062725e-07
        }
    ],
    "64136fbf201352f04a00003d_0001": [
        {
            "start_logit": 3.033170461654663,
            "end_logit": 1.8057658672332764,
            "text": "area under the receiver operator characteristics curve (area under the receiver operating characteristic curve)",
            "probability": 0.5791172385215759
        },
        {
            "start_logit": 3.033170461654663,
            "end_logit": 1.3041961193084717,
            "text": "area under the receiver operator characteristics curve",
            "probability": 0.3507014214992523
        },
        {
            "start_logit": 3.033170461654663,
            "end_logit": -1.450589656829834,
            "text": "area under the receiver operator characteristics curve (area under the receiver operating characteristic curve",
            "probability": 0.022312551736831665
        },
        {
            "start_logit": -0.746035635471344,
            "end_logit": 1.8057658672332764,
            "text": "The area under the receiver operator characteristics curve (area under the receiver operating characteristic curve)",
            "probability": 0.013227511197328568
        },
        {
            "start_logit": 3.033170461654663,
            "end_logit": -2.400019645690918,
            "text": "area under the receiver operator characteristics",
            "probability": 0.008634097874164581
        },
        {
            "start_logit": -0.746035635471344,
            "end_logit": 1.3041961193084717,
            "text": "The area under the receiver operator characteristics curve",
            "probability": 0.00801030546426773
        },
        {
            "start_logit": -1.8835923671722412,
            "end_logit": 1.8057658672332764,
            "text": "receiver operator characteristics curve (area under the receiver operating characteristic curve)",
            "probability": 0.004240758251398802
        },
        {
            "start_logit": 3.033170461654663,
            "end_logit": -3.268268585205078,
            "text": "area under the receiver operator characteristics curve (area under the receiver operating characteristic",
            "probability": 0.003623607801273465
        },
        {
            "start_logit": 3.033170461654663,
            "end_logit": -3.3894121646881104,
            "text": "area under the receiver operator characteristics curve (",
            "probability": 0.0032101795077323914
        },
        {
            "start_logit": -1.8835923671722412,
            "end_logit": 1.3041961193084717,
            "text": "receiver operator characteristics curve",
            "probability": 0.0025681154802441597
        },
        {
            "start_logit": -3.0667078495025635,
            "end_logit": 1.8057658672332764,
            "text": "area under the receiver operating characteristic curve)",
            "probability": 0.0012990414397791028
        },
        {
            "start_logit": 3.033170461654663,
            "end_logit": -4.621773719787598,
            "text": "area under",
            "probability": 0.000936098222155124
        },
        {
            "start_logit": -0.746035635471344,
            "end_logit": -1.450589656829834,
            "text": "The area under the receiver operator characteristics curve (area under the receiver operating characteristic curve",
            "probability": 0.0005096369422972202
        },
        {
            "start_logit": 3.033170461654663,
            "end_logit": -5.45245885848999,
            "text": "area under the receiver operator",
            "probability": 0.00040790557977743447
        },
        {
            "start_logit": 3.033170461654663,
            "end_logit": -5.7918829917907715,
            "text": "area",
            "probability": 0.0002905023575294763
        },
        {
            "start_logit": 3.033170461654663,
            "end_logit": -5.977030277252197,
            "text": "area under the receiver operator characteristics curve (area under the receiver operating",
            "probability": 0.00024140215828083456
        },
        {
            "start_logit": -0.746035635471344,
            "end_logit": -2.400019645690918,
            "text": "The area under the receiver operator characteristics",
            "probability": 0.00019720989803317934
        },
        {
            "start_logit": 3.033170461654663,
            "end_logit": -6.2661333084106445,
            "text": "area under the receiver operator characteristics curve (area under",
            "probability": 0.00018079446454066783
        },
        {
            "start_logit": -1.8835923671722412,
            "end_logit": -1.450589656829834,
            "text": "receiver operator characteristics curve (area under the receiver operating characteristic curve",
            "probability": 0.00016339027206413448
        },
        {
            "start_logit": -5.3825602531433105,
            "end_logit": 1.8057658672332764,
            "text": ". The area under the receiver operator characteristics curve (area under the receiver operating characteristic curve)",
            "probability": 0.0001281920849578455
        }
    ],
    "64136fbf201352f04a00003d_0002": [
        {
            "start_logit": 3.539175271987915,
            "end_logit": 1.367487907409668,
            "text": "area under receiver operator curve",
            "probability": 0.4751197099685669
        },
        {
            "start_logit": 3.539175271987915,
            "end_logit": 1.3021371364593506,
            "text": "area under receiver operator curve [area under the receiver operating characteristic curve]",
            "probability": 0.44506320357322693
        },
        {
            "start_logit": 3.539175271987915,
            "end_logit": -0.8351653218269348,
            "text": "area under receiver operator curve [area under the receiver operating characteristic curve",
            "probability": 0.052505288273096085
        },
        {
            "start_logit": 3.539175271987915,
            "end_logit": -2.8858349323272705,
            "text": "area under receiver operator curve [area under the receiver operating characteristic",
            "probability": 0.006754738278687
        },
        {
            "start_logit": 3.539175271987915,
            "end_logit": -3.040722370147705,
            "text": "area under receiver operator curve [",
            "probability": 0.005785512737929821
        },
        {
            "start_logit": -1.3393421173095703,
            "end_logit": 1.367487907409668,
            "text": "receiver operator curve",
            "probability": 0.003614847082644701
        },
        {
            "start_logit": -1.3393421173095703,
            "end_logit": 1.3021371364593506,
            "text": "receiver operator curve [area under the receiver operating characteristic curve]",
            "probability": 0.0033861687406897545
        },
        {
            "start_logit": -1.600089192390442,
            "end_logit": 1.3021371364593506,
            "text": "area under the receiver operating characteristic curve]",
            "probability": 0.0026089597959071398
        },
        {
            "start_logit": 3.539175271987915,
            "end_logit": -4.045860290527344,
            "text": "area under",
            "probability": 0.0021174626890569925
        },
        {
            "start_logit": 3.539175271987915,
            "end_logit": -4.946770191192627,
            "text": "area under receiver operator",
            "probability": 0.0008601134759373963
        },
        {
            "start_logit": 3.539175271987915,
            "end_logit": -5.5498762130737305,
            "text": "area",
            "probability": 0.0004705762548837811
        },
        {
            "start_logit": 3.539175271987915,
            "end_logit": -5.659888744354248,
            "text": "area under receiver operator curve [area under the receiver operating",
            "probability": 0.0004215531807858497
        },
        {
            "start_logit": -1.3393421173095703,
            "end_logit": -0.8351653218269348,
            "text": "receiver operator curve [area under the receiver operating characteristic curve",
            "probability": 0.00039947530603967607
        },
        {
            "start_logit": -1.600089192390442,
            "end_logit": -0.8351653218269348,
            "text": "area under the receiver operating characteristic curve",
            "probability": 0.00030778595828451216
        },
        {
            "start_logit": 3.539175271987915,
            "end_logit": -6.361349582672119,
            "text": "area under receiver operator curve [area under",
            "probability": 0.00020903151016682386
        },
        {
            "start_logit": 3.539175271987915,
            "end_logit": -6.444303035736084,
            "text": "area under receiver operator curve [area under the",
            "probability": 0.00019239133689552546
        },
        {
            "start_logit": -1.3393421173095703,
            "end_logit": -2.8858349323272705,
            "text": "receiver operator curve [area under the receiver operating characteristic",
            "probability": 5.139198401593603e-05
        },
        {
            "start_logit": -5.595004558563232,
            "end_logit": 1.3021371364593506,
            "text": "receiver operating characteristic curve]",
            "probability": 4.802834882866591e-05
        },
        {
            "start_logit": -1.3393421173095703,
            "end_logit": -3.040722370147705,
            "text": "receiver operator curve [",
            "probability": 4.401780461193994e-05
        },
        {
            "start_logit": -1.600089192390442,
            "end_logit": -2.8858349323272705,
            "text": "area under the receiver operating characteristic",
            "probability": 3.9596248825546354e-05
        }
    ],
    "64136fbf201352f04a00003d_0003": [
        {
            "start_logit": 1.5095109939575195,
            "end_logit": 1.6452934741973877,
            "text": "area under the receiver operating characteristic curve (area under the receiver operating characteristic curve)",
            "probability": 0.537760853767395
        },
        {
            "start_logit": 1.5095109939575195,
            "end_logit": 1.263000249862671,
            "text": "area under the receiver operating characteristic curve",
            "probability": 0.36691150069236755
        },
        {
            "start_logit": 1.5095109939575195,
            "end_logit": -1.3754570484161377,
            "text": "area under the receiver operating characteristic curve (area under the receiver operating characteristic curve",
            "probability": 0.026223694905638695
        },
        {
            "start_logit": -1.7332810163497925,
            "end_logit": 1.6452934741973877,
            "text": "The model performance was evaluated using the area under the receiver operating characteristic curve (area under the receiver operating characteristic curve)",
            "probability": 0.021002085879445076
        },
        {
            "start_logit": -1.7332810163497925,
            "end_logit": 1.263000249862671,
            "text": "The model performance was evaluated using the area under the receiver operating characteristic curve",
            "probability": 0.014329618774354458
        },
        {
            "start_logit": -2.579134464263916,
            "end_logit": 1.6452934741973877,
            "text": "area under the receiver operating characteristic curve)",
            "probability": 0.009013904258608818
        },
        {
            "start_logit": 1.5095109939575195,
            "end_logit": -3.0471348762512207,
            "text": "area under the receiver operating characteristic",
            "probability": 0.00492825685068965
        },
        {
            "start_logit": -3.4420623779296875,
            "end_logit": 1.6452934741973877,
            "text": "receiver operating characteristic curve (area under the receiver operating characteristic curve)",
            "probability": 0.003803191240876913
        },
        {
            "start_logit": 1.5095109939575195,
            "end_logit": -3.351731777191162,
            "text": "area under the receiver operating characteristic curve (",
            "probability": 0.0036341978702694178
        },
        {
            "start_logit": -3.4420623779296875,
            "end_logit": 1.263000249862671,
            "text": "receiver operating characteristic curve",
            "probability": 0.002594898222014308
        },
        {
            "start_logit": 1.5095109939575195,
            "end_logit": -3.851701259613037,
            "text": "area under the receiver operating characteristic curve (area under the receiver operating characteristic",
            "probability": 0.002204319927841425
        },
        {
            "start_logit": 1.5095109939575195,
            "end_logit": -4.5874176025390625,
            "text": "area under",
            "probability": 0.0010562269017100334
        },
        {
            "start_logit": -4.747130393981934,
            "end_logit": 1.6452934741973877,
            "text": "the area under the receiver operating characteristic curve (area under the receiver operating characteristic curve)",
            "probability": 0.0010312509257346392
        },
        {
            "start_logit": -1.7332810163497925,
            "end_logit": -1.3754570484161377,
            "text": "The model performance was evaluated using the area under the receiver operating characteristic curve (area under the receiver operating characteristic curve",
            "probability": 0.0010241589043289423
        },
        {
            "start_logit": -4.873061180114746,
            "end_logit": 1.6452934741973877,
            "text": "performance was evaluated using the area under the receiver operating characteristic curve (area under the receiver operating characteristic curve)",
            "probability": 0.0009092289838008583
        },
        {
            "start_logit": -4.876758575439453,
            "end_logit": 1.6452934741973877,
            "text": "model performance was evaluated using the area under the receiver operating characteristic curve (area under the receiver operating characteristic curve)",
            "probability": 0.0009058734867721796
        },
        {
            "start_logit": -4.747130393981934,
            "end_logit": 1.263000249862671,
            "text": "the area under the receiver operating characteristic curve",
            "probability": 0.0007036172319203615
        },
        {
            "start_logit": -5.138088226318359,
            "end_logit": 1.6452934741973877,
            "text": "evaluated using the area under the receiver operating characteristic curve (area under the receiver operating characteristic curve)",
            "probability": 0.0006975471042096615
        },
        {
            "start_logit": -5.219334125518799,
            "end_logit": 1.6452934741973877,
            "text": "receiver operating characteristic curve)",
            "probability": 0.0006431153160519898
        },
        {
            "start_logit": -5.251833915710449,
            "end_logit": 1.6452934741973877,
            "text": "using the area under the receiver operating characteristic curve (area under the receiver operating characteristic curve)",
            "probability": 0.0006225502002052963
        }
    ],
    "64136664201352f04a00003b_0001": [
        {
            "start_logit": 5.836897373199463,
            "end_logit": 5.61323881149292,
            "text": "autonomic dysfunction",
            "probability": 0.2948969006538391
        },
        {
            "start_logit": 5.503501892089844,
            "end_logit": 5.61323881149292,
            "text": "sensory disturbances, or autonomic dysfunction",
            "probability": 0.21128982305526733
        },
        {
            "start_logit": 5.503501892089844,
            "end_logit": 5.518104553222656,
            "text": "sensory disturbances",
            "probability": 0.19211536645889282
        },
        {
            "start_logit": 5.016992092132568,
            "end_logit": 5.61323881149292,
            "text": "pain, sensory disturbances, or autonomic dysfunction",
            "probability": 0.12989424169063568
        },
        {
            "start_logit": 5.016992092132568,
            "end_logit": 5.518104553222656,
            "text": "pain, sensory disturbances",
            "probability": 0.11810649186372757
        },
        {
            "start_logit": 2.4715113639831543,
            "end_logit": 5.61323881149292,
            "text": "large fiber affection) manifests with pain, sensory disturbances, or autonomic dysfunction",
            "probability": 0.010188298299908638
        },
        {
            "start_logit": 5.016992092132568,
            "end_logit": 2.9746150970458984,
            "text": "pain",
            "probability": 0.009282183833420277
        },
        {
            "start_logit": 2.4715113639831543,
            "end_logit": 5.518104553222656,
            "text": "large fiber affection) manifests with pain, sensory disturbances",
            "probability": 0.009263718500733376
        },
        {
            "start_logit": 5.836897373199463,
            "end_logit": 2.109177350997925,
            "text": "autonomic dysfunction. T",
            "probability": 0.008869018405675888
        },
        {
            "start_logit": 5.503501892089844,
            "end_logit": 2.109177350997925,
            "text": "sensory disturbances, or autonomic dysfunction. T",
            "probability": 0.0063545373268425465
        },
        {
            "start_logit": 5.016992092132568,
            "end_logit": 2.109177350997925,
            "text": "pain, sensory disturbances, or autonomic dysfunction. T",
            "probability": 0.003906566184014082
        },
        {
            "start_logit": 5.503501892089844,
            "end_logit": 0.3005504012107849,
            "text": "sensory disturbances,",
            "probability": 0.0010413751006126404
        },
        {
            "start_logit": 0.04405415058135986,
            "end_logit": 5.61323881149292,
            "text": "small fiber neuropathy (without large fiber affection) manifests with pain, sensory disturbances, or autonomic dysfunction",
            "probability": 0.0008992289658635855
        },
        {
            "start_logit": 0.04405415058135986,
            "end_logit": 5.518104553222656,
            "text": "small fiber neuropathy (without large fiber affection) manifests with pain, sensory disturbances",
            "probability": 0.0008176247356459498
        },
        {
            "start_logit": 2.4715113639831543,
            "end_logit": 2.9746150970458984,
            "text": "large fiber affection) manifests with pain",
            "probability": 0.0007280512363649905
        },
        {
            "start_logit": 5.016992092132568,
            "end_logit": 0.3005504012107849,
            "text": "pain, sensory disturbances,",
            "probability": 0.0006402043509297073
        },
        {
            "start_logit": 5.016992092132568,
            "end_logit": 0.12094911187887192,
            "text": "pain,",
            "probability": 0.000534956983756274
        },
        {
            "start_logit": -0.7254968881607056,
            "end_logit": 5.61323881149292,
            "text": "without large fiber affection) manifests with pain, sensory disturbances, or autonomic dysfunction",
            "probability": 0.00041654182132333517
        },
        {
            "start_logit": -0.7254968881607056,
            "end_logit": 5.518104553222656,
            "text": "without large fiber affection) manifests with pain, sensory disturbances",
            "probability": 0.000378741038730368
        },
        {
            "start_logit": 5.503501892089844,
            "end_logit": -0.7176966071128845,
            "text": "sensory disturbance",
            "probability": 0.00037617338239215314
        }
    ],
    "64136664201352f04a00003b_0002": [
        {
            "start_logit": 6.272119522094727,
            "end_logit": 5.8700175285339355,
            "text": "Neuropathic pain (Neuropathic pain)",
            "probability": 0.37863022089004517
        },
        {
            "start_logit": 6.272119522094727,
            "end_logit": 5.448619842529297,
            "text": "Neuropathic pain",
            "probability": 0.24843020737171173
        },
        {
            "start_logit": 5.8174147605896,
            "end_logit": 5.684263706207275,
            "text": "Restless legs syndrome",
            "probability": 0.19955722987651825
        },
        {
            "start_logit": 4.776646614074707,
            "end_logit": 5.8700175285339355,
            "text": "Neuropathic pain)",
            "probability": 0.08486707508563995
        },
        {
            "start_logit": 6.272119522094727,
            "end_logit": 3.4672985076904297,
            "text": "Neuropathic pain (Neuropathic pain",
            "probability": 0.03425527364015579
        },
        {
            "start_logit": 5.8174147605896,
            "end_logit": 3.2565560340881348,
            "text": "Restless legs syndrome (Restless legs syndrome)",
            "probability": 0.017608705908060074
        },
        {
            "start_logit": 6.272119522094727,
            "end_logit": 2.142483711242676,
            "text": "Neuropathic pain (Neuropathic pain) is a main feature of Fabry disease (Fabry disease)",
            "probability": 0.009106839075684547
        },
        {
            "start_logit": 4.776646614074707,
            "end_logit": 3.4672985076904297,
            "text": "Neuropathic pain",
            "probability": 0.007678065914660692
        },
        {
            "start_logit": 6.272119522094727,
            "end_logit": 1.4768199920654297,
            "text": "Neuropathic pain (Neuropathic pain) is a main feature of Fabry disease",
            "probability": 0.004680299200117588
        },
        {
            "start_logit": 1.7778069972991943,
            "end_logit": 5.684263706207275,
            "text": "Fabry disease (Fabry disease) as consequence of small fiber neuropathy. Restless legs syndrome",
            "probability": 0.0035130796022713184
        },
        {
            "start_logit": 1.7451977729797363,
            "end_logit": 5.684263706207275,
            "text": "small fiber neuropathy. Restless legs syndrome",
            "probability": 0.0034003693144768476
        },
        {
            "start_logit": 4.776646614074707,
            "end_logit": 2.142483711242676,
            "text": "Neuropathic pain) is a main feature of Fabry disease (Fabry disease)",
            "probability": 0.0020412306766957045
        },
        {
            "start_logit": 4.776646614074707,
            "end_logit": 1.9216927289962769,
            "text": "Neuropathic pain) is a main feature of Fabry disease (Fabry disease) as consequence of small fiber neuropathy",
            "probability": 0.0016368309734389186
        },
        {
            "start_logit": 5.8174147605896,
            "end_logit": 0.5859275460243225,
            "text": "Restless legs syndrome (Restless legs syndrome",
            "probability": 0.001218675635755062
        },
        {
            "start_logit": 4.776646614074707,
            "end_logit": 1.4768199920654297,
            "text": "Neuropathic pain) is a main feature of Fabry disease",
            "probability": 0.0010490543209016323
        },
        {
            "start_logit": 6.272119522094727,
            "end_logit": -0.48382270336151123,
            "text": "Neuropathic pain (Neuropathic pain) is a main feature of Fabry disease (Fabry disease",
            "probability": 0.0006588359246961772
        },
        {
            "start_logit": 4.776646614074707,
            "end_logit": 0.9990683794021606,
            "text": "Neuropathic pain) is a main feature of Fabry disease (Fabry disease) as consequence of small fiber neuropathy.",
            "probability": 0.0006505985511466861
        },
        {
            "start_logit": -0.5765156149864197,
            "end_logit": 5.8700175285339355,
            "text": "pain (Neuropathic pain)",
            "probability": 0.00040168961277231574
        },
        {
            "start_logit": 1.7778069972991943,
            "end_logit": 3.2565560340881348,
            "text": "Fabry disease (Fabry disease) as consequence of small fiber neuropathy. Restless legs syndrome (Restless legs syndrome)",
            "probability": 0.00030999016598798335
        },
        {
            "start_logit": 1.7637696266174316,
            "end_logit": 3.2565560340881348,
            "text": "Restless legs syndrome)",
            "probability": 0.000305669178487733
        }
    ],
    "64136664201352f04a00003b_0003": [
        {
            "start_logit": 3.5926198959350586,
            "end_logit": 2.248871326446533,
            "text": "autoantibodies",
            "probability": 0.5621508359909058
        },
        {
            "start_logit": 3.5926198959350586,
            "end_logit": 0.8058708906173706,
            "text": "autoantibodies, including those of IgM class",
            "probability": 0.13279011845588684
        },
        {
            "start_logit": 3.5926198959350586,
            "end_logit": 0.2991340458393097,
            "text": "autoantibodies,",
            "probability": 0.08000050485134125
        },
        {
            "start_logit": 1.3786146640777588,
            "end_logit": 2.248871326446533,
            "text": "mall fiber neuropathy (small fiber neuropathy) can be associated with autoantibodies",
            "probability": 0.06142180413007736
        },
        {
            "start_logit": 1.3786146640777588,
            "end_logit": 1.477394938468933,
            "text": "mall fiber neuropathy",
            "probability": 0.02839713916182518
        },
        {
            "start_logit": 0.3684900403022766,
            "end_logit": 2.442058563232422,
            "text": "trisulfated heparan disaccharide (Trisulfated Heparin Disaccharide) antigen.",
            "probability": 0.027135081589221954
        },
        {
            "start_logit": 1.3786146640777588,
            "end_logit": 1.3438572883605957,
            "text": "mall fiber neuropathy (small fiber neuropathy)",
            "probability": 0.02484734170138836
        },
        {
            "start_logit": 1.3786146640777588,
            "end_logit": 0.8058708906173706,
            "text": "mall fiber neuropathy (small fiber neuropathy) can be associated with autoantibodies, including those of IgM class",
            "probability": 0.014508930034935474
        },
        {
            "start_logit": -0.2175396829843521,
            "end_logit": 2.248871326446533,
            "text": "associated with autoantibodies",
            "probability": 0.012448628433048725
        },
        {
            "start_logit": 3.5926198959350586,
            "end_logit": -1.647641658782959,
            "text": "autoantibodies, including those of IgM class with specificity",
            "probability": 0.011418755166232586
        },
        {
            "start_logit": 1.3786146640777588,
            "end_logit": 0.2991340458393097,
            "text": "mall fiber neuropathy (small fiber neuropathy) can be associated with autoantibodies,",
            "probability": 0.008741026744246483
        },
        {
            "start_logit": 0.3684900403022766,
            "end_logit": 1.0728669166564941,
            "text": "trisulfated heparan disaccharide (Trisulfated Heparin Disaccharide) antigen",
            "probability": 0.006900791544467211
        },
        {
            "start_logit": 0.4356583058834076,
            "end_logit": 0.8058708906173706,
            "text": "IgM class",
            "probability": 0.0056508611887693405
        },
        {
            "start_logit": 3.5926198959350586,
            "end_logit": -2.3823065757751465,
            "text": "autoantibodies, including those of IgM class with specificity for the trisulfated heparan disaccharide",
            "probability": 0.005477190017700195
        },
        {
            "start_logit": 3.5926198959350586,
            "end_logit": -2.461745262145996,
            "text": "autoantibodies, including those",
            "probability": 0.0050589232705533504
        },
        {
            "start_logit": 0.20636865496635437,
            "end_logit": 0.8058708906173706,
            "text": "those of IgM class",
            "probability": 0.004492990206927061
        },
        {
            "start_logit": -0.2175396829843521,
            "end_logit": 0.8058708906173706,
            "text": "associated with autoantibodies, including those of IgM class",
            "probability": 0.0029405897948890924
        },
        {
            "start_logit": 1.3786146640777588,
            "end_logit": -1.1917859315872192,
            "text": "mall fiber neuropathy (small fiber neuropathy",
            "probability": 0.0019681768026202917
        },
        {
            "start_logit": -2.327453374862671,
            "end_logit": 2.442058563232422,
            "text": "heparan disaccharide (Trisulfated Heparin Disaccharide) antigen.",
            "probability": 0.001831040601246059
        },
        {
            "start_logit": -2.3339109420776367,
            "end_logit": 2.442058563232422,
            "text": "Trisulfated Heparin Disaccharide) antigen.",
            "probability": 0.0018192538991570473
        }
    ],
    "64136664201352f04a00003b_0004": [
        {
            "start_logit": 2.7330422401428223,
            "end_logit": 3.2894229888916016,
            "text": "fibroblast growth factor receptor 3",
            "probability": 0.7137473821640015
        },
        {
            "start_logit": 2.7330422401428223,
            "end_logit": 0.7007670402526855,
            "text": "fibroblast growth factor receptor 3 (FGFR-3)",
            "probability": 0.05361736938357353
        },
        {
            "start_logit": 2.4005093574523926,
            "end_logit": 0.8587477207183838,
            "text": "Trisulfated Heparin Disaccharide",
            "probability": 0.045029640197753906
        },
        {
            "start_logit": 2.4005093574523926,
            "end_logit": 0.545432448387146,
            "text": "Trisulfated Heparin Disaccharide (Trisulfated Heparin Disaccharide)",
            "probability": 0.03291754424571991
        },
        {
            "start_logit": 1.8393011093139648,
            "end_logit": 1.0916740894317627,
            "text": "small fiber neuropathy (small fiber neuropathy)",
            "probability": 0.032428547739982605
        },
        {
            "start_logit": 1.8393011093139648,
            "end_logit": 0.7916586399078369,
            "text": "small fiber neuropathy",
            "probability": 0.024023286998271942
        },
        {
            "start_logit": -1.106722354888916,
            "end_logit": 3.2894229888916016,
            "text": "Trisulfated Heparin Disaccharide) and fibroblast growth factor receptor 3",
            "probability": 0.01534461323171854
        },
        {
            "start_logit": 1.8393011093139648,
            "end_logit": 0.24983805418014526,
            "text": "small fiber neuropathy (small fiber neuropathy) cases are idiopathic",
            "probability": 0.013974064029753208
        },
        {
            "start_logit": 2.7330422401428223,
            "end_logit": -0.7349240183830261,
            "text": "fibroblast growth factor receptor",
            "probability": 0.012758297845721245
        },
        {
            "start_logit": 1.0896135568618774,
            "end_logit": 0.8587477207183838,
            "text": "idiopathic, but novel antibodies to Trisulfated Heparin Disaccharide",
            "probability": 0.01213902235031128
        },
        {
            "start_logit": -1.3942124843597412,
            "end_logit": 3.2894229888916016,
            "text": "Heparin Disaccharide (Trisulfated Heparin Disaccharide) and fibroblast growth factor receptor 3",
            "probability": 0.011510672979056835
        },
        {
            "start_logit": 2.7330422401428223,
            "end_logit": -0.9579874873161316,
            "text": "fibroblast growth factor",
            "probability": 0.010207454673945904
        },
        {
            "start_logit": 1.0896135568618774,
            "end_logit": 0.24983805418014526,
            "text": "idiopathic",
            "probability": 0.006602941080927849
        },
        {
            "start_logit": 2.4005093574523926,
            "end_logit": -1.7362676858901978,
            "text": "Trisulfated Heparin Disaccharide (Trisulfated Heparin Disaccharide",
            "probability": 0.0033612253610044718
        },
        {
            "start_logit": -0.6218743324279785,
            "end_logit": 1.0916740894317627,
            "text": "50% of small fiber neuropathy (small fiber neuropathy)",
            "probability": 0.002767276018857956
        },
        {
            "start_logit": 1.8393011093139648,
            "end_logit": -1.5309771299362183,
            "text": "small fiber neuropathy (small fiber neuropathy) cases are idiopathic,",
            "probability": 0.0023546393495053053
        },
        {
            "start_logit": -0.6218743324279785,
            "end_logit": 0.7916586399078369,
            "text": "50% of small fiber neuropathy",
            "probability": 0.0020500163082033396
        },
        {
            "start_logit": -0.7292038798332214,
            "end_logit": 0.8587477207183838,
            "text": "antibodies to Trisulfated Heparin Disaccharide",
            "probability": 0.0019691612105816603
        },
        {
            "start_logit": 1.8393011093139648,
            "end_logit": -1.8350369930267334,
            "text": "small fiber neuropathy (small fiber neuropathy",
            "probability": 0.0017372930888086557
        },
        {
            "start_logit": -3.459294080734253,
            "end_logit": 3.2894229888916016,
            "text": "3",
            "probability": 0.001459644641727209
        }
    ],
    "6415c53e690f196b51000012_0001": [
        {
            "start_logit": 4.2848615646362305,
            "end_logit": 5.070096969604492,
            "text": "2016",
            "probability": 0.7691475749015808
        },
        {
            "start_logit": 2.542355537414551,
            "end_logit": 5.070096969604492,
            "text": "On October 24, 2016",
            "probability": 0.1346631944179535
        },
        {
            "start_logit": 4.2848615646362305,
            "end_logit": 2.5881423950195312,
            "text": "2016, the U.S. Food and Drug Administration (Food and Drug Administration) approved pembrolizumab",
            "probability": 0.06428512185811996
        },
        {
            "start_logit": 2.831389904022217,
            "end_logit": 2.5881423950195312,
            "text": "pembrolizumab",
            "probability": 0.015027121640741825
        },
        {
            "start_logit": -0.06882023811340332,
            "end_logit": 5.070096969604492,
            "text": "October 24, 2016",
            "probability": 0.009890762157738209
        },
        {
            "start_logit": 2.542355537414551,
            "end_logit": 0.7353513240814209,
            "text": "On October 24",
            "probability": 0.0017647894565016031
        },
        {
            "start_logit": -2.1331920623779297,
            "end_logit": 5.070096969604492,
            "text": "24, 2016",
            "probability": 0.0012551175896078348
        },
        {
            "start_logit": 4.2848615646362305,
            "end_logit": -1.4658046960830688,
            "text": "2016, the U.S. Food and Drug Administration (Food and Drug Administration)",
            "probability": 0.0011155875399708748
        },
        {
            "start_logit": 1.254756212234497,
            "end_logit": 1.4073256254196167,
            "text": "anaplastic lymphoma kinase",
            "probability": 0.0009535208228044212
        },
        {
            "start_logit": 0.2759072184562683,
            "end_logit": 1.4073256254196167,
            "text": "epidermal growth factor receptor (epidermal growth factor receptor) or anaplastic lymphoma kinase",
            "probability": 0.00035827915417030454
        },
        {
            "start_logit": 0.2974908947944641,
            "end_logit": 0.9958953261375427,
            "text": "treatment of patients with metastatic non-small cell lung cancer (metastatic non-small cell lung cancer)",
            "probability": 0.00024261261569336057
        },
        {
            "start_logit": 1.254756212234497,
            "end_logit": -0.16834768652915955,
            "text": "anaplastic lymphoma kinase (anaplastic lymphoma kinase)",
            "probability": 0.00019725320453289896
        },
        {
            "start_logit": 2.542355537414551,
            "end_logit": -1.4658046960830688,
            "text": "On October 24, 2016, the U.S. Food and Drug Administration (Food and Drug Administration)",
            "probability": 0.00019531823636498302
        },
        {
            "start_logit": 2.542355537414551,
            "end_logit": -1.5165634155273438,
            "text": "On October 24,",
            "probability": 0.0001856515882536769
        },
        {
            "start_logit": 0.2759072184562683,
            "end_logit": 0.4887312352657318,
            "text": "epidermal growth factor receptor",
            "probability": 0.00014298182213678956
        },
        {
            "start_logit": -0.06882023811340332,
            "end_logit": 0.7353513240814209,
            "text": "October 24",
            "probability": 0.00012962053006049246
        },
        {
            "start_logit": -0.7536414265632629,
            "end_logit": 1.4073256254196167,
            "text": "epidermal growth factor receptor) or anaplastic lymphoma kinase",
            "probability": 0.0001279659481951967
        },
        {
            "start_logit": -0.07803495228290558,
            "end_logit": 0.6494296193122864,
            "text": "programmed death-ligand 1 (programmed death-ligand 1)",
            "probability": 0.00011785729293478653
        },
        {
            "start_logit": -2.1331920623779297,
            "end_logit": 2.5881423950195312,
            "text": "24, 2016, the U.S. Food and Drug Administration (Food and Drug Administration) approved pembrolizumab",
            "probability": 0.00010490235581528395
        },
        {
            "start_logit": -2.2344248294830322,
            "end_logit": 2.5881423950195312,
            "text": "U.S. Food and Drug Administration (Food and Drug Administration) approved pembrolizumab",
            "probability": 9.480265725869685e-05
        }
    ],
    "6417949d690f196b51000035_0001": [
        {
            "start_logit": 4.148214340209961,
            "end_logit": 4.418436050415039,
            "text": "gene therapies",
            "probability": 0.5288600921630859
        },
        {
            "start_logit": 3.7436017990112305,
            "end_logit": 3.109487533569336,
            "text": "trying to reverse or block the pathophysiological processes of the disease, such as inflammation, fibrosis, muscle regeneration",
            "probability": 0.0953126773238182
        },
        {
            "start_logit": 3.7436017990112305,
            "end_logit": 2.671645402908325,
            "text": "trying to reverse or block the pathophysiological processes of the disease, such as inflammation, fibrosis, muscle regeneration, etc.",
            "probability": 0.06151742860674858
        },
        {
            "start_logit": 4.148214340209961,
            "end_logit": 2.1701207160949707,
            "text": "gene therapies and 2) trying to reverse or block the pathophysiological processes of the disease, such as inflammation, fibrosis",
            "probability": 0.05583542585372925
        },
        {
            "start_logit": 2.810242176055908,
            "end_logit": 3.109487533569336,
            "text": "muscle regeneration",
            "probability": 0.037479840219020844
        },
        {
            "start_logit": 3.7436017990112305,
            "end_logit": 2.1701207160949707,
            "text": "trying to reverse or block the pathophysiological processes of the disease, such as inflammation, fibrosis",
            "probability": 0.03725536912679672
        },
        {
            "start_logit": 4.148214340209961,
            "end_logit": 1.6422877311706543,
            "text": "gene therapies and 2) trying to reverse or block the pathophysiological processes of the disease, such as inflammation",
            "probability": 0.03293630853295326
        },
        {
            "start_logit": 2.4437975883483887,
            "end_logit": 3.109487533569336,
            "text": "fibrosis, muscle regeneration",
            "probability": 0.02598082460463047
        },
        {
            "start_logit": 2.810242176055908,
            "end_logit": 2.671645402908325,
            "text": "muscle regeneration, etc.",
            "probability": 0.02419053204357624
        },
        {
            "start_logit": 3.7436017990112305,
            "end_logit": 1.6422877311706543,
            "text": "trying to reverse or block the pathophysiological processes of the disease, such as inflammation",
            "probability": 0.02197626791894436
        },
        {
            "start_logit": 2.006281852722168,
            "end_logit": 3.109487533569336,
            "text": "inflammation, fibrosis, muscle regeneration",
            "probability": 0.016774214804172516
        },
        {
            "start_logit": 2.4437975883483887,
            "end_logit": 2.671645402908325,
            "text": "fibrosis, muscle regeneration, etc.",
            "probability": 0.016768746078014374
        },
        {
            "start_logit": 2.006281852722168,
            "end_logit": 2.671645402908325,
            "text": "inflammation, fibrosis, muscle regeneration, etc.",
            "probability": 0.010826540179550648
        },
        {
            "start_logit": 2.4437975883483887,
            "end_logit": 2.1701207160949707,
            "text": "fibrosis",
            "probability": 0.010155260562896729
        },
        {
            "start_logit": -0.01698404550552368,
            "end_logit": 4.418436050415039,
            "text": "the area of gene therapies",
            "probability": 0.008211418054997921
        },
        {
            "start_logit": 2.006281852722168,
            "end_logit": 2.1701207160949707,
            "text": "inflammation, fibrosis",
            "probability": 0.0065566254779696465
        },
        {
            "start_logit": 2.006281852722168,
            "end_logit": 1.6422877311706543,
            "text": "inflammation",
            "probability": 0.003867634804919362
        },
        {
            "start_logit": 3.7436017990112305,
            "end_logit": -0.4749123454093933,
            "text": "trying to reverse or block the pathophysiological processes of the disease, such as inflammation, fibrosis, muscle regeneration,",
            "probability": 0.0026452424935996532
        },
        {
            "start_logit": 4.148214340209961,
            "end_logit": -1.49825918674469,
            "text": "gene therapies and 2)",
            "probability": 0.0014247961807996035
        },
        {
            "start_logit": -1.7685284614562988,
            "end_logit": 4.418436050415039,
            "text": "area of gene therapies",
            "probability": 0.0014247283106669784
        }
    ],
    "6417949d690f196b51000035_0002": [
        {
            "start_logit": 6.407771110534668,
            "end_logit": 6.2548065185546875,
            "text": "gene replacement",
            "probability": 0.18378807604312897
        },
        {
            "start_logit": 6.407771110534668,
            "end_logit": 6.169486045837402,
            "text": "gene replacement, exon skipping, suppression of stop codons",
            "probability": 0.16875751316547394
        },
        {
            "start_logit": 6.407771110534668,
            "end_logit": 6.158868312835693,
            "text": "gene replacement, exon skipping",
            "probability": 0.16697509586811066
        },
        {
            "start_logit": 6.351747035980225,
            "end_logit": 6.169486045837402,
            "text": "suppression of stop codons",
            "probability": 0.15956290066242218
        },
        {
            "start_logit": 6.330455303192139,
            "end_logit": 6.169486045837402,
            "text": "exon skipping, suppression of stop codons",
            "probability": 0.15620146691799164
        },
        {
            "start_logit": 6.330455303192139,
            "end_logit": 6.158868312835693,
            "text": "exon skipping",
            "probability": 0.15455178916454315
        },
        {
            "start_logit": 2.12125563621521,
            "end_logit": 6.169486045837402,
            "text": "stop codons",
            "probability": 0.0023208826314657927
        },
        {
            "start_logit": 6.407771110534668,
            "end_logit": 1.8815505504608154,
            "text": "gene replacement,",
            "probability": 0.0023175892420113087
        },
        {
            "start_logit": 6.407771110534668,
            "end_logit": 1.3626315593719482,
            "text": "gene replacement, exon skipping,",
            "probability": 0.0013793447287753224
        },
        {
            "start_logit": 6.330455303192139,
            "end_logit": 1.3626315593719482,
            "text": "exon skipping,",
            "probability": 0.001276717521250248
        },
        {
            "start_logit": 0.9808720350265503,
            "end_logit": 6.169486045837402,
            "text": "skipping, suppression of stop codons",
            "probability": 0.0007419776520691812
        },
        {
            "start_logit": 0.9808720350265503,
            "end_logit": 6.158868312835693,
            "text": "skipping",
            "probability": 0.000734141212888062
        },
        {
            "start_logit": -0.2786474823951721,
            "end_logit": 6.2548065185546875,
            "text": "Several promising gene therapies are currently under investigation. These include gene replacement",
            "probability": 0.00022932037245482206
        },
        {
            "start_logit": -0.2786474823951721,
            "end_logit": 6.169486045837402,
            "text": "Several promising gene therapies are currently under investigation. These include gene replacement, exon skipping, suppression of stop codons",
            "probability": 0.00021056609693914652
        },
        {
            "start_logit": -0.2786474823951721,
            "end_logit": 6.158868312835693,
            "text": "Several promising gene therapies are currently under investigation. These include gene replacement, exon skipping",
            "probability": 0.00020834220049437135
        },
        {
            "start_logit": -0.5935397744178772,
            "end_logit": 6.2548065185546875,
            "text": "replacement",
            "probability": 0.00016737348050810397
        },
        {
            "start_logit": -0.5935397744178772,
            "end_logit": 6.169486045837402,
            "text": "replacement, exon skipping, suppression of stop codons",
            "probability": 0.00015368533786386251
        },
        {
            "start_logit": -0.5935397744178772,
            "end_logit": 6.158868312835693,
            "text": "replacement, exon skipping",
            "probability": 0.0001520621735835448
        },
        {
            "start_logit": 6.407771110534668,
            "end_logit": -0.9193745851516724,
            "text": "gene replacement, exon skip",
            "probability": 0.00014080241089686751
        },
        {
            "start_logit": 6.330455303192139,
            "end_logit": -0.9193745851516724,
            "text": "exon skip",
            "probability": 0.00013032634160481393
        }
    ],
    "6417949d690f196b51000035_0003": [
        {
            "start_logit": 6.243808746337891,
            "end_logit": 6.344311714172363,
            "text": "CRISPR/Cas9",
            "probability": 0.46106022596359253
        },
        {
            "start_logit": 6.243808746337891,
            "end_logit": 6.056073188781738,
            "text": "CRISPR",
            "probability": 0.34560278058052063
        },
        {
            "start_logit": 5.320514678955078,
            "end_logit": 6.344311714172363,
            "text": "Cas9",
            "probability": 0.18313701450824738
        },
        {
            "start_logit": 1.636090874671936,
            "end_logit": 6.344311714172363,
            "text": "gene editing tool referred to as CRISPR/Cas9",
            "probability": 0.004598870407789946
        },
        {
            "start_logit": 1.636090874671936,
            "end_logit": 6.056073188781738,
            "text": "gene editing tool referred to as CRISPR",
            "probability": 0.003447233932092786
        },
        {
            "start_logit": 6.243808746337891,
            "end_logit": -1.0856542587280273,
            "text": "CRISPR/Cas9 offers exciting perspectives for restoring dystrophin",
            "probability": 0.00027350446907803416
        },
        {
            "start_logit": -1.2437684535980225,
            "end_logit": 6.344311714172363,
            "text": "9",
            "probability": 0.0002581927692517638
        },
        {
            "start_logit": -1.2736668586730957,
            "end_logit": 6.344311714172363,
            "text": "R/Cas9",
            "probability": 0.00025058756000362337
        },
        {
            "start_logit": -1.2736668586730957,
            "end_logit": 6.056073188781738,
            "text": "R",
            "probability": 0.0001878361072158441
        },
        {
            "start_logit": 6.243808746337891,
            "end_logit": -1.4920992851257324,
            "text": "CRISP",
            "probability": 0.0001821577170630917
        },
        {
            "start_logit": 6.243808746337891,
            "end_logit": -1.529502272605896,
            "text": "CRISPR/",
            "probability": 0.00017547031166031957
        },
        {
            "start_logit": 6.243808746337891,
            "end_logit": -1.9477657079696655,
            "text": "CRISPR/Cas9 offers exciting perspectives for restoring dystrophin expression in patients with DMD.",
            "probability": 0.00011549253395060077
        },
        {
            "start_logit": -2.1075570583343506,
            "end_logit": 6.344311714172363,
            "text": "promising gene editing tool referred to as CRISPR/Cas9",
            "probability": 0.00010884423682000488
        },
        {
            "start_logit": 5.320514678955078,
            "end_logit": -1.0856542587280273,
            "text": "Cas9 offers exciting perspectives for restoring dystrophin",
            "probability": 0.00010863829083973542
        },
        {
            "start_logit": 6.243808746337891,
            "end_logit": -2.0563974380493164,
            "text": "CRISPR/Ca",
            "probability": 0.00010360388841945678
        },
        {
            "start_logit": 6.243808746337891,
            "end_logit": -2.1180131435394287,
            "text": "CRISPR/Cas9 offers exciting perspectives for restoring dystrophin expression",
            "probability": 9.741291432874277e-05
        },
        {
            "start_logit": -2.351912498474121,
            "end_logit": 6.344311714172363,
            "text": "editing tool referred to as CRISPR/Cas9",
            "probability": 8.524783333996311e-05
        },
        {
            "start_logit": -2.1075570583343506,
            "end_logit": 6.056073188781738,
            "text": "promising gene editing tool referred to as CRISPR",
            "probability": 8.158777200151235e-05
        },
        {
            "start_logit": -2.351912498474121,
            "end_logit": 6.056073188781738,
            "text": "editing tool referred to as CRISPR",
            "probability": 6.390030466718599e-05
        },
        {
            "start_logit": -2.679713249206543,
            "end_logit": 6.344311714172363,
            "text": "More recently, a promising gene editing tool referred to as CRISPR/Cas9",
            "probability": 6.142162601463497e-05
        }
    ],
    "6417949d690f196b51000035_0004": [
        {
            "start_logit": 5.6873064041137695,
            "end_logit": 5.053101539611816,
            "text": "Adeno-associated virus-vectorized gene therapies to restore dystrophin protein expression using gene replacement",
            "probability": 0.45986640453338623
        },
        {
            "start_logit": 5.436202526092529,
            "end_logit": 4.692222595214844,
            "text": "antisense oligonucleotide-mediated pre-mRNA splicing modulation",
            "probability": 0.24937397241592407
        },
        {
            "start_logit": 4.246918678283691,
            "end_logit": 5.053101539611816,
            "text": "gene replacement",
            "probability": 0.1089128851890564
        },
        {
            "start_logit": 5.6873064041137695,
            "end_logit": 3.401416063308716,
            "text": "Adeno-associated virus-vectorized gene therapies",
            "probability": 0.08816855400800705
        },
        {
            "start_logit": 4.246918678283691,
            "end_logit": 4.692222595214844,
            "text": "gene replacement or antisense oligonucleotide-mediated pre-mRNA splicing modulation",
            "probability": 0.07591918110847473
        },
        {
            "start_logit": 0.6575552225112915,
            "end_logit": 5.053101539611816,
            "text": "gene therapies to restore dystrophin protein expression using gene replacement",
            "probability": 0.0030077272094786167
        },
        {
            "start_logit": 5.6873064041137695,
            "end_logit": -0.2752958834171295,
            "text": "Adeno-associated virus-vectorized",
            "probability": 0.0022311981301754713
        },
        {
            "start_logit": 5.6873064041137695,
            "end_logit": -0.29726845026016235,
            "text": "Adeno-associated virus-vectorized gene therapies to restore dystrophin protein expression",
            "probability": 0.002182707656174898
        },
        {
            "start_logit": 0.12310159206390381,
            "end_logit": 5.053101539611816,
            "text": "dystrophin protein expression using gene replacement",
            "probability": 0.001762496423907578
        },
        {
            "start_logit": 5.6873064041137695,
            "end_logit": -0.5501152276992798,
            "text": "Adeno-associated virus-vectorized gene therapies to restore dystrophin",
            "probability": 0.0016950620338320732
        },
        {
            "start_logit": 0.22354215383529663,
            "end_logit": 4.692222595214844,
            "text": "pre-mRNA splicing modulation",
            "probability": 0.001358379959128797
        },
        {
            "start_logit": -0.4814743399620056,
            "end_logit": 5.053101539611816,
            "text": "using gene replacement",
            "probability": 0.0009628624538891017
        },
        {
            "start_logit": -0.7090668082237244,
            "end_logit": 5.053101539611816,
            "text": "restore dystrophin protein expression using gene replacement",
            "probability": 0.0007668705657124519
        },
        {
            "start_logit": -0.4814743399620056,
            "end_logit": 4.692222595214844,
            "text": "using gene replacement or antisense oligonucleotide-mediated pre-mRNA splicing modulation",
            "probability": 0.0006711760652251542
        },
        {
            "start_logit": 5.436202526092529,
            "end_logit": -1.296561360359192,
            "text": "antisense oligonucleotide",
            "probability": 0.0006251081358641386
        },
        {
            "start_logit": 0.6575552225112915,
            "end_logit": 3.401416063308716,
            "text": "gene therapies",
            "probability": 0.0005766611429862678
        },
        {
            "start_logit": -0.7054370045661926,
            "end_logit": 4.692222595214844,
            "text": "se oligonucleotide-mediated pre-mRNA splicing modulation",
            "probability": 0.0005365014658309519
        },
        {
            "start_logit": 5.6873064041137695,
            "end_logit": -1.778632402420044,
            "text": "Adeno-associated virus",
            "probability": 0.0004961893428117037
        },
        {
            "start_logit": -1.1546330451965332,
            "end_logit": 5.053101539611816,
            "text": "vectorized gene therapies to restore dystrophin protein expression using gene replacement",
            "probability": 0.0004911511205136776
        },
        {
            "start_logit": 5.6873064041137695,
            "end_logit": -2.007303237915039,
            "text": "Adeno-associated virus-vectorized gene therapies to restore dystrophin protein",
            "probability": 0.0003947633667849004
        }
    ],
    "641368ee201352f04a00003c_0001": [
        {
            "start_logit": 6.718327522277832,
            "end_logit": 6.400699615478516,
            "text": "glioblastoma",
            "probability": 0.16750094294548035
        },
        {
            "start_logit": 6.682847023010254,
            "end_logit": 6.332213878631592,
            "text": "astrocytoma",
            "probability": 0.15096111595630646
        },
        {
            "start_logit": 6.647171974182129,
            "end_logit": 6.331367492675781,
            "text": "oligodendroglioma",
            "probability": 0.1455473154783249
        },
        {
            "start_logit": 6.718327522277832,
            "end_logit": 5.799040794372559,
            "text": "glioblastoma, isocitrate dehydrogenase-wildtype",
            "probability": 0.0917740985751152
        },
        {
            "start_logit": 6.682847023010254,
            "end_logit": 5.636218070983887,
            "text": "astrocytoma, isocitrate dehydrogenase (isocitrate dehydrogenase)-mutant",
            "probability": 0.07526587694883347
        },
        {
            "start_logit": 6.647171974182129,
            "end_logit": 5.562835693359375,
            "text": "oligodendroglioma, isocitrate dehydrogenase-mutant and 1p/19q codeleted",
            "probability": 0.06748932600021362
        },
        {
            "start_logit": 5.657920837402344,
            "end_logit": 6.400699615478516,
            "text": "1p/19q codeleted, and glioblastoma",
            "probability": 0.05800808221101761
        },
        {
            "start_logit": 6.262872219085693,
            "end_logit": 5.636218070983887,
            "text": "isocitrate dehydrogenase (isocitrate dehydrogenase)-mutant",
            "probability": 0.04945443198084831
        },
        {
            "start_logit": 5.657920837402344,
            "end_logit": 5.799040794372559,
            "text": "1p/19q codeleted, and glioblastoma, isocitrate dehydrogenase-wildtype",
            "probability": 0.03178274258971214
        },
        {
            "start_logit": 6.682847023010254,
            "end_logit": 4.628630638122559,
            "text": "astrocytoma, isocitrate dehydrogenase",
            "probability": 0.02747947722673416
        },
        {
            "start_logit": 6.647171974182129,
            "end_logit": 4.635566711425781,
            "text": "oligodendroglioma, isocitrate dehydrogenase-mutant",
            "probability": 0.026700986549258232
        },
        {
            "start_logit": 5.657920837402344,
            "end_logit": 5.562835693359375,
            "text": "1p/19q codeleted",
            "probability": 0.02509624883532524
        },
        {
            "start_logit": 4.525270938873291,
            "end_logit": 6.400699615478516,
            "text": "isocitrate dehydrogenase-mutant and 1p/19q codeleted, and glioblastoma",
            "probability": 0.01868893951177597
        },
        {
            "start_logit": 6.262872219085693,
            "end_logit": 4.628630638122559,
            "text": "isocitrate dehydrogenase",
            "probability": 0.01805575005710125
        },
        {
            "start_logit": 6.647171974182129,
            "end_logit": 3.6642539501190186,
            "text": "oligodendroglioma,",
            "probability": 0.010108614340424538
        },
        {
            "start_logit": 6.682847023010254,
            "end_logit": 3.4650163650512695,
            "text": "astrocytoma,",
            "probability": 0.008583358488976955
        },
        {
            "start_logit": 4.525270938873291,
            "end_logit": 5.562835693359375,
            "text": "isocitrate dehydrogenase-mutant and 1p/19q codeleted",
            "probability": 0.008085464127361774
        },
        {
            "start_logit": 6.647171974182129,
            "end_logit": 3.3618502616882324,
            "text": "oligodendroglioma, isocitrate dehydrogenase-mutant and 1p/19q codeleted,",
            "probability": 0.007470661774277687
        },
        {
            "start_logit": 6.682847023010254,
            "end_logit": 3.2905969619750977,
            "text": "astrocytoma, isocitrate dehydrogenase (isocitrate dehydrogenase)-mutant,",
            "probability": 0.007209545001387596
        },
        {
            "start_logit": 6.262872219085693,
            "end_logit": 3.2905969619750977,
            "text": "isocitrate dehydrogenase (isocitrate dehydrogenase)-mutant,",
            "probability": 0.004737125709652901
        }
    ],
    "641368ee201352f04a00003c_0002": [
        {
            "start_logit": 6.017978668212891,
            "end_logit": 5.587444305419922,
            "text": "glioblastoma",
            "probability": 0.0804029107093811
        },
        {
            "start_logit": 5.870927810668945,
            "end_logit": 5.679318428039551,
            "text": "oligodendroglioma",
            "probability": 0.07608671486377716
        },
        {
            "start_logit": 6.017978668212891,
            "end_logit": 5.474297523498535,
            "text": "glioblastoma, isocitrate dehydrogenase-wildtype",
            "probability": 0.07180137187242508
        },
        {
            "start_logit": 5.676349639892578,
            "end_logit": 5.785577774047852,
            "text": "intermediate-risk",
            "probability": 0.06965501606464386
        },
        {
            "start_logit": 5.844386100769043,
            "end_logit": 5.525975227355957,
            "text": "astrocytoma, isocitrate dehydrogenase-mutant; and (3) high-risk",
            "probability": 0.06356028467416763
        },
        {
            "start_logit": 5.469619274139404,
            "end_logit": 5.848602771759033,
            "text": "low-risk",
            "probability": 0.06033119931817055
        },
        {
            "start_logit": 5.844386100769043,
            "end_logit": 5.455193042755127,
            "text": "astrocytoma",
            "probability": 0.05921689793467522
        },
        {
            "start_logit": 5.676349639892578,
            "end_logit": 5.525975227355957,
            "text": "intermediate-risk, expecting astrocytoma, isocitrate dehydrogenase-mutant; and (3) high-risk",
            "probability": 0.05372896417975426
        },
        {
            "start_logit": 5.469619274139404,
            "end_logit": 5.679318428039551,
            "text": "low-risk, expecting oligodendroglioma",
            "probability": 0.05093572661280632
        },
        {
            "start_logit": 5.551717758178711,
            "end_logit": 5.587444305419922,
            "text": "high-risk, expecting glioblastoma",
            "probability": 0.05044025182723999
        },
        {
            "start_logit": 5.3464508056640625,
            "end_logit": 5.785577774047852,
            "text": "1p/19q-codeleted; (2) intermediate-risk",
            "probability": 0.05008171126246452
        },
        {
            "start_logit": 5.676349639892578,
            "end_logit": 5.455193042755127,
            "text": "intermediate-risk, expecting astrocytoma",
            "probability": 0.050057366490364075
        },
        {
            "start_logit": 5.551717758178711,
            "end_logit": 5.525975227355957,
            "text": "high-risk",
            "probability": 0.04743310064077377
        },
        {
            "start_logit": 5.551717758178711,
            "end_logit": 5.474297523498535,
            "text": "high-risk, expecting glioblastoma, isocitrate dehydrogenase-wildtype",
            "probability": 0.045044127851724625
        },
        {
            "start_logit": 5.520155906677246,
            "end_logit": 5.453080177307129,
            "text": "isocitrate dehydrogenase (isocitrate dehydrogenase)-mutant",
            "probability": 0.04272838309407234
        },
        {
            "start_logit": 5.3464508056640625,
            "end_logit": 5.455193042755127,
            "text": "1p/19q-codeleted; (2) intermediate-risk, expecting astrocytoma",
            "probability": 0.03599106892943382
        },
        {
            "start_logit": 5.3464508056640625,
            "end_logit": 5.3186211585998535,
            "text": "1p/19q-codeleted",
            "probability": 0.03139657899737358
        },
        {
            "start_logit": 5.870927810668945,
            "end_logit": 4.469388008117676,
            "text": "oligodendroglioma, isocitrate dehydrogenase",
            "probability": 0.022690430283546448
        },
        {
            "start_logit": 5.844386100769043,
            "end_logit": 4.409854888916016,
            "text": "astrocytoma, isocitrate dehydrogenase-mutant",
            "probability": 0.020819049328565598
        },
        {
            "start_logit": 5.676349639892578,
            "end_logit": 4.409854888916016,
            "text": "intermediate-risk, expecting astrocytoma, isocitrate dehydrogenase-mutant",
            "probability": 0.017598820850253105
        }
    ],
    "6415bc8d690f196b5100000f_0001": [
        {
            "start_logit": 6.802002429962158,
            "end_logit": 7.128030776977539,
            "text": "8%",
            "probability": 0.7718436121940613
        },
        {
            "start_logit": 6.802002429962158,
            "end_logit": 5.697773456573486,
            "text": "8% and 10-12%",
            "probability": 0.1846616417169571
        },
        {
            "start_logit": 5.074664115905762,
            "end_logit": 5.697773456573486,
            "text": "10-12%",
            "probability": 0.03282489627599716
        },
        {
            "start_logit": 3.567133903503418,
            "end_logit": 5.697773456573486,
            "text": "12%",
            "probability": 0.007269279100000858
        },
        {
            "start_logit": -0.09675562381744385,
            "end_logit": 7.128030776977539,
            "text": "about 8%",
            "probability": 0.0007788198417983949
        },
        {
            "start_logit": 6.802002429962158,
            "end_logit": -0.16911762952804565,
            "text": "8",
            "probability": 0.0005228996160440147
        },
        {
            "start_logit": -0.6258310079574585,
            "end_logit": 7.128030776977539,
            "text": "reduced time and costs by online counseling with about 8%",
            "probability": 0.0004588411538861692
        },
        {
            "start_logit": -1.0380711555480957,
            "end_logit": 7.128030776977539,
            "text": "%",
            "probability": 0.0003038287104573101
        },
        {
            "start_logit": 6.802002429962158,
            "end_logit": -1.0214734077453613,
            "text": "8% and 10-12%, respectively.",
            "probability": 0.00022296917450148612
        },
        {
            "start_logit": -0.09675562381744385,
            "end_logit": 5.697773456573486,
            "text": "about 8% and 10-12%",
            "probability": 0.0001863305806182325
        },
        {
            "start_logit": -1.6066170930862427,
            "end_logit": 7.128030776977539,
            "text": "costs by online counseling with about 8%",
            "probability": 0.00017207291966769844
        },
        {
            "start_logit": -1.7370322942733765,
            "end_logit": 7.128030776977539,
            "text": "time and costs by online counseling with about 8%",
            "probability": 0.00015103374607861042
        },
        {
            "start_logit": 6.802002429962158,
            "end_logit": -1.5073728561401367,
            "text": "8% and 10-12%, respectively",
            "probability": 0.00013715814566239715
        },
        {
            "start_logit": -0.6258310079574585,
            "end_logit": 5.697773456573486,
            "text": "reduced time and costs by online counseling with about 8% and 10-12%",
            "probability": 0.00010977653437294066
        },
        {
            "start_logit": 6.802002429962158,
            "end_logit": -1.953029990196228,
            "text": "8% and 10",
            "probability": 8.78364808158949e-05
        },
        {
            "start_logit": -2.4157676696777344,
            "end_logit": 7.128030776977539,
            "text": "online counseling with about 8%",
            "probability": 7.661306881345809e-05
        },
        {
            "start_logit": -1.0380711555480957,
            "end_logit": 5.697773456573486,
            "text": "% and 10-12%",
            "probability": 7.269021443789825e-05
        },
        {
            "start_logit": -1.6066170930862427,
            "end_logit": 5.697773456573486,
            "text": "costs by online counseling with about 8% and 10-12%",
            "probability": 4.1167968447552994e-05
        },
        {
            "start_logit": 5.074664115905762,
            "end_logit": -1.0214734077453613,
            "text": "10-12%, respectively.",
            "probability": 3.963429480791092e-05
        },
        {
            "start_logit": 6.802002429962158,
            "end_logit": -2.765190362930298,
            "text": "8% and 10-12%,",
            "probability": 3.89904307667166e-05
        }
    ],
    "6402bc2d201352f04a000005_0001": [
        {
            "start_logit": 5.623821258544922,
            "end_logit": 5.297891616821289,
            "text": "CD20",
            "probability": 0.9811338186264038
        },
        {
            "start_logit": 5.623821258544922,
            "end_logit": 0.6792497038841248,
            "text": "CD20 on B cells and engage T cells via CD3",
            "probability": 0.009680049493908882
        },
        {
            "start_logit": -0.03915932774543762,
            "end_logit": 5.297891616821289,
            "text": "monospecific antigen-binding regions that target CD20",
            "probability": 0.0034066459629684687
        },
        {
            "start_logit": 5.623821258544922,
            "end_logit": -1.2168127298355103,
            "text": "CD20 on B cells",
            "probability": 0.0014535437803715467
        },
        {
            "start_logit": 5.623821258544922,
            "end_logit": -1.3335434198379517,
            "text": "CD20 on B cells and engage T cells via CD3 in a 1:1 or 2:1 CD20",
            "probability": 0.0012933993712067604
        },
        {
            "start_logit": 5.623821258544922,
            "end_logit": -1.9854390621185303,
            "text": "CD20 on B cells and engage T cells via CD3 in a 1:1 or 2:1 CD20:CD3",
            "probability": 0.0006739347008988261
        },
        {
            "start_logit": -1.7199900150299072,
            "end_logit": 5.297891616821289,
            "text": "20",
            "probability": 0.0006343831191770732
        },
        {
            "start_logit": 5.623821258544922,
            "end_logit": -2.304713249206543,
            "text": "C",
            "probability": 0.0004897325416095555
        },
        {
            "start_logit": 5.623821258544922,
            "end_logit": -2.5026583671569824,
            "text": "CD20 on B cells and engage T cells via CD3 in a 1:1 or 2:1",
            "probability": 0.00040178385097533464
        },
        {
            "start_logit": 5.623821258544922,
            "end_logit": -2.696291208267212,
            "text": "CD20 on B cells and engage T cells via CD3 in a 1:1",
            "probability": 0.0003310540341772139
        },
        {
            "start_logit": -3.1079254150390625,
            "end_logit": 5.297891616821289,
            "text": "antigen-binding regions that target CD20",
            "probability": 0.00015833570796530694
        },
        {
            "start_logit": 1.0738548040390015,
            "end_logit": 0.6792497038841248,
            "text": "CD3",
            "probability": 0.00010229446343146265
        },
        {
            "start_logit": -3.6068687438964844,
            "end_logit": 5.297891616821289,
            "text": "two different monospecific antigen-binding regions that target CD20",
            "probability": 9.613698784960434e-05
        },
        {
            "start_logit": -4.171051025390625,
            "end_logit": 5.297891616821289,
            "text": "ospecific antigen-binding regions that target CD20",
            "probability": 5.468513336381875e-05
        },
        {
            "start_logit": -0.03915932774543762,
            "end_logit": 0.6792497038841248,
            "text": "monospecific antigen-binding regions that target CD20 on B cells and engage T cells via CD3",
            "probability": 3.361059498274699e-05
        },
        {
            "start_logit": 1.0738548040390015,
            "end_logit": -1.1565473079681396,
            "text": "CD3 in a 1:1 or 2:1 CD20:CD3 antigen binding fragment",
            "probability": 1.631457962503191e-05
        },
        {
            "start_logit": 1.0738548040390015,
            "end_logit": -1.3335434198379517,
            "text": "CD3 in a 1:1 or 2:1 CD20",
            "probability": 1.3668076462636236e-05
        },
        {
            "start_logit": 1.0738548040390015,
            "end_logit": -1.4796373844146729,
            "text": "CD3 in a 1:1 or 2:1 CD20:CD3 antigen binding fragment (Fab) format.",
            "probability": 1.181025891128229e-05
        },
        {
            "start_logit": -0.03915932774543762,
            "end_logit": -0.8271657228469849,
            "text": "monospecific antigen-binding regions",
            "probability": 7.451578312611673e-06
        },
        {
            "start_logit": 0.2562500834465027,
            "end_logit": -1.1565473079681396,
            "text": "CD3 antigen binding fragment",
            "probability": 7.202686447271844e-06
        }
    ],
    "6402bc2d201352f04a000005_0002": [
        {
            "start_logit": 6.21357536315918,
            "end_logit": 6.003119945526123,
            "text": "CD20",
            "probability": 0.4394015967845917
        },
        {
            "start_logit": 6.21357536315918,
            "end_logit": 5.635897159576416,
            "text": "CD20/CD3",
            "probability": 0.3043535649776459
        },
        {
            "start_logit": 6.026283264160156,
            "end_logit": 5.635897159576416,
            "text": "CD3",
            "probability": 0.2523704469203949
        },
        {
            "start_logit": -0.172450453042984,
            "end_logit": 6.003119945526123,
            "text": "20",
            "probability": 0.0007403645431622863
        },
        {
            "start_logit": -0.172450453042984,
            "end_logit": 5.635897159576416,
            "text": "20/CD3",
            "probability": 0.0005128174088895321
        },
        {
            "start_logit": 6.21357536315918,
            "end_logit": -1.05372154712677,
            "text": "C",
            "probability": 0.00037854205584153533
        },
        {
            "start_logit": -0.7077648639678955,
            "end_logit": 5.635897159576416,
            "text": "3",
            "probability": 0.0003002469602506608
        },
        {
            "start_logit": 6.21357536315918,
            "end_logit": -1.3021639585494995,
            "text": "CD20/C",
            "probability": 0.0002952683425974101
        },
        {
            "start_logit": 6.026283264160156,
            "end_logit": -1.3021639585494995,
            "text": "C",
            "probability": 0.00024483693414367735
        },
        {
            "start_logit": 6.21357536315918,
            "end_logit": -1.5500304698944092,
            "text": "CD20/CD",
            "probability": 0.00023044631234370172
        },
        {
            "start_logit": 6.026283264160156,
            "end_logit": -1.5500304698944092,
            "text": "CD",
            "probability": 0.00019108642300125211
        },
        {
            "start_logit": 6.21357536315918,
            "end_logit": -1.8233120441436768,
            "text": "CD20/",
            "probability": 0.00017534174548927695
        },
        {
            "start_logit": 6.21357536315918,
            "end_logit": -2.045818567276001,
            "text": "CD20/CD3 T-cell",
            "probability": 0.0001403627684339881
        },
        {
            "start_logit": 6.026283264160156,
            "end_logit": -2.045818567276001,
            "text": "CD3 T-cell",
            "probability": 0.00011638901924015954
        },
        {
            "start_logit": 6.21357536315918,
            "end_logit": -2.2581145763397217,
            "text": "CD",
            "probability": 0.0001135148704634048
        },
        {
            "start_logit": 6.21357536315918,
            "end_logit": -2.311911106109619,
            "text": "CD20/CD3 T-cell engaging bispecific antibody",
            "probability": 0.00010756959090940654
        },
        {
            "start_logit": 6.21357536315918,
            "end_logit": -2.4753575325012207,
            "text": "CD20/CD3 T-cell engaging",
            "probability": 9.134939318755642e-05
        },
        {
            "start_logit": 6.026283264160156,
            "end_logit": -2.311911106109619,
            "text": "CD3 T-cell engaging bispecific antibody",
            "probability": 8.919686661101878e-05
        },
        {
            "start_logit": 6.026283264160156,
            "end_logit": -2.4753575325012207,
            "text": "CD3 T-cell engaging",
            "probability": 7.57470479584299e-05
        },
        {
            "start_logit": 6.21357536315918,
            "end_logit": -2.722921371459961,
            "text": "CD20/CD3 T-cell engaging bispecific",
            "probability": 7.131646998459473e-05
        }
    ],
    "6402bc2d201352f04a000005_0003": [
        {
            "start_logit": 4.50873327255249,
            "end_logit": 3.656507968902588,
            "text": "CD3",
            "probability": 0.7279514074325562
        },
        {
            "start_logit": 2.7429819107055664,
            "end_logit": 3.7313928604125977,
            "text": "CD20",
            "probability": 0.1342049092054367
        },
        {
            "start_logit": 2.7429819107055664,
            "end_logit": 3.656507968902588,
            "text": "CD20\u2009\u00d7\u2009CD3",
            "probability": 0.12452207505702972
        },
        {
            "start_logit": -1.207006812095642,
            "end_logit": 3.656507968902588,
            "text": "3",
            "probability": 0.002397662028670311
        },
        {
            "start_logit": 4.50873327255249,
            "end_logit": -2.5104715824127197,
            "text": "C",
            "probability": 0.0015269230352714658
        },
        {
            "start_logit": 4.50873327255249,
            "end_logit": -2.610238552093506,
            "text": "CD3 T-cell",
            "probability": 0.0013819392770528793
        },
        {
            "start_logit": -2.033740758895874,
            "end_logit": 3.7313928604125977,
            "text": "20",
            "probability": 0.001130482996813953
        },
        {
            "start_logit": 4.50873327255249,
            "end_logit": -2.880596160888672,
            "text": "CD",
            "probability": 0.0010545668192207813
        },
        {
            "start_logit": -2.033740758895874,
            "end_logit": 3.656507968902588,
            "text": "20\u2009\u00d7\u2009CD3",
            "probability": 0.0010489193955436349
        },
        {
            "start_logit": 4.50873327255249,
            "end_logit": -2.916447162628174,
            "text": "CD3 T-cell-engaging bispecific monoclonal antibody",
            "probability": 0.0010174292838200927
        },
        {
            "start_logit": 4.50873327255249,
            "end_logit": -3.500331163406372,
            "text": "CD3 T-cell-engaging bispecific",
            "probability": 0.0005674486747011542
        },
        {
            "start_logit": -2.7289185523986816,
            "end_logit": 3.7313928604125977,
            "text": "Mosunetuzumab is a CD20",
            "probability": 0.0005640949821099639
        },
        {
            "start_logit": -2.7289185523986816,
            "end_logit": 3.656507968902588,
            "text": "Mosunetuzumab is a CD20\u2009\u00d7\u2009CD3",
            "probability": 0.0005233957199379802
        },
        {
            "start_logit": 4.50873327255249,
            "end_logit": -3.680191993713379,
            "text": "CD3 T-cell-engaging bispecific monoclonal antibody that redirects T cells",
            "probability": 0.0004740389995276928
        },
        {
            "start_logit": 4.50873327255249,
            "end_logit": -3.9446563720703125,
            "text": "CD3 T-cell-engaging bispecific monoclonal antibody that redirects T cells to eliminate malignant B",
            "probability": 0.00036388044827617705
        },
        {
            "start_logit": 4.50873327255249,
            "end_logit": -4.115734100341797,
            "text": "CD3 T",
            "probability": 0.0003066624340135604
        },
        {
            "start_logit": 4.50873327255249,
            "end_logit": -4.252230167388916,
            "text": "CD3 T-cell-engaging",
            "probability": 0.0002675352734513581
        },
        {
            "start_logit": 2.7429819107055664,
            "end_logit": -2.5104715824127197,
            "text": "CD20\u2009\u00d7\u2009C",
            "probability": 0.00026119279209524393
        },
        {
            "start_logit": 2.7429819107055664,
            "end_logit": -2.610238552093506,
            "text": "CD20\u2009\u00d7\u2009CD3 T-cell",
            "probability": 0.00023639218125026673
        },
        {
            "start_logit": -3.695558786392212,
            "end_logit": 3.656507968902588,
            "text": "\u00d7\u2009CD3",
            "probability": 0.00019907811656594276
        }
    ],
    "6402bc2d201352f04a000005_0004": [
        {
            "start_logit": 3.238759994506836,
            "end_logit": 2.820413112640381,
            "text": "CD3",
            "probability": 0.7044119238853455
        },
        {
            "start_logit": 1.665985107421875,
            "end_logit": 2.820413112640381,
            "text": "CD20 \u00d7 CD3",
            "probability": 0.14614342153072357
        },
        {
            "start_logit": 1.665985107421875,
            "end_logit": 2.5644454956054688,
            "text": "CD20",
            "probability": 0.11313941329717636
        },
        {
            "start_logit": 3.238759994506836,
            "end_logit": -0.864356517791748,
            "text": "CD3 BsAbs including odronextamab",
            "probability": 0.017682824283838272
        },
        {
            "start_logit": -1.9342917203903198,
            "end_logit": 2.820413112640381,
            "text": "3",
            "probability": 0.003992076031863689
        },
        {
            "start_logit": 1.665985107421875,
            "end_logit": -0.864356517791748,
            "text": "CD20 \u00d7 CD3 BsAbs including odronextamab",
            "probability": 0.0036686318926513195
        },
        {
            "start_logit": 3.238759994506836,
            "end_logit": -2.540090560913086,
            "text": "CD3 BsAbs including odronextamab, mosunetuzumab, glofitamab",
            "probability": 0.0033097071573138237
        },
        {
            "start_logit": 3.238759994506836,
            "end_logit": -3.363675117492676,
            "text": "CD3 BsAbs including odronextamab, mosunetuzumab",
            "probability": 0.0014524839352816343
        },
        {
            "start_logit": -3.0749590396881104,
            "end_logit": 2.820413112640381,
            "text": "20 \u00d7 CD3",
            "probability": 0.0012758908560499549
        },
        {
            "start_logit": -3.0749590396881104,
            "end_logit": 2.5644454956054688,
            "text": "20",
            "probability": 0.0009877519914880395
        },
        {
            "start_logit": 3.238759994506836,
            "end_logit": -3.897862434387207,
            "text": "CD3 BsAbs",
            "probability": 0.0008513669017702341
        },
        {
            "start_logit": 3.238759994506836,
            "end_logit": -4.026508808135986,
            "text": "CD",
            "probability": 0.0007485939422622323
        },
        {
            "start_logit": 1.665985107421875,
            "end_logit": -2.540090560913086,
            "text": "CD20 \u00d7 CD3 BsAbs including odronextamab, mosunetuzumab, glofitamab",
            "probability": 0.0006866605253890157
        },
        {
            "start_logit": 3.238759994506836,
            "end_logit": -4.361950874328613,
            "text": "C",
            "probability": 0.0005352610605768859
        },
        {
            "start_logit": 1.665985107421875,
            "end_logit": -3.363675117492676,
            "text": "CD20 \u00d7 CD3 BsAbs including odronextamab, mosunetuzumab",
            "probability": 0.0003013449313584715
        },
        {
            "start_logit": -4.9993085861206055,
            "end_logit": 2.820413112640381,
            "text": "\u00d7 CD3",
            "probability": 0.00018624258518684655
        },
        {
            "start_logit": 1.665985107421875,
            "end_logit": -3.897862434387207,
            "text": "CD20 \u00d7 CD3 BsAbs",
            "probability": 0.00017663202015683055
        },
        {
            "start_logit": -5.1773271560668945,
            "end_logit": 2.820413112640381,
            "text": "D3",
            "probability": 0.0001558714429847896
        },
        {
            "start_logit": 1.665985107421875,
            "end_logit": -4.026508808135986,
            "text": "CD20 \u00d7 CD",
            "probability": 0.00015530979726463556
        },
        {
            "start_logit": -5.294244766235352,
            "end_logit": 2.820413112640381,
            "text": "D20 \u00d7 CD3",
            "probability": 0.00013867233064956963
        }
    ],
    "6415c6b6690f196b51000015_0001": [
        {
            "start_logit": 5.187557697296143,
            "end_logit": 5.928240776062012,
            "text": "KEYNOTE-024",
            "probability": 0.9708333611488342
        },
        {
            "start_logit": 5.187557697296143,
            "end_logit": 1.2642146348953247,
            "text": "KEYNOTE-024, patients with previously untreated metastatic non-small cell lung cancer",
            "probability": 0.009153425693511963
        },
        {
            "start_logit": 3.001650333404541,
            "end_logit": 2.566459894180298,
            "text": "two randomized, open-label, active-controlled trials",
            "probability": 0.003782806918025017
        },
        {
            "start_logit": -0.817928671836853,
            "end_logit": 5.928240776062012,
            "text": "024",
            "probability": 0.0023932871408760548
        },
        {
            "start_logit": 5.187557697296143,
            "end_logit": -0.08379827439785004,
            "text": "KEYNOTE",
            "probability": 0.0023776560556143522
        },
        {
            "start_logit": 5.187557697296143,
            "end_logit": -0.20251190662384033,
            "text": "KEYNOTE-02",
            "probability": 0.002111506648361683
        },
        {
            "start_logit": 5.187557697296143,
            "end_logit": -0.7407074570655823,
            "text": "KEYNOTE-",
            "probability": 0.0012326992582529783
        },
        {
            "start_logit": -1.5479931831359863,
            "end_logit": 5.928240776062012,
            "text": "chemotherapy. In KEYNOTE-024",
            "probability": 0.0011532724602147937
        },
        {
            "start_logit": 1.746248722076416,
            "end_logit": 2.566459894180298,
            "text": "randomized, open-label, active-controlled trials",
            "probability": 0.0010779538424685597
        },
        {
            "start_logit": 1.64089834690094,
            "end_logit": 2.566459894180298,
            "text": "open-label, active-controlled trials",
            "probability": 0.0009701682720333338
        },
        {
            "start_logit": -1.7589936256408691,
            "end_logit": 5.928240776062012,
            "text": "overall survival (overall survival) for patients randomized to pembrolizumab compared with chemotherapy. In KEYNOTE-024",
            "probability": 0.0009338897070847452
        },
        {
            "start_logit": 1.1305108070373535,
            "end_logit": 2.834446668624878,
            "text": "KEYNOTE-010",
            "probability": 0.0007613311754539609
        },
        {
            "start_logit": 1.330644130706787,
            "end_logit": 2.566459894180298,
            "text": "active-controlled trials",
            "probability": 0.0007113861502148211
        },
        {
            "start_logit": -2.046473979949951,
            "end_logit": 5.928240776062012,
            "text": "4",
            "probability": 0.0007005584775470197
        },
        {
            "start_logit": 5.187557697296143,
            "end_logit": -1.6260638236999512,
            "text": "KEYNOTE-024,",
            "probability": 0.0005085711600258946
        },
        {
            "start_logit": 3.001650333404541,
            "end_logit": 0.5380366444587708,
            "text": "two randomized, open-label, active-controlled trials demonstrating statistically significant improvements in progression-free survival (progression-free survival)",
            "probability": 0.0004976009367965162
        },
        {
            "start_logit": 3.001650333404541,
            "end_logit": 0.34312647581100464,
            "text": "two",
            "probability": 0.0004094801261089742
        },
        {
            "start_logit": 1.746248722076416,
            "end_logit": 0.5380366444587708,
            "text": "randomized, open-label, active-controlled trials demonstrating statistically significant improvements in progression-free survival (progression-free survival)",
            "probability": 0.0001417970343027264
        },
        {
            "start_logit": 1.64089834690094,
            "end_logit": 0.5380366444587708,
            "text": "open-label, active-controlled trials demonstrating statistically significant improvements in progression-free survival (progression-free survival)",
            "probability": 0.0001276186085306108
        },
        {
            "start_logit": 1.330644130706787,
            "end_logit": 0.8004876375198364,
            "text": "active-controlled trials demonstrating statistically significant improvements in progression-free survival (progression-free survival) and overall survival (overall survival)",
            "probability": 0.00012166159285698086
        }
    ],
    "640c8309201352f04a000024_0001": [
        {
            "start_logit": 3.1549949645996094,
            "end_logit": 3.288724660873413,
            "text": "bile acid retention",
            "probability": 0.6303572654724121
        },
        {
            "start_logit": 2.121164083480835,
            "end_logit": 2.2119882106781006,
            "text": "alkaline phosphatase",
            "probability": 0.07637987285852432
        },
        {
            "start_logit": 1.3645626306533813,
            "end_logit": 2.715865135192871,
            "text": "yellowing of the skin and mucus membranes, associated with elevated serum bilirubin levels",
            "probability": 0.05932284891605377
        },
        {
            "start_logit": 0.8723391890525818,
            "end_logit": 2.715865135192871,
            "text": "mucus membranes, associated with elevated serum bilirubin levels",
            "probability": 0.03626203164458275
        },
        {
            "start_logit": 0.7986687421798706,
            "end_logit": 2.715865135192871,
            "text": "serum bilirubin levels",
            "probability": 0.03368662670254707
        },
        {
            "start_logit": 3.1549949645996094,
            "end_logit": 0.10361503064632416,
            "text": "bile acid retention, whether within the hepatocyte or in the bile ducts of any caliber.",
            "probability": 0.026080215349793434
        },
        {
            "start_logit": 2.121164083480835,
            "end_logit": 0.7362924814224243,
            "text": "alkaline phosphatase that is 1.67-times higher than the upper limit of normal",
            "probability": 0.01746193878352642
        },
        {
            "start_logit": 0.6020334362983704,
            "end_logit": 2.2119882106781006,
            "text": "Biochemically, it is defined by a level of alkaline phosphatase",
            "probability": 0.016719713807106018
        },
        {
            "start_logit": 1.9323498010635376,
            "end_logit": 0.7362924814224243,
            "text": "1.67-times higher than the upper limit of normal",
            "probability": 0.014457440935075283
        },
        {
            "start_logit": -0.06273448467254639,
            "end_logit": 2.715865135192871,
            "text": "bilirubin levels",
            "probability": 0.014234909787774086
        },
        {
            "start_logit": -0.10036811232566833,
            "end_logit": 2.715865135192871,
            "text": "elevated serum bilirubin levels",
            "probability": 0.013709156773984432
        },
        {
            "start_logit": 0.09634068608283997,
            "end_logit": 2.2119882106781006,
            "text": "level of alkaline phosphatase",
            "probability": 0.010083450935781002
        },
        {
            "start_logit": 1.3645626306533813,
            "end_logit": 0.7916080951690674,
            "text": "yellowing of the skin and mucus membranes, associated with elevated serum bilirubin",
            "probability": 0.008660199120640755
        },
        {
            "start_logit": 1.2435206174850464,
            "end_logit": 0.7916080951690674,
            "text": "hepatitis), withjaundice (yellowing of the skin and mucus membranes, associated with elevated serum bilirubin",
            "probability": 0.0076729063875973225
        },
        {
            "start_logit": -1.3384819030761719,
            "end_logit": 3.288724660873413,
            "text": "cholestasis refers to bile acid retention",
            "probability": 0.007048464845865965
        },
        {
            "start_logit": 3.1549949645996094,
            "end_logit": -1.2657314538955688,
            "text": "bile acid retention, whether within the hepatocyte or in the bile ducts",
            "probability": 0.006631497293710709
        },
        {
            "start_logit": 1.3645626306533813,
            "end_logit": 0.3981335759162903,
            "text": "yellowing of the skin and mucus membranes",
            "probability": 0.005843109916895628
        },
        {
            "start_logit": 0.8723391890525818,
            "end_logit": 0.7916080951690674,
            "text": "mucus membranes, associated with elevated serum bilirubin",
            "probability": 0.005293681751936674
        },
        {
            "start_logit": 1.2435206174850464,
            "end_logit": 0.3981335759162903,
            "text": "hepatitis), withjaundice (yellowing of the skin and mucus membranes",
            "probability": 0.005176975391805172
        },
        {
            "start_logit": 0.7986687421798706,
            "end_logit": 0.7916080951690674,
            "text": "serum bilirubin",
            "probability": 0.0049177128821611404
        }
    ],
    "640c8309201352f04a000024_0002": [
        {
            "start_logit": 5.23586368560791,
            "end_logit": 5.383882999420166,
            "text": "alkaline phosphatase",
            "probability": 0.2744086682796478
        },
        {
            "start_logit": 5.265063285827637,
            "end_logit": 5.276228904724121,
            "text": "conjugated bilirubin",
            "probability": 0.2537028193473816
        },
        {
            "start_logit": 5.23586368560791,
            "end_logit": 5.276228904724121,
            "text": "alkaline phosphatase, and conjugated bilirubin",
            "probability": 0.24640192091464996
        },
        {
            "start_logit": 3.6408002376556396,
            "end_logit": 5.383882999420166,
            "text": "liver transaminases, alkaline phosphatase",
            "probability": 0.05567629262804985
        },
        {
            "start_logit": 3.6408002376556396,
            "end_logit": 5.276228904724121,
            "text": "liver transaminases, alkaline phosphatase, and conjugated bilirubin",
            "probability": 0.049993887543678284
        },
        {
            "start_logit": 3.6408002376556396,
            "end_logit": 5.267773151397705,
            "text": "liver transaminases",
            "probability": 0.049572911113500595
        },
        {
            "start_logit": 2.411464214324951,
            "end_logit": 5.383882999420166,
            "text": "transaminases, alkaline phosphatase",
            "probability": 0.016284577548503876
        },
        {
            "start_logit": 2.411464214324951,
            "end_logit": 5.276228904724121,
            "text": "transaminases, alkaline phosphatase, and conjugated bilirubin",
            "probability": 0.014622543938457966
        },
        {
            "start_logit": 2.411464214324951,
            "end_logit": 5.267773151397705,
            "text": "transaminases",
            "probability": 0.01449942123144865
        },
        {
            "start_logit": 1.7216362953186035,
            "end_logit": 5.383882999420166,
            "text": "elevated liver transaminases, alkaline phosphatase",
            "probability": 0.00816936045885086
        },
        {
            "start_logit": 1.7216362953186035,
            "end_logit": 5.276228904724121,
            "text": "elevated liver transaminases, alkaline phosphatase, and conjugated bilirubin",
            "probability": 0.0073355804197490215
        },
        {
            "start_logit": 1.7216362953186035,
            "end_logit": 5.267773151397705,
            "text": "elevated liver transaminases",
            "probability": 0.007273814640939236
        },
        {
            "start_logit": -0.5036666393280029,
            "end_logit": 5.276228904724121,
            "text": "bilirubin",
            "probability": 0.0007924968958832324
        },
        {
            "start_logit": 5.23586368560791,
            "end_logit": -1.6865482330322266,
            "text": "alkaline phosphatase,",
            "probability": 0.00023321063781622797
        },
        {
            "start_logit": -2.02786922454834,
            "end_logit": 5.383882999420166,
            "text": "Workup revealed elevated liver transaminases, alkaline phosphatase",
            "probability": 0.0001922199735417962
        },
        {
            "start_logit": 5.23586368560791,
            "end_logit": -1.8818533420562744,
            "text": "alkaline phospha",
            "probability": 0.00019183529366273433
        },
        {
            "start_logit": -2.02786922454834,
            "end_logit": 5.276228904724121,
            "text": "Workup revealed elevated liver transaminases, alkaline phosphatase, and conjugated bilirubin",
            "probability": 0.00017260164895560592
        },
        {
            "start_logit": -2.02786922454834,
            "end_logit": 5.267773151397705,
            "text": "Workup revealed elevated liver transaminases",
            "probability": 0.00017114832007791847
        },
        {
            "start_logit": 5.23586368560791,
            "end_logit": -2.0472774505615234,
            "text": "alkaline phosphatase, and",
            "probability": 0.00016258694813586771
        },
        {
            "start_logit": -2.3297996520996094,
            "end_logit": 5.383882999420166,
            "text": "tase",
            "probability": 0.00014212544192560017
        }
    ],
    "640c8309201352f04a000024_0003": [
        {
            "start_logit": 5.38826847076416,
            "end_logit": 5.447723388671875,
            "text": "conjugated bilirubin",
            "probability": 0.3102322220802307
        },
        {
            "start_logit": 5.38826847076416,
            "end_logit": 5.322990417480469,
            "text": "conjugated bilirubin and alkaline phosphatase",
            "probability": 0.27385208010673523
        },
        {
            "start_logit": 5.13063907623291,
            "end_logit": 5.322990417480469,
            "text": "alkaline phosphatase",
            "probability": 0.21165524423122406
        },
        {
            "start_logit": 5.38826847076416,
            "end_logit": 4.066194534301758,
            "text": "conjugated bilirubin and alkaline phosphatase suggestive of cholestatic jaundice",
            "probability": 0.07792853564023972
        },
        {
            "start_logit": 5.13063907623291,
            "end_logit": 4.066194534301758,
            "text": "alkaline phosphatase suggestive of cholestatic jaundice",
            "probability": 0.060229528695344925
        },
        {
            "start_logit": 4.749769687652588,
            "end_logit": 4.066194534301758,
            "text": "jaundice",
            "probability": 0.041152842342853546
        },
        {
            "start_logit": 1.093636393547058,
            "end_logit": 5.447723388671875,
            "text": "liver enzymes with elevated conjugated bilirubin",
            "probability": 0.004232061095535755
        },
        {
            "start_logit": 1.093636393547058,
            "end_logit": 5.322990417480469,
            "text": "liver enzymes with elevated conjugated bilirubin and alkaline phosphatase",
            "probability": 0.0037357783876359463
        },
        {
            "start_logit": 0.8289564847946167,
            "end_logit": 5.447723388671875,
            "text": "abnormal liver enzymes with elevated conjugated bilirubin",
            "probability": 0.0032479020301252604
        },
        {
            "start_logit": 0.8289564847946167,
            "end_logit": 5.322990417480469,
            "text": "abnormal liver enzymes with elevated conjugated bilirubin and alkaline phosphatase",
            "probability": 0.0028670290485024452
        },
        {
            "start_logit": 0.48565882444381714,
            "end_logit": 5.447723388671875,
            "text": "elevated conjugated bilirubin",
            "probability": 0.0023041486274451017
        },
        {
            "start_logit": 0.48565882444381714,
            "end_logit": 5.322990417480469,
            "text": "elevated conjugated bilirubin and alkaline phosphatase",
            "probability": 0.002033947268500924
        },
        {
            "start_logit": 1.093636393547058,
            "end_logit": 4.066194534301758,
            "text": "liver enzymes with elevated conjugated bilirubin and alkaline phosphatase suggestive of cholestatic jaundice",
            "probability": 0.0010630693286657333
        },
        {
            "start_logit": -0.3441171944141388,
            "end_logit": 5.447723388671875,
            "text": "laboratory tests showed abnormal liver enzymes with elevated conjugated bilirubin",
            "probability": 0.001004947698675096
        },
        {
            "start_logit": -0.4517846703529358,
            "end_logit": 5.447723388671875,
            "text": "bilirubin",
            "probability": 0.0009023686870932579
        },
        {
            "start_logit": -0.3441171944141388,
            "end_logit": 5.322990417480469,
            "text": "laboratory tests showed abnormal liver enzymes with elevated conjugated bilirubin and alkaline phosphatase",
            "probability": 0.0008871000027284026
        },
        {
            "start_logit": 0.8289564847946167,
            "end_logit": 4.066194534301758,
            "text": "abnormal liver enzymes with elevated conjugated bilirubin and alkaline phosphatase suggestive of cholestatic jaundice",
            "probability": 0.0008158542914316058
        },
        {
            "start_logit": -0.4517846703529358,
            "end_logit": 5.322990417480469,
            "text": "bilirubin and alkaline phosphatase",
            "probability": 0.0007965503027662635
        },
        {
            "start_logit": 0.48565882444381714,
            "end_logit": 4.066194534301758,
            "text": "elevated conjugated bilirubin and alkaline phosphatase suggestive of cholestatic jaundice",
            "probability": 0.0005787888076156378
        },
        {
            "start_logit": 5.38826847076416,
            "end_logit": -1.0234318971633911,
            "text": "conjugated bilirubin and alkaline phosphatase suggestive of cholestatic jaundice.",
            "probability": 0.00048006491851992905
        }
    ],
    "640c8309201352f04a000024_0004": [
        {
            "start_logit": 4.643002986907959,
            "end_logit": 4.798840045928955,
            "text": "alanine aminotransferase",
            "probability": 0.09429711848497391
        },
        {
            "start_logit": 4.70544958114624,
            "end_logit": 4.697669982910156,
            "text": "aspartate aminotransferase",
            "probability": 0.0907154530286789
        },
        {
            "start_logit": 4.643002986907959,
            "end_logit": 4.697669982910156,
            "text": "alanine aminotransferase, aspartate aminotransferase",
            "probability": 0.08522383123636246
        },
        {
            "start_logit": 4.70544958114624,
            "end_logit": 4.580683708190918,
            "text": "aspartate aminotransferase, alkaline phosphatase, gamma-glutamyl transpeptidase",
            "probability": 0.08070014417171478
        },
        {
            "start_logit": 4.70544958114624,
            "end_logit": 4.531002998352051,
            "text": "aspartate aminotransferase, alkaline phosphatase",
            "probability": 0.07678886502981186
        },
        {
            "start_logit": 4.643002986907959,
            "end_logit": 4.531002998352051,
            "text": "alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase",
            "probability": 0.07214031368494034
        },
        {
            "start_logit": 4.441777229309082,
            "end_logit": 4.580683708190918,
            "text": "gamma-glutamyl transpeptidase",
            "probability": 0.061995916068553925
        },
        {
            "start_logit": 4.177096843719482,
            "end_logit": 4.580683708190918,
            "text": "alkaline phosphatase, gamma-glutamyl transpeptidase",
            "probability": 0.04757881537079811
        },
        {
            "start_logit": 4.177096843719482,
            "end_logit": 4.531002998352051,
            "text": "alkaline phosphatase",
            "probability": 0.0452728234231472
        },
        {
            "start_logit": 4.36659574508667,
            "end_logit": 4.33305025100708,
            "text": "conjugated bilirubin",
            "probability": 0.044891729950904846
        },
        {
            "start_logit": 4.441777229309082,
            "end_logit": 4.235745906829834,
            "text": "gamma-glutamyl transpeptidase, cholesterol, total serum tasting bile acids",
            "probability": 0.043909478932619095
        },
        {
            "start_logit": 4.219664096832275,
            "end_logit": 4.33305025100708,
            "text": "bile acids and total and conjugated bilirubin",
            "probability": 0.038757409900426865
        },
        {
            "start_logit": 4.219664096832275,
            "end_logit": 4.235745906829834,
            "text": "bile acids",
            "probability": 0.03516381233930588
        },
        {
            "start_logit": 4.441777229309082,
            "end_logit": 4.00151252746582,
            "text": "gamma-glutamyl transpeptidase, cholesterol",
            "probability": 0.03474019467830658
        },
        {
            "start_logit": 3.9907588958740234,
            "end_logit": 4.33305025100708,
            "text": "cholesterol, total serum tasting bile acids and total and conjugated bilirubin",
            "probability": 0.030827779322862625
        },
        {
            "start_logit": 3.9907588958740234,
            "end_logit": 4.235745906829834,
            "text": "cholesterol, total serum tasting bile acids",
            "probability": 0.027969447895884514
        },
        {
            "start_logit": 4.177096843719482,
            "end_logit": 4.00151252746582,
            "text": "alkaline phosphatase, gamma-glutamyl transpeptidase, cholesterol",
            "probability": 0.02666141465306282
        },
        {
            "start_logit": 3.9907588958740234,
            "end_logit": 4.00151252746582,
            "text": "cholesterol",
            "probability": 0.02212877757847309
        },
        {
            "start_logit": 3.6114425659179688,
            "end_logit": 4.33305025100708,
            "text": "total serum tasting bile acids and total and conjugated bilirubin",
            "probability": 0.021096358075737953
        },
        {
            "start_logit": 3.6114425659179688,
            "end_logit": 4.235745906829834,
            "text": "total serum tasting bile acids",
            "probability": 0.019140299409627914
        }
    ],
    "6415c599690f196b51000013_0001": [
        {
            "start_logit": 8.020873069763184,
            "end_logit": 6.046463489532471,
            "text": "Merck",
            "probability": 0.950710117816925
        },
        {
            "start_logit": 8.020873069763184,
            "end_logit": 2.3878543376922607,
            "text": "Merck & Co",
            "probability": 0.02449820563197136
        },
        {
            "start_logit": 8.020873069763184,
            "end_logit": 2.0861992835998535,
            "text": "Merck & Co.",
            "probability": 0.018118709325790405
        },
        {
            "start_logit": 2.3465383052825928,
            "end_logit": 6.046463489532471,
            "text": "pembrolizumab (Keytruda; Merck",
            "probability": 0.003263739636167884
        },
        {
            "start_logit": 8.020873069763184,
            "end_logit": 0.08189365267753601,
            "text": "Merck & Co., Inc., https://www.merck.com)",
            "probability": 0.002441565040498972
        },
        {
            "start_logit": 8.020873069763184,
            "end_logit": -1.2042584419250488,
            "text": "Me",
            "probability": 0.0006746824365109205
        },
        {
            "start_logit": 2.3465383052825928,
            "end_logit": 2.3878543376922607,
            "text": "pembrolizumab (Keytruda; Merck & Co",
            "probability": 8.41010914882645e-05
        },
        {
            "start_logit": 2.3465383052825928,
            "end_logit": 2.0861992835998535,
            "text": "pembrolizumab (Keytruda; Merck & Co.",
            "probability": 6.220060458872467e-05
        },
        {
            "start_logit": -1.9195992946624756,
            "end_logit": 6.046463489532471,
            "text": "k",
            "probability": 4.580951645039022e-05
        },
        {
            "start_logit": 2.3465383052825928,
            "end_logit": 1.7548011541366577,
            "text": "pembrolizumab",
            "probability": 4.46550220658537e-05
        },
        {
            "start_logit": 1.5847585201263428,
            "end_logit": 1.5551629066467285,
            "text": "anaplastic lymphoma kinase",
            "probability": 1.7073858543881215e-05
        },
        {
            "start_logit": 0.9965044260025024,
            "end_logit": 1.5551629066467285,
            "text": "epidermal growth factor receptor (epidermal growth factor receptor) or anaplastic lymphoma kinase",
            "probability": 9.481046618020628e-06
        },
        {
            "start_logit": -3.53495454788208,
            "end_logit": 6.046463489532471,
            "text": "rck",
            "probability": 9.10784729057923e-06
        },
        {
            "start_logit": -3.5502285957336426,
            "end_logit": 6.046463489532471,
            "text": "Food and Drug Administration (Food and Drug Administration) approved pembrolizumab (Keytruda; Merck",
            "probability": 8.969790542323608e-06
        },
        {
            "start_logit": 0.9965044260025024,
            "end_logit": 0.38722342252731323,
            "text": "epidermal growth factor receptor",
            "probability": 2.948673909486388e-06
        },
        {
            "start_logit": 2.3465383052825928,
            "end_logit": -1.2042584419250488,
            "text": "pembrolizumab (Keytruda; Me",
            "probability": 2.3161517219705274e-06
        },
        {
            "start_logit": 1.5847585201263428,
            "end_logit": -0.48782193660736084,
            "text": "anaplastic lymphoma kinase (anaplastic lymphoma kinase)",
            "probability": 2.2134752271085745e-06
        },
        {
            "start_logit": 0.9965044260025024,
            "end_logit": -0.1530999094247818,
            "text": "epidermal growth factor receptor (epidermal growth factor receptor)",
            "probability": 1.7177791278299992e-06
        },
        {
            "start_logit": -0.03218147158622742,
            "end_logit": 0.5162043571472168,
            "text": "programmed death-ligand 1 (programmed death-ligand 1)",
            "probability": 1.1991951396339573e-06
        },
        {
            "start_logit": -1.9195992946624756,
            "end_logit": 2.3878543376922607,
            "text": "k & Co",
            "probability": 1.1804344239862985e-06
        }
    ],
    "6414638c201352f04a000047_0001": [
        {
            "start_logit": 6.282466888427734,
            "end_logit": 5.9724836349487305,
            "text": "thalidomide",
            "probability": 0.976402997970581
        },
        {
            "start_logit": 1.7920951843261719,
            "end_logit": 5.9724836349487305,
            "text": "Cereblon is a well-known target of thalidomide",
            "probability": 0.010951797477900982
        },
        {
            "start_logit": 6.282466888427734,
            "end_logit": 1.4419138431549072,
            "text": "thalidomide and its derivatives",
            "probability": 0.010520284995436668
        },
        {
            "start_logit": 6.282466888427734,
            "end_logit": -0.3499376177787781,
            "text": "thalidomide and its derivatives.",
            "probability": 0.0017532202182337642
        },
        {
            "start_logit": 1.7920951843261719,
            "end_logit": 1.4419138431549072,
            "text": "Cereblon is a well-known target of thalidomide and its derivatives",
            "probability": 0.0001180005056085065
        },
        {
            "start_logit": 6.282466888427734,
            "end_logit": -3.172888994216919,
            "text": "th",
            "probability": 0.00010419438331155106
        },
        {
            "start_logit": -3.300909996032715,
            "end_logit": 5.9724836349487305,
            "text": "ide",
            "probability": 6.723903061356395e-05
        },
        {
            "start_logit": 1.7920951843261719,
            "end_logit": -0.3499376177787781,
            "text": "Cereblon is a well-known target of thalidomide and its derivatives.",
            "probability": 1.966494892258197e-05
        },
        {
            "start_logit": 6.282466888427734,
            "end_logit": -5.331597805023193,
            "text": "thalidomide and its",
            "probability": 1.2031759069941472e-05
        },
        {
            "start_logit": -5.063342094421387,
            "end_logit": 5.9724836349487305,
            "text": "domide",
            "probability": 1.1540027117007412e-05
        },
        {
            "start_logit": -5.359470844268799,
            "end_logit": 5.9724836349487305,
            "text": "ereblon is a well-known target of thalidomide",
            "probability": 8.582226655562408e-06
        },
        {
            "start_logit": -5.403364181518555,
            "end_logit": 5.9724836349487305,
            "text": "alidomide",
            "probability": 8.213668479584157e-06
        },
        {
            "start_logit": 6.282466888427734,
            "end_logit": -6.023221969604492,
            "text": "thalidomide and",
            "probability": 6.025045877322555e-06
        },
        {
            "start_logit": -5.768766403198242,
            "end_logit": 5.9724836349487305,
            "text": "blon is a well-known target of thalidomide",
            "probability": 5.69960775465006e-06
        },
        {
            "start_logit": 6.282466888427734,
            "end_logit": -6.576176643371582,
            "text": "thalidom",
            "probability": 3.465893314569257e-06
        },
        {
            "start_logit": -6.537720203399658,
            "end_logit": 5.9724836349487305,
            "text": "well-known target of thalidomide",
            "probability": 2.641756509547122e-06
        },
        {
            "start_logit": -7.110329627990723,
            "end_logit": 5.9724836349487305,
            "text": "lon is a well-known target of thalidomide",
            "probability": 1.490086560806958e-06
        },
        {
            "start_logit": 1.7920951843261719,
            "end_logit": -3.172888994216919,
            "text": "Cereblon is a well-known target of th",
            "probability": 1.168693643194274e-06
        },
        {
            "start_logit": -7.557783126831055,
            "end_logit": 5.9724836349487305,
            "text": "known target of thalidomide",
            "probability": 9.525436439616897e-07
        },
        {
            "start_logit": -7.781580924987793,
            "end_logit": 5.9724836349487305,
            "text": "of thalidomide",
            "probability": 7.615365120727802e-07
        }
    ],
    "6414638c201352f04a000047_0002": [
        {
            "start_logit": 1.4881068468093872,
            "end_logit": 1.7832770347595215,
            "text": "DHFO",
            "probability": 0.6722627878189087
        },
        {
            "start_logit": -0.4313305914402008,
            "end_logit": 1.7832770347595215,
            "text": "cereblon inhibitors, namely DHFO",
            "probability": 0.09861388802528381
        },
        {
            "start_logit": -0.4313305914402008,
            "end_logit": 1.6131858825683594,
            "text": "cereblon inhibitors",
            "probability": 0.0831894651055336
        },
        {
            "start_logit": 1.4881068468093872,
            "end_logit": -0.5949279069900513,
            "text": "DHFO and its analogs",
            "probability": 0.06233009696006775
        },
        {
            "start_logit": 1.4881068468093872,
            "end_logit": -1.2898362874984741,
            "text": "DHFO and its analogs, with structural features that are slightly different from thalidomide",
            "probability": 0.031110208481550217
        },
        {
            "start_logit": 1.4881068468093872,
            "end_logit": -1.6798644065856934,
            "text": "DHFO and its analogs, with structural features that are slightly different from thalidomide but stronger cereblon-binding affinity.",
            "probability": 0.021062787622213364
        },
        {
            "start_logit": -0.4313305914402008,
            "end_logit": -0.5949279069900513,
            "text": "cereblon inhibitors, namely DHFO and its analogs",
            "probability": 0.009143169037997723
        },
        {
            "start_logit": -0.4313305914402008,
            "end_logit": -1.2898362874984741,
            "text": "cereblon inhibitors, namely DHFO and its analogs, with structural features that are slightly different from thalidomide",
            "probability": 0.0045635392889380455
        },
        {
            "start_logit": -0.5915793776512146,
            "end_logit": -1.2898362874984741,
            "text": "thalidomide",
            "probability": 0.0038878240156918764
        },
        {
            "start_logit": 1.4881068468093872,
            "end_logit": -3.6866345405578613,
            "text": "DHFO and its analogs, with structural features that are slightly different from thalidomide but stronger cereblon-binding affinity",
            "probability": 0.002831305144354701
        },
        {
            "start_logit": -0.5915793776512146,
            "end_logit": -1.6798644065856934,
            "text": "thalidomide but stronger cereblon-binding affinity.",
            "probability": 0.002632204443216324
        },
        {
            "start_logit": -4.525082588195801,
            "end_logit": 1.7832770347595215,
            "text": "novel cereblon inhibitors, namely DHFO",
            "probability": 0.00164453883189708
        },
        {
            "start_logit": -4.582973480224609,
            "end_logit": 1.7832770347595215,
            "text": "FO",
            "probability": 0.0015520383603870869
        },
        {
            "start_logit": -4.525082588195801,
            "end_logit": 1.6131858825683594,
            "text": "novel cereblon inhibitors",
            "probability": 0.0013873130083084106
        },
        {
            "start_logit": 1.4881068468093872,
            "end_logit": -4.972078323364258,
            "text": "DHFO and its analogs,",
            "probability": 0.0007829346577636898
        },
        {
            "start_logit": 1.4881068468093872,
            "end_logit": -5.0395402908325195,
            "text": "D",
            "probability": 0.0007318585412576795
        },
        {
            "start_logit": -5.41536808013916,
            "end_logit": 1.7832770347595215,
            "text": "ereblon inhibitors, namely DHFO",
            "probability": 0.0006751465261913836
        },
        {
            "start_logit": -5.41536808013916,
            "end_logit": 1.6131858825683594,
            "text": "ereblon inhibitors",
            "probability": 0.0005695454892702401
        },
        {
            "start_logit": 1.4881068468093872,
            "end_logit": -5.308923721313477,
            "text": "DHFO and its analogs, with structural features",
            "probability": 0.000559030391741544
        },
        {
            "start_logit": 1.4881068468093872,
            "end_logit": -5.4817633628845215,
            "text": "DHFO and its analogs, with structural features that are slightly different from thalidomide but stronger cereblon",
            "probability": 0.00047029685811139643
        }
    ],
    "6414638c201352f04a000047_0003": [
        {
            "start_logit": 6.686203956604004,
            "end_logit": 7.30351448059082,
            "text": "immunomodulatory drugs",
            "probability": 0.9464581608772278
        },
        {
            "start_logit": 6.686203956604004,
            "end_logit": 4.017651081085205,
            "text": "immunomodulatory drugs (immunomodulatory drugs",
            "probability": 0.03540537878870964
        },
        {
            "start_logit": 6.686203956604004,
            "end_logit": 2.1241002082824707,
            "text": "immunomodulatory drugs (immunomodulatory drugs) thalidomide, lenalidomide",
            "probability": 0.005329796113073826
        },
        {
            "start_logit": 4.036149024963379,
            "end_logit": 4.3422417640686035,
            "text": "immunomodulatory drugs",
            "probability": 0.003460453124716878
        },
        {
            "start_logit": 6.686203956604004,
            "end_logit": 1.5680651664733887,
            "text": "immunomodulatory drugs (immunomodulatory drugs) thalidomide",
            "probability": 0.0030565198976546526
        },
        {
            "start_logit": 6.686203956604004,
            "end_logit": 1.2197821140289307,
            "text": "immunomodulatory drugs (immunomodulatory drugs)",
            "probability": 0.002157595008611679
        },
        {
            "start_logit": 2.530827522277832,
            "end_logit": 4.3422417640686035,
            "text": "lenalidomide, and pomalidomide. immunomodulatory drugs",
            "probability": 0.0007680330891162157
        },
        {
            "start_logit": -0.698427677154541,
            "end_logit": 7.30351448059082,
            "text": "drugs",
            "probability": 0.0005874847993254662
        },
        {
            "start_logit": 2.2511141300201416,
            "end_logit": 4.3422417640686035,
            "text": "thalidomide, lenalidomide, and pomalidomide. immunomodulatory drugs",
            "probability": 0.0005806334665976465
        },
        {
            "start_logit": -0.9886165261268616,
            "end_logit": 7.30351448059082,
            "text": "anti-myeloma effect of the immunomodulatory drugs",
            "probability": 0.00043951047700829804
        },
        {
            "start_logit": -1.2578189373016357,
            "end_logit": 7.30351448059082,
            "text": "myeloma effect of the immunomodulatory drugs",
            "probability": 0.00033578090369701385
        },
        {
            "start_logit": 1.7026511430740356,
            "end_logit": 4.3422417640686035,
            "text": "pomalidomide. immunomodulatory drugs",
            "probability": 0.00033551151864230633
        },
        {
            "start_logit": 1.9512290954589844,
            "end_logit": 4.017651081085205,
            "text": "immunomodulatory drugs",
            "probability": 0.00031095376471057534
        },
        {
            "start_logit": 6.686203956604004,
            "end_logit": -0.7723707556724548,
            "text": "immunomodulatory",
            "probability": 0.0002942989522125572
        },
        {
            "start_logit": -2.198918104171753,
            "end_logit": 7.30351448059082,
            "text": "modulates the anti-myeloma effect of the immunomodulatory drugs",
            "probability": 0.0001310212683165446
        },
        {
            "start_logit": -2.478646755218506,
            "end_logit": 7.30351448059082,
            "text": "nomodulatory drugs",
            "probability": 9.905068873194978e-05
        },
        {
            "start_logit": 2.530827522277832,
            "end_logit": 2.1241002082824707,
            "text": "lenalidomide",
            "probability": 8.357052138308063e-05
        },
        {
            "start_logit": 2.2511141300201416,
            "end_logit": 2.1241002082824707,
            "text": "thalidomide, lenalidomide",
            "probability": 6.317939551081508e-05
        },
        {
            "start_logit": 6.686203956604004,
            "end_logit": -2.425901412963867,
            "text": "im",
            "probability": 5.6320928706554696e-05
        },
        {
            "start_logit": 1.9512290954589844,
            "end_logit": 2.1241002082824707,
            "text": "immunomodulatory drugs) thalidomide, lenalidomide",
            "probability": 4.6809836931061e-05
        }
    ],
    "6414638c201352f04a000047_0004": [
        {
            "start_logit": 6.370087146759033,
            "end_logit": 6.5581374168396,
            "text": "immunomodulatory agents",
            "probability": 0.7839908599853516
        },
        {
            "start_logit": 6.370087146759033,
            "end_logit": 4.836223125457764,
            "text": "immunomodulatory agents (immunomodulatory drugs\u00ae) lenalidomide",
            "probability": 0.14011773467063904
        },
        {
            "start_logit": 5.1630167961120605,
            "end_logit": 4.836223125457764,
            "text": "lenalidomide",
            "probability": 0.04190531373023987
        },
        {
            "start_logit": 6.370087146759033,
            "end_logit": 2.345507860183716,
            "text": "immunomodulatory agents (immunomodulatory drugs",
            "probability": 0.011608853004872799
        },
        {
            "start_logit": 1.728493571281433,
            "end_logit": 6.5581374168396,
            "text": "Cereblon (cereblon)-targeting immunomodulatory agents",
            "probability": 0.007559487596154213
        },
        {
            "start_logit": 5.1630167961120605,
            "end_logit": 2.6309306621551514,
            "text": "lenalidomide (Lenacapavir) and pomalidomide",
            "probability": 0.004618730861693621
        },
        {
            "start_logit": 6.370087146759033,
            "end_logit": 1.0899752378463745,
            "text": "immunomodulatory agents (immunomodulatory drugs\u00ae) lenalidomide (Lenacapavir",
            "probability": 0.0033076407853513956
        },
        {
            "start_logit": 6.370087146759033,
            "end_logit": 0.7666112184524536,
            "text": "immunomodulatory agents (immunomodulatory drugs\u00ae)",
            "probability": 0.0023937735240906477
        },
        {
            "start_logit": 3.7817635536193848,
            "end_logit": 2.6309306621551514,
            "text": "pomalidomide",
            "probability": 0.0011605183826759458
        },
        {
            "start_logit": 5.1630167961120605,
            "end_logit": 1.0899752378463745,
            "text": "lenalidomide (Lenacapavir",
            "probability": 0.0009892233647406101
        },
        {
            "start_logit": 6.370087146759033,
            "end_logit": -0.5273211598396301,
            "text": "immunomodulatory",
            "probability": 0.0006563497590832412
        },
        {
            "start_logit": 6.370087146759033,
            "end_logit": -0.6221805810928345,
            "text": "immunomodulatory agents (immunomodulatory drugs\u00ae) lenalidomide (Lenacapavir)",
            "probability": 0.0005969507619738579
        },
        {
            "start_logit": 0.17883670330047607,
            "end_logit": 4.836223125457764,
            "text": "immunomodulatory drugs\u00ae) lenalidomide",
            "probability": 0.0002868581796064973
        },
        {
            "start_logit": 5.1630167961120605,
            "end_logit": -0.5351107716560364,
            "text": "lenalidomide (Lenacapavir) and pomalidomide (pomalidomide)",
            "probability": 0.00019477283058222383
        },
        {
            "start_logit": 5.1630167961120605,
            "end_logit": -0.6221805810928345,
            "text": "lenalidomide (Lenacapavir)",
            "probability": 0.00017853137978818268
        },
        {
            "start_logit": -2.220791816711426,
            "end_logit": 6.5581374168396,
            "text": "agents",
            "probability": 0.00014565972378477454
        },
        {
            "start_logit": 1.728493571281433,
            "end_logit": 2.345507860183716,
            "text": "Cereblon (cereblon)-targeting immunomodulatory agents (immunomodulatory drugs",
            "probability": 0.00011193622776772827
        },
        {
            "start_logit": -2.9838638305664062,
            "end_logit": 6.5581374168396,
            "text": "nomodulatory agents",
            "probability": 6.791127088945359e-05
        },
        {
            "start_logit": 5.1630167961120605,
            "end_logit": -1.7125577926635742,
            "text": "lenalidomide (Lenacapavir) and pomalidomide (pomalidomide",
            "probability": 6.000251596560702e-05
        },
        {
            "start_logit": 3.7817635536193848,
            "end_logit": -0.5351107716560364,
            "text": "pomalidomide (pomalidomide)",
            "probability": 4.8939302359940484e-05
        }
    ],
    "6414638c201352f04a000047_0005": [
        {
            "start_logit": 7.45710563659668,
            "end_logit": 6.574158668518066,
            "text": "Thalidomide",
            "probability": 0.993831992149353
        },
        {
            "start_logit": 7.45710563659668,
            "end_logit": 0.8838649392127991,
            "text": "Thalidomide, well known for its potent teratogenicity, has been re-evaluated as a clinically effective drug",
            "probability": 0.0033577624708414078
        },
        {
            "start_logit": 7.45710563659668,
            "end_logit": 0.058330222964286804,
            "text": "Thalidomide, well known for its potent teratogenicity,",
            "probability": 0.0014707015361636877
        },
        {
            "start_logit": 7.45710563659668,
            "end_logit": -0.3387932777404785,
            "text": "Thalidomide, well known for its potent teratogenicity",
            "probability": 0.0009886807529255748
        },
        {
            "start_logit": 7.45710563659668,
            "end_logit": -1.8737907409667969,
            "text": "Th",
            "probability": 0.00021301743981894106
        },
        {
            "start_logit": 7.45710563659668,
            "end_logit": -3.6013946533203125,
            "text": "Thalidomide, well known for its potent teratogenic",
            "probability": 3.7855268601560965e-05
        },
        {
            "start_logit": -2.800292491912842,
            "end_logit": 6.574158668518066,
            "text": "ide",
            "probability": 3.488039146759547e-05
        },
        {
            "start_logit": 0.8029115200042725,
            "end_logit": 2.3072144985198975,
            "text": "thalidomide had been unclear until recently, we identified cereblon (cereblon) as a primary direct target of this drug",
            "probability": 1.7960675904760137e-05
        },
        {
            "start_logit": 7.45710563659668,
            "end_logit": -4.780157089233398,
            "text": "Thalidomide, well known for its potent teratogenicity, has been re-evaluated as a clinically effective",
            "probability": 1.1646524399111513e-05
        },
        {
            "start_logit": 7.45710563659668,
            "end_logit": -4.815638065338135,
            "text": "Thalidomide, well known",
            "probability": 1.1240531421208289e-05
        },
        {
            "start_logit": 1.127716302871704,
            "end_logit": 0.8838649392127991,
            "text": "teratogenicity, has been re-evaluated as a clinically effective drug",
            "probability": 5.987300482956925e-06
        },
        {
            "start_logit": -0.6232011914253235,
            "end_logit": 2.3072144985198975,
            "text": "this drug",
            "probability": 4.314892976253759e-06
        },
        {
            "start_logit": 0.8029115200042725,
            "end_logit": 0.8182627558708191,
            "text": "thalidomide",
            "probability": 4.052094936923822e-06
        },
        {
            "start_logit": 1.127716302871704,
            "end_logit": 0.058330222964286804,
            "text": "teratogenicity,",
            "probability": 2.62244157056557e-06
        },
        {
            "start_logit": -1.3278518915176392,
            "end_logit": 2.3072144985198975,
            "text": "cereblon (cereblon) as a primary direct target of this drug",
            "probability": 2.132770305252052e-06
        },
        {
            "start_logit": 1.127716302871704,
            "end_logit": -0.2763737440109253,
            "text": "teratogenicity, has been re-evaluated as a clinically effective drug for the treatment of multiple myeloma",
            "probability": 1.8764869764709147e-06
        },
        {
            "start_logit": 1.127716302871704,
            "end_logit": -0.3387932777404785,
            "text": "teratogenicity",
            "probability": 1.7629390640649945e-06
        },
        {
            "start_logit": 1.127716302871704,
            "end_logit": -1.403820276260376,
            "text": "teratogenicity, has been re-evaluated as a clinically effective drug for the treatment of multiple myeloma.",
            "probability": 6.077176522012451e-07
        },
        {
            "start_logit": -1.4710161685943604,
            "end_logit": 0.8182627558708191,
            "text": "multiple myeloma. Although the direct target of thalidomide",
            "probability": 4.169893088601384e-07
        },
        {
            "start_logit": -2.979107618331909,
            "end_logit": 2.3072144985198975,
            "text": "drug",
            "probability": 4.090843219728413e-07
        }
    ],
    "6414638c201352f04a000047_0006": [
        {
            "start_logit": 7.805014610290527,
            "end_logit": 8.05156135559082,
            "text": "immunomodulatory drugs",
            "probability": 0.9890989065170288
        },
        {
            "start_logit": 5.565552711486816,
            "end_logit": 5.735098838806152,
            "text": "immunomodulatory drugs",
            "probability": 0.010390271432697773
        },
        {
            "start_logit": -0.4473809003829956,
            "end_logit": 8.05156135559082,
            "text": "drugs",
            "probability": 0.0002577922132331878
        },
        {
            "start_logit": 7.805014610290527,
            "end_logit": -1.1104217767715454,
            "text": "immunomodulatory",
            "probability": 0.00010381038737250492
        },
        {
            "start_logit": 7.805014610290527,
            "end_logit": -1.4611215591430664,
            "text": "im",
            "probability": 7.310280489036813e-05
        },
        {
            "start_logit": -2.7439942359924316,
            "end_logit": 8.05156135559082,
            "text": "The molecular mechanism of action of immunomodulatory drugs",
            "probability": 2.5933619326679036e-05
        },
        {
            "start_logit": -3.7704734802246094,
            "end_logit": 8.05156135559082,
            "text": "nomodulatory drugs",
            "probability": 9.291143214795738e-06
        },
        {
            "start_logit": 7.805014610290527,
            "end_logit": -3.7676432132720947,
            "text": "immunomodulator",
            "probability": 7.281560556293698e-06
        },
        {
            "start_logit": 7.805014610290527,
            "end_logit": -3.9148635864257812,
            "text": "immunomodulatory drugs remained unclear for a long time until 2010 when the protein cereblon",
            "probability": 6.284741175477393e-06
        },
        {
            "start_logit": 7.805014610290527,
            "end_logit": -3.993626594543457,
            "text": "immunomodulatory drugs remained unclear for a long time until 2010 when the protein cereblon (cereblon)",
            "probability": 5.808728474221425e-06
        },
        {
            "start_logit": 7.805014610290527,
            "end_logit": -4.188037872314453,
            "text": "immu",
            "probability": 4.78243782708887e-06
        },
        {
            "start_logit": -4.508874416351318,
            "end_logit": 8.05156135559082,
            "text": "modulatory drugs",
            "probability": 4.4400294427759945e-06
        },
        {
            "start_logit": -4.847142696380615,
            "end_logit": 8.05156135559082,
            "text": "munomodulatory drugs",
            "probability": 3.1657586987421382e-06
        },
        {
            "start_logit": -2.950108528137207,
            "end_logit": 5.735098838806152,
            "text": "cereblon (cereblon) was identified as a primary direct target. immunomodulatory drugs",
            "probability": 2.0812401544390013e-06
        },
        {
            "start_logit": 5.565552711486816,
            "end_logit": -2.9256958961486816,
            "text": "immunomodulatory",
            "probability": 1.800079530767107e-06
        },
        {
            "start_logit": -3.12442684173584,
            "end_logit": 5.735098838806152,
            "text": "drugs",
            "probability": 1.7483031342635513e-06
        },
        {
            "start_logit": 5.565552711486816,
            "end_logit": -3.3732779026031494,
            "text": "immunomodulatory drugs binds to cereblon",
            "probability": 1.15055991045665e-06
        },
        {
            "start_logit": -3.555980682373047,
            "end_logit": 5.735098838806152,
            "text": "direct target. immunomodulatory drugs",
            "probability": 1.1355211881891591e-06
        },
        {
            "start_logit": -4.141395092010498,
            "end_logit": 5.735098838806152,
            "text": "cereblon) was identified as a primary direct target. immunomodulatory drugs",
            "probability": 6.323431307464489e-07
        },
        {
            "start_logit": 5.565552711486816,
            "end_logit": -4.074518203735352,
            "text": "im",
            "probability": 5.70642782804498e-07
        }
    ],
    "63f03a20f36125a42600001c_0001": [
        {
            "start_logit": 6.63063383102417,
            "end_logit": 6.437858581542969,
            "text": "tixagevimab",
            "probability": 0.33611583709716797
        },
        {
            "start_logit": 6.63063383102417,
            "end_logit": 6.430886268615723,
            "text": "tixagevimab [AZD8895] and cilgavimab",
            "probability": 0.3337801992893219
        },
        {
            "start_logit": 6.57087516784668,
            "end_logit": 6.430886268615723,
            "text": "cilgavimab",
            "probability": 0.31441837549209595
        },
        {
            "start_logit": 2.665895938873291,
            "end_logit": 6.437858581542969,
            "text": "monoclonal antibodies (tixagevimab",
            "probability": 0.006377122830599546
        },
        {
            "start_logit": 2.665895938873291,
            "end_logit": 6.430886268615723,
            "text": "monoclonal antibodies (tixagevimab [AZD8895] and cilgavimab",
            "probability": 0.006332820281386375
        },
        {
            "start_logit": 0.2752406597137451,
            "end_logit": 6.430886268615723,
            "text": "ilgavimab",
            "probability": 0.0005798941128887236
        },
        {
            "start_logit": -0.43848657608032227,
            "end_logit": 6.437858581542969,
            "text": "long-acting monoclonal antibodies (tixagevimab",
            "probability": 0.0002860281674657017
        },
        {
            "start_logit": -0.4553181529045105,
            "end_logit": 6.437858581542969,
            "text": "ixagevimab",
            "probability": 0.00028125420794822276
        },
        {
            "start_logit": -0.4553181529045105,
            "end_logit": 6.430886268615723,
            "text": "ixagevimab [AZD8895] and cilgavimab",
            "probability": 0.00027930003125220537
        },
        {
            "start_logit": 6.63063383102417,
            "end_logit": -0.8910712599754333,
            "text": "tixagevimab [AZD8895]",
            "probability": 0.00022058449394535273
        },
        {
            "start_logit": 6.63063383102417,
            "end_logit": -1.1124613285064697,
            "text": "tixagevimab [AZD8895] and c",
            "probability": 0.0001767772773746401
        },
        {
            "start_logit": 6.63063383102417,
            "end_logit": -1.1607937812805176,
            "text": "tixagevima",
            "probability": 0.00016843642515596002
        },
        {
            "start_logit": 6.57087516784668,
            "end_logit": -1.1124613285064697,
            "text": "c",
            "probability": 0.00016652281919959933
        },
        {
            "start_logit": 6.63063383102417,
            "end_logit": -1.277779221534729,
            "text": "t",
            "probability": 0.00014984073641244322
        },
        {
            "start_logit": 6.57087516784668,
            "end_logit": -1.319901466369629,
            "text": "cilgavimab [AZD1061]), has been authorized for the prevention and treatment of coronavirus disease 2019",
            "probability": 0.00013532671437133104
        },
        {
            "start_logit": -1.296506643295288,
            "end_logit": 6.430886268615723,
            "text": "b",
            "probability": 0.00012043348397128284
        },
        {
            "start_logit": -1.3401410579681396,
            "end_logit": 6.437858581542969,
            "text": "b",
            "probability": 0.00011609809735091403
        },
        {
            "start_logit": -1.3401410579681396,
            "end_logit": 6.430886268615723,
            "text": "b [AZD8895] and cilgavimab",
            "probability": 0.00011529144831001759
        },
        {
            "start_logit": 6.63063383102417,
            "end_logit": -1.7769122123718262,
            "text": "tixagevimab [AZD8895] and cilgavima",
            "probability": 9.096181747736409e-05
        },
        {
            "start_logit": -1.6072334051132202,
            "end_logit": 6.437858581542969,
            "text": "two long-acting monoclonal antibodies (tixagevimab",
            "probability": 8.88850336195901e-05
        }
    ],
    "63f03a20f36125a42600001c_0002": [
        {
            "start_logit": 6.997196674346924,
            "end_logit": 6.745370864868164,
            "text": "tixagevimab",
            "probability": 0.35386714339256287
        },
        {
            "start_logit": 6.997196674346924,
            "end_logit": 6.723801612854004,
            "text": "tixagevimab-cilgavimab",
            "probability": 0.34631654620170593
        },
        {
            "start_logit": 6.842432022094727,
            "end_logit": 6.723801612854004,
            "text": "cilgavimab",
            "probability": 0.2966603934764862
        },
        {
            "start_logit": 6.997196674346924,
            "end_logit": -0.28498896956443787,
            "text": "tixagevimab-cilgavima",
            "probability": 0.00031303579453378916
        },
        {
            "start_logit": -0.15570688247680664,
            "end_logit": 6.745370864868164,
            "text": "Intramuscular AZD7442 (tixagevimab",
            "probability": 0.00027693246374838054
        },
        {
            "start_logit": -0.15570688247680664,
            "end_logit": 6.723801612854004,
            "text": "Intramuscular AZD7442 (tixagevimab-cilgavimab",
            "probability": 0.0002710231929086149
        },
        {
            "start_logit": 6.842432022094727,
            "end_logit": -0.28498896956443787,
            "text": "cilgavima",
            "probability": 0.0002681516925804317
        },
        {
            "start_logit": -0.1978018581867218,
            "end_logit": 6.723801612854004,
            "text": "ilgavimab",
            "probability": 0.00025985122192651033
        },
        {
            "start_logit": 6.997196674346924,
            "end_logit": -0.5189297199249268,
            "text": "tixagevima",
            "probability": 0.0002477391390129924
        },
        {
            "start_logit": 6.997196674346924,
            "end_logit": -0.6907068490982056,
            "text": "tixagevimab-c",
            "probability": 0.00020863777899648994
        },
        {
            "start_logit": 6.997196674346924,
            "end_logit": -0.7383601665496826,
            "text": "t",
            "probability": 0.00019892871205229312
        },
        {
            "start_logit": 6.842432022094727,
            "end_logit": -0.6907068490982056,
            "text": "c",
            "probability": 0.00017872262105811387
        },
        {
            "start_logit": -0.6863458752632141,
            "end_logit": 6.723801612854004,
            "text": "gavimab",
            "probability": 0.00015942366735544056
        },
        {
            "start_logit": -0.957106351852417,
            "end_logit": 6.723801612854004,
            "text": "b",
            "probability": 0.00012160825281171128
        },
        {
            "start_logit": -1.009344458580017,
            "end_logit": 6.745370864868164,
            "text": "b",
            "probability": 0.00011793534213211387
        },
        {
            "start_logit": 6.997196674346924,
            "end_logit": -1.2697347402572632,
            "text": "tixagevimab-cilgavimab) for prevention of Covid-19.",
            "probability": 0.00011692955013131723
        },
        {
            "start_logit": -1.009344458580017,
            "end_logit": 6.723801612854004,
            "text": "b-cilgavimab",
            "probability": 0.00011541868298081681
        },
        {
            "start_logit": -1.1563351154327393,
            "end_logit": 6.745370864868164,
            "text": "ixagevimab",
            "probability": 0.00010181380639551207
        },
        {
            "start_logit": 6.842432022094727,
            "end_logit": -1.2697347402572632,
            "text": "cilgavimab) for prevention of Covid-19.",
            "probability": 0.00010016375017585233
        },
        {
            "start_logit": -1.1563351154327393,
            "end_logit": 6.723801612854004,
            "text": "ixagevimab-cilgavimab",
            "probability": 9.964127093553543e-05
        }
    ],
    "63f03a20f36125a42600001c_0003": [
        {
            "start_logit": 7.0805182456970215,
            "end_logit": 6.768754959106445,
            "text": "Tixagevimab",
            "probability": 0.3588307499885559
        },
        {
            "start_logit": 7.0805182456970215,
            "end_logit": 6.72383975982666,
            "text": "Tixagevimab-Cilgavimab",
            "probability": 0.34307006001472473
        },
        {
            "start_logit": 6.9306135177612305,
            "end_logit": 6.72383975982666,
            "text": "Cilgavimab",
            "probability": 0.2953113913536072
        },
        {
            "start_logit": 0.8279160261154175,
            "end_logit": 6.72383975982666,
            "text": "ilgavimab",
            "probability": 0.0006605602102354169
        },
        {
            "start_logit": -0.2402699738740921,
            "end_logit": 6.768754959106445,
            "text": "ixagevimab",
            "probability": 0.00023741679615341127
        },
        {
            "start_logit": 7.0805182456970215,
            "end_logit": -0.5741090178489685,
            "text": "Tixagevimab-C",
            "probability": 0.00023223308380693197
        },
        {
            "start_logit": 7.0805182456970215,
            "end_logit": -0.5752790570259094,
            "text": "T",
            "probability": 0.00023196148686110973
        },
        {
            "start_logit": -0.2402699738740921,
            "end_logit": 6.72383975982666,
            "text": "ixagevimab-Cilgavimab",
            "probability": 0.000226989111979492
        },
        {
            "start_logit": 6.9306135177612305,
            "end_logit": -0.5741090178489685,
            "text": "C",
            "probability": 0.00019990390865132213
        },
        {
            "start_logit": 7.0805182456970215,
            "end_logit": -0.9609590172767639,
            "text": "Tixagevima",
            "probability": 0.00015773110499139875
        },
        {
            "start_logit": 7.0805182456970215,
            "end_logit": -1.0703262090682983,
            "text": "Tixagevimab-Cilgavima",
            "probability": 0.000141390337375924
        },
        {
            "start_logit": 6.9306135177612305,
            "end_logit": -1.0703262090682983,
            "text": "Cilgavima",
            "probability": 0.00012170738773420453
        },
        {
            "start_logit": -0.9157059192657471,
            "end_logit": 6.72383975982666,
            "text": "b",
            "probability": 0.00011552262731129304
        },
        {
            "start_logit": -0.9639657735824585,
            "end_logit": 6.768754959106445,
            "text": "b",
            "probability": 0.00011513679783092812
        },
        {
            "start_logit": -0.9639657735824585,
            "end_logit": 6.72383975982666,
            "text": "b-Cilgavimab",
            "probability": 0.0001100799345294945
        },
        {
            "start_logit": -1.263832926750183,
            "end_logit": 6.72383975982666,
            "text": "gavimab",
            "probability": 8.156002149917185e-05
        },
        {
            "start_logit": -1.7770023345947266,
            "end_logit": 6.768754959106445,
            "text": "agevimab",
            "probability": 5.10642712470144e-05
        },
        {
            "start_logit": -1.7770023345947266,
            "end_logit": 6.72383975982666,
            "text": "agevimab-Cilgavimab",
            "probability": 4.882145003648475e-05
        },
        {
            "start_logit": -2.295322895050049,
            "end_logit": 6.72383975982666,
            "text": "vimab",
            "probability": 2.9074129997752607e-05
        },
        {
            "start_logit": 7.0805182456970215,
            "end_logit": -2.741170644760132,
            "text": "Tix",
            "probability": 2.6593857910484076e-05
        }
    ],
    "63f03a20f36125a42600001c_0004": [
        {
            "start_logit": 6.949824333190918,
            "end_logit": 6.684890270233154,
            "text": "Tixagevimab",
            "probability": 0.34604907035827637
        },
        {
            "start_logit": 6.949824333190918,
            "end_logit": 6.677510738372803,
            "text": "Tixagevimab-Cilgavimab",
            "probability": 0.34350478649139404
        },
        {
            "start_logit": 6.8393096923828125,
            "end_logit": 6.677510738372803,
            "text": "Cilgavimab",
            "probability": 0.30756527185440063
        },
        {
            "start_logit": -0.12856632471084595,
            "end_logit": 6.677510738372803,
            "text": "ilgavimab",
            "probability": 0.0002896189980674535
        },
        {
            "start_logit": 6.949824333190918,
            "end_logit": -0.421123206615448,
            "text": "Tixagevimab-Cilgavimab, (Evusheld)",
            "probability": 0.0002838151413016021
        },
        {
            "start_logit": 6.8393096923828125,
            "end_logit": -0.421123206615448,
            "text": "Cilgavimab, (Evusheld)",
            "probability": 0.0002541204448789358
        },
        {
            "start_logit": 6.949824333190918,
            "end_logit": -0.659107506275177,
            "text": "Tixagevima",
            "probability": 0.00022370727674569935
        },
        {
            "start_logit": 6.949824333190918,
            "end_logit": -0.714546799659729,
            "text": "Tixagevimab-C",
            "probability": 0.00021164267673157156
        },
        {
            "start_logit": 6.949824333190918,
            "end_logit": -0.798150897026062,
            "text": "T",
            "probability": 0.00019466789672151208
        },
        {
            "start_logit": 6.8393096923828125,
            "end_logit": -0.714546799659729,
            "text": "C",
            "probability": 0.00018949918739963323
        },
        {
            "start_logit": 6.949824333190918,
            "end_logit": -0.8717617392539978,
            "text": "Tixagevimab-Cilgavima",
            "probability": 0.00018085296323988587
        },
        {
            "start_logit": 6.8393096923828125,
            "end_logit": -0.8717617392539978,
            "text": "Cilgavima",
            "probability": 0.00016193088958971202
        },
        {
            "start_logit": -0.8547162413597107,
            "end_logit": 6.684890270233154,
            "text": "Intramuscular AZD7442 (Tixagevimab",
            "probability": 0.00014114612713456154
        },
        {
            "start_logit": -0.8547162413597107,
            "end_logit": 6.677510738372803,
            "text": "Intramuscular AZD7442 (Tixagevimab-Cilgavimab",
            "probability": 0.00014010835730005056
        },
        {
            "start_logit": -0.9665204286575317,
            "end_logit": 6.677510738372803,
            "text": "b",
            "probability": 0.00012528762454167008
        },
        {
            "start_logit": -0.9865800142288208,
            "end_logit": 6.684890270233154,
            "text": "b",
            "probability": 0.00012370901822578162
        },
        {
            "start_logit": -0.9865800142288208,
            "end_logit": 6.677510738372803,
            "text": "b-Cilgavimab",
            "probability": 0.00012279945076443255
        },
        {
            "start_logit": -1.1291412115097046,
            "end_logit": 6.677510738372803,
            "text": "gavimab",
            "probability": 0.00010648362513165921
        },
        {
            "start_logit": -1.6149070262908936,
            "end_logit": 6.684890270233154,
            "text": "ixagevimab",
            "probability": 6.599673361051828e-05
        },
        {
            "start_logit": -1.6149070262908936,
            "end_logit": 6.677510738372803,
            "text": "ixagevimab-Cilgavimab",
            "probability": 6.551149272127077e-05
        }
    ],
    "640ddd9d201352f04a000028_0001": [
        {
            "start_logit": 7.041965484619141,
            "end_logit": 6.698691368103027,
            "text": "Nivolumab",
            "probability": 0.3474629521369934
        },
        {
            "start_logit": 7.041965484619141,
            "end_logit": 6.694378852844238,
            "text": "Nivolumab and Pembrolizumab",
            "probability": 0.34596773982048035
        },
        {
            "start_logit": 6.881570816040039,
            "end_logit": 6.694378852844238,
            "text": "Pembrolizumab",
            "probability": 0.29469794034957886
        },
        {
            "start_logit": 2.7868220806121826,
            "end_logit": 6.698691368103027,
            "text": "programmed cell death protein 1 (programmed death 1) inhibitors, Nivolumab",
            "probability": 0.004930867347866297
        },
        {
            "start_logit": 2.7868220806121826,
            "end_logit": 6.694378852844238,
            "text": "programmed cell death protein 1 (programmed death 1) inhibitors, Nivolumab and Pembrolizumab",
            "probability": 0.004909649025648832
        },
        {
            "start_logit": 7.041965484619141,
            "end_logit": 0.2697021961212158,
            "text": "Nivolumab and Pembrolizumab.",
            "probability": 0.0005608334322459996
        },
        {
            "start_logit": 6.881570816040039,
            "end_logit": 0.2697021961212158,
            "text": "Pembrolizumab.",
            "probability": 0.00047772214747965336
        },
        {
            "start_logit": 7.041965484619141,
            "end_logit": -0.7343760132789612,
            "text": "Nivolumab and P",
            "probability": 0.00020547947497107089
        },
        {
            "start_logit": 7.041965484619141,
            "end_logit": -0.7863898873329163,
            "text": "Ni",
            "probability": 0.00019506488752085716
        },
        {
            "start_logit": 6.881570816040039,
            "end_logit": -0.7343760132789612,
            "text": "P",
            "probability": 0.0001750289520714432
        },
        {
            "start_logit": 7.041965484619141,
            "end_logit": -1.795197606086731,
            "text": "Nivolumab and Pembrolizuma",
            "probability": 7.113109313650057e-05
        },
        {
            "start_logit": -1.4535995721817017,
            "end_logit": 6.694378852844238,
            "text": "b",
            "probability": 7.0706351834815e-05
        },
        {
            "start_logit": -1.4761192798614502,
            "end_logit": 6.698691368103027,
            "text": "ab",
            "probability": 6.943068001419306e-05
        },
        {
            "start_logit": -1.4761192798614502,
            "end_logit": 6.694378852844238,
            "text": "ab and Pembrolizumab",
            "probability": 6.913190736668184e-05
        },
        {
            "start_logit": 6.881570816040039,
            "end_logit": -1.795197606086731,
            "text": "Pembrolizuma",
            "probability": 6.058999497327022e-05
        },
        {
            "start_logit": 2.7868220806121826,
            "end_logit": 1.1675841808319092,
            "text": "programmed cell death protein 1 (programmed death 1)",
            "probability": 1.953411083377432e-05
        },
        {
            "start_logit": 7.041965484619141,
            "end_logit": -3.2934410572052,
            "text": "Nivolumab and Pem",
            "probability": 1.589939529367257e-05
        },
        {
            "start_logit": 6.881570816040039,
            "end_logit": -3.2934410572052,
            "text": "Pem",
            "probability": 1.3543225577450357e-05
        },
        {
            "start_logit": 7.041965484619141,
            "end_logit": -3.457315683364868,
            "text": "Nivolum",
            "probability": 1.3496178326022346e-05
        },
        {
            "start_logit": -3.1335813999176025,
            "end_logit": 6.698691368103027,
            "text": "programmed death 1) inhibitors, Nivolumab",
            "probability": 1.3235024198365863e-05
        }
    ],
    "640ddd9d201352f04a000028_0002": [
        {
            "start_logit": 7.007401943206787,
            "end_logit": 6.7695488929748535,
            "text": "nivolumab",
            "probability": 0.34079909324645996
        },
        {
            "start_logit": 7.007401943206787,
            "end_logit": 6.762213706970215,
            "text": "nivolumab and pembrolizumab",
            "probability": 0.3383082449436188
        },
        {
            "start_logit": 6.770027160644531,
            "end_logit": 6.762213706970215,
            "text": "pembrolizumab",
            "probability": 0.26682236790657043
        },
        {
            "start_logit": 5.111048698425293,
            "end_logit": 6.7695488929748535,
            "text": "monoclonal antibodies against the immune checkpoint programmed death 1 (programmed death 1) receptor, nivolumab",
            "probability": 0.051159098744392395
        },
        {
            "start_logit": 5.111048698425293,
            "end_logit": 2.6462221145629883,
            "text": "monoclonal antibodies",
            "probability": 0.0008282941416837275
        },
        {
            "start_logit": 0.5647906064987183,
            "end_logit": 6.7695488929748535,
            "text": "immune checkpoint programmed death 1 (programmed death 1) receptor, nivolumab",
            "probability": 0.0005426350980997086
        },
        {
            "start_logit": 0.5647906064987183,
            "end_logit": 6.762213706970215,
            "text": "immune checkpoint programmed death 1 (programmed death 1) receptor, nivolumab and pembrolizumab",
            "probability": 0.000538669410161674
        },
        {
            "start_logit": 7.007401943206787,
            "end_logit": -0.8558101654052734,
            "text": "nivolumab and p",
            "probability": 0.00016628269804641604
        },
        {
            "start_logit": 7.007401943206787,
            "end_logit": -0.9557918310165405,
            "text": "ni",
            "probability": 0.0001504615502199158
        },
        {
            "start_logit": 6.770027160644531,
            "end_logit": -0.8558101654052734,
            "text": "p",
            "probability": 0.00013114642933942378
        },
        {
            "start_logit": -1.4730169773101807,
            "end_logit": 6.762213706970215,
            "text": "b",
            "probability": 7.019621989456937e-05
        },
        {
            "start_logit": -1.572554349899292,
            "end_logit": 6.7695488929748535,
            "text": "ab",
            "probability": 6.401338760042563e-05
        },
        {
            "start_logit": -1.572554349899292,
            "end_logit": 6.762213706970215,
            "text": "ab and pembrolizumab",
            "probability": 6.354553624987602e-05
        },
        {
            "start_logit": 5.111048698425293,
            "end_logit": 0.046337246894836426,
            "text": "monoclonal antibodies against the immune checkpoint programmed death 1 (programmed death 1) receptor",
            "probability": 6.152744754217565e-05
        },
        {
            "start_logit": 5.111048698425293,
            "end_logit": -0.05338698625564575,
            "text": "monoclonal antibodies against the immune checkpoint programmed death 1 (programmed death 1)",
            "probability": 5.568766573560424e-05
        },
        {
            "start_logit": -1.7235205173492432,
            "end_logit": 6.7695488929748535,
            "text": "programmed death 1 (programmed death 1) receptor, nivolumab",
            "probability": 5.504360160557553e-05
        },
        {
            "start_logit": -1.7235205173492432,
            "end_logit": 6.762213706970215,
            "text": "programmed death 1 (programmed death 1) receptor, nivolumab and pembrolizumab",
            "probability": 5.46413502888754e-05
        },
        {
            "start_logit": 7.007401943206787,
            "end_logit": -2.156461715698242,
            "text": "nivolumab and pembrolizuma",
            "probability": 4.528782665147446e-05
        },
        {
            "start_logit": -1.9488859176635742,
            "end_logit": 6.762213706970215,
            "text": "brolizumab",
            "probability": 4.361605897429399e-05
        },
        {
            "start_logit": -2.0401782989501953,
            "end_logit": 6.7695488929748535,
            "text": "The first monoclonal antibodies against the immune checkpoint programmed death 1 (programmed death 1) receptor, nivolumab",
            "probability": 4.010365955764428e-05
        }
    ],
    "640ddd9d201352f04a000028_0003": [
        {
            "start_logit": 6.996633052825928,
            "end_logit": 6.688877105712891,
            "text": "nivolumab",
            "probability": 0.34915846586227417
        },
        {
            "start_logit": 6.996633052825928,
            "end_logit": 6.68541145324707,
            "text": "nivolumab and pembrolizumab",
            "probability": 0.3479504883289337
        },
        {
            "start_logit": 6.824030876159668,
            "end_logit": 6.68541145324707,
            "text": "pembrolizumab",
            "probability": 0.29279056191444397
        },
        {
            "start_logit": 2.6021034717559814,
            "end_logit": 6.688877105712891,
            "text": "programmed cell death protein 1 (programmed death 1) inhibitors, nivolumab",
            "probability": 0.004310248419642448
        },
        {
            "start_logit": 2.6021034717559814,
            "end_logit": 6.68541145324707,
            "text": "programmed cell death protein 1 (programmed death 1) inhibitors, nivolumab and pembrolizumab",
            "probability": 0.004295336082577705
        },
        {
            "start_logit": 6.996633052825928,
            "end_logit": -0.6726375222206116,
            "text": "nivolumab and p",
            "probability": 0.00022179777442943305
        },
        {
            "start_logit": 6.996633052825928,
            "end_logit": -0.7967950105667114,
            "text": "ni",
            "probability": 0.00019590085139498115
        },
        {
            "start_logit": 6.824030876159668,
            "end_logit": -0.6726375222206116,
            "text": "p",
            "probability": 0.00018663669470697641
        },
        {
            "start_logit": 6.996633052825928,
            "end_logit": -1.1506376266479492,
            "text": "nivolumab and pembrolizumab,",
            "probability": 0.0001375195279251784
        },
        {
            "start_logit": 6.824030876159668,
            "end_logit": -1.1506376266479492,
            "text": "pembrolizumab,",
            "probability": 0.00011571887444006279
        },
        {
            "start_logit": -1.1505980491638184,
            "end_logit": 6.688877105712891,
            "text": "e programmed cell death protein 1 (programmed death 1) inhibitors, nivolumab",
            "probability": 0.0001010938358376734
        },
        {
            "start_logit": -1.1505980491638184,
            "end_logit": 6.68541145324707,
            "text": "e programmed cell death protein 1 (programmed death 1) inhibitors, nivolumab and pembrolizumab",
            "probability": 0.00010074406600324437
        },
        {
            "start_logit": -1.3991446495056152,
            "end_logit": 6.68541145324707,
            "text": "b",
            "probability": 7.857368473196402e-05
        },
        {
            "start_logit": 6.996633052825928,
            "end_logit": -1.7207438945770264,
            "text": "nivolumab and pembrolizuma",
            "probability": 7.776254642521963e-05
        },
        {
            "start_logit": -1.4478737115859985,
            "end_logit": 6.688877105712891,
            "text": "ab",
            "probability": 7.509646820835769e-05
        },
        {
            "start_logit": -1.4478737115859985,
            "end_logit": 6.68541145324707,
            "text": "ab and pembrolizumab",
            "probability": 7.483665103791282e-05
        },
        {
            "start_logit": 6.824030876159668,
            "end_logit": -1.7207438945770264,
            "text": "pembrolizuma",
            "probability": 6.543499330291525e-05
        },
        {
            "start_logit": 6.996633052825928,
            "end_logit": -2.8991549015045166,
            "text": "nivolumab and pem",
            "probability": 2.3932763724587858e-05
        },
        {
            "start_logit": 6.824030876159668,
            "end_logit": -2.8991549015045166,
            "text": "pem",
            "probability": 2.013876655837521e-05
        },
        {
            "start_logit": -2.7859764099121094,
            "end_logit": 6.688877105712891,
            "text": "programmed death 1) inhibitors, nivolumab",
            "probability": 1.9701034034369513e-05
        }
    ],
    "640ddd9d201352f04a000028_0004": [
        {
            "start_logit": 7.369480133056641,
            "end_logit": 7.081151962280273,
            "text": "pembrolizumab",
            "probability": 0.8224573731422424
        },
        {
            "start_logit": 6.519469261169434,
            "end_logit": 6.372658729553223,
            "text": "nivolumab",
            "probability": 0.17308668792247772
        },
        {
            "start_logit": 7.369480133056641,
            "end_logit": 0.6975788474082947,
            "text": "pembrolizumab, was recently approved by the United States Food and Drug Administration for the treatment of melanoma",
            "probability": 0.0013891932321712375
        },
        {
            "start_logit": 1.6730070114135742,
            "end_logit": 6.372658729553223,
            "text": "treatment of melanoma; nivolumab",
            "probability": 0.0013597900979220867
        },
        {
            "start_logit": 7.369480133056641,
            "end_logit": -0.7132959365844727,
            "text": "pembrolizumab, was recently approved by the United States Food and Drug Administration for the treatment of melanoma;",
            "probability": 0.0003388657351024449
        },
        {
            "start_logit": 7.369480133056641,
            "end_logit": -0.9757017493247986,
            "text": "p",
            "probability": 0.00026065498241223395
        },
        {
            "start_logit": -0.8895081281661987,
            "end_logit": 7.081151962280273,
            "text": "programmed death 1 (programmed death 1) inhibitor, pembrolizumab",
            "probability": 0.00021295133046805859
        },
        {
            "start_logit": 7.369480133056641,
            "end_logit": -1.5542397499084473,
            "text": "pembrolizuma",
            "probability": 0.00014615397958550602
        },
        {
            "start_logit": 7.369480133056641,
            "end_logit": -1.56776762008667,
            "text": "pembrolizumab,",
            "probability": 0.00014418999489862472
        },
        {
            "start_logit": -1.6309131383895874,
            "end_logit": 7.081151962280273,
            "text": "b",
            "probability": 0.00010145942360395566
        },
        {
            "start_logit": 7.369480133056641,
            "end_logit": -1.9324684143066406,
            "text": "pembrolizumab, was recently approved by the United States Food and Drug Administration for the treatment of melanoma; ni",
            "probability": 0.00010012622078647837
        },
        {
            "start_logit": 7.369480133056641,
            "end_logit": -2.0526485443115234,
            "text": "pembrolizumab, was recently approved by the United States Food and Drug Administration",
            "probability": 8.878798689693213e-05
        },
        {
            "start_logit": 6.519469261169434,
            "end_logit": -1.4188051223754883,
            "text": "nivolumab was previously approved in Japan",
            "probability": 7.152764010243118e-05
        },
        {
            "start_logit": -1.6309131383895874,
            "end_logit": 6.372658729553223,
            "text": "b, was recently approved by the United States Food and Drug Administration for the treatment of melanoma; nivolumab",
            "probability": 4.995711424271576e-05
        },
        {
            "start_logit": 6.519469261169434,
            "end_logit": -1.9324684143066406,
            "text": "ni",
            "probability": 4.2794974433491006e-05
        },
        {
            "start_logit": -2.5709924697875977,
            "end_logit": 7.081151962280273,
            "text": "brolizumab",
            "probability": 3.96297182305716e-05
        },
        {
            "start_logit": 6.519469261169434,
            "end_logit": -2.0563557147979736,
            "text": "nivolumab was previously approved in Japan.",
            "probability": 3.780848783208057e-05
        },
        {
            "start_logit": -2.164905548095703,
            "end_logit": 6.372658729553223,
            "text": "melanoma; nivolumab",
            "probability": 2.9287855795701034e-05
        },
        {
            "start_logit": -2.456657886505127,
            "end_logit": 6.372658729553223,
            "text": "United States Food and Drug Administration for the treatment of melanoma; nivolumab",
            "probability": 2.1876656319363974e-05
        },
        {
            "start_logit": 7.369480133056641,
            "end_logit": -3.5059542655944824,
            "text": "pembroli",
            "probability": 2.0758281607413664e-05
        }
    ],
    "6414c4cf690f196b51000006_0001": [
        {
            "start_logit": 2.046420097351074,
            "end_logit": -0.19432097673416138,
            "text": "Dermatillomania or skin picking disorder (skin picking disorder)",
            "probability": 0.5730698704719543
        },
        {
            "start_logit": 2.046420097351074,
            "end_logit": -1.6108146905899048,
            "text": "Dermatillomania",
            "probability": 0.13900555670261383
        },
        {
            "start_logit": 2.046420097351074,
            "end_logit": -1.8026390075683594,
            "text": "Dermatillomania or skin picking disorder (skin picking disorder) is a chronic, recurrent, and treatment resistant neuropsychiatric disorder",
            "probability": 0.11474239081144333
        },
        {
            "start_logit": 2.046420097351074,
            "end_logit": -2.482116937637329,
            "text": "Dermatillomania or skin picking disorder",
            "probability": 0.05816080421209335
        },
        {
            "start_logit": -0.9574712514877319,
            "end_logit": -0.19432097673416138,
            "text": "skin picking disorder (skin picking disorder)",
            "probability": 0.02842065691947937
        },
        {
            "start_logit": 2.046420097351074,
            "end_logit": -3.339841842651367,
            "text": "Dermatillomania or skin picking disorder (skin picking disorder) is a chronic, recurrent, and treatment resistant neuropsychiatric",
            "probability": 0.02466750331223011
        },
        {
            "start_logit": 2.046420097351074,
            "end_logit": -3.7727575302124023,
            "text": "Dermatillomania or skin picking disorder (skin picking disorder",
            "probability": 0.015999717637896538
        },
        {
            "start_logit": 2.046420097351074,
            "end_logit": -4.061551094055176,
            "text": "Dermatillomania or skin picking disorder (skin picking disorder) is a chronic, recurrent, and treatment resistant",
            "probability": 0.01198645867407322
        },
        {
            "start_logit": -0.9574712514877319,
            "end_logit": -1.8026390075683594,
            "text": "skin picking disorder (skin picking disorder) is a chronic, recurrent, and treatment resistant neuropsychiatric disorder",
            "probability": 0.0056905015371739864
        },
        {
            "start_logit": 2.046420097351074,
            "end_logit": -4.816314220428467,
            "text": "Dermatillomania or skin picking disorder (skin picking disorder) is a chronic, recurrent",
            "probability": 0.0056350985541939735
        },
        {
            "start_logit": 2.046420097351074,
            "end_logit": -4.825615882873535,
            "text": "Dermatillomania or skin picking disorder (skin picking disorder) is a chronic, recurrent, and treatment resistant neuro",
            "probability": 0.005582923535257578
        },
        {
            "start_logit": -0.9574712514877319,
            "end_logit": -2.320556640625,
            "text": "skin picking disorder (skin picking disorder) is a chronic, recurrent, and treatment resistant neuropsychiatric disorder with an underestimated prevalence",
            "probability": 0.0033901722636073828
        },
        {
            "start_logit": -0.9574712514877319,
            "end_logit": -2.482116937637329,
            "text": "skin picking disorder",
            "probability": 0.002884410787373781
        },
        {
            "start_logit": -1.9599642753601074,
            "end_logit": -1.8026390075683594,
            "text": "treatment resistant neuropsychiatric disorder",
            "probability": 0.0020882063545286655
        },
        {
            "start_logit": -2.7892305850982666,
            "end_logit": -1.1943011283874512,
            "text": "underestimated prevalence that has a concerning negative impact on an individual's health and quality of life.",
            "probability": 0.0016742692096158862
        },
        {
            "start_logit": -2.831739902496338,
            "end_logit": -1.1943011283874512,
            "text": "neuropsychiatric disorder with an underestimated prevalence that has a concerning negative impact on an individual's health and quality of life.",
            "probability": 0.001604588353075087
        },
        {
            "start_logit": -3.9052257537841797,
            "end_logit": -0.19432097673416138,
            "text": "skin picking disorder)",
            "probability": 0.0014908730518072844
        },
        {
            "start_logit": -2.3326773643493652,
            "end_logit": -1.8026390075683594,
            "text": "recurrent, and treatment resistant neuropsychiatric disorder",
            "probability": 0.0014384876703843474
        },
        {
            "start_logit": -1.9599642753601074,
            "end_logit": -2.320556640625,
            "text": "treatment resistant neuropsychiatric disorder with an underestimated prevalence",
            "probability": 0.001244069542735815
        },
        {
            "start_logit": -0.9574712514877319,
            "end_logit": -3.339841842651367,
            "text": "skin picking disorder (skin picking disorder) is a chronic, recurrent, and treatment resistant neuropsychiatric",
            "probability": 0.0012233529705554247
        }
    ],
    "63eefa3bf36125a426000012_0001": [
        {
            "start_logit": 0.8445969820022583,
            "end_logit": 1.4221222400665283,
            "text": "R. japonica",
            "probability": 0.4313088059425354
        },
        {
            "start_logit": 1.899259090423584,
            "end_logit": -0.4349229633808136,
            "text": "Rickettsia species LON strains closely related to an agent of Japanese spotted fever (Japanese spotted fever)",
            "probability": 0.19333823025226593
        },
        {
            "start_logit": 1.899259090423584,
            "end_logit": -1.4239099025726318,
            "text": "Rickettsia species LON strains closely related to an agent of Japanese spotted fever",
            "probability": 0.07191280275583267
        },
        {
            "start_logit": -0.9764816164970398,
            "end_logit": 1.4221222400665283,
            "text": "Japanese spotted fever (Japanese spotted fever), R. japonica",
            "probability": 0.06980779021978378
        },
        {
            "start_logit": 1.899259090423584,
            "end_logit": -1.7596443891525269,
            "text": "Rickettsia",
            "probability": 0.051404181867837906
        },
        {
            "start_logit": 1.899259090423584,
            "end_logit": -1.9994540214538574,
            "text": "Rickettsia species LON",
            "probability": 0.04044366627931595
        },
        {
            "start_logit": 0.8445969820022583,
            "end_logit": -1.4962358474731445,
            "text": "R. japonica, were isolated in Japan from Haemaphysalis longicornis",
            "probability": 0.0233002956956625
        },
        {
            "start_logit": -2.26261043548584,
            "end_logit": 1.4221222400665283,
            "text": "fever (Japanese spotted fever), R. japonica",
            "probability": 0.019290577620267868
        },
        {
            "start_logit": -0.8852861523628235,
            "end_logit": -0.4349229633808136,
            "text": "Non-pathogenic Rickettsia species LON strains closely related to an agent of Japanese spotted fever (Japanese spotted fever)",
            "probability": 0.011940022930502892
        },
        {
            "start_logit": -0.9764816164970398,
            "end_logit": -0.4349229633808136,
            "text": "Japanese spotted fever (Japanese spotted fever)",
            "probability": 0.010899320244789124
        },
        {
            "start_logit": 1.899259090423584,
            "end_logit": -3.3745369911193848,
            "text": "Rickettsia species",
            "probability": 0.010224911384284496
        },
        {
            "start_logit": 1.899259090423584,
            "end_logit": -3.425830841064453,
            "text": "Rickettsia species LON strains closely related to an agent of Japanese spotted fever (Japanese spotted fever",
            "probability": 0.00971365999430418
        },
        {
            "start_logit": 1.899259090423584,
            "end_logit": -3.4503350257873535,
            "text": "Rickett",
            "probability": 0.00947852898389101
        },
        {
            "start_logit": -3.0440657138824463,
            "end_logit": 1.4221222400665283,
            "text": "strains closely related to an agent of Japanese spotted fever (Japanese spotted fever), R. japonica",
            "probability": 0.008830058388411999
        },
        {
            "start_logit": -3.219892740249634,
            "end_logit": 1.4221222400665283,
            "text": "Japanese spotted fever), R. japonica",
            "probability": 0.0074063255451619625
        },
        {
            "start_logit": -3.3118104934692383,
            "end_logit": 1.4221222400665283,
            "text": "japonica",
            "probability": 0.006755904760211706
        },
        {
            "start_logit": 0.8445969820022583,
            "end_logit": -2.7492752075195312,
            "text": "R. japonica, were isolated in Japan from Haemaphysalis longicornis ticks in 2001.",
            "probability": 0.006655387580394745
        },
        {
            "start_logit": -3.4089126586914062,
            "end_logit": 1.4221222400665283,
            "text": "LON strains closely related to an agent of Japanese spotted fever (Japanese spotted fever), R. japonica",
            "probability": 0.006130736321210861
        },
        {
            "start_logit": 1.899259090423584,
            "end_logit": -3.9100098609924316,
            "text": "Rickettsia species LON strains",
            "probability": 0.005985585507005453
        },
        {
            "start_logit": 1.899259090423584,
            "end_logit": -4.055877685546875,
            "text": "Rickettsia species LON strains closely related",
            "probability": 0.005173174198716879
        }
    ],
    "63eefa3bf36125a426000012_0002": [
        {
            "start_logit": 2.5249078273773193,
            "end_logit": 2.7768759727478027,
            "text": "fever with thrombocytopenia",
            "probability": 0.34360018372535706
        },
        {
            "start_logit": 2.444305419921875,
            "end_logit": 2.7768759727478027,
            "text": "thrombocytopenia",
            "probability": 0.31699198484420776
        },
        {
            "start_logit": 2.5249078273773193,
            "end_logit": 1.2740980386734009,
            "text": "fever with thrombocytopenia syndrome (SFTS) and Japanese spotted fever",
            "probability": 0.07645490765571594
        },
        {
            "start_logit": 2.444305419921875,
            "end_logit": 1.2740980386734009,
            "text": "thrombocytopenia syndrome (SFTS) and Japanese spotted fever",
            "probability": 0.07053425908088684
        },
        {
            "start_logit": 2.5249078273773193,
            "end_logit": 0.5068175792694092,
            "text": "fever",
            "probability": 0.03549601882696152
        },
        {
            "start_logit": 2.5249078273773193,
            "end_logit": 0.17186950147151947,
            "text": "fever with thrombocytopenia syndrome (SFTS)",
            "probability": 0.02539297193288803
        },
        {
            "start_logit": 0.946073055267334,
            "end_logit": 1.684262990951538,
            "text": "fever (Japanese spotted fever; a spotted fever group rickettsiosis",
            "probability": 0.023760655894875526
        },
        {
            "start_logit": 2.444305419921875,
            "end_logit": 0.17186950147151947,
            "text": "thrombocytopenia syndrome (SFTS)",
            "probability": 0.02342655323445797
        },
        {
            "start_logit": 2.5249078273773193,
            "end_logit": -0.1299608051776886,
            "text": "fever with thrombocytopenia syndrome",
            "probability": 0.01877717673778534
        },
        {
            "start_logit": 2.444305419921875,
            "end_logit": -0.1299608051776886,
            "text": "thrombocytopenia syndrome",
            "probability": 0.017323080450296402
        },
        {
            "start_logit": 0.946073055267334,
            "end_logit": 1.2740980386734009,
            "text": "fever",
            "probability": 0.015766164287924767
        },
        {
            "start_logit": -0.09794585406780243,
            "end_logit": 1.684262990951538,
            "text": "Japanese spotted fever (Japanese spotted fever; a spotted fever group rickettsiosis",
            "probability": 0.008364630863070488
        },
        {
            "start_logit": -0.09794585406780243,
            "end_logit": 1.2740980386734009,
            "text": "Japanese spotted fever",
            "probability": 0.005550274159759283
        },
        {
            "start_logit": 0.946073055267334,
            "end_logit": 0.08207941055297852,
            "text": "fever (Japanese spotted fever; a spotted fever group rickettsiosis)",
            "probability": 0.004786730278283358
        },
        {
            "start_logit": -0.8506945371627808,
            "end_logit": 1.684262990951538,
            "text": "Japanese spotted fever; a spotted fever group rickettsiosis",
            "probability": 0.003940326627343893
        },
        {
            "start_logit": -1.4662503004074097,
            "end_logit": 1.684262990951538,
            "text": "rickettsiosis",
            "probability": 0.0021291181910783052
        },
        {
            "start_logit": -1.5210779905319214,
            "end_logit": 1.684262990951538,
            "text": "spotted fever group rickettsiosis",
            "probability": 0.0020155261736363173
        },
        {
            "start_logit": 2.5249078273773193,
            "end_logit": -2.3761565685272217,
            "text": "fever with thrombocytopenia syndrome (SFTS) and Japanese spotted fever (Japanese spotted fever",
            "probability": 0.001986643299460411
        },
        {
            "start_logit": 2.5249078273773193,
            "end_logit": -2.436645746231079,
            "text": "fever with thrombocytopenia syndrome (SFTS) and Japanese spotted fever (Japanese spotted fever; a spotted fever group",
            "probability": 0.0018700351938605309
        },
        {
            "start_logit": 2.444305419921875,
            "end_logit": -2.3761565685272217,
            "text": "thrombocytopenia syndrome (SFTS) and Japanese spotted fever (Japanese spotted fever",
            "probability": 0.0018327978905290365
        }
    ],
    "63eefa3bf36125a426000012_0003": [
        {
            "start_logit": 7.339900016784668,
            "end_logit": 7.316801071166992,
            "text": "Rickettsia japonica",
            "probability": 0.9984954595565796
        },
        {
            "start_logit": 7.339900016784668,
            "end_logit": -0.03662833571434021,
            "text": "Rickettsia japonica is a member of SFG rickettsiae",
            "probability": 0.000639428966678679
        },
        {
            "start_logit": 7.339900016784668,
            "end_logit": -0.8941607475280762,
            "text": "Rickettsia",
            "probability": 0.00027125043561682105
        },
        {
            "start_logit": 7.339900016784668,
            "end_logit": -1.4764503240585327,
            "text": "Rickettsia japonica is a member of SFG rickettsiae causing Japanese spotted fever",
            "probability": 0.0001515254843980074
        },
        {
            "start_logit": 7.339900016784668,
            "end_logit": -1.9965037107467651,
            "text": "R",
            "probability": 9.008015331346542e-05
        },
        {
            "start_logit": -2.090639591217041,
            "end_logit": 7.316801071166992,
            "text": "ica",
            "probability": 8.011514000827447e-05
        },
        {
            "start_logit": 7.339900016784668,
            "end_logit": -2.6689741611480713,
            "text": "Rickettsia japonica is a member of SFG rickettsia",
            "probability": 4.598107625497505e-05
        },
        {
            "start_logit": 7.339900016784668,
            "end_logit": -2.745788097381592,
            "text": "Rickett",
            "probability": 4.258130138623528e-05
        },
        {
            "start_logit": -2.860304355621338,
            "end_logit": 7.316801071166992,
            "text": "japonica",
            "probability": 3.710679447976872e-05
        },
        {
            "start_logit": 7.339900016784668,
            "end_logit": -3.1471595764160156,
            "text": "Rickettsia japonica is a",
            "probability": 2.850399505405221e-05
        },
        {
            "start_logit": 7.339900016784668,
            "end_logit": -3.189112663269043,
            "text": "Rickettsia japonica is",
            "probability": 2.7332902391208336e-05
        },
        {
            "start_logit": 7.339900016784668,
            "end_logit": -3.656893014907837,
            "text": "Rickettsia japonica is a member of SFG rickett",
            "probability": 1.7121090422733687e-05
        },
        {
            "start_logit": -3.6711528301239014,
            "end_logit": 7.316801071166992,
            "text": "ickettsia japonica",
            "probability": 1.6493257135152817e-05
        },
        {
            "start_logit": 7.339900016784668,
            "end_logit": -3.8047146797180176,
            "text": "Rickettsia japonica is a member",
            "probability": 1.4768397704756353e-05
        },
        {
            "start_logit": 7.339900016784668,
            "end_logit": -3.9296486377716064,
            "text": "Rickettsia japon",
            "probability": 1.3033922186878044e-05
        },
        {
            "start_logit": 7.339900016784668,
            "end_logit": -4.189353942871094,
            "text": "Rickettsia japonica is a member of SFG rick",
            "probability": 1.0052786819869652e-05
        },
        {
            "start_logit": 7.339900016784668,
            "end_logit": -4.214476108551025,
            "text": "Rick",
            "probability": 9.803389730222989e-06
        },
        {
            "start_logit": -4.446096420288086,
            "end_logit": 7.316801071166992,
            "text": "sia japonica",
            "probability": 7.59893828217173e-06
        },
        {
            "start_logit": 1.2494244575500488,
            "end_logit": -0.03662833571434021,
            "text": "rickettsiae",
            "probability": 1.447879526494944e-06
        },
        {
            "start_logit": 0.1762302964925766,
            "end_logit": -0.03662833571434021,
            "text": "SFG rickettsiae",
            "probability": 4.950510401613428e-07
        }
    ],
    "6414c0f7690f196b51000001_0001": [
        {
            "start_logit": 6.59197998046875,
            "end_logit": 6.07499361038208,
            "text": "hyperammonaemic encephalopathy",
            "probability": 0.3809632658958435
        },
        {
            "start_logit": 6.453305244445801,
            "end_logit": 6.07499361038208,
            "text": "neonatal presentation with hyperammonaemic encephalopathy",
            "probability": 0.3316330909729004
        },
        {
            "start_logit": 6.453305244445801,
            "end_logit": 5.351862907409668,
            "text": "neonatal presentation",
            "probability": 0.1609184890985489
        },
        {
            "start_logit": 6.59197998046875,
            "end_logit": 3.370638370513916,
            "text": "hyperammonaemic encephalopathy.",
            "probability": 0.025491569191217422
        },
        {
            "start_logit": 3.785978317260742,
            "end_logit": 6.07499361038208,
            "text": "asymptomatic carrier state to severe neonatal presentation with hyperammonaemic encephalopathy",
            "probability": 0.023027779534459114
        },
        {
            "start_logit": 6.453305244445801,
            "end_logit": 3.370638370513916,
            "text": "neonatal presentation with hyperammonaemic encephalopathy.",
            "probability": 0.022190717980265617
        },
        {
            "start_logit": 3.4496870040893555,
            "end_logit": 6.07499361038208,
            "text": "severe neonatal presentation with hyperammonaemic encephalopathy",
            "probability": 0.016451407223939896
        },
        {
            "start_logit": 3.785978317260742,
            "end_logit": 5.351862907409668,
            "text": "asymptomatic carrier state to severe neonatal presentation",
            "probability": 0.0111737921833992
        },
        {
            "start_logit": 3.4496870040893555,
            "end_logit": 5.351862907409668,
            "text": "severe neonatal presentation",
            "probability": 0.007982724346220493
        },
        {
            "start_logit": 6.453305244445801,
            "end_logit": 2.231775999069214,
            "text": "neonatal",
            "probability": 0.007105088792741299
        },
        {
            "start_logit": 2.2666549682617188,
            "end_logit": 6.07499361038208,
            "text": "ammonaemic encephalopathy",
            "probability": 0.005039858166128397
        },
        {
            "start_logit": 3.785978317260742,
            "end_logit": 3.8526182174682617,
            "text": "asymptomatic carrier state",
            "probability": 0.0024950942024588585
        },
        {
            "start_logit": 3.785978317260742,
            "end_logit": 3.370638370513916,
            "text": "asymptomatic carrier state to severe neonatal presentation with hyperammonaemic encephalopathy.",
            "probability": 0.0015408690087497234
        },
        {
            "start_logit": 3.4496870040893555,
            "end_logit": 3.370638370513916,
            "text": "severe neonatal presentation with hyperammonaemic encephalopathy.",
            "probability": 0.0011008197907358408
        },
        {
            "start_logit": 0.4512440264225006,
            "end_logit": 6.07499361038208,
            "text": "carrier state to severe neonatal presentation with hyperammonaemic encephalopathy",
            "probability": 0.0008203430334106088
        },
        {
            "start_logit": 3.785978317260742,
            "end_logit": 2.231775999069214,
            "text": "asymptomatic carrier state to severe neonatal",
            "probability": 0.0004933602758683264
        },
        {
            "start_logit": -0.07639341056346893,
            "end_logit": 6.07499361038208,
            "text": "encephalopathy",
            "probability": 0.00048400010564364493
        },
        {
            "start_logit": 0.4512440264225006,
            "end_logit": 5.351862907409668,
            "text": "carrier state to severe neonatal presentation",
            "probability": 0.0003980556793976575
        },
        {
            "start_logit": 3.4496870040893555,
            "end_logit": 2.231775999069214,
            "text": "severe neonatal",
            "probability": 0.0003524639760144055
        },
        {
            "start_logit": 2.2666549682617188,
            "end_logit": 3.370638370513916,
            "text": "ammonaemic encephalopathy.",
            "probability": 0.00033723446540534496
        }
    ],
    "6414c0f7690f196b51000001_0002": [
        {
            "start_logit": 6.469359397888184,
            "end_logit": 6.030597686767578,
            "text": "neonatal hyperammonemic events",
            "probability": 0.6814015507698059
        },
        {
            "start_logit": 6.469359397888184,
            "end_logit": 4.37503719329834,
            "text": "neonatal hyperammonemic events to moderate symptoms",
            "probability": 0.13013745844364166
        },
        {
            "start_logit": 4.435182571411133,
            "end_logit": 6.030597686767578,
            "text": "lethal neonatal hyperammonemic events",
            "probability": 0.08911921828985214
        },
        {
            "start_logit": 3.3500633239746094,
            "end_logit": 6.030597686767578,
            "text": "ammonemic events",
            "probability": 0.03010995127260685
        },
        {
            "start_logit": 4.651241302490234,
            "end_logit": 4.37503719329834,
            "text": "moderate symptoms",
            "probability": 0.021125338971614838
        },
        {
            "start_logit": 4.435182571411133,
            "end_logit": 4.37503719329834,
            "text": "lethal neonatal hyperammonemic events to moderate symptoms",
            "probability": 0.01702043041586876
        },
        {
            "start_logit": 3.3500633239746094,
            "end_logit": 4.37503719329834,
            "text": "ammonemic events to moderate symptoms",
            "probability": 0.005750548094511032
        },
        {
            "start_logit": 6.469359397888184,
            "end_logit": 1.2033660411834717,
            "text": "neonatal hyperammonemic events to moderate symptoms and even asymptomatic individual",
            "probability": 0.005457115825265646
        },
        {
            "start_logit": 6.469359397888184,
            "end_logit": 1.156764268875122,
            "text": "neonatal hyperammonemic",
            "probability": 0.0052086366340518
        },
        {
            "start_logit": 1.2322062253952026,
            "end_logit": 6.030597686767578,
            "text": "hyperammonemic events",
            "probability": 0.0036218997556716204
        },
        {
            "start_logit": 1.0580425262451172,
            "end_logit": 6.030597686767578,
            "text": "urea cycle disorder. Due to high phenotypic heterogeneity, ranging from lethal neonatal hyperammonemic events",
            "probability": 0.003042972879484296
        },
        {
            "start_logit": 6.469359397888184,
            "end_logit": 0.3043789565563202,
            "text": "neonatal hyperammonemic events to moderate symptoms and even asymptomatic",
            "probability": 0.002220945665612817
        },
        {
            "start_logit": 4.651241302490234,
            "end_logit": 1.2033660411834717,
            "text": "moderate symptoms and even asymptomatic individual",
            "probability": 0.0008858587825670838
        },
        {
            "start_logit": 6.469359397888184,
            "end_logit": -0.6269307732582092,
            "text": "neonatal",
            "probability": 0.0008751354762353003
        },
        {
            "start_logit": -0.37209340929985046,
            "end_logit": 6.030597686767578,
            "text": "ranging from lethal neonatal hyperammonemic events",
            "probability": 0.0007281117723323405
        },
        {
            "start_logit": 4.435182571411133,
            "end_logit": 1.2033660411834717,
            "text": "lethal neonatal hyperammonemic events to moderate symptoms and even asymptomatic individual",
            "probability": 0.0007137258071452379
        },
        {
            "start_logit": 1.2322062253952026,
            "end_logit": 4.37503719329834,
            "text": "hyperammonemic events to moderate symptoms",
            "probability": 0.0006917285500094295
        },
        {
            "start_logit": 4.435182571411133,
            "end_logit": 1.156764268875122,
            "text": "lethal neonatal hyperammonemic",
            "probability": 0.0006812276551499963
        },
        {
            "start_logit": 6.469359397888184,
            "end_logit": -0.9789016246795654,
            "text": "neonatal hyperammonemic events to moderate",
            "probability": 0.0006154830916784704
        },
        {
            "start_logit": 1.077627182006836,
            "end_logit": 4.37503719329834,
            "text": "symptoms",
            "probability": 0.0005926561425440013
        }
    ],
    "6414c0f7690f196b51000001_0003": [
        {
            "start_logit": 7.0380096435546875,
            "end_logit": 6.819985866546631,
            "text": "hyperammonemia",
            "probability": 0.8854151964187622
        },
        {
            "start_logit": 4.9692702293396,
            "end_logit": 6.819985866546631,
            "text": "ammonemia",
            "probability": 0.11186768859624863
        },
        {
            "start_logit": 0.3656969368457794,
            "end_logit": 6.819985866546631,
            "text": "urea cycle, results in hyperammonemia",
            "probability": 0.0011204646434634924
        },
        {
            "start_logit": 7.0380096435546875,
            "end_logit": -0.7028363943099976,
            "text": "h",
            "probability": 0.00047865931992419064
        },
        {
            "start_logit": 7.0380096435546875,
            "end_logit": -0.9714743494987488,
            "text": "hyperammon",
            "probability": 0.0003658968780655414
        },
        {
            "start_logit": -0.8193806409835815,
            "end_logit": 6.819985866546631,
            "text": "emia",
            "probability": 0.0003425511531531811
        },
        {
            "start_logit": -1.878243327140808,
            "end_logit": 6.819985866546631,
            "text": "yperammonemia",
            "probability": 0.00011881383397849277
        },
        {
            "start_logit": 7.0380096435546875,
            "end_logit": -2.3763771057128906,
            "text": "hyperam",
            "probability": 8.978774712886661e-05
        },
        {
            "start_logit": -2.300936460494995,
            "end_logit": 6.819985866546631,
            "text": "ornithine transcarbamylase, an enzyme in the urea cycle, results in hyperammonemia",
            "probability": 7.785635534673929e-05
        },
        {
            "start_logit": 4.9692702293396,
            "end_logit": -0.9714743494987488,
            "text": "ammon",
            "probability": 4.6229222789406776e-05
        },
        {
            "start_logit": 7.0380096435546875,
            "end_logit": -3.300306797027588,
            "text": "hyper",
            "probability": 3.564180588000454e-05
        },
        {
            "start_logit": 4.9692702293396,
            "end_logit": -2.3763771057128906,
            "text": "am",
            "probability": 1.1344233826093841e-05
        },
        {
            "start_logit": -4.63932991027832,
            "end_logit": 6.819985866546631,
            "text": "Deficiency of ornithine transcarbamylase, an enzyme in the urea cycle, results in hyperammonemia",
            "probability": 7.511780040658778e-06
        },
        {
            "start_logit": -4.7217912673950195,
            "end_logit": 6.819985866546631,
            "text": "monemia",
            "probability": 6.917193331901217e-06
        },
        {
            "start_logit": -5.220419883728027,
            "end_logit": 6.819985866546631,
            "text": "enzyme in the urea cycle, results in hyperammonemia",
            "probability": 4.201247520541074e-06
        },
        {
            "start_logit": 0.3656969368457794,
            "end_logit": 0.8562919497489929,
            "text": "urea cycle",
            "probability": 2.8800411655538483e-06
        },
        {
            "start_logit": -5.624707221984863,
            "end_logit": 6.819985866546631,
            "text": "results in hyperammonemia",
            "probability": 2.8041324640071252e-06
        },
        {
            "start_logit": -5.628852367401123,
            "end_logit": 6.819985866546631,
            "text": "cycle, results in hyperammonemia",
            "probability": 2.7925343601964414e-06
        },
        {
            "start_logit": -6.339653491973877,
            "end_logit": 6.819985866546631,
            "text": "thine transcarbamylase, an enzyme in the urea cycle, results in hyperammonemia",
            "probability": 1.3718338323087664e-06
        },
        {
            "start_logit": -6.4437150955200195,
            "end_logit": 6.819985866546631,
            "text": "transcarbamylase, an enzyme in the urea cycle, results in hyperammonemia",
            "probability": 1.2362544339339365e-06
        }
    ],
    "6414c0f7690f196b51000001_0004": [
        {
            "start_logit": 6.640227317810059,
            "end_logit": 6.3879804611206055,
            "text": "vomiting and lethargy (100 percent), protein avoidance (92 percent), ataxia",
            "probability": 0.06019378826022148
        },
        {
            "start_logit": 6.615304946899414,
            "end_logit": 6.3879804611206055,
            "text": "ataxia",
            "probability": 0.058712154626846313
        },
        {
            "start_logit": 6.640227317810059,
            "end_logit": 6.314048767089844,
            "text": "vomiting and lethargy",
            "probability": 0.0559040866792202
        },
        {
            "start_logit": 6.559242248535156,
            "end_logit": 6.3879804611206055,
            "text": "lethargy (100 percent), protein avoidance (92 percent), ataxia",
            "probability": 0.05551115795969963
        },
        {
            "start_logit": 6.640227317810059,
            "end_logit": 6.2991437911987305,
            "text": "vomiting and lethargy (100 percent), protein avoidance (92 percent), ataxia (77 percent), Stage II coma",
            "probability": 0.05507701262831688
        },
        {
            "start_logit": 6.615304946899414,
            "end_logit": 6.2991437911987305,
            "text": "ataxia (77 percent), Stage II coma",
            "probability": 0.05372132733464241
        },
        {
            "start_logit": 6.640227317810059,
            "end_logit": 6.253661155700684,
            "text": "vomiting",
            "probability": 0.052628085017204285
        },
        {
            "start_logit": 6.559242248535156,
            "end_logit": 6.314048767089844,
            "text": "lethargy",
            "probability": 0.05155516415834427
        },
        {
            "start_logit": 6.559242248535156,
            "end_logit": 6.2991437911987305,
            "text": "lethargy (100 percent), protein avoidance (92 percent), ataxia (77 percent), Stage II coma",
            "probability": 0.05079243332147598
        },
        {
            "start_logit": 6.5432634353637695,
            "end_logit": 6.314048767089844,
            "text": "irritability (100 percent), episodic vomiting and lethargy",
            "probability": 0.05073791742324829
        },
        {
            "start_logit": 6.590569972991943,
            "end_logit": 6.249706268310547,
            "text": "seizures",
            "probability": 0.049880895763635635
        },
        {
            "start_logit": 6.615304946899414,
            "end_logit": 6.20226526260376,
            "text": "ataxia (77 percent), Stage II coma (46 percent), delayed physical growth (38 percent), developmental delay",
            "probability": 0.04876101389527321
        },
        {
            "start_logit": 6.5432634353637695,
            "end_logit": 6.253661155700684,
            "text": "irritability (100 percent), episodic vomiting",
            "probability": 0.047764651477336884
        },
        {
            "start_logit": 6.375958442687988,
            "end_logit": 6.3879804611206055,
            "text": "protein avoidance (92 percent), ataxia",
            "probability": 0.046214811503887177
        },
        {
            "start_logit": 6.640227317810059,
            "end_logit": 6.1111321449279785,
            "text": "vomiting and lethargy (100 percent), protein avoidance",
            "probability": 0.045637112110853195
        },
        {
            "start_logit": 6.5432634353637695,
            "end_logit": 6.179989814758301,
            "text": "irritability",
            "probability": 0.04437226057052612
        },
        {
            "start_logit": 6.467637538909912,
            "end_logit": 6.249706268310547,
            "text": "delayed physical growth (38 percent), developmental delay (38 percent), and seizures",
            "probability": 0.04411084204912186
        },
        {
            "start_logit": 6.615304946899414,
            "end_logit": 6.100706100463867,
            "text": "ataxia (77 percent), Stage II coma (46 percent), delayed physical growth",
            "probability": 0.04405207186937332
        },
        {
            "start_logit": 6.375958442687988,
            "end_logit": 6.2991437911987305,
            "text": "protein avoidance (92 percent), ataxia (77 percent), Stage II coma",
            "probability": 0.04228631779551506
        },
        {
            "start_logit": 6.559242248535156,
            "end_logit": 6.1111321449279785,
            "text": "lethargy (100 percent), protein avoidance",
            "probability": 0.04208684712648392
        }
    ],
    "63eef60ef36125a42600000c_0001": [
        {
            "start_logit": 8.785609245300293,
            "end_logit": 8.62540340423584,
            "text": "rheumatoid arthritis",
            "probability": 0.9996911287307739
        },
        {
            "start_logit": 8.785609245300293,
            "end_logit": -0.334741473197937,
            "text": "r",
            "probability": 0.00012838795373681933
        },
        {
            "start_logit": -0.6997806429862976,
            "end_logit": 8.62540340423584,
            "text": "interleukin 6, in combination with methotrexate in patients with rheumatoid arthritis",
            "probability": 7.593000191263855e-05
        },
        {
            "start_logit": 8.785609245300293,
            "end_logit": -1.704723596572876,
            "text": "rheumatoid arthr",
            "probability": 3.262487007305026e-05
        },
        {
            "start_logit": -1.5776216983795166,
            "end_logit": 8.62540340423584,
            "text": "itis",
            "probability": 3.1562536605633795e-05
        },
        {
            "start_logit": 8.785609245300293,
            "end_logit": -2.7356619834899902,
            "text": "rheumatoid art",
            "probability": 1.1636383533186745e-05
        },
        {
            "start_logit": 8.785609245300293,
            "end_logit": -3.5077428817749023,
            "text": "rheumatoid",
            "probability": 5.376595254347194e-06
        },
        {
            "start_logit": -3.490274429321289,
            "end_logit": 8.62540340423584,
            "text": "methotrexate in patients with rheumatoid arthritis",
            "probability": 4.661410002881894e-06
        },
        {
            "start_logit": -3.5198047161102295,
            "end_logit": 8.62540340423584,
            "text": "heumatoid arthritis",
            "probability": 4.52576841780683e-06
        },
        {
            "start_logit": -4.026797294616699,
            "end_logit": 8.62540340423584,
            "text": "patients with rheumatoid arthritis",
            "probability": 2.7258902264293283e-06
        },
        {
            "start_logit": 8.785609245300293,
            "end_logit": -4.252535820007324,
            "text": "rheuma",
            "probability": 2.5529827780701453e-06
        },
        {
            "start_logit": 8.785609245300293,
            "end_logit": -4.481504440307617,
            "text": "rheumato",
            "probability": 2.0305240013840375e-06
        },
        {
            "start_logit": 8.785609245300293,
            "end_logit": -4.4885711669921875,
            "text": "rheumatoid arthritis inadequately controlled by methotrexate",
            "probability": 2.016225153056439e-06
        },
        {
            "start_logit": 8.785609245300293,
            "end_logit": -4.628632068634033,
            "text": "rheumatoid arthritis inadequately controlled by methotrexate:",
            "probability": 1.7527142972539878e-06
        },
        {
            "start_logit": 8.785609245300293,
            "end_logit": -5.600253105163574,
            "text": "rhe",
            "probability": 6.633484304074955e-07
        },
        {
            "start_logit": -5.450796604156494,
            "end_logit": 8.62540340423584,
            "text": "toid arthritis",
            "probability": 6.562557359757193e-07
        },
        {
            "start_logit": 8.785609245300293,
            "end_logit": -5.848487377166748,
            "text": "rheumatoid arthritis inadequately controlled by methotrexate: efficacy and safety results",
            "probability": 5.175295427761739e-07
        },
        {
            "start_logit": -5.711789131164551,
            "end_logit": 8.62540340423584,
            "text": "combination with methotrexate in patients with rheumatoid arthritis",
            "probability": 5.055052838542906e-07
        },
        {
            "start_logit": -5.724705696105957,
            "end_logit": 8.62540340423584,
            "text": "umatoid arthritis",
            "probability": 4.990179149899632e-07
        },
        {
            "start_logit": 8.785609245300293,
            "end_logit": -5.919491291046143,
            "text": "rheumatoid arthritis inadequately controlled by methotrexate: efficacy and safety results of a randomised controlled phase III",
            "probability": 4.820567482965998e-07
        }
    ],
    "63eef60ef36125a42600000c_0002": [
        {
            "start_logit": 9.069382667541504,
            "end_logit": 8.871829986572266,
            "text": "rheumatoid arthritis",
            "probability": 0.9996764659881592
        },
        {
            "start_logit": 9.069382667541504,
            "end_logit": 0.3030838668346405,
            "text": "r",
            "probability": 0.00018988930969499052
        },
        {
            "start_logit": -1.2871525287628174,
            "end_logit": 8.871829986572266,
            "text": "itis",
            "probability": 3.177414328092709e-05
        },
        {
            "start_logit": 9.069382667541504,
            "end_logit": -1.6114811897277832,
            "text": "rheumatoid arthr",
            "probability": 2.799080903059803e-05
        },
        {
            "start_logit": 9.069382667541504,
            "end_logit": -2.253000020980835,
            "text": "rheumatoid arthritis despite treatment with methotrexate (methotrexate).",
            "probability": 1.4736945558979642e-05
        },
        {
            "start_logit": -2.1608660221099854,
            "end_logit": 8.871829986572266,
            "text": "heumatoid arthritis",
            "probability": 1.3262486390885897e-05
        },
        {
            "start_logit": 9.069382667541504,
            "end_logit": -2.662216901779175,
            "text": "rheumatoid art",
            "probability": 9.787841008801479e-06
        },
        {
            "start_logit": 9.069382667541504,
            "end_logit": -2.944741725921631,
            "text": "rheumatoid",
            "probability": 7.378841928584734e-06
        },
        {
            "start_logit": -3.0378336906433105,
            "end_logit": 8.871829986572266,
            "text": "olokizumab (olokizumab) in patients with active rheumatoid arthritis",
            "probability": 5.517754289030563e-06
        },
        {
            "start_logit": 9.069382667541504,
            "end_logit": -3.2661824226379395,
            "text": "rheumatoid arthritis despite treatment with methotrexate (methotrexate)",
            "probability": 5.35042045157752e-06
        },
        {
            "start_logit": -3.485443592071533,
            "end_logit": 8.871829986572266,
            "text": "patients with active rheumatoid arthritis",
            "probability": 3.5266982649773126e-06
        },
        {
            "start_logit": 9.069382667541504,
            "end_logit": -3.7984774112701416,
            "text": "rheuma",
            "probability": 3.1420663617609534e-06
        },
        {
            "start_logit": 9.069382667541504,
            "end_logit": -4.179347038269043,
            "text": "rheumatoid arthritis despite treatment with methotrexate",
            "probability": 2.146869974239962e-06
        },
        {
            "start_logit": 9.069382667541504,
            "end_logit": -4.205046653747559,
            "text": "rheumato",
            "probability": 2.0923991996824043e-06
        },
        {
            "start_logit": -4.191275596618652,
            "end_logit": 8.871829986572266,
            "text": "active rheumatoid arthritis",
            "probability": 1.74112187778519e-06
        },
        {
            "start_logit": -4.280759334564209,
            "end_logit": 8.871829986572266,
            "text": "olokizumab) in patients with active rheumatoid arthritis",
            "probability": 1.5920865052976296e-06
        },
        {
            "start_logit": 9.069382667541504,
            "end_logit": -4.54472017288208,
            "text": "rheumatoid arthritis despite treatment with methotrexate (methotrexate",
            "probability": 1.4897932487656362e-06
        },
        {
            "start_logit": 9.069382667541504,
            "end_logit": -4.88075590133667,
            "text": "rhe",
            "probability": 1.0646034525052528e-06
        },
        {
            "start_logit": -5.048120021820068,
            "end_logit": 8.871829986572266,
            "text": "umatoid arthritis",
            "probability": 7.39105018965347e-07
        },
        {
            "start_logit": -5.637903690338135,
            "end_logit": 8.871829986572266,
            "text": "toid arthritis",
            "probability": 4.097950920822768e-07
        }
    ],
    "63eef60ef36125a42600000c_0003": [
        {
            "start_logit": 8.874674797058105,
            "end_logit": 8.521822929382324,
            "text": "rheumatoid arthritis",
            "probability": 0.9996681213378906
        },
        {
            "start_logit": 8.874674797058105,
            "end_logit": -0.10275247693061829,
            "text": "r",
            "probability": 0.00017957680393010378
        },
        {
            "start_logit": 8.874674797058105,
            "end_logit": -1.5845589637756348,
            "text": "rheumatoid arthr",
            "probability": 4.080465805600397e-05
        },
        {
            "start_logit": -1.7283344268798828,
            "end_logit": 8.521822929382324,
            "text": "itis",
            "probability": 2.4832901544868946e-05
        },
        {
            "start_logit": 8.874674797058105,
            "end_logit": -2.4463887214660645,
            "text": "rheumatoid arthritis without discernible differences between the two regimens.",
            "probability": 1.723541754472535e-05
        },
        {
            "start_logit": 8.874674797058105,
            "end_logit": -2.708218574523926,
            "text": "rheumatoid arthritis without discernible differences between the two regimens",
            "probability": 1.3265107554616407e-05
        },
        {
            "start_logit": 8.874674797058105,
            "end_logit": -2.740880250930786,
            "text": "rheumatoid art",
            "probability": 1.2838848306273576e-05
        },
        {
            "start_logit": -2.626127243041992,
            "end_logit": 8.521822929382324,
            "text": "heumatoid arthritis",
            "probability": 1.011861240840517e-05
        },
        {
            "start_logit": 8.874674797058105,
            "end_logit": -3.3197689056396484,
            "text": "rheumatoid",
            "probability": 7.196442311396822e-06
        },
        {
            "start_logit": -3.2025082111358643,
            "end_logit": 8.521822929382324,
            "text": "Treatment with olokizumab was associated with significant improvement in signs, symptoms and physical function of rheumatoid arthritis",
            "probability": 5.68593668504036e-06
        },
        {
            "start_logit": 8.874674797058105,
            "end_logit": -3.6688501834869385,
            "text": "rheuma",
            "probability": 5.075909484730801e-06
        },
        {
            "start_logit": 8.874674797058105,
            "end_logit": -4.141888618469238,
            "text": "rheumato",
            "probability": 3.1628296710550785e-06
        },
        {
            "start_logit": -4.082581043243408,
            "end_logit": 8.521822929382324,
            "text": "olokizumab was associated with significant improvement in signs, symptoms and physical function of rheumatoid arthritis",
            "probability": 2.358256097068079e-06
        },
        {
            "start_logit": -4.089662551879883,
            "end_logit": 8.521822929382324,
            "text": "improvement in signs, symptoms and physical function of rheumatoid arthritis",
            "probability": 2.3416159820044413e-06
        },
        {
            "start_logit": -4.2855353355407715,
            "end_logit": 8.521822929382324,
            "text": "physical function of rheumatoid arthritis",
            "probability": 1.925082642628695e-06
        },
        {
            "start_logit": 8.874674797058105,
            "end_logit": -4.847090721130371,
            "text": "rhe",
            "probability": 1.5624653997292626e-06
        },
        {
            "start_logit": -4.551881790161133,
            "end_logit": 8.521822929382324,
            "text": "signs, symptoms and physical function of rheumatoid arthritis",
            "probability": 1.4749469983144081e-06
        },
        {
            "start_logit": -4.867038726806641,
            "end_logit": 8.521822929382324,
            "text": "symptoms and physical function of rheumatoid arthritis",
            "probability": 1.0762310012069065e-06
        },
        {
            "start_logit": -5.206028938293457,
            "end_logit": 8.521822929382324,
            "text": "significant improvement in signs, symptoms and physical function of rheumatoid arthritis",
            "probability": 7.668031116736529e-07
        },
        {
            "start_logit": -5.21689510345459,
            "end_logit": 8.521822929382324,
            "text": "umatoid arthritis",
            "probability": 7.585161370116111e-07
        }
    ],
    "63eef60ef36125a42600000c_0004": [
        {
            "start_logit": 8.49800968170166,
            "end_logit": 8.197054862976074,
            "text": "Rheumatoid Arthritis",
            "probability": 0.9987913966178894
        },
        {
            "start_logit": 8.49800968170166,
            "end_logit": 1.1783831119537354,
            "text": "Rheumatoid Arthritis.",
            "probability": 0.0008939316030591726
        },
        {
            "start_logit": 8.49800968170166,
            "end_logit": -0.6348302960395813,
            "text": "R",
            "probability": 0.00014582625590264797
        },
        {
            "start_logit": 8.49800968170166,
            "end_logit": -1.730824589729309,
            "text": "Rheumatoid Arthr",
            "probability": 4.873618672718294e-05
        },
        {
            "start_logit": -1.5982149839401245,
            "end_logit": 8.197054862976074,
            "text": "Olokizumab versus Placebo or Adalimumab in Rheumatoid Arthritis",
            "probability": 4.118509605177678e-05
        },
        {
            "start_logit": -2.0685057640075684,
            "end_logit": 8.197054862976074,
            "text": "itis",
            "probability": 2.5733306756592356e-05
        },
        {
            "start_logit": -2.6182799339294434,
            "end_logit": 8.197054862976074,
            "text": "heumatoid Arthritis",
            "probability": 1.4850181287329178e-05
        },
        {
            "start_logit": 8.49800968170166,
            "end_logit": -3.000850200653076,
            "text": "Rheumatoid Art",
            "probability": 1.3686317288374994e-05
        },
        {
            "start_logit": 8.49800968170166,
            "end_logit": -3.714641809463501,
            "text": "Rheumatoid",
            "probability": 6.703332019242225e-06
        },
        {
            "start_logit": -3.8179478645324707,
            "end_logit": 8.197054862976074,
            "text": "Adalimumab in Rheumatoid Arthritis",
            "probability": 4.474270099308342e-06
        },
        {
            "start_logit": 8.49800968170166,
            "end_logit": -4.145543098449707,
            "text": "Rheuma",
            "probability": 4.356649697001558e-06
        },
        {
            "start_logit": 8.49800968170166,
            "end_logit": -4.614272117614746,
            "text": "Rheumato",
            "probability": 2.7263786250841804e-06
        },
        {
            "start_logit": -4.530021667480469,
            "end_logit": 8.197054862976074,
            "text": "Placebo or Adalimumab in Rheumatoid Arthritis",
            "probability": 2.1951927919872105e-06
        },
        {
            "start_logit": -5.381146430969238,
            "end_logit": 8.197054862976074,
            "text": "toid Arthritis",
            "probability": 9.3720348104398e-07
        },
        {
            "start_logit": -5.400312900543213,
            "end_logit": 8.197054862976074,
            "text": "Arthritis",
            "probability": 9.194111498800339e-07
        },
        {
            "start_logit": -5.4243927001953125,
            "end_logit": 8.197054862976074,
            "text": "umatoid Arthritis",
            "probability": 8.975367791208555e-07
        },
        {
            "start_logit": 8.49800968170166,
            "end_logit": -5.753600120544434,
            "text": "Rhe",
            "probability": 8.725338602744159e-07
        },
        {
            "start_logit": -6.669254302978516,
            "end_logit": 8.197054862976074,
            "text": "alimumab in Rheumatoid Arthritis",
            "probability": 2.584733351795876e-07
        },
        {
            "start_logit": -6.696661949157715,
            "end_logit": 8.197054862976074,
            "text": "id Arthritis",
            "probability": 2.514854031687719e-07
        },
        {
            "start_logit": -6.842982292175293,
            "end_logit": 8.197054862976074,
            "text": "hritis",
            "probability": 2.1725341525780095e-07
        }
    ],
    "63eef60ef36125a42600000c_0005": [
        {
            "start_logit": 8.178510665893555,
            "end_logit": 7.007973670959473,
            "text": "rheumatoid arthritis",
            "probability": 0.9940495491027832
        },
        {
            "start_logit": 2.87073016166687,
            "end_logit": 7.007973670959473,
            "text": "interleukin-6 is involved in the pathogenesis of rheumatoid arthritis",
            "probability": 0.004923436790704727
        },
        {
            "start_logit": 8.178510665893555,
            "end_logit": -1.1266026496887207,
            "text": "r",
            "probability": 0.0002914783253800124
        },
        {
            "start_logit": 8.178510665893555,
            "end_logit": -1.3678969144821167,
            "text": "rheumatoid arthritis.",
            "probability": 0.00022898847237229347
        },
        {
            "start_logit": 8.178510665893555,
            "end_logit": -1.8185787200927734,
            "text": "rheumatoid arthr",
            "probability": 0.00014590997307095677
        },
        {
            "start_logit": -0.7467689514160156,
            "end_logit": 7.007973670959473,
            "text": "cytokine interleukin-6 is involved in the pathogenesis of rheumatoid arthritis",
            "probability": 0.00013219297397881746
        },
        {
            "start_logit": 2.87073016166687,
            "end_logit": 2.9545278549194336,
            "text": "interleukin-6",
            "probability": 8.54828831506893e-05
        },
        {
            "start_logit": 8.178510665893555,
            "end_logit": -3.401710033416748,
            "text": "rheumatoid art",
            "probability": 2.9959877792862244e-05
        },
        {
            "start_logit": 8.178510665893555,
            "end_logit": -3.4084835052490234,
            "text": "rheumatoid",
            "probability": 2.975761890411377e-05
        },
        {
            "start_logit": 8.178510665893555,
            "end_logit": -3.898984670639038,
            "text": "rheumatoid arthritis. Olokizumab, a humanized monoclonal antibody",
            "probability": 1.8221162463305518e-05
        },
        {
            "start_logit": 2.4104905128479004,
            "end_logit": 1.7241133451461792,
            "text": "rheumatoid arthritis",
            "probability": 1.5762952898512594e-05
        },
        {
            "start_logit": -2.9522013664245605,
            "end_logit": 7.007973670959473,
            "text": "itis",
            "probability": 1.4568036021955777e-05
        },
        {
            "start_logit": -3.0232787132263184,
            "end_logit": 7.007973670959473,
            "text": "pathogenesis of rheumatoid arthritis",
            "probability": 1.3568520444096066e-05
        },
        {
            "start_logit": -4.015886306762695,
            "end_logit": 7.007973670959473,
            "text": "heumatoid arthritis",
            "probability": 5.028618488722714e-06
        },
        {
            "start_logit": 2.4104905128479004,
            "end_logit": 0.3977191746234894,
            "text": "rheumatoid arthritis.",
            "probability": 4.18399895352195e-06
        },
        {
            "start_logit": -4.43770170211792,
            "end_logit": 7.007973670959473,
            "text": "involved in the pathogenesis of rheumatoid arthritis",
            "probability": 3.298043793620309e-06
        },
        {
            "start_logit": -4.544631004333496,
            "end_logit": 7.007973670959473,
            "text": "the pathogenesis of rheumatoid arthritis",
            "probability": 2.963587576232385e-06
        },
        {
            "start_logit": -0.7467689514160156,
            "end_logit": 2.9545278549194336,
            "text": "cytokine interleukin-6",
            "probability": 2.295192871315521e-06
        },
        {
            "start_logit": -4.979430198669434,
            "end_logit": 7.007973670959473,
            "text": "6 is involved in the pathogenesis of rheumatoid arthritis",
            "probability": 1.9186106783308787e-06
        },
        {
            "start_logit": -5.221030235290527,
            "end_logit": 7.007973670959473,
            "text": "The cytokine interleukin-6 is involved in the pathogenesis of rheumatoid arthritis",
            "probability": 1.5068197853906895e-06
        }
    ],
    "63eef60ef36125a42600000c_0006": [
        {
            "start_logit": 8.992436408996582,
            "end_logit": 8.166646957397461,
            "text": "rheumatoid arthritis",
            "probability": 0.9995197057723999
        },
        {
            "start_logit": 8.992436408996582,
            "end_logit": 0.15166717767715454,
            "text": "r",
            "probability": 0.00033031601924449205
        },
        {
            "start_logit": 8.992436408996582,
            "end_logit": -1.7651598453521729,
            "text": "rheumatoid arthr",
            "probability": 4.8580517614027485e-05
        },
        {
            "start_logit": 8.992436408996582,
            "end_logit": -2.4840188026428223,
            "text": "rheumatoid arthritis who were receiving maintenance methotrexate",
            "probability": 2.3673659597989172e-05
        },
        {
            "start_logit": -2.106409788131714,
            "end_logit": 8.166646957397461,
            "text": "itis",
            "probability": 1.5122484910534695e-05
        },
        {
            "start_logit": 8.992436408996582,
            "end_logit": -2.952526569366455,
            "text": "rheumatoid",
            "probability": 1.4818186173215508e-05
        },
        {
            "start_logit": 8.992436408996582,
            "end_logit": -3.335092544555664,
            "text": "rheumatoid art",
            "probability": 1.0107622074428946e-05
        },
        {
            "start_logit": 8.992436408996582,
            "end_logit": -3.399252414703369,
            "text": "rheumatoid arthritis who were receiving maintenance methotrexate, olokizumab was superior to placebo",
            "probability": 9.479479558649473e-06
        },
        {
            "start_logit": 8.992436408996582,
            "end_logit": -3.54244327545166,
            "text": "rheuma",
            "probability": 8.214812623918988e-06
        },
        {
            "start_logit": 8.992436408996582,
            "end_logit": -4.018000602722168,
            "text": "rheumato",
            "probability": 5.105823220219463e-06
        },
        {
            "start_logit": -3.204646587371826,
            "end_logit": 8.166646957397461,
            "text": "In patients with rheumatoid arthritis",
            "probability": 5.042720204073703e-06
        },
        {
            "start_logit": -3.3763058185577393,
            "end_logit": 8.166646957397461,
            "text": "patients with rheumatoid arthritis",
            "probability": 4.247316155669978e-06
        },
        {
            "start_logit": 8.992436408996582,
            "end_logit": -4.430731773376465,
            "text": "rheumatoid arthritis who were receiving maintenance methotrexate, olokizumab",
            "probability": 3.3792387057474116e-06
        },
        {
            "start_logit": -4.168124675750732,
            "end_logit": 8.166646957397461,
            "text": "heumatoid arthritis",
            "probability": 1.9241178961237893e-06
        },
        {
            "start_logit": -5.876820087432861,
            "end_logit": 8.166646957397461,
            "text": "CONCLUSIONS: In patients with rheumatoid arthritis",
            "probability": 3.484617252524913e-07
        },
        {
            "start_logit": -3.204646587371826,
            "end_logit": 0.15166717767715454,
            "text": "In patients with r",
            "probability": 1.666494942043073e-09
        },
        {
            "start_logit": -3.3763058185577393,
            "end_logit": 0.15166717767715454,
            "text": "patients with r",
            "probability": 1.4036319884169757e-09
        },
        {
            "start_logit": -2.89837646484375,
            "end_logit": -1.6796624660491943,
            "text": "rheumatoid arthritis",
            "probability": 3.6264238834071705e-10
        },
        {
            "start_logit": -2.106409788131714,
            "end_logit": -2.4840188026428223,
            "text": "itis who were receiving maintenance methotrexate",
            "probability": 3.5817759869161137e-10
        },
        {
            "start_logit": -3.204646587371826,
            "end_logit": -1.7651598453521729,
            "text": "In patients with rheumatoid arthr",
            "probability": 2.450959712962941e-10
        }
    ],
    "63f03fc8f36125a426000021_0001": [
        {
            "start_logit": 7.302238464355469,
            "end_logit": 6.940309524536133,
            "text": "human immunodeficiency virus",
            "probability": 0.9764906167984009
        },
        {
            "start_logit": 7.302238464355469,
            "end_logit": 3.0115370750427246,
            "text": "human immunodeficiency virus type 1",
            "probability": 0.019205434247851372
        },
        {
            "start_logit": 7.302238464355469,
            "end_logit": 0.3974039554595947,
            "text": "human immunodeficiency virus type 1 Capsid Inhibitor Lenacapavir.",
            "probability": 0.0014064364368095994
        },
        {
            "start_logit": 7.302238464355469,
            "end_logit": 0.27616873383522034,
            "text": "human immunodeficiency",
            "probability": 0.0012458580313250422
        },
        {
            "start_logit": 0.43212634325027466,
            "end_logit": 6.940309524536133,
            "text": "Viral Resistance to human immunodeficiency virus",
            "probability": 0.0010139496298506856
        },
        {
            "start_logit": 7.302238464355469,
            "end_logit": -2.0219273567199707,
            "text": "human",
            "probability": 0.00012514636910054833
        },
        {
            "start_logit": 7.302238464355469,
            "end_logit": -2.1787052154541016,
            "text": "human immunodeficiency virus type 1 Capsid Inhibitor",
            "probability": 0.00010698683036025614
        },
        {
            "start_logit": 7.302238464355469,
            "end_logit": -2.2188098430633545,
            "text": "human immunodeficiency virus type 1 Capsid",
            "probability": 0.00010278103582095355
        },
        {
            "start_logit": -2.011904239654541,
            "end_logit": 6.940309524536133,
            "text": "virus",
            "probability": 8.802123920759186e-05
        },
        {
            "start_logit": -2.3408713340759277,
            "end_logit": 6.940309524536133,
            "text": "Structural and Mechanistic Bases of Viral Resistance to human immunodeficiency virus",
            "probability": 6.334589852485806e-05
        },
        {
            "start_logit": -2.5717365741729736,
            "end_logit": 6.940309524536133,
            "text": "Mechanistic Bases of Viral Resistance to human immunodeficiency virus",
            "probability": 5.028695159126073e-05
        },
        {
            "start_logit": 7.302238464355469,
            "end_logit": -3.7105798721313477,
            "text": "human immu",
            "probability": 2.3123075152398087e-05
        },
        {
            "start_logit": 0.43212634325027466,
            "end_logit": 3.0115370750427246,
            "text": "Viral Resistance to human immunodeficiency virus type 1",
            "probability": 1.9942159269703552e-05
        },
        {
            "start_logit": 7.302238464355469,
            "end_logit": -4.286215782165527,
            "text": "human immunode",
            "probability": 1.3003193998883944e-05
        },
        {
            "start_logit": -3.9854283332824707,
            "end_logit": 6.940309524536133,
            "text": "Resistance to human immunodeficiency virus",
            "probability": 1.223198341904208e-05
        },
        {
            "start_logit": 7.302238464355469,
            "end_logit": -4.669424057006836,
            "text": "human immuno",
            "probability": 8.86389989318559e-06
        },
        {
            "start_logit": -4.381726264953613,
            "end_logit": 6.940309524536133,
            "text": "immunodeficiency virus",
            "probability": 8.229751074395608e-06
        },
        {
            "start_logit": 7.302238464355469,
            "end_logit": -4.897263050079346,
            "text": "human immunodeficiency virus type",
            "probability": 7.057905349938665e-06
        },
        {
            "start_logit": 7.302238464355469,
            "end_logit": -5.198254585266113,
            "text": "human im",
            "probability": 5.223440894042142e-06
        },
        {
            "start_logit": -5.26986026763916,
            "end_logit": 6.940309524536133,
            "text": "nodeficiency virus",
            "probability": 3.3859064387797844e-06
        }
    ],
    "63f03fc8f36125a426000021_0002": [
        {
            "start_logit": 6.802553653717041,
            "end_logit": 6.707035064697266,
            "text": "human immunodeficiency virus",
            "probability": 0.9458856582641602
        },
        {
            "start_logit": 6.802553653717041,
            "end_logit": 3.7430930137634277,
            "text": "human immunodeficiency virus type 1",
            "probability": 0.04882195591926575
        },
        {
            "start_logit": 6.802553653717041,
            "end_logit": 0.9132142066955566,
            "text": "human immunodeficiency virus type 1 capsid (capsid) inhibitor.",
            "probability": 0.002881471998989582
        },
        {
            "start_logit": -0.1820051372051239,
            "end_logit": 6.707035064697266,
            "text": "Lenacapavir (Lenacapavir) is a long-acting, highly potent human immunodeficiency virus",
            "probability": 0.0008759587071835995
        },
        {
            "start_logit": 6.802553653717041,
            "end_logit": -0.5925856232643127,
            "text": "human immunodeficiency",
            "probability": 0.0006392252398654819
        },
        {
            "start_logit": 6.802553653717041,
            "end_logit": -1.8908907175064087,
            "text": "human immunodeficiency virus type 1 capsid",
            "probability": 0.00017450470477342606
        },
        {
            "start_logit": 6.802553653717041,
            "end_logit": -2.075847625732422,
            "text": "human immunodeficiency virus type 1 capsid (capsid)",
            "probability": 0.00014503777492791414
        },
        {
            "start_logit": 6.802553653717041,
            "end_logit": -2.106226921081543,
            "text": "human immunodeficiency virus type 1 capsid (capsid) inhibitor",
            "probability": 0.00014069803000893444
        },
        {
            "start_logit": -2.0243213176727295,
            "end_logit": 6.707035064697266,
            "text": "virus",
            "probability": 0.0001387955853715539
        },
        {
            "start_logit": 6.802553653717041,
            "end_logit": -2.350092649459839,
            "text": "human",
            "probability": 0.0001102499445551075
        },
        {
            "start_logit": -0.1820051372051239,
            "end_logit": 3.7430930137634277,
            "text": "Lenacapavir (Lenacapavir) is a long-acting, highly potent human immunodeficiency virus type 1",
            "probability": 4.521262599155307e-05
        },
        {
            "start_logit": -3.4465370178222656,
            "end_logit": 6.707035064697266,
            "text": "immunodeficiency virus",
            "probability": 3.347459642100148e-05
        },
        {
            "start_logit": 6.802553653717041,
            "end_logit": -3.8262577056884766,
            "text": "human immunodeficiency virus type 1 capsid (capsid",
            "probability": 2.519345434848219e-05
        },
        {
            "start_logit": -3.8404202461242676,
            "end_logit": 6.707035064697266,
            "text": "Lenacapavir) is a long-acting, highly potent human immunodeficiency virus",
            "probability": 2.257637788716238e-05
        },
        {
            "start_logit": 6.802553653717041,
            "end_logit": -4.32014799118042,
            "text": "human immu",
            "probability": 1.5374254871858284e-05
        },
        {
            "start_logit": 6.802553653717041,
            "end_logit": -4.333718299865723,
            "text": "human immunodeficiency virus type",
            "probability": 1.5167038327490445e-05
        },
        {
            "start_logit": -4.854157447814941,
            "end_logit": 6.707035064697266,
            "text": "highly potent human immunodeficiency virus",
            "probability": 8.19206798041705e-06
        },
        {
            "start_logit": 6.802553653717041,
            "end_logit": -5.0810465812683105,
            "text": "human immunode",
            "probability": 7.1835647759144194e-06
        },
        {
            "start_logit": -2.0243213176727295,
            "end_logit": 3.7430930137634277,
            "text": "virus type 1",
            "probability": 7.163943791965721e-06
        },
        {
            "start_logit": -5.048570156097412,
            "end_logit": 6.707035064697266,
            "text": "nodeficiency virus",
            "probability": 6.744674465153366e-06
        }
    ],
    "63f03fc8f36125a426000021_0003": [
        {
            "start_logit": 7.645747184753418,
            "end_logit": 7.693188667297363,
            "text": "human immunodeficiency virus",
            "probability": 0.7502273917198181
        },
        {
            "start_logit": 7.645747184753418,
            "end_logit": 6.591381072998047,
            "text": "human immunodeficiency virus type 1",
            "probability": 0.2492779940366745
        },
        {
            "start_logit": 7.645747184753418,
            "end_logit": -1.0917766094207764,
            "text": "human immunodeficiency",
            "probability": 0.00011479708336992189
        },
        {
            "start_logit": -1.296628475189209,
            "end_logit": 7.693188667297363,
            "text": "virus",
            "probability": 9.807735477807e-05
        },
        {
            "start_logit": 7.645747184753418,
            "end_logit": -1.3386988639831543,
            "text": "human immunodeficiency virus type 1 inside the nucleus without displacing the tightly bound cellular cofactor from virus cores.",
            "probability": 8.967971371021122e-05
        },
        {
            "start_logit": 7.645747184753418,
            "end_logit": -1.873692274093628,
            "text": "human",
            "probability": 5.2522958867484704e-05
        },
        {
            "start_logit": -1.296628475189209,
            "end_logit": 6.591381072998047,
            "text": "virus type 1",
            "probability": 3.258811921114102e-05
        },
        {
            "start_logit": 7.645747184753418,
            "end_logit": -2.6031785011291504,
            "text": "human immunodeficiency virus type",
            "probability": 2.5324288799311034e-05
        },
        {
            "start_logit": 7.645747184753418,
            "end_logit": -2.988206624984741,
            "text": "human immunodeficiency virus type 1 inside the nucleus",
            "probability": 1.723144669085741e-05
        },
        {
            "start_logit": -2.024745225906372,
            "end_logit": 6.591381072998047,
            "text": "1",
            "probability": 1.5734123735455796e-05
        },
        {
            "start_logit": -3.8589630126953125,
            "end_logit": 7.693188667297363,
            "text": "lenacapavir accesses unoccupied hydrophobic pockets in the complex to potently impair human immunodeficiency virus",
            "probability": 7.564160569017986e-06
        },
        {
            "start_logit": -4.038683891296387,
            "end_logit": 7.693188667297363,
            "text": "unoccupied hydrophobic pockets in the complex to potently impair human immunodeficiency virus",
            "probability": 6.3198817770171445e-06
        },
        {
            "start_logit": -3.0120067596435547,
            "end_logit": 6.591381072998047,
            "text": "type 1",
            "probability": 5.862464149686275e-06
        },
        {
            "start_logit": 7.645747184753418,
            "end_logit": -4.07582950592041,
            "text": "human immu",
            "probability": 5.807286470371764e-06
        },
        {
            "start_logit": -4.1430511474609375,
            "end_logit": 7.693188667297363,
            "text": "hydrophobic pockets in the complex to potently impair human immunodeficiency virus",
            "probability": 5.6935459724627435e-06
        },
        {
            "start_logit": 7.645747184753418,
            "end_logit": -4.4287214279174805,
            "text": "human immunode",
            "probability": 4.0805080061545596e-06
        },
        {
            "start_logit": 7.645747184753418,
            "end_logit": -4.512716293334961,
            "text": "human immunodeficiency virus type 1 inside the nucleus without displacing the tightly bound cellular cofactor from virus",
            "probability": 3.7517659166041994e-06
        },
        {
            "start_logit": -4.567271709442139,
            "end_logit": 7.693188667297363,
            "text": "immunodeficiency virus",
            "probability": 3.7251725188980345e-06
        },
        {
            "start_logit": -4.77226448059082,
            "end_logit": 7.693188667297363,
            "text": "impair human immunodeficiency virus",
            "probability": 3.0347221127158264e-06
        },
        {
            "start_logit": 7.645747184753418,
            "end_logit": -4.773930549621582,
            "text": "human immunodeficiency virus type 1 inside the nucleus without displacing the tightly bound cellular cofactor",
            "probability": 2.8892945920233615e-06
        }
    ],
    "63f03fc8f36125a426000021_0004": [
        {
            "start_logit": 7.183801651000977,
            "end_logit": 6.554064750671387,
            "text": "human immunodeficiency virus",
            "probability": 0.5430680513381958
        },
        {
            "start_logit": 7.183801651000977,
            "end_logit": 6.376687049865723,
            "text": "human immunodeficiency virus type\u00a01",
            "probability": 0.4547996520996094
        },
        {
            "start_logit": 7.183801651000977,
            "end_logit": -0.6921801567077637,
            "text": "human immunodeficiency virus type\u00a01 (human immunodeficiency virus type 1",
            "probability": 0.00038712398963980377
        },
        {
            "start_logit": 7.183801651000977,
            "end_logit": -0.9735463857650757,
            "text": "human immunodeficiency",
            "probability": 0.0002921825216617435
        },
        {
            "start_logit": 7.183801651000977,
            "end_logit": -0.9815798997879028,
            "text": "human immunodeficiency virus type\u00a01 (human immunodeficiency virus type 1)",
            "probability": 0.0002898447564803064
        },
        {
            "start_logit": -0.5195226073265076,
            "end_logit": 6.554064750671387,
            "text": "capsid inhibitor of human immunodeficiency virus",
            "probability": 0.00024509982904419303
        },
        {
            "start_logit": -0.5195226073265076,
            "end_logit": 6.376687049865723,
            "text": "capsid inhibitor of human immunodeficiency virus type\u00a01",
            "probability": 0.00020526214211713523
        },
        {
            "start_logit": -1.2800990343093872,
            "end_logit": 6.554064750671387,
            "text": "Lenacapavir (Sunlenca\u00ae) is a long-acting capsid inhibitor of human immunodeficiency virus",
            "probability": 0.00011455892672529444
        },
        {
            "start_logit": 7.183801651000977,
            "end_logit": -2.0068249702453613,
            "text": "human",
            "probability": 0.0001039697090163827
        },
        {
            "start_logit": -1.2800990343093872,
            "end_logit": 6.376687049865723,
            "text": "Lenacapavir (Sunlenca\u00ae) is a long-acting capsid inhibitor of human immunodeficiency virus type\u00a01",
            "probability": 9.593891445547342e-05
        },
        {
            "start_logit": 7.183801651000977,
            "end_logit": -2.1341018676757812,
            "text": "human immunodeficiency virus type\u00a01 (human immunodeficiency virus type 1) being developed by Gilead Sciences Inc.",
            "probability": 9.154433064395562e-05
        },
        {
            "start_logit": 7.183801651000977,
            "end_logit": -2.318028211593628,
            "text": "human immunodeficiency virus type\u00a01 (human immunodeficiency virus",
            "probability": 7.616458606207743e-05
        },
        {
            "start_logit": -2.01397967338562,
            "end_logit": 6.554064750671387,
            "text": "virus",
            "probability": 5.4993135563563555e-05
        },
        {
            "start_logit": -1.8721457719802856,
            "end_logit": 6.376687049865723,
            "text": "1",
            "probability": 5.307282117428258e-05
        },
        {
            "start_logit": -2.01397967338562,
            "end_logit": 6.376687049865723,
            "text": "virus type\u00a01",
            "probability": 4.605474168783985e-05
        },
        {
            "start_logit": 7.183801651000977,
            "end_logit": -3.765810966491699,
            "text": "human immunodeficiency virus type",
            "probability": 1.79056132765254e-05
        },
        {
            "start_logit": -3.154017925262451,
            "end_logit": 6.554064750671387,
            "text": "immunodeficiency virus",
            "probability": 1.758717371558305e-05
        },
        {
            "start_logit": 7.183801651000977,
            "end_logit": -3.878469944000244,
            "text": "human immunodeficiency virus type\u00a01 (human immunodeficiency",
            "probability": 1.5997857190086506e-05
        },
        {
            "start_logit": -3.154017925262451,
            "end_logit": 6.376687049865723,
            "text": "immunodeficiency virus type\u00a01",
            "probability": 1.4728614587511402e-05
        },
        {
            "start_logit": 7.183801651000977,
            "end_logit": -4.331752300262451,
            "text": "human immu",
            "probability": 1.0167265827476513e-05
        }
    ],
    "63f03fc8f36125a426000021_0005": [
        {
            "start_logit": 7.0316057205200195,
            "end_logit": 7.536688804626465,
            "text": "human immunodeficiency virus type 1 infection",
            "probability": 0.6063531041145325
        },
        {
            "start_logit": 6.407828330993652,
            "end_logit": 7.012271404266357,
            "text": "HIV infection",
            "probability": 0.19234049320220947
        },
        {
            "start_logit": 7.0316057205200195,
            "end_logit": 5.962137222290039,
            "text": "human immunodeficiency virus",
            "probability": 0.1255759745836258
        },
        {
            "start_logit": 5.138273239135742,
            "end_logit": 7.012271404266357,
            "text": "multi-drug resistant HIV infection",
            "probability": 0.054039373993873596
        },
        {
            "start_logit": 7.0316057205200195,
            "end_logit": 4.125598907470703,
            "text": "human immunodeficiency virus type 1",
            "probability": 0.020012808963656425
        },
        {
            "start_logit": -0.17843517661094666,
            "end_logit": 7.536688804626465,
            "text": "infection",
            "probability": 0.000448171776952222
        },
        {
            "start_logit": 0.03528314828872681,
            "end_logit": 7.012271404266357,
            "text": "adults with multi-drug resistant HIV infection",
            "probability": 0.00032848058617673814
        },
        {
            "start_logit": 6.407828330993652,
            "end_logit": 0.6282375454902649,
            "text": "HIV",
            "probability": 0.00032472843304276466
        },
        {
            "start_logit": -0.6905229091644287,
            "end_logit": 7.012271404266357,
            "text": "infection",
            "probability": 0.00015896305558271706
        },
        {
            "start_logit": 7.0316057205200195,
            "end_logit": -1.0681501626968384,
            "text": "human immunodeficiency",
            "probability": 0.00011109418846899644
        },
        {
            "start_logit": 5.138273239135742,
            "end_logit": 0.6282375454902649,
            "text": "multi-drug resistant HIV",
            "probability": 9.123460768023506e-05
        },
        {
            "start_logit": -2.5445244312286377,
            "end_logit": 7.536688804626465,
            "text": "virus type 1 infection",
            "probability": 4.205960431136191e-05
        },
        {
            "start_logit": 7.0316057205200195,
            "end_logit": -2.344215154647827,
            "text": "human immunodeficiency virus type 1 infection.",
            "probability": 3.101011679973453e-05
        },
        {
            "start_logit": -2.90944504737854,
            "end_logit": 7.536688804626465,
            "text": "type 1 infection",
            "probability": 2.9199956770753488e-05
        },
        {
            "start_logit": 7.0316057205200195,
            "end_logit": -2.500192165374756,
            "text": "human",
            "probability": 2.6531617550062947e-05
        },
        {
            "start_logit": 6.407828330993652,
            "end_logit": -2.124598264694214,
            "text": "HIV infection,",
            "probability": 2.0700401364592835e-05
        },
        {
            "start_logit": -3.382152557373047,
            "end_logit": 7.536688804626465,
            "text": "lenacapavir leading to this first approval for the treatment of human immunodeficiency virus type 1 infection",
            "probability": 1.820068973756861e-05
        },
        {
            "start_logit": -3.4407644271850586,
            "end_logit": 7.536688804626465,
            "text": "1 infection",
            "probability": 1.716457336442545e-05
        },
        {
            "start_logit": 6.407828330993652,
            "end_logit": -2.3410472869873047,
            "text": "HIV infection, for whom it is otherwise not possible to construct a suppressive anti-viral regimen.",
            "probability": 1.667155811446719e-05
        },
        {
            "start_logit": 6.407828330993652,
            "end_logit": -2.5144591331481934,
            "text": "HI",
            "probability": 1.4017307876201812e-05
        }
    ],
    "63f03fc8f36125a426000021_0006": [
        {
            "start_logit": 6.801847457885742,
            "end_logit": 6.466418266296387,
            "text": "human immunodeficiency virus",
            "probability": 0.9610505104064941
        },
        {
            "start_logit": 6.801847457885742,
            "end_logit": 3.0839004516601562,
            "text": "human immunodeficiency virus type 1",
            "probability": 0.0326390378177166
        },
        {
            "start_logit": 6.801847457885742,
            "end_logit": 0.7481173872947693,
            "text": "human immunodeficiency virus type 1 capsid inhibitor.",
            "probability": 0.0031573281157761812
        },
        {
            "start_logit": 6.801847457885742,
            "end_logit": 0.3196333944797516,
            "text": "human immunodeficiency",
            "probability": 0.0020569865591824055
        },
        {
            "start_logit": -0.6017489433288574,
            "end_logit": 6.466418266296387,
            "text": "Lenacapavir: a first-in-class human immunodeficiency virus",
            "probability": 0.0005853358888998628
        },
        {
            "start_logit": 6.801847457885742,
            "end_logit": -2.3271734714508057,
            "text": "human",
            "probability": 0.00014579342678189278
        },
        {
            "start_logit": -2.4711990356445312,
            "end_logit": 6.466418266296387,
            "text": "virus",
            "probability": 9.026372572407126e-05
        },
        {
            "start_logit": 6.801847457885742,
            "end_logit": -3.143758535385132,
            "text": "human immunodeficiency virus type 1 capsid",
            "probability": 6.443166785174981e-05
        },
        {
            "start_logit": 6.801847457885742,
            "end_logit": -3.169560432434082,
            "text": "human immunodeficiency virus type 1 capsid inhibitor",
            "probability": 6.279048830037937e-05
        },
        {
            "start_logit": -3.4346442222595215,
            "end_logit": 6.466418266296387,
            "text": "immunodeficiency virus",
            "probability": 3.4442462492734194e-05
        },
        {
            "start_logit": 6.801847457885742,
            "end_logit": -3.875049591064453,
            "text": "human immu",
            "probability": 3.101014226558618e-05
        },
        {
            "start_logit": -0.6017489433288574,
            "end_logit": 3.0839004516601562,
            "text": "Lenacapavir: a first-in-class human immunodeficiency virus type 1",
            "probability": 1.987909126910381e-05
        },
        {
            "start_logit": 6.801847457885742,
            "end_logit": -4.547279357910156,
            "text": "human immunode",
            "probability": 1.5832811186555773e-05
        },
        {
            "start_logit": 6.801847457885742,
            "end_logit": -4.851800918579102,
            "text": "human immunodeficiency virus type",
            "probability": 1.1676323083520401e-05
        },
        {
            "start_logit": 6.801847457885742,
            "end_logit": -4.961726188659668,
            "text": "human immuno",
            "probability": 1.046082797984127e-05
        },
        {
            "start_logit": -4.923628807067871,
            "end_logit": 6.466418266296387,
            "text": "nodeficiency virus",
            "probability": 7.770277989038732e-06
        },
        {
            "start_logit": -5.331049919128418,
            "end_logit": 6.466418266296387,
            "text": "munodeficiency virus",
            "probability": 5.1700631047424395e-06
        },
        {
            "start_logit": 6.801847457885742,
            "end_logit": -5.7446465492248535,
            "text": "human im",
            "probability": 4.781320967595093e-06
        },
        {
            "start_logit": -5.74594259262085,
            "end_logit": 6.466418266296387,
            "text": "deficiency virus",
            "probability": 3.414365437492961e-06
        },
        {
            "start_logit": -2.4711990356445312,
            "end_logit": 3.0839004516601562,
            "text": "virus type 1",
            "probability": 3.0655221507913666e-06
        }
    ],
    "63f03fc8f36125a426000021_0007": [
        {
            "start_logit": 6.282477855682373,
            "end_logit": 5.51396369934082,
            "text": "human immunodeficiency virus type 1",
            "probability": 0.8758651614189148
        },
        {
            "start_logit": 6.282477855682373,
            "end_logit": 3.355264663696289,
            "text": "human immunodeficiency virus",
            "probability": 0.10114074498414993
        },
        {
            "start_logit": 2.147052526473999,
            "end_logit": 5.51396369934082,
            "text": "persons with human immunodeficiency virus type 1",
            "probability": 0.014010213315486908
        },
        {
            "start_logit": 6.282477855682373,
            "end_logit": -0.46742528676986694,
            "text": "human immunodeficiency virus type 1. In persons with human immunodeficiency virus type 1",
            "probability": 0.0022118352353572845
        },
        {
            "start_logit": 6.282477855682373,
            "end_logit": -0.7507027387619019,
            "text": "human immunodeficiency",
            "probability": 0.0016661991830915213
        },
        {
            "start_logit": 2.147052526473999,
            "end_logit": 3.355264663696289,
            "text": "persons with human immunodeficiency virus",
            "probability": 0.0016178329242393374
        },
        {
            "start_logit": 6.282477855682373,
            "end_logit": -0.8009690642356873,
            "text": "human immunodeficiency virus type 1.",
            "probability": 0.0015845156740397215
        },
        {
            "start_logit": 6.282477855682373,
            "end_logit": -1.997528314590454,
            "text": "human immunodeficiency virus type 1. In persons with human immunodeficiency virus",
            "probability": 0.0004788918304257095
        },
        {
            "start_logit": 6.282477855682373,
            "end_logit": -2.6489410400390625,
            "text": "human",
            "probability": 0.00024965067859739065
        },
        {
            "start_logit": 6.282477855682373,
            "end_logit": -2.8435025215148926,
            "text": "human immunodeficiency virus type",
            "probability": 0.0002055112418020144
        },
        {
            "start_logit": -2.101088047027588,
            "end_logit": 5.51396369934082,
            "text": "no cross resistance to existing antiretroviral classes and potent antiviral activity in persons with human immunodeficiency virus type 1",
            "probability": 0.00020021693489979953
        },
        {
            "start_logit": -2.108759641647339,
            "end_logit": 5.51396369934082,
            "text": "retroviral classes and potent antiviral activity in persons with human immunodeficiency virus type 1",
            "probability": 0.00019868668459821492
        },
        {
            "start_logit": -2.170687675476074,
            "end_logit": 5.51396369934082,
            "text": "cross resistance to existing antiretroviral classes and potent antiviral activity in persons with human immunodeficiency virus type 1",
            "probability": 0.000186755700269714
        },
        {
            "start_logit": -2.709744930267334,
            "end_logit": 5.51396369934082,
            "text": "1",
            "probability": 0.00010893416038015857
        },
        {
            "start_logit": -2.9385223388671875,
            "end_logit": 5.51396369934082,
            "text": "potent antiviral activity in persons with human immunodeficiency virus type 1",
            "probability": 8.665777568239719e-05
        },
        {
            "start_logit": -3.046549081802368,
            "end_logit": 5.51396369934082,
            "text": "antiretroviral classes and potent antiviral activity in persons with human immunodeficiency virus type 1",
            "probability": 7.778435247018933e-05
        },
        {
            "start_logit": 2.147052526473999,
            "end_logit": -0.46742528676986694,
            "text": "persons with human immunodeficiency virus type 1. In persons with human immunodeficiency virus type 1",
            "probability": 3.538021701388061e-05
        },
        {
            "start_logit": 2.147052526473999,
            "end_logit": -0.7507027387619019,
            "text": "persons with human immunodeficiency",
            "probability": 2.665229476406239e-05
        },
        {
            "start_logit": 2.147052526473999,
            "end_logit": -0.8009690642356873,
            "text": "persons with human immunodeficiency virus type 1.",
            "probability": 2.5345696485601366e-05
        },
        {
            "start_logit": -2.101088047027588,
            "end_logit": 3.355264663696289,
            "text": "no cross resistance to existing antiretroviral classes and potent antiviral activity in persons with human immunodeficiency virus",
            "probability": 2.312010110472329e-05
        }
    ],
    "63f03fc8f36125a426000021_0008": [
        {
            "start_logit": 7.117622375488281,
            "end_logit": 6.722054481506348,
            "text": "human immunodeficiency virus type 1",
            "probability": 0.4878028929233551
        },
        {
            "start_logit": 7.117622375488281,
            "end_logit": 6.09226131439209,
            "text": "human immunodeficiency virus",
            "probability": 0.2598536014556885
        },
        {
            "start_logit": 5.988968849182129,
            "end_logit": 6.722054481506348,
            "text": "multidrug-resistant human immunodeficiency virus type 1",
            "probability": 0.15778888761997223
        },
        {
            "start_logit": 5.988968849182129,
            "end_logit": 6.09226131439209,
            "text": "multidrug-resistant human immunodeficiency virus",
            "probability": 0.08405444025993347
        },
        {
            "start_logit": 7.117622375488281,
            "end_logit": 2.3100879192352295,
            "text": "human immunodeficiency virus type 1 and in treatment-naive persons with human immunodeficiency virus type 1",
            "probability": 0.005917683709412813
        },
        {
            "start_logit": 5.988968849182129,
            "end_logit": 2.3100879192352295,
            "text": "multidrug-resistant human immunodeficiency virus type 1 and in treatment-naive persons with human immunodeficiency virus type 1",
            "probability": 0.001914184307679534
        },
        {
            "start_logit": 7.117622375488281,
            "end_logit": 0.36467230319976807,
            "text": "human immunodeficiency",
            "probability": 0.0008458012016490102
        },
        {
            "start_logit": 7.117622375488281,
            "end_logit": 0.0795494019985199,
            "text": "human immunodeficiency virus type 1 and in treatment-naive persons with human immunodeficiency virus",
            "probability": 0.0006359764374792576
        },
        {
            "start_logit": 5.988968849182129,
            "end_logit": 0.36467230319976807,
            "text": "multidrug-resistant human immunodeficiency",
            "probability": 0.0002735900634434074
        },
        {
            "start_logit": -0.6049752831459045,
            "end_logit": 6.722054481506348,
            "text": "drug-resistant human immunodeficiency virus type 1",
            "probability": 0.0002159547875635326
        },
        {
            "start_logit": 5.988968849182129,
            "end_logit": 0.0795494019985199,
            "text": "multidrug-resistant human immunodeficiency virus type 1 and in treatment-naive persons with human immunodeficiency virus",
            "probability": 0.00020571834465954453
        },
        {
            "start_logit": 5.988968849182129,
            "end_logit": -0.4644136130809784,
            "text": "multidrug-resistant",
            "probability": 0.00011940787953790277
        },
        {
            "start_logit": -0.6049752831459045,
            "end_logit": 6.09226131439209,
            "text": "drug-resistant human immunodeficiency virus",
            "probability": 0.00011503959831316024
        },
        {
            "start_logit": 7.117622375488281,
            "end_logit": -2.0090441703796387,
            "text": "human",
            "probability": 7.877287134760991e-05
        },
        {
            "start_logit": -1.8825156688690186,
            "end_logit": 6.722054481506348,
            "text": "1",
            "probability": 6.0191341617610306e-05
        },
        {
            "start_logit": 7.117622375488281,
            "end_logit": -2.965418815612793,
            "text": "human immunodeficiency virus type 1 and in treatment-naive persons with human immunodeficiency",
            "probability": 3.0271097784861922e-05
        },
        {
            "start_logit": 5.988968849182129,
            "end_logit": -2.0090441703796387,
            "text": "multidrug-resistant human",
            "probability": 2.5480514523223974e-05
        },
        {
            "start_logit": -2.7750697135925293,
            "end_logit": 6.722054481506348,
            "text": "virus type 1",
            "probability": 2.4654862500028685e-05
        },
        {
            "start_logit": 7.117622375488281,
            "end_logit": -3.4040045738220215,
            "text": "human immunodeficiency virus type",
            "probability": 1.9523289665812626e-05
        },
        {
            "start_logit": -3.0940656661987305,
            "end_logit": 6.722054481506348,
            "text": "In heavily treatment-experienced persons with multidrug-resistant human immunodeficiency virus type 1",
            "probability": 1.7921096514328383e-05
        }
    ],
    "64041701201352f04a000017_0001": [
        {
            "start_logit": 6.917072296142578,
            "end_logit": 6.760774612426758,
            "text": "urinary tract abnormalities, and bilateral cryptorchidism",
            "probability": 0.13533392548561096
        },
        {
            "start_logit": 6.83907413482666,
            "end_logit": 6.760774612426758,
            "text": "bilateral cryptorchidism",
            "probability": 0.12517929077148438
        },
        {
            "start_logit": 6.757912635803223,
            "end_logit": 6.760774612426758,
            "text": "defective abdominal wall muscles, urinary tract abnormalities, and bilateral cryptorchidism",
            "probability": 0.11542090773582458
        },
        {
            "start_logit": 6.917072296142578,
            "end_logit": 6.512944221496582,
            "text": "urinary tract abnormalities",
            "probability": 0.10562708228826523
        },
        {
            "start_logit": 6.633021831512451,
            "end_logit": 6.760774612426758,
            "text": "absent or defective abdominal wall muscles, urinary tract abnormalities, and bilateral cryptorchidism",
            "probability": 0.10186975449323654
        },
        {
            "start_logit": 6.757912635803223,
            "end_logit": 6.512944221496582,
            "text": "defective abdominal wall muscles, urinary tract abnormalities",
            "probability": 0.09008513391017914
        },
        {
            "start_logit": 6.757912635803223,
            "end_logit": 6.421071529388428,
            "text": "defective abdominal wall muscles",
            "probability": 0.08217753469944
        },
        {
            "start_logit": 6.412167549133301,
            "end_logit": 6.760774612426758,
            "text": "cryptorchidism",
            "probability": 0.08168255537748337
        },
        {
            "start_logit": 6.633021831512451,
            "end_logit": 6.512944221496582,
            "text": "absent or defective abdominal wall muscles, urinary tract abnormalities",
            "probability": 0.07950849086046219
        },
        {
            "start_logit": 6.633021831512451,
            "end_logit": 6.421071529388428,
            "text": "absent or defective abdominal wall muscles",
            "probability": 0.0725293755531311
        },
        {
            "start_logit": 6.917072296142578,
            "end_logit": 2.71726131439209,
            "text": "urinary tract",
            "probability": 0.0023731826804578304
        },
        {
            "start_logit": 6.757912635803223,
            "end_logit": 2.71726131439209,
            "text": "defective abdominal wall muscles, urinary tract",
            "probability": 0.0020239930599927902
        },
        {
            "start_logit": 6.633021831512451,
            "end_logit": 2.71726131439209,
            "text": "absent or defective abdominal wall muscles, urinary tract",
            "probability": 0.0017863615648820996
        },
        {
            "start_logit": 6.757912635803223,
            "end_logit": 1.9373857975006104,
            "text": "defective abdominal wall muscles,",
            "probability": 0.0009279257501475513
        },
        {
            "start_logit": 6.633021831512451,
            "end_logit": 1.9373857975006104,
            "text": "absent or defective abdominal wall muscles,",
            "probability": 0.0008189814980141819
        },
        {
            "start_logit": 6.917072296142578,
            "end_logit": 1.5148656368255615,
            "text": "urinary tract abnormal",
            "probability": 0.000713078654371202
        },
        {
            "start_logit": 6.757912635803223,
            "end_logit": 1.5148656368255615,
            "text": "defective abdominal wall muscles, urinary tract abnormal",
            "probability": 0.0006081564351916313
        },
        {
            "start_logit": 6.633021831512451,
            "end_logit": 1.5148656368255615,
            "text": "absent or defective abdominal wall muscles, urinary tract abnormal",
            "probability": 0.0005367544945329428
        },
        {
            "start_logit": 1.1315152645111084,
            "end_logit": 6.760774612426758,
            "text": "abdominal wall muscles, urinary tract abnormalities, and bilateral cryptorchidism",
            "probability": 0.0004156916111242026
        },
        {
            "start_logit": 6.917072296142578,
            "end_logit": 0.8902864456176758,
            "text": "urinary tract abnormalities,",
            "probability": 0.0003818440600298345
        }
    ],
    "64041701201352f04a000017_0002": [
        {
            "start_logit": 6.712942600250244,
            "end_logit": 6.618698596954346,
            "text": "urological abnormalities, and bilateral cryptorchidism",
            "probability": 0.1420934647321701
        },
        {
            "start_logit": 6.6971025466918945,
            "end_logit": 6.618698596954346,
            "text": "bilateral cryptorchidism",
            "probability": 0.13986051082611084
        },
        {
            "start_logit": 6.473897933959961,
            "end_logit": 6.618698596954346,
            "text": "deficiency or absence of abdominal wall muscles, urological abnormalities, and bilateral cryptorchidism",
            "probability": 0.11188145726919174
        },
        {
            "start_logit": 6.712942600250244,
            "end_logit": 6.319815635681152,
            "text": "urological abnormalities",
            "probability": 0.10538312047719955
        },
        {
            "start_logit": 6.323116779327393,
            "end_logit": 6.618698596954346,
            "text": "cryptorchidism",
            "probability": 0.09622211009263992
        },
        {
            "start_logit": 6.211682319641113,
            "end_logit": 6.618698596954346,
            "text": "absence of abdominal wall muscles, urological abnormalities, and bilateral cryptorchidism",
            "probability": 0.08607553690671921
        },
        {
            "start_logit": 6.473897933959961,
            "end_logit": 6.319815635681152,
            "text": "deficiency or absence of abdominal wall muscles, urological abnormalities",
            "probability": 0.08297649770975113
        },
        {
            "start_logit": 6.211682319641113,
            "end_logit": 6.319815635681152,
            "text": "absence of abdominal wall muscles, urological abnormalities",
            "probability": 0.06383755803108215
        },
        {
            "start_logit": 6.473897933959961,
            "end_logit": 6.042079925537109,
            "text": "deficiency or absence of abdominal wall muscles",
            "probability": 0.06285444647073746
        },
        {
            "start_logit": 6.211682319641113,
            "end_logit": 6.042079925537109,
            "text": "absence of abdominal wall muscles",
            "probability": 0.048356764018535614
        },
        {
            "start_logit": 6.712942600250244,
            "end_logit": 4.188997745513916,
            "text": "urological abnormalities, and bilateral cryptorchidism.",
            "probability": 0.012513200752437115
        },
        {
            "start_logit": 6.6971025466918945,
            "end_logit": 4.188997745513916,
            "text": "bilateral cryptorchidism.",
            "probability": 0.012316558510065079
        },
        {
            "start_logit": 6.473897933959961,
            "end_logit": 4.188997745513916,
            "text": "deficiency or absence of abdominal wall muscles, urological abnormalities, and bilateral cryptorchidism.",
            "probability": 0.009852636605501175
        },
        {
            "start_logit": 6.323116779327393,
            "end_logit": 4.188997745513916,
            "text": "cryptorchidism.",
            "probability": 0.008473624475300312
        },
        {
            "start_logit": 6.211682319641113,
            "end_logit": 4.188997745513916,
            "text": "absence of abdominal wall muscles, urological abnormalities, and bilateral cryptorchidism.",
            "probability": 0.007580085191875696
        },
        {
            "start_logit": 2.723310947418213,
            "end_logit": 6.618698596954346,
            "text": "abdominal wall muscles, urological abnormalities, and bilateral cryptorchidism",
            "probability": 0.002629657043144107
        },
        {
            "start_logit": 6.473897933959961,
            "end_logit": 2.615095615386963,
            "text": "deficiency or absence of abdominal wall muscles,",
            "probability": 0.0020418106578290462
        },
        {
            "start_logit": 2.723310947418213,
            "end_logit": 6.319815635681152,
            "text": "abdominal wall muscles, urological abnormalities",
            "probability": 0.0019502760842442513
        },
        {
            "start_logit": 6.211682319641113,
            "end_logit": 2.615095615386963,
            "text": "absence of abdominal wall muscles,",
            "probability": 0.0015708584105595946
        },
        {
            "start_logit": 6.712942600250244,
            "end_logit": 2.08736252784729,
            "text": "urological abnormalities,",
            "probability": 0.0015298186335712671
        }
    ],
    "64041701201352f04a000017_0003": [
        {
            "start_logit": 6.854256629943848,
            "end_logit": 6.6749067306518555,
            "text": "deficiency of the abdominal muscles, malformations of the urinary tract, and bilateral cryptorchidism",
            "probability": 0.1601526439189911
        },
        {
            "start_logit": 6.7240753173828125,
            "end_logit": 6.6749067306518555,
            "text": "malformations of the urinary tract, and bilateral cryptorchidism",
            "probability": 0.14060381054878235
        },
        {
            "start_logit": 6.698348045349121,
            "end_logit": 6.6749067306518555,
            "text": "bilateral cryptorchidism",
            "probability": 0.13703259825706482
        },
        {
            "start_logit": 6.677023410797119,
            "end_logit": 6.6749067306518555,
            "text": "cryptorchidism",
            "probability": 0.13414143025875092
        },
        {
            "start_logit": 6.854256629943848,
            "end_logit": 6.425466060638428,
            "text": "deficiency of the abdominal muscles, malformations of the urinary tract",
            "probability": 0.12479674071073532
        },
        {
            "start_logit": 6.7240753173828125,
            "end_logit": 6.425466060638428,
            "text": "malformations of the urinary tract",
            "probability": 0.1095636859536171
        },
        {
            "start_logit": 6.854256629943848,
            "end_logit": 6.284916877746582,
            "text": "deficiency of the abdominal muscles",
            "probability": 0.1084335520863533
        },
        {
            "start_logit": 5.269714832305908,
            "end_logit": 6.6749067306518555,
            "text": "urinary tract, and bilateral cryptorchidism",
            "probability": 0.032837994396686554
        },
        {
            "start_logit": 5.269714832305908,
            "end_logit": 6.425466060638428,
            "text": "urinary tract",
            "probability": 0.02558854967355728
        },
        {
            "start_logit": 3.96915340423584,
            "end_logit": 6.6749067306518555,
            "text": "abdominal muscles, malformations of the urinary tract, and bilateral cryptorchidism",
            "probability": 0.008944368921220303
        },
        {
            "start_logit": 3.96915340423584,
            "end_logit": 6.425466060638428,
            "text": "abdominal muscles, malformations of the urinary tract",
            "probability": 0.0069697764702141285
        },
        {
            "start_logit": 3.96915340423584,
            "end_logit": 6.284916877746582,
            "text": "abdominal muscles",
            "probability": 0.006055908277630806
        },
        {
            "start_logit": 6.854256629943848,
            "end_logit": 1.9327199459075928,
            "text": "deficiency of the abdominal muscles,",
            "probability": 0.0013964605750516057
        },
        {
            "start_logit": 6.854256629943848,
            "end_logit": 1.189812421798706,
            "text": "deficiency of the abdominal muscles, malformations",
            "probability": 0.0006643363740295172
        },
        {
            "start_logit": 1.3173553943634033,
            "end_logit": 6.6749067306518555,
            "text": "symptoms: deficiency of the abdominal muscles, malformations of the urinary tract, and bilateral cryptorchidism",
            "probability": 0.0006307951989583671
        },
        {
            "start_logit": 6.7240753173828125,
            "end_logit": 1.189812421798706,
            "text": "malformations",
            "probability": 0.0005832450115121901
        },
        {
            "start_logit": 1.3173553943634033,
            "end_logit": 6.425466060638428,
            "text": "symptoms: deficiency of the abdominal muscles, malformations of the urinary tract",
            "probability": 0.0004915388999506831
        },
        {
            "start_logit": 1.3173553943634033,
            "end_logit": 6.284916877746582,
            "text": "symptoms: deficiency of the abdominal muscles",
            "probability": 0.0004270885547157377
        },
        {
            "start_logit": 6.854256629943848,
            "end_logit": 0.5907872915267944,
            "text": "deficiency of the abdominal muscles, malformations of the urinary tract,",
            "probability": 0.0003649510908871889
        },
        {
            "start_logit": 6.7240753173828125,
            "end_logit": 0.5907872915267944,
            "text": "malformations of the urinary tract,",
            "probability": 0.0003204037784598768
        }
    ],
    "64041701201352f04a000017_0004": [
        {
            "start_logit": 6.949504852294922,
            "end_logit": 6.76348876953125,
            "text": "cryptorchidism",
            "probability": 0.1665978729724884
        },
        {
            "start_logit": 6.917206287384033,
            "end_logit": 6.76348876953125,
            "text": "urinary tract anomalies, and cryptorchidism",
            "probability": 0.16130289435386658
        },
        {
            "start_logit": 6.917206287384033,
            "end_logit": 6.607704162597656,
            "text": "urinary tract anomalies",
            "probability": 0.1380338966846466
        },
        {
            "start_logit": 6.628207206726074,
            "end_logit": 6.76348876953125,
            "text": "absence or hypoplasia of the abdominal wall musculature, urinary tract anomalies, and cryptorchidism",
            "probability": 0.12081799656152725
        },
        {
            "start_logit": 6.628207206726074,
            "end_logit": 6.607704162597656,
            "text": "absence or hypoplasia of the abdominal wall musculature, urinary tract anomalies",
            "probability": 0.10338922590017319
        },
        {
            "start_logit": 6.431820869445801,
            "end_logit": 6.76348876953125,
            "text": "hypoplasia of the abdominal wall musculature, urinary tract anomalies, and cryptorchidism",
            "probability": 0.09927551448345184
        },
        {
            "start_logit": 6.431820869445801,
            "end_logit": 6.607704162597656,
            "text": "hypoplasia of the abdominal wall musculature, urinary tract anomalies",
            "probability": 0.08495436608791351
        },
        {
            "start_logit": 6.628207206726074,
            "end_logit": 6.040876388549805,
            "text": "absence or hypoplasia of the abdominal wall musculature",
            "probability": 0.05865500867366791
        },
        {
            "start_logit": 6.431820869445801,
            "end_logit": 6.040876388549805,
            "text": "hypoplasia of the abdominal wall musculature",
            "probability": 0.04819650948047638
        },
        {
            "start_logit": 6.949504852294922,
            "end_logit": 2.5065016746520996,
            "text": "cryptorchidism in males.",
            "probability": 0.0023598456755280495
        },
        {
            "start_logit": 6.917206287384033,
            "end_logit": 2.5065016746520996,
            "text": "urinary tract anomalies, and cryptorchidism in males.",
            "probability": 0.002284843008965254
        },
        {
            "start_logit": 2.474184513092041,
            "end_logit": 6.76348876953125,
            "text": "abdominal wall musculature, urinary tract anomalies, and cryptorchidism",
            "probability": 0.0018969778902828693
        },
        {
            "start_logit": 6.628207206726074,
            "end_logit": 2.5852878093719482,
            "text": "absence or hypoplasia of the abdominal wall musculature,",
            "probability": 0.001851663924753666
        },
        {
            "start_logit": 6.628207206726074,
            "end_logit": 2.5220282077789307,
            "text": "absence or hypoplasia",
            "probability": 0.0017381557263433933
        },
        {
            "start_logit": 2.474184513092041,
            "end_logit": 6.607704162597656,
            "text": "abdominal wall musculature, urinary tract anomalies",
            "probability": 0.0016233266796916723
        },
        {
            "start_logit": 6.949504852294922,
            "end_logit": 2.1104581356048584,
            "text": "cryptorchidism in males",
            "probability": 0.0015881225699558854
        },
        {
            "start_logit": 6.917206287384033,
            "end_logit": 2.1104581356048584,
            "text": "urinary tract anomalies, and cryptorchidism in males",
            "probability": 0.0015376473311334848
        },
        {
            "start_logit": 6.431820869445801,
            "end_logit": 2.5852878093719482,
            "text": "hypoplasia of the abdominal wall musculature,",
            "probability": 0.0015215023886412382
        },
        {
            "start_logit": 6.431820869445801,
            "end_logit": 2.5220282077789307,
            "text": "hypoplasia",
            "probability": 0.0014282332267612219
        },
        {
            "start_logit": 6.431820869445801,
            "end_logit": 2.1104581356048584,
            "text": "hypoplasia of the abdominal wall musculature, urinary tract anomalies, and cryptorchidism in males",
            "probability": 0.0009463606984354556
        }
    ],
    "640c85e9201352f04a000026_0001": [
        {
            "start_logit": 2.1894614696502686,
            "end_logit": 0.29909181594848633,
            "text": "B-cell",
            "probability": 0.4869161546230316
        },
        {
            "start_logit": 2.1894614696502686,
            "end_logit": -0.7978795170783997,
            "text": "B",
            "probability": 0.1625719517469406
        },
        {
            "start_logit": 2.1894614696502686,
            "end_logit": -1.535326361656189,
            "text": "B-cell non-Hodgkin lymph",
            "probability": 0.0777636170387268
        },
        {
            "start_logit": 2.1894614696502686,
            "end_logit": -1.5921279191970825,
            "text": "B-cell non-Hodgkin lymphoma, typically presenting with extensive lymphadenopathy,",
            "probability": 0.07346963882446289
        },
        {
            "start_logit": 2.1894614696502686,
            "end_logit": -1.8348453044891357,
            "text": "B-cell non-Hodgkin",
            "probability": 0.05763642489910126
        },
        {
            "start_logit": 2.1894614696502686,
            "end_logit": -1.9206531047821045,
            "text": "B-cell non-Hodgkin lymphoma",
            "probability": 0.05289702117443085
        },
        {
            "start_logit": 2.1894614696502686,
            "end_logit": -2.9100921154022217,
            "text": "B-cell non-Hod",
            "probability": 0.01966632902622223
        },
        {
            "start_logit": -1.0269743204116821,
            "end_logit": 0.29909181594848633,
            "text": "Mantle cell lymphoma (Mantle cell lymphoma) is a relatively rare B-cell",
            "probability": 0.01952422596514225
        },
        {
            "start_logit": 2.1894614696502686,
            "end_logit": -3.312905788421631,
            "text": "B-cell non-Hodgkin lymphoma,",
            "probability": 0.013145695440471172
        },
        {
            "start_logit": 2.1894614696502686,
            "end_logit": -3.5173792839050293,
            "text": "B-cell non-Hodgkin lymphoma, typically presenting with extensive lymphadenopathy",
            "probability": 0.01071474514901638
        },
        {
            "start_logit": -1.0269743204116821,
            "end_logit": -0.7978795170783997,
            "text": "Mantle cell lymphoma (Mantle cell lymphoma) is a relatively rare B",
            "probability": 0.006518765818327665
        },
        {
            "start_logit": -1.0269743204116821,
            "end_logit": -1.535326361656189,
            "text": "Mantle cell lymphoma (Mantle cell lymphoma) is a relatively rare B-cell non-Hodgkin lymph",
            "probability": 0.003118144813925028
        },
        {
            "start_logit": -1.0269743204116821,
            "end_logit": -1.7873616218566895,
            "text": "Mantle cell lymph",
            "probability": 0.0024234766606241465
        },
        {
            "start_logit": -1.0269743204116821,
            "end_logit": -1.8348453044891357,
            "text": "Mantle cell lymphoma (Mantle cell lymphoma) is a relatively rare B-cell non-Hodgkin",
            "probability": 0.0023110888432711363
        },
        {
            "start_logit": -1.0269743204116821,
            "end_logit": -1.8633949756622314,
            "text": "Mantle cell lymphoma (Mantle cell lymphoma)",
            "probability": 0.0022460417822003365
        },
        {
            "start_logit": -1.0269743204116821,
            "end_logit": -1.9206531047821045,
            "text": "Mantle cell lymphoma (Mantle cell lymphoma) is a relatively rare B-cell non-Hodgkin lymphoma",
            "probability": 0.0021210492122918367
        },
        {
            "start_logit": -3.271998882293701,
            "end_logit": 0.29909181594848633,
            "text": "Mantle cell lymphoma) is a relatively rare B-cell",
            "probability": 0.0020681030582636595
        },
        {
            "start_logit": -1.0269743204116821,
            "end_logit": -2.0125954151153564,
            "text": "Mantle cell",
            "probability": 0.0019347324268892407
        },
        {
            "start_logit": -3.4542508125305176,
            "end_logit": 0.29909181594848633,
            "text": "cell",
            "probability": 0.0017235392006114125
        },
        {
            "start_logit": -1.0269743204116821,
            "end_logit": -2.46626615524292,
            "text": "Mantle cell lymphoma",
            "probability": 0.0012291200691834092
        }
    ],
    "640c85e9201352f04a000026_0002": [
        {
            "start_logit": 3.98380184173584,
            "end_logit": 4.627654075622559,
            "text": "large cell",
            "probability": 0.3458944857120514
        },
        {
            "start_logit": 3.468900203704834,
            "end_logit": 4.627654075622559,
            "text": "diffuse large cell",
            "probability": 0.2066923975944519
        },
        {
            "start_logit": 3.98380184173584,
            "end_logit": 2.568873405456543,
            "text": "large cell lymphoma, follicular lymphoma",
            "probability": 0.04413940757513046
        },
        {
            "start_logit": 3.257035732269287,
            "end_logit": 3.289827346801758,
            "text": "mantle cell lymphoma (Mantle cell lymphoma), chronic lymphocytic leukemia",
            "probability": 0.043883610516786575
        },
        {
            "start_logit": 3.3548855781555176,
            "end_logit": 2.9807076454162598,
            "text": "lymphocyte-predominant Hodgkin lymphoma, and Waldenstr\u00f6m macroglobulinemia",
            "probability": 0.03552621975541115
        },
        {
            "start_logit": 1.6392109394073486,
            "end_logit": 4.627654075622559,
            "text": "B-cell lymphoma, including diffuse large cell",
            "probability": 0.03316657617688179
        },
        {
            "start_logit": 2.902223587036133,
            "end_logit": 3.289827346801758,
            "text": "chronic lymphocytic leukemia",
            "probability": 0.030775804072618484
        },
        {
            "start_logit": 3.98380184173584,
            "end_logit": 2.203378677368164,
            "text": "large cell lymphoma",
            "probability": 0.03062627464532852
        },
        {
            "start_logit": 3.98380184173584,
            "end_logit": 2.0984678268432617,
            "text": "large cell lymphoma, follicular lymphoma (follicular lymphoma), mantle cell",
            "probability": 0.02757604792714119
        },
        {
            "start_logit": 3.5029866695404053,
            "end_logit": 2.568873405456543,
            "text": "follicular lymphoma",
            "probability": 0.02729048579931259
        },
        {
            "start_logit": 3.468900203704834,
            "end_logit": 2.568873405456543,
            "text": "diffuse large cell lymphoma, follicular lymphoma",
            "probability": 0.026375917717814445
        },
        {
            "start_logit": 3.98380184173584,
            "end_logit": 2.000117301940918,
            "text": "large cell lymphoma, follicular lymphoma (follicular lymphoma)",
            "probability": 0.02499302849173546
        },
        {
            "start_logit": 3.468900203704834,
            "end_logit": 2.203378677368164,
            "text": "diffuse large cell lymphoma",
            "probability": 0.018301019445061684
        },
        {
            "start_logit": 3.5029866695404053,
            "end_logit": 2.0984678268432617,
            "text": "follicular lymphoma (follicular lymphoma), mantle cell",
            "probability": 0.017049700021743774
        },
        {
            "start_logit": 3.468900203704834,
            "end_logit": 2.0984678268432617,
            "text": "diffuse large cell lymphoma, follicular lymphoma (follicular lymphoma), mantle cell",
            "probability": 0.016478324308991432
        },
        {
            "start_logit": 3.5029866695404053,
            "end_logit": 2.000117301940918,
            "text": "follicular lymphoma (follicular lymphoma)",
            "probability": 0.0154526736587286
        },
        {
            "start_logit": 3.3548855781555176,
            "end_logit": 2.1172168254852295,
            "text": "lymphocyte-predominant Hodgkin lymphoma",
            "probability": 0.014980959706008434
        },
        {
            "start_logit": 3.468900203704834,
            "end_logit": 2.000117301940918,
            "text": "diffuse large cell lymphoma, follicular lymphoma (follicular lymphoma)",
            "probability": 0.01493481919169426
        },
        {
            "start_logit": 3.257035732269287,
            "end_logit": 2.0984678268432617,
            "text": "mantle cell",
            "probability": 0.013332189060747623
        },
        {
            "start_logit": 3.5029866695404053,
            "end_logit": 1.7904590368270874,
            "text": "follicular lymphoma (follicular lymphoma), mantle cell lymphoma (Mantle cell lymphoma)",
            "probability": 0.012529970146715641
        }
    ],
    "640c85e9201352f04a000026_0003": [
        {
            "start_logit": 2.2396230697631836,
            "end_logit": 0.4695156514644623,
            "text": "B-cell",
            "probability": 0.4003307819366455
        },
        {
            "start_logit": 2.2396230697631836,
            "end_logit": -0.2674400806427002,
            "text": "B-cell non-Hodgkin's lymphoma seen predominantly in males.",
            "probability": 0.19158576428890228
        },
        {
            "start_logit": 2.2396230697631836,
            "end_logit": -1.0451455116271973,
            "text": "B-cell non-Hodgkin's lymphoma",
            "probability": 0.08802580833435059
        },
        {
            "start_logit": 2.2396230697631836,
            "end_logit": -1.0688021183013916,
            "text": "B-cell non-Hodgkin's lymph",
            "probability": 0.08596785366535187
        },
        {
            "start_logit": 2.2396230697631836,
            "end_logit": -1.5081735849380493,
            "text": "B",
            "probability": 0.05540124326944351
        },
        {
            "start_logit": -0.03875917196273804,
            "end_logit": 0.4695156514644623,
            "text": "Mantle cell lymphoma (Mantle cell lymphoma) is a subtype of B-cell",
            "probability": 0.041013818234205246
        },
        {
            "start_logit": 2.2396230697631836,
            "end_logit": -2.150151252746582,
            "text": "B-cell non-Hodgkin's",
            "probability": 0.029154939576983452
        },
        {
            "start_logit": 2.2396230697631836,
            "end_logit": -2.2573955059051514,
            "text": "B-cell non-Hod",
            "probability": 0.02619006298482418
        },
        {
            "start_logit": 2.2396230697631836,
            "end_logit": -2.5654296875,
            "text": "B-cell non-Hodgkin",
            "probability": 0.019246820360422134
        },
        {
            "start_logit": -0.03875917196273804,
            "end_logit": -0.8483023047447205,
            "text": "Mantle cell",
            "probability": 0.010980172082781792
        },
        {
            "start_logit": 2.2396230697631836,
            "end_logit": -3.1621599197387695,
            "text": "B-cell non-Hodg",
            "probability": 0.010597473941743374
        },
        {
            "start_logit": -0.03875917196273804,
            "end_logit": -1.0688021183013916,
            "text": "Mantle cell lymphoma (Mantle cell lymphoma) is a subtype of B-cell non-Hodgkin's lymph",
            "probability": 0.008807390928268433
        },
        {
            "start_logit": -0.03875917196273804,
            "end_logit": -1.3097624778747559,
            "text": "Mantle cell lymphoma (Mantle cell lymphoma)",
            "probability": 0.00692149018868804
        },
        {
            "start_logit": -0.03875917196273804,
            "end_logit": -1.4524269104003906,
            "text": "Mantle cell lymph",
            "probability": 0.006001240108162165
        },
        {
            "start_logit": -0.03875917196273804,
            "end_logit": -1.5081735849380493,
            "text": "Mantle cell lymphoma (Mantle cell lymphoma) is a subtype of B",
            "probability": 0.005675848573446274
        },
        {
            "start_logit": -0.03875917196273804,
            "end_logit": -2.002639055252075,
            "text": "Mantle cell lymphoma",
            "probability": 0.003461680607870221
        },
        {
            "start_logit": -2.6554954051971436,
            "end_logit": 0.4695156514644623,
            "text": "Mantle cell lymphoma) is a subtype of B-cell",
            "probability": 0.0029956833459436893
        },
        {
            "start_logit": -0.03875917196273804,
            "end_logit": -2.150151252746582,
            "text": "Mantle cell lymphoma (Mantle cell lymphoma) is a subtype of B-cell non-Hodgkin's",
            "probability": 0.0029869170393794775
        },
        {
            "start_logit": -0.03875917196273804,
            "end_logit": -2.2573955059051514,
            "text": "Mantle cell lymphoma (Mantle cell lymphoma) is a subtype of B-cell non-Hod",
            "probability": 0.00268316688016057
        },
        {
            "start_logit": -0.03875917196273804,
            "end_logit": -2.5654296875,
            "text": "Mantle cell lymphoma (Mantle cell lymphoma) is a subtype of B-cell non-Hodgkin",
            "probability": 0.0019718327093869448
        }
    ],
    "6415bb3c690f196b5100000e_0001": [
        {
            "start_logit": 6.757454872131348,
            "end_logit": 6.825223922729492,
            "text": "8%",
            "probability": 0.7379427552223206
        },
        {
            "start_logit": 6.757454872131348,
            "end_logit": 5.565471649169922,
            "text": "8% and 10-12%",
            "probability": 0.20937229692935944
        },
        {
            "start_logit": 5.0214643478393555,
            "end_logit": 5.565471649169922,
            "text": "10-12%",
            "probability": 0.03689675033092499
        },
        {
            "start_logit": 3.4420719146728516,
            "end_logit": 5.565471649169922,
            "text": "12%",
            "probability": 0.007604430429637432
        },
        {
            "start_logit": 1.2749807834625244,
            "end_logit": 6.825223922729492,
            "text": "online counseling with about 8%",
            "probability": 0.003069123486056924
        },
        {
            "start_logit": 1.2749807834625244,
            "end_logit": 5.565471649169922,
            "text": "online counseling with about 8% and 10-12%",
            "probability": 0.000870784861035645
        },
        {
            "start_logit": 6.757454872131348,
            "end_logit": -0.01278090849518776,
            "text": "8",
            "probability": 0.0007912520668469369
        },
        {
            "start_logit": -0.10335119068622589,
            "end_logit": 6.825223922729492,
            "text": "time and costs by online counseling with about 8%",
            "probability": 0.0007734147366136312
        },
        {
            "start_logit": -0.2797936201095581,
            "end_logit": 6.825223922729492,
            "text": "about 8%",
            "probability": 0.0006483125616796315
        },
        {
            "start_logit": -0.6980196833610535,
            "end_logit": 6.825223922729492,
            "text": "reduced time and costs by online counseling with about 8%",
            "probability": 0.0004267281910870224
        },
        {
            "start_logit": -1.2196887731552124,
            "end_logit": 6.825223922729492,
            "text": "%",
            "probability": 0.00025327547336928546
        },
        {
            "start_logit": -0.10335119068622589,
            "end_logit": 5.565471649169922,
            "text": "time and costs by online counseling with about 8% and 10-12%",
            "probability": 0.0002194367116317153
        },
        {
            "start_logit": 6.757454872131348,
            "end_logit": -1.3361982107162476,
            "text": "8% and 10-12%, respectively.",
            "probability": 0.00021065017790533602
        },
        {
            "start_logit": 6.757454872131348,
            "end_logit": -1.4706060886383057,
            "text": "8% and 10-12%, respectively",
            "probability": 0.00018415757222101092
        },
        {
            "start_logit": -0.2797936201095581,
            "end_logit": 5.565471649169922,
            "text": "about 8% and 10-12%",
            "probability": 0.00018394202925264835
        },
        {
            "start_logit": -1.5921697616577148,
            "end_logit": 6.825223922729492,
            "text": "costs by online counseling with about 8%",
            "probability": 0.00017451260646339506
        },
        {
            "start_logit": 6.757454872131348,
            "end_logit": -1.775585651397705,
            "text": "8% and 10",
            "probability": 0.00013574966578744352
        },
        {
            "start_logit": -0.6980196833610535,
            "end_logit": 5.565471649169922,
            "text": "reduced time and costs by online counseling with about 8% and 10-12%",
            "probability": 0.00012107309157727286
        },
        {
            "start_logit": -1.2196887731552124,
            "end_logit": 5.565471649169922,
            "text": "% and 10-12%",
            "probability": 7.186038419604301e-05
        },
        {
            "start_logit": -1.5921697616577148,
            "end_logit": 5.565471649169922,
            "text": "costs by online counseling with about 8% and 10-12%",
            "probability": 4.951345908921212e-05
        }
    ],
    "63f03ae6f36125a42600001d_0001": [
        {
            "start_logit": 8.140703201293945,
            "end_logit": 8.397276878356934,
            "text": "PDE4B",
            "probability": 0.9941030144691467
        },
        {
            "start_logit": 8.140703201293945,
            "end_logit": 3.200843334197998,
            "text": "PDE4",
            "probability": 0.0055036344565451145
        },
        {
            "start_logit": 8.140703201293945,
            "end_logit": -0.1588062047958374,
            "text": "PDE4B subtype",
            "probability": 0.00019123716629110277
        },
        {
            "start_logit": -1.628784418106079,
            "end_logit": 8.397276878356934,
            "text": "DE4B",
            "probability": 5.6832574045984074e-05
        },
        {
            "start_logit": -1.7112736701965332,
            "end_logit": 8.397276878356934,
            "text": "B",
            "probability": 5.2332608902361244e-05
        },
        {
            "start_logit": 8.140703201293945,
            "end_logit": -1.6212029457092285,
            "text": "P",
            "probability": 4.430589251569472e-05
        },
        {
            "start_logit": 8.140703201293945,
            "end_logit": -2.689633369445801,
            "text": "PDE4B subtype, in patients with idiopathic pulmonary fibrosis.",
            "probability": 1.5221162357192952e-05
        },
        {
            "start_logit": -3.2845513820648193,
            "end_logit": 8.397276878356934,
            "text": "4B",
            "probability": 1.085192161554005e-05
        },
        {
            "start_logit": -3.729949474334717,
            "end_logit": 8.397276878356934,
            "text": "preferential inhibitor of the PDE4B",
            "probability": 6.951412615308072e-06
        },
        {
            "start_logit": 8.140703201293945,
            "end_logit": -3.8881068229675293,
            "text": "PDE",
            "probability": 4.59152852272382e-06
        },
        {
            "start_logit": 8.140703201293945,
            "end_logit": -4.160672187805176,
            "text": "PDE4B subtype, in patients with idiopathic pulmonary fibrosis",
            "probability": 3.4960999073518906e-06
        },
        {
            "start_logit": -4.426094055175781,
            "end_logit": 8.397276878356934,
            "text": "oral preferential inhibitor of the PDE4B",
            "probability": 3.4653019156394294e-06
        },
        {
            "start_logit": -5.56484317779541,
            "end_logit": 8.397276878356934,
            "text": "inhibitor of the PDE4B",
            "probability": 1.1096567504864652e-06
        },
        {
            "start_logit": -6.055610656738281,
            "end_logit": 8.397276878356934,
            "text": "ential inhibitor of the PDE4B",
            "probability": 6.792833460167458e-07
        },
        {
            "start_logit": -6.2576494216918945,
            "end_logit": 8.397276878356934,
            "text": "BI 1015550, an oral preferential inhibitor of the PDE4B",
            "probability": 5.550174932977825e-07
        },
        {
            "start_logit": -6.4286580085754395,
            "end_logit": 8.397276878356934,
            "text": "placebo-controlled trial, we investigated the efficacy and safety of BI 1015550, an oral preferential inhibitor of the PDE4B",
            "probability": 4.677764877669688e-07
        },
        {
            "start_logit": -6.53629732131958,
            "end_logit": 8.397276878356934,
            "text": "the PDE4B",
            "probability": 4.200406067411677e-07
        },
        {
            "start_logit": -6.606733798980713,
            "end_logit": 8.397276878356934,
            "text": "the efficacy and safety of BI 1015550, an oral preferential inhibitor of the PDE4B",
            "probability": 3.914722981335217e-07
        },
        {
            "start_logit": -1.628784418106079,
            "end_logit": 3.200843334197998,
            "text": "DE4",
            "probability": 3.1464057315133687e-07
        },
        {
            "start_logit": -3.2845513820648193,
            "end_logit": 3.200843334197998,
            "text": "4",
            "probability": 6.007924469031423e-08
        }
    ],
    "63f03ae6f36125a42600001d_0002": [
        {
            "start_logit": 7.542990207672119,
            "end_logit": 6.604442596435547,
            "text": "phosphodiesterase 4B",
            "probability": 0.990348219871521
        },
        {
            "start_logit": 7.542990207672119,
            "end_logit": 1.3725700378417969,
            "text": "phosphodiesterase 4",
            "probability": 0.00529193552210927
        },
        {
            "start_logit": 7.542990207672119,
            "end_logit": 0.5860264897346497,
            "text": "phosphodiesterase",
            "probability": 0.0024100348819047213
        },
        {
            "start_logit": 0.12499257922172546,
            "end_logit": 6.604442596435547,
            "text": "odiesterase 4B",
            "probability": 0.0005945558077655733
        },
        {
            "start_logit": 7.542990207672119,
            "end_logit": -1.2341240644454956,
            "text": "phosphodiesterase 4B inhibitor",
            "probability": 0.00039042881689965725
        },
        {
            "start_logit": -0.5339549779891968,
            "end_logit": 6.604442596435547,
            "text": "preferential phosphodiesterase 4B",
            "probability": 0.0003076207358390093
        },
        {
            "start_logit": 7.542990207672119,
            "end_logit": -1.7243725061416626,
            "text": "phosphodiesterase 4B inhibitor, in healthy males and patients with idiopathic pulmonary fibrosis.",
            "probability": 0.00023912762117106467
        },
        {
            "start_logit": 7.542990207672119,
            "end_logit": -1.7486151456832886,
            "text": "p",
            "probability": 0.00023340007464867085
        },
        {
            "start_logit": -2.5357913970947266,
            "end_logit": 6.604442596435547,
            "text": "phodiesterase 4B",
            "probability": 4.15555368817877e-05
        },
        {
            "start_logit": -2.684629201889038,
            "end_logit": 6.604442596435547,
            "text": "B",
            "probability": 3.58087636413984e-05
        },
        {
            "start_logit": 7.542990207672119,
            "end_logit": -4.213804721832275,
            "text": "phosphodiesterase 4B inhibitor, in healthy males and patients with idiopathic pulmonary fibrosis",
            "probability": 1.9837321815430187e-05
        },
        {
            "start_logit": 7.542990207672119,
            "end_logit": -4.455777168273926,
            "text": "phosphodiestera",
            "probability": 1.557384712214116e-05
        },
        {
            "start_logit": 7.542990207672119,
            "end_logit": -4.543298721313477,
            "text": "phos",
            "probability": 1.426873313903343e-05
        },
        {
            "start_logit": -3.642406940460205,
            "end_logit": 6.604442596435547,
            "text": "4B",
            "probability": 1.3741434486291837e-05
        },
        {
            "start_logit": -3.8625402450561523,
            "end_logit": 6.604442596435547,
            "text": "hosphodiesterase 4B",
            "probability": 1.1026283573301043e-05
        },
        {
            "start_logit": -3.909018039703369,
            "end_logit": 6.604442596435547,
            "text": "terase 4B",
            "probability": 1.0525539437367115e-05
        },
        {
            "start_logit": 7.542990207672119,
            "end_logit": -5.126694679260254,
            "text": "phosph",
            "probability": 7.961963092384394e-06
        },
        {
            "start_logit": 7.542990207672119,
            "end_logit": -5.210203647613525,
            "text": "phosphodiesterase 4B inhibitor,",
            "probability": 7.324069883907214e-06
        },
        {
            "start_logit": 7.542990207672119,
            "end_logit": -5.8785505294799805,
            "text": "phosphodies",
            "probability": 3.7539916775131132e-06
        },
        {
            "start_logit": 7.542990207672119,
            "end_logit": -6.020944118499756,
            "text": "phosphodiesterase 4B inhibitor, in healthy males",
            "probability": 3.2557597933191573e-06
        }
    ],
    "63f03ae6f36125a42600001d_0003": [
        {
            "start_logit": 6.947536468505859,
            "end_logit": 5.492639541625977,
            "text": "phosphodiesterase 4",
            "probability": 0.9821471571922302
        },
        {
            "start_logit": 6.947536468505859,
            "end_logit": 0.7139863967895508,
            "text": "phosphodiesterase 4 (phosphodiesterase 4) inhibitor that has antifibrotic properties.",
            "probability": 0.008257219567894936
        },
        {
            "start_logit": 6.947536468505859,
            "end_logit": 0.16521920263767242,
            "text": "phosphodiesterase 4 (phosphodiesterase 4",
            "probability": 0.004769878927618265
        },
        {
            "start_logit": 6.947536468505859,
            "end_logit": -1.0870553255081177,
            "text": "phosphodiesterase 4 (phosphodiesterase 4)",
            "probability": 0.001363488263450563
        },
        {
            "start_logit": 6.947536468505859,
            "end_logit": -1.4061062335968018,
            "text": "phosphodiesterase",
            "probability": 0.0009910360677167773
        },
        {
            "start_logit": 6.947536468505859,
            "end_logit": -1.786364197731018,
            "text": "phosphodiesterase 4 (phosphodiesterase 4) inhibitor",
            "probability": 0.0006775563815608621
        },
        {
            "start_logit": 6.947536468505859,
            "end_logit": -2.0363283157348633,
            "text": "phosphodiesterase 4 (phosphodiesterase 4) inhibitor that has antifibrotic",
            "probability": 0.0005277002928778529
        },
        {
            "start_logit": 6.947536468505859,
            "end_logit": -2.141852855682373,
            "text": "p",
            "probability": 0.0004748523933812976
        },
        {
            "start_logit": 6.947536468505859,
            "end_logit": -2.9618847370147705,
            "text": "phosphodiesterase 4 (phosphodiesterase",
            "probability": 0.0002091334026772529
        },
        {
            "start_logit": -1.5901356935501099,
            "end_logit": 5.492639541625977,
            "text": "odiesterase 4",
            "probability": 0.00019244769646320492
        },
        {
            "start_logit": 6.947536468505859,
            "end_logit": -3.2130353450775146,
            "text": "phosphodiesterase 4 (phosphodiesterase 4) inhibitor that has antifibrotic properties",
            "probability": 0.00016268587205559015
        },
        {
            "start_logit": -2.7160701751708984,
            "end_logit": 5.492639541625977,
            "text": "4",
            "probability": 6.242025847313926e-05
        },
        {
            "start_logit": 6.947536468505859,
            "end_logit": -4.47402286529541,
            "text": "phosphodiesterase 4 (phosphodiesterase 4) inhibitor that",
            "probability": 4.610096584656276e-05
        },
        {
            "start_logit": 6.947536468505859,
            "end_logit": -4.879286289215088,
            "text": "phosphodiesterase 4 (phosphodiesterase 4) inhibitor that has antifibro",
            "probability": 3.074019696214236e-05
        },
        {
            "start_logit": 6.947536468505859,
            "end_logit": -4.933781623840332,
            "text": "phosphodiestera",
            "probability": 2.9109811293892562e-05
        },
        {
            "start_logit": 6.947536468505859,
            "end_logit": -5.062134742736816,
            "text": "phos",
            "probability": 2.560332177381497e-05
        },
        {
            "start_logit": -4.330198287963867,
            "end_logit": 5.492639541625977,
            "text": "phodiesterase 4",
            "probability": 1.2425634849932976e-05
        },
        {
            "start_logit": -4.477792739868164,
            "end_logit": 5.492639541625977,
            "text": "hosphodiesterase 4",
            "probability": 1.0720600585045759e-05
        },
        {
            "start_logit": -5.061446189880371,
            "end_logit": 5.492639541625977,
            "text": "BI 1015550 is a phosphodiesterase 4",
            "probability": 5.98055703449063e-06
        },
        {
            "start_logit": -5.483705520629883,
            "end_logit": 5.492639541625977,
            "text": "terase 4",
            "probability": 3.920637936971616e-06
        }
    ],
    "63f03ae6f36125a42600001d_0004": [
        {
            "start_logit": 8.047378540039062,
            "end_logit": 8.03300666809082,
            "text": "PDE4B",
            "probability": 0.9992671608924866
        },
        {
            "start_logit": 8.047378540039062,
            "end_logit": -0.07998006045818329,
            "text": "PDE4",
            "probability": 0.0002994030946865678
        },
        {
            "start_logit": 8.047378540039062,
            "end_logit": -0.4218348562717438,
            "text": "PDE4B Inhibitor and a Clinical Drug Candidate for the Oral Treatment of Idiopathic Pulmonary Fibrosis.",
            "probability": 0.0002127113111782819
        },
        {
            "start_logit": 8.047378540039062,
            "end_logit": -1.601158618927002,
            "text": "P",
            "probability": 6.540590402437374e-05
        },
        {
            "start_logit": -1.7543683052062988,
            "end_logit": 8.03300666809082,
            "text": "DE4B",
            "probability": 5.5314278142759576e-05
        },
        {
            "start_logit": -1.9217536449432373,
            "end_logit": 8.03300666809082,
            "text": "B",
            "probability": 4.6788853069301695e-05
        },
        {
            "start_logit": 8.047378540039062,
            "end_logit": -2.4534687995910645,
            "text": "PDE4B Inhibitor",
            "probability": 2.789095560729038e-05
        },
        {
            "start_logit": 8.047378540039062,
            "end_logit": -3.2015879154205322,
            "text": "PDE4B Inhibitor and a Clinical Drug Candidate for the Oral Treatment of Idiopathic Pulmonary Fibrosis",
            "probability": 1.319955390499672e-05
        },
        {
            "start_logit": -4.565380096435547,
            "end_logit": 8.03300666809082,
            "text": "BI 1015550 is a PDE4B",
            "probability": 3.3268265724473167e-06
        },
        {
            "start_logit": 8.047378540039062,
            "end_logit": -5.013546466827393,
            "text": "PDE",
            "probability": 2.1559355900535593e-06
        },
        {
            "start_logit": -5.312627792358398,
            "end_logit": 8.03300666809082,
            "text": "4B",
            "probability": 1.5758126892251312e-06
        },
        {
            "start_logit": 8.047378540039062,
            "end_logit": -5.364861488342285,
            "text": "PDE4B Inhibitor and a Clinical Drug Candidate for the Oral Treatment of Idiopathic Pulmonary Fibro",
            "probability": 1.517264763606363e-06
        },
        {
            "start_logit": 8.047378540039062,
            "end_logit": -5.423068523406982,
            "text": "PDE4B Inhibitor and a Clinical Drug Candidate",
            "probability": 1.4314698546513682e-06
        },
        {
            "start_logit": 8.047378540039062,
            "end_logit": -6.412237167358398,
            "text": "PDE4B Inhibitor and",
            "probability": 5.323434493220702e-07
        },
        {
            "start_logit": 8.047378540039062,
            "end_logit": -6.43519401550293,
            "text": "PDE4B Inhibitor and a Clinical Drug Candidate for the Oral Treatment of Idiopathic Pulmonary",
            "probability": 5.202617785471375e-07
        },
        {
            "start_logit": 8.047378540039062,
            "end_logit": -6.662260055541992,
            "text": "PDE4B Inhibitor and a Clinical Drug Candidate for the Oral Treatment of Idiopathic Pulmonary Fi",
            "probability": 4.145800289734325e-07
        },
        {
            "start_logit": -6.670979022979736,
            "end_logit": 8.03300666809082,
            "text": "1015550 is a PDE4B",
            "probability": 4.0511690713174175e-07
        },
        {
            "start_logit": -6.986945152282715,
            "end_logit": 8.03300666809082,
            "text": "a PDE4B",
            "probability": 2.953641740077728e-07
        },
        {
            "start_logit": -1.7543683052062988,
            "end_logit": -0.07998006045818329,
            "text": "DE4",
            "probability": 1.65733986534633e-08
        },
        {
            "start_logit": -1.7543683052062988,
            "end_logit": -0.4218348562717438,
            "text": "DE4B Inhibitor and a Clinical Drug Candidate for the Oral Treatment of Idiopathic Pulmonary Fibrosis.",
            "probability": 1.1774599961711374e-08
        }
    ],
    "63f03ae6f36125a42600001d_0005": [
        {
            "start_logit": 7.000099182128906,
            "end_logit": 6.598542213439941,
            "text": "phosphodiesterase 4",
            "probability": 0.9889714121818542
        },
        {
            "start_logit": 7.000099182128906,
            "end_logit": 1.859439730644226,
            "text": "phosphodiesterase 4 inhibitor showing a preferential enzymatic inhibition of PDE4B",
            "probability": 0.008650032803416252
        },
        {
            "start_logit": -0.31186676025390625,
            "end_logit": 6.598542213439941,
            "text": "odiesterase 4",
            "probability": 0.0006601419299840927
        },
        {
            "start_logit": 7.000099182128906,
            "end_logit": -0.9436683058738708,
            "text": "phosphodiesterase",
            "probability": 0.0005243766354396939
        },
        {
            "start_logit": 7.000099182128906,
            "end_logit": -1.3813129663467407,
            "text": "phosphodiesterase 4 inhibitor showing a preferential enzymatic inhibition of PDE4B.",
            "probability": 0.0003385140444152057
        },
        {
            "start_logit": 7.000099182128906,
            "end_logit": -1.5763776302337646,
            "text": "phosphodiesterase 4 inhibitor showing a preferential enzymatic inhibition of PDE4",
            "probability": 0.00027852298808284104
        },
        {
            "start_logit": 7.000099182128906,
            "end_logit": -1.9435467720031738,
            "text": "phosphodiesterase 4 inhibitor",
            "probability": 0.00019293073273729533
        },
        {
            "start_logit": 7.000099182128906,
            "end_logit": -2.3744239807128906,
            "text": "p",
            "probability": 0.00012539321323856711
        },
        {
            "start_logit": -2.380615234375,
            "end_logit": 6.598542213439941,
            "text": "4",
            "probability": 8.340483327629045e-05
        },
        {
            "start_logit": 2.1828033924102783,
            "end_logit": 1.859439730644226,
            "text": "PDE4B",
            "probability": 6.996690353844315e-05
        },
        {
            "start_logit": -3.6559085845947266,
            "end_logit": 6.598542213439941,
            "text": "BI 1015550 is a novel phosphodiesterase 4",
            "probability": 2.3299056920222938e-05
        },
        {
            "start_logit": -4.259803771972656,
            "end_logit": 6.598542213439941,
            "text": "terase 4",
            "probability": 1.2737084944092203e-05
        },
        {
            "start_logit": -4.354161262512207,
            "end_logit": 6.598542213439941,
            "text": "phodiesterase 4",
            "probability": 1.1590203939704224e-05
        },
        {
            "start_logit": -4.417862415313721,
            "end_logit": 6.598542213439941,
            "text": "hosphodiesterase 4",
            "probability": 1.0874924555537291e-05
        },
        {
            "start_logit": 7.000099182128906,
            "end_logit": -4.8346028327941895,
            "text": "phosphodiesterase 4 inhibitor showing a preferential enzymatic inhibition of PDE",
            "probability": 1.0711040886235423e-05
        },
        {
            "start_logit": 7.000099182128906,
            "end_logit": -5.041833877563477,
            "text": "phos",
            "probability": 8.706279913894832e-06
        },
        {
            "start_logit": 7.000099182128906,
            "end_logit": -5.181711673736572,
            "text": "phosphodiesterase 4 inhibitor showing a preferential enzymatic inhibition",
            "probability": 7.569796707684873e-06
        },
        {
            "start_logit": 7.000099182128906,
            "end_logit": -5.18277645111084,
            "text": "phosph",
            "probability": 7.561745860584779e-06
        },
        {
            "start_logit": 7.000099182128906,
            "end_logit": -5.3177618980407715,
            "text": "phosphodiestera",
            "probability": 6.606916485907277e-06
        },
        {
            "start_logit": -0.31186676025390625,
            "end_logit": 1.859439730644226,
            "text": "odiesterase 4 inhibitor showing a preferential enzymatic inhibition of PDE4B",
            "probability": 5.773927114205435e-06
        }
    ],
    "63f03ae6f36125a42600001d_0006": [
        {
            "start_logit": 7.940301418304443,
            "end_logit": 8.008804321289062,
            "text": "PDE4B",
            "probability": 0.9989486336708069
        },
        {
            "start_logit": 7.940301418304443,
            "end_logit": 0.933091938495636,
            "text": "PDE4",
            "probability": 0.0008445006678812206
        },
        {
            "start_logit": -1.8022253513336182,
            "end_logit": 8.008804321289062,
            "text": "B",
            "probability": 5.867017898708582e-05
        },
        {
            "start_logit": -2.009523868560791,
            "end_logit": 8.008804321289062,
            "text": "preferential inhibition of PDE4B",
            "probability": 4.7685785830253735e-05
        },
        {
            "start_logit": 7.940301418304443,
            "end_logit": -2.0089221000671387,
            "text": "P",
            "probability": 4.455532325664535e-05
        },
        {
            "start_logit": -2.477691173553467,
            "end_logit": 8.008804321289062,
            "text": "DE4B",
            "probability": 2.985836545121856e-05
        },
        {
            "start_logit": 7.940301418304443,
            "end_logit": -3.5459651947021484,
            "text": "PDE4B by BI 1015550 and its anticipated improved tolerability in humans, plus its anti-inflammatory and antifibrotic",
            "probability": 9.580110599927139e-06
        },
        {
            "start_logit": 7.940301418304443,
            "end_logit": -4.304986953735352,
            "text": "PDE",
            "probability": 4.4846806304121856e-06
        },
        {
            "start_logit": 7.940301418304443,
            "end_logit": -4.748998641967773,
            "text": "PDE4B by BI 1015550 and its anticipated improved tolerability in humans, plus its anti-inflammatory and antifibrotic potential",
            "probability": 2.876734242818202e-06
        },
        {
            "start_logit": 7.940301418304443,
            "end_logit": -4.825760841369629,
            "text": "PDE4B by BI 1015550 and its anticipated improved tolerability in humans, plus its anti-inflammatory",
            "probability": 2.6641698696039384e-06
        },
        {
            "start_logit": -5.041521072387695,
            "end_logit": 8.008804321289062,
            "text": "unique preferential inhibition of PDE4B",
            "probability": 2.299371089975466e-06
        },
        {
            "start_logit": -5.712536811828613,
            "end_logit": 8.008804321289062,
            "text": "4B",
            "probability": 1.1754134447983233e-06
        },
        {
            "start_logit": -5.713810920715332,
            "end_logit": 8.008804321289062,
            "text": "inhibition of PDE4B",
            "probability": 1.1739166438928805e-06
        },
        {
            "start_logit": -5.773404121398926,
            "end_logit": 8.008804321289062,
            "text": "In summary, the unique preferential inhibition of PDE4B",
            "probability": 1.1060029692089302e-06
        },
        {
            "start_logit": -6.076910018920898,
            "end_logit": 8.008804321289062,
            "text": "the unique preferential inhibition of PDE4B",
            "probability": 8.164795985976525e-07
        },
        {
            "start_logit": -2.009523868560791,
            "end_logit": 0.933091938495636,
            "text": "preferential inhibition of PDE4",
            "probability": 4.031309686070017e-08
        },
        {
            "start_logit": -2.477691173553467,
            "end_logit": 0.933091938495636,
            "text": "DE4",
            "probability": 2.524197206810186e-08
        },
        {
            "start_logit": -2.009523868560791,
            "end_logit": -2.0089221000671387,
            "text": "preferential inhibition of P",
            "probability": 2.1268917738126447e-09
        },
        {
            "start_logit": -5.041521072387695,
            "end_logit": 0.933091938495636,
            "text": "unique preferential inhibition of PDE4",
            "probability": 1.9438657350434596e-09
        },
        {
            "start_logit": -5.712536811828613,
            "end_logit": 0.933091938495636,
            "text": "4",
            "probability": 9.936840239532785e-10
        }
    ],
    "63eeeaaaf36125a426000004_0001": [
        {
            "start_logit": 6.159687519073486,
            "end_logit": 6.114625453948975,
            "text": "Recessive dystrophic epidermolysis bullosa",
            "probability": 0.7937672734260559
        },
        {
            "start_logit": 6.159687519073486,
            "end_logit": 4.109794616699219,
            "text": "Recessive dystrophic epidermolysis bullosa (Recessive dystrophic epidermolysis bullosa)",
            "probability": 0.10690698027610779
        },
        {
            "start_logit": 3.3127458095550537,
            "end_logit": 6.114625453948975,
            "text": "epidermolysis bullosa",
            "probability": 0.04605555534362793
        },
        {
            "start_logit": 3.159381151199341,
            "end_logit": 6.114625453948975,
            "text": "dystrophic epidermolysis bullosa",
            "probability": 0.03950725123286247
        },
        {
            "start_logit": 3.3127458095550537,
            "end_logit": 4.109794616699219,
            "text": "epidermolysis bullosa (Recessive dystrophic epidermolysis bullosa)",
            "probability": 0.0062029073014855385
        },
        {
            "start_logit": 3.159381151199341,
            "end_logit": 4.109794616699219,
            "text": "dystrophic epidermolysis bullosa (Recessive dystrophic epidermolysis bullosa)",
            "probability": 0.005320955533534288
        },
        {
            "start_logit": 6.159687519073486,
            "end_logit": -0.20979318022727966,
            "text": "Recessive dystrophic epidermolysis bullosa (Recessive dystrophic epidermolysis bullosa",
            "probability": 0.0014224372571334243
        },
        {
            "start_logit": 6.159687519073486,
            "end_logit": -1.7897334098815918,
            "text": "Recessive dystrophic epidermolysis",
            "probability": 0.0002930041227955371
        },
        {
            "start_logit": 6.159687519073486,
            "end_logit": -2.3737196922302246,
            "text": "Recessive dystrophic epidermolysis bull",
            "probability": 0.0001633998763281852
        },
        {
            "start_logit": 3.3127458095550537,
            "end_logit": -0.20979318022727966,
            "text": "epidermolysis bullosa (Recessive dystrophic epidermolysis bullosa",
            "probability": 8.25319584691897e-05
        },
        {
            "start_logit": -1.030822992324829,
            "end_logit": 4.109794616699219,
            "text": "Recessive dystrophic epidermolysis bullosa)",
            "probability": 8.057629747781903e-05
        },
        {
            "start_logit": 3.159381151199341,
            "end_logit": -0.20979318022727966,
            "text": "dystrophic epidermolysis bullosa (Recessive dystrophic epidermolysis bullosa",
            "probability": 7.079727220116183e-05
        },
        {
            "start_logit": -3.2909717559814453,
            "end_logit": 6.114625453948975,
            "text": "bullosa",
            "probability": 6.242006929824129e-05
        },
        {
            "start_logit": 3.3127458095550537,
            "end_logit": -1.7897334098815918,
            "text": "epidermolysis",
            "probability": 1.700053508102428e-05
        },
        {
            "start_logit": 3.159381151199341,
            "end_logit": -1.7897334098815918,
            "text": "dystrophic epidermolysis",
            "probability": 1.4583352822228335e-05
        },
        {
            "start_logit": 3.3127458095550537,
            "end_logit": -2.3737196922302246,
            "text": "epidermolysis bull",
            "probability": 9.480702829023357e-06
        },
        {
            "start_logit": -3.2909717559814453,
            "end_logit": 4.109794616699219,
            "text": "bullosa (Recessive dystrophic epidermolysis bullosa)",
            "probability": 8.40692337078508e-06
        },
        {
            "start_logit": 3.159381151199341,
            "end_logit": -2.3737196922302246,
            "text": "dystrophic epidermolysis bull",
            "probability": 8.132710718200542e-06
        },
        {
            "start_logit": -3.852475166320801,
            "end_logit": 4.109794616699219,
            "text": ")",
            "probability": 4.7948965402611066e-06
        },
        {
            "start_logit": -1.030822992324829,
            "end_logit": 0.05193600058555603,
            "text": "Recessive dystrophic epidermolysis bullosa) is a lifelong genodermatosis",
            "probability": 1.3928416819908307e-06
        }
    ],
    "63eeeaaaf36125a426000004_0002": [
        {
            "start_logit": 4.446863651275635,
            "end_logit": 5.572736740112305,
            "text": "Recessive dystrophic epidermolysis bullosa",
            "probability": 0.7669804692268372
        },
        {
            "start_logit": 3.0315332412719727,
            "end_logit": 5.572736740112305,
            "text": "dystrophic epidermolysis bullosa",
            "probability": 0.1862577497959137
        },
        {
            "start_logit": 1.0876924991607666,
            "end_logit": 5.572736740112305,
            "text": "epidermolysis bullosa",
            "probability": 0.026663362979888916
        },
        {
            "start_logit": 4.446863651275635,
            "end_logit": 1.0648913383483887,
            "text": "Recessive dystrophic epidermolysis",
            "probability": 0.00845380313694477
        },
        {
            "start_logit": 4.446863651275635,
            "end_logit": -0.11470071971416473,
            "text": "Recessive dystrophic",
            "probability": 0.002598733641207218
        },
        {
            "start_logit": 4.446863651275635,
            "end_logit": -0.27031171321868896,
            "text": "Recessive dystrophic epidermolysis bull",
            "probability": 0.002224235562607646
        },
        {
            "start_logit": 3.0315332412719727,
            "end_logit": 1.0648913383483887,
            "text": "dystrophic epidermolysis",
            "probability": 0.002052966970950365
        },
        {
            "start_logit": -2.058474540710449,
            "end_logit": 5.572736740112305,
            "text": "patients with Recessive dystrophic epidermolysis bullosa",
            "probability": 0.0011469698511064053
        },
        {
            "start_logit": 3.0315332412719727,
            "end_logit": -0.11470071971416473,
            "text": "dystrophic",
            "probability": 0.0006310904282145202
        },
        {
            "start_logit": 4.446863651275635,
            "end_logit": -1.5538026094436646,
            "text": "Recessive",
            "probability": 0.0006162655772641301
        },
        {
            "start_logit": 3.0315332412719727,
            "end_logit": -0.27031171321868896,
            "text": "dystrophic epidermolysis bull",
            "probability": 0.000540145265404135
        },
        {
            "start_logit": -3.003002166748047,
            "end_logit": 5.572736740112305,
            "text": "topical molecular corrective therapy promoting wound healing in patients with Recessive dystrophic epidermolysis bullosa",
            "probability": 0.0004460143973119557
        },
        {
            "start_logit": 1.0876924991607666,
            "end_logit": 1.0648913383483887,
            "text": "epidermolysis",
            "probability": 0.0002938885590992868
        },
        {
            "start_logit": -3.5545105934143066,
            "end_logit": 5.572736740112305,
            "text": "bullosa",
            "probability": 0.0002569401985965669
        },
        {
            "start_logit": -3.5951104164123535,
            "end_logit": 5.572736740112305,
            "text": "wound healing in patients with Recessive dystrophic epidermolysis bullosa",
            "probability": 0.00024671739083714783
        },
        {
            "start_logit": -4.185888290405273,
            "end_logit": 5.572736740112305,
            "text": "molecular corrective therapy promoting wound healing in patients with Recessive dystrophic epidermolysis bullosa",
            "probability": 0.00013665576989296824
        },
        {
            "start_logit": 4.446863651275635,
            "end_logit": -3.1453583240509033,
            "text": "Recessive dystrophic epidermolysis bullosa.",
            "probability": 0.00012547691585496068
        },
        {
            "start_logit": 4.446863651275635,
            "end_logit": -3.2373580932617188,
            "text": "Recessive dystrophic epid",
            "probability": 0.00011444814299466088
        },
        {
            "start_logit": -4.374321937561035,
            "end_logit": 5.572736740112305,
            "text": "osa",
            "probability": 0.00011318589531583712
        },
        {
            "start_logit": 4.446863651275635,
            "end_logit": -3.363995313644409,
            "text": "Recessive dystrophic e",
            "probability": 0.00010083497181767598
        }
    ],
    "64138ce8201352f04a000042_0001": [
        {
            "start_logit": 2.81461763381958,
            "end_logit": 2.4509389400482178,
            "text": "renal failure",
            "probability": 0.6725494265556335
        },
        {
            "start_logit": 1.6889348030090332,
            "end_logit": 1.8833324909210205,
            "text": "Hairpatches\" (Hairpatches\")",
            "probability": 0.12369100749492645
        },
        {
            "start_logit": 1.6889348030090332,
            "end_logit": 1.050078272819519,
            "text": "Hairpatches\" (Hairpatches\") is a naturally occurring, autosomal semi-dominant mouse mutation.",
            "probability": 0.05376014858484268
        },
        {
            "start_logit": 2.81461763381958,
            "end_logit": -0.5259047150611877,
            "text": "renal failure accompanied by patchy alopecia",
            "probability": 0.03426869213581085
        },
        {
            "start_logit": -0.34147870540618896,
            "end_logit": 2.4509389400482178,
            "text": "Hairpatches\"/+ heterozygotes exhibit progressive renal failure",
            "probability": 0.028645019978284836
        },
        {
            "start_logit": 1.6889348030090332,
            "end_logit": -0.15520013868808746,
            "text": "Hairpatches\"",
            "probability": 0.016107002273201942
        },
        {
            "start_logit": -0.38536524772644043,
            "end_logit": 1.8833324909210205,
            "text": "\"Hairpatches\" (Hairpatches\")",
            "probability": 0.0155410747975111
        },
        {
            "start_logit": 2.81461763381958,
            "end_logit": -1.5132577419281006,
            "text": "renal failure accompanied by patchy alopecia.",
            "probability": 0.012767196632921696
        },
        {
            "start_logit": -0.38536524772644043,
            "end_logit": 1.050078272819519,
            "text": "\"Hairpatches\" (Hairpatches\") is a naturally occurring, autosomal semi-dominant mouse mutation.",
            "probability": 0.006754657253623009
        },
        {
            "start_logit": -1.7883996963500977,
            "end_logit": 2.4509389400482178,
            "text": "progressive renal failure",
            "probability": 0.006739992182701826
        },
        {
            "start_logit": -0.6656628847122192,
            "end_logit": 1.050078272819519,
            "text": "autosomal semi-dominant mouse mutation.",
            "probability": 0.005103542469441891
        },
        {
            "start_logit": 1.6889348030090332,
            "end_logit": -1.543450117111206,
            "text": "Hairpatches\" (Hairpatches\") is a naturally occurring, autosomal semi-dominant mouse mutation",
            "probability": 0.004018883220851421
        },
        {
            "start_logit": 1.6889348030090332,
            "end_logit": -1.6526070833206177,
            "text": "Hairpatches",
            "probability": 0.0036032891366630793
        },
        {
            "start_logit": 1.6889348030090332,
            "end_logit": -1.6555089950561523,
            "text": "Hairpatches\" (Hairpatches\") is a naturally occurring, autosomal semi-dominant",
            "probability": 0.003592847613617778
        },
        {
            "start_logit": -2.7173712253570557,
            "end_logit": 2.4509389400482178,
            "text": "die in utero, while Hairpatches\"/+ heterozygotes exhibit progressive renal failure",
            "probability": 0.0026620246935635805
        },
        {
            "start_logit": 0.04514044523239136,
            "end_logit": -0.42284318804740906,
            "text": "Hairpatches\"/Hairpatches\" homozygotes die in utero,",
            "probability": 0.002381704980507493
        },
        {
            "start_logit": 2.81461763381958,
            "end_logit": -3.2622828483581543,
            "text": "renal",
            "probability": 0.002220769878476858
        },
        {
            "start_logit": -2.3824081420898438,
            "end_logit": 1.8833324909210205,
            "text": "Hairpatches\")",
            "probability": 0.0021094840485602617
        },
        {
            "start_logit": -0.38536524772644043,
            "end_logit": -0.15520013868808746,
            "text": "\"Hairpatches\"",
            "probability": 0.002023753011599183
        },
        {
            "start_logit": -0.34147870540618896,
            "end_logit": -0.5259047150611877,
            "text": "Hairpatches\"/+ heterozygotes exhibit progressive renal failure accompanied by patchy alopecia",
            "probability": 0.0014595610555261374
        }
    ],
    "64138ce8201352f04a000042_0002": [
        {
            "start_logit": 6.39431095123291,
            "end_logit": 4.6244611740112305,
            "text": "renal disease",
            "probability": 0.9666823148727417
        },
        {
            "start_logit": 6.39431095123291,
            "end_logit": 0.054252028465270996,
            "text": "renal disease and alopecia in the mouse.",
            "probability": 0.010010764002799988
        },
        {
            "start_logit": 1.3291605710983276,
            "end_logit": 4.6244611740112305,
            "text": "progressive renal disease",
            "probability": 0.006102629005908966
        },
        {
            "start_logit": 0.9327616691589355,
            "end_logit": 4.6244611740112305,
            "text": "Hairpatches, a single gene mutation characterized by progressive renal disease",
            "probability": 0.0041054715402424335
        },
        {
            "start_logit": 6.39431095123291,
            "end_logit": -0.8479974269866943,
            "text": "renal disease and alopecia in the mouse. A potential model for a newly described heritable human disorder.",
            "probability": 0.004060926381498575
        },
        {
            "start_logit": 6.39431095123291,
            "end_logit": -0.8680111169815063,
            "text": "renal",
            "probability": 0.0039804610423743725
        },
        {
            "start_logit": 6.39431095123291,
            "end_logit": -1.3303120136260986,
            "text": "renal disease and alopecia",
            "probability": 0.0025070253759622574
        },
        {
            "start_logit": 6.39431095123291,
            "end_logit": -2.158950090408325,
            "text": "re",
            "probability": 0.0010946765542030334
        },
        {
            "start_logit": 6.39431095123291,
            "end_logit": -2.8311767578125,
            "text": "renal disease and alopecia in the mouse",
            "probability": 0.0005589093780145049
        },
        {
            "start_logit": 6.39431095123291,
            "end_logit": -3.061814546585083,
            "text": "renal disease and alopecia in the mouse. A potential model for a newly described heritable human disorder",
            "probability": 0.0004437891475390643
        },
        {
            "start_logit": 6.39431095123291,
            "end_logit": -4.447592735290527,
            "text": "renal disease and alope",
            "probability": 0.00011100456322310492
        },
        {
            "start_logit": -3.1273229122161865,
            "end_logit": 4.6244611740112305,
            "text": "disease",
            "probability": 7.080935029080138e-05
        },
        {
            "start_logit": 1.3291605710983276,
            "end_logit": 0.054252028465270996,
            "text": "progressive renal disease and alopecia in the mouse.",
            "probability": 6.319754174910486e-05
        },
        {
            "start_logit": 6.39431095123291,
            "end_logit": -5.215502738952637,
            "text": "renal disease and",
            "probability": 5.150409560883418e-05
        },
        {
            "start_logit": 0.9327616691589355,
            "end_logit": 0.054252028465270996,
            "text": "Hairpatches, a single gene mutation characterized by progressive renal disease and alopecia in the mouse.",
            "probability": 4.251541759003885e-05
        },
        {
            "start_logit": 1.3291605710983276,
            "end_logit": -0.8479974269866943,
            "text": "progressive renal disease and alopecia in the mouse. A potential model for a newly described heritable human disorder.",
            "probability": 2.5636472855694592e-05
        },
        {
            "start_logit": 1.3291605710983276,
            "end_logit": -0.8680111169815063,
            "text": "progressive renal",
            "probability": 2.512848914193455e-05
        },
        {
            "start_logit": -4.260649681091309,
            "end_logit": 4.6244611740112305,
            "text": "nal disease",
            "probability": 2.279781074321363e-05
        },
        {
            "start_logit": 6.39431095123291,
            "end_logit": -6.100061893463135,
            "text": "renal disease and alopecia in",
            "probability": 2.1265828763716854e-05
        },
        {
            "start_logit": 0.13609087467193604,
            "end_logit": 0.054252028465270996,
            "text": "alopecia in the mouse.",
            "probability": 1.9167113350704312e-05
        }
    ],
    "63f9cd0b33942b094c000010_0001": [
        {
            "start_logit": 0.15065401792526245,
            "end_logit": 1.4348554611206055,
            "text": "HSPA12A pre-RNA by SRSF11 contributes to metastasis potential of colorectal cancer.",
            "probability": 0.2774291932582855
        },
        {
            "start_logit": -0.2157851755619049,
            "end_logit": 1.4348554611206055,
            "text": "metastasis potential of colorectal cancer.",
            "probability": 0.19231344759464264
        },
        {
            "start_logit": 0.5772668719291687,
            "end_logit": 0.25976312160491943,
            "text": "Alternative splicing of HSPA12A",
            "probability": 0.13124768435955048
        },
        {
            "start_logit": 0.15065401792526245,
            "end_logit": 0.25976312160491943,
            "text": "HSPA12A",
            "probability": 0.08566747605800629
        },
        {
            "start_logit": 0.5772668719291687,
            "end_logit": -0.6361584067344666,
            "text": "Alternative splicing of HSPA12A pre-RNA by SRSF11 contributes to metastasis potential",
            "probability": 0.05357939749956131
        },
        {
            "start_logit": 0.5772668719291687,
            "end_logit": -0.9678972959518433,
            "text": "Alternative splicing of HSPA12A pre-RNA",
            "probability": 0.03845257684588432
        },
        {
            "start_logit": 0.15065401792526245,
            "end_logit": -0.6361584067344666,
            "text": "HSPA12A pre-RNA by SRSF11 contributes to metastasis potential",
            "probability": 0.034972142428159714
        },
        {
            "start_logit": -2.0593981742858887,
            "end_logit": 1.4348554611206055,
            "text": "contributes to metastasis potential of colorectal cancer.",
            "probability": 0.030432574450969696
        },
        {
            "start_logit": -2.2209904193878174,
            "end_logit": 1.4348554611206055,
            "text": "SRSF11 contributes to metastasis potential of colorectal cancer.",
            "probability": 0.02589166909456253
        },
        {
            "start_logit": 0.15065401792526245,
            "end_logit": -0.9678972959518433,
            "text": "HSPA12A pre-RNA",
            "probability": 0.025098619982600212
        },
        {
            "start_logit": -0.2157851755619049,
            "end_logit": -0.6361584067344666,
            "text": "metastasis potential",
            "probability": 0.02424262836575508
        },
        {
            "start_logit": -2.4992213249206543,
            "end_logit": 1.4348554611206055,
            "text": "to metastasis potential of colorectal cancer.",
            "probability": 0.019603151828050613
        },
        {
            "start_logit": 0.5772668719291687,
            "end_logit": -2.2675724029541016,
            "text": "Alternative splicing of HSPA12A pre-RNA by SRSF11 contributes to metastasis potential of colorectal cancer",
            "probability": 0.010482956655323505
        },
        {
            "start_logit": 0.5772668719291687,
            "end_logit": -2.3098676204681396,
            "text": "Alternative splicing of HSPA12A pre-RNA by SRSF11",
            "probability": 0.01004882249981165
        },
        {
            "start_logit": 0.5772668719291687,
            "end_logit": -2.3229899406433105,
            "text": "Alternative splicing",
            "probability": 0.009917821735143661
        },
        {
            "start_logit": 0.5772668719291687,
            "end_logit": -2.635786771774292,
            "text": "Alternative splicing of HSPA12A pre-RNA by SRSF11 contributes to metastasis",
            "probability": 0.007253879215568304
        },
        {
            "start_logit": 0.15065401792526245,
            "end_logit": -2.2675724029541016,
            "text": "HSPA12A pre-RNA by SRSF11 contributes to metastasis potential of colorectal cancer",
            "probability": 0.006842395290732384
        },
        {
            "start_logit": 0.15065401792526245,
            "end_logit": -2.3098676204681396,
            "text": "HSPA12A pre-RNA by SRSF11",
            "probability": 0.006559029687196016
        },
        {
            "start_logit": -3.822153091430664,
            "end_logit": 1.4348554611206055,
            "text": "colorectal cancer.",
            "probability": 0.005221364088356495
        },
        {
            "start_logit": -0.2157851755619049,
            "end_logit": -2.2675724029541016,
            "text": "metastasis potential of colorectal cancer",
            "probability": 0.004743136465549469
        }
    ],
    "63f9cd0b33942b094c000010_0002": [
        {
            "start_logit": 4.517669677734375,
            "end_logit": 4.148892879486084,
            "text": "metastasis",
            "probability": 0.6786723732948303
        },
        {
            "start_logit": 4.517669677734375,
            "end_logit": 2.756808280944824,
            "text": "metastasis in colorectal cancer.",
            "probability": 0.16868844628334045
        },
        {
            "start_logit": 2.692502975463867,
            "end_logit": 4.148892879486084,
            "text": "associated with metastasis",
            "probability": 0.10939568281173706
        },
        {
            "start_logit": 2.692502975463867,
            "end_logit": 2.756808280944824,
            "text": "associated with metastasis in colorectal cancer.",
            "probability": 0.02719101868569851
        },
        {
            "start_logit": 4.517669677734375,
            "end_logit": 0.04765672981739044,
            "text": "metastasis in colorectal cancer",
            "probability": 0.011233515106141567
        },
        {
            "start_logit": 2.692502975463867,
            "end_logit": 0.04765672981739044,
            "text": "associated with metastasis in colorectal cancer",
            "probability": 0.0018107398645952344
        },
        {
            "start_logit": -2.1034858226776123,
            "end_logit": 4.148892879486084,
            "text": "Alternative microexon splicing by RBFOX2 and PTBP1 is associated with metastasis",
            "probability": 0.0009039175347425044
        },
        {
            "start_logit": 4.517669677734375,
            "end_logit": -3.3954813480377197,
            "text": "metastasis in",
            "probability": 0.0003590707201510668
        },
        {
            "start_logit": -3.152132034301758,
            "end_logit": 4.148892879486084,
            "text": "with metastasis",
            "probability": 0.00031674327328801155
        },
        {
            "start_logit": -2.1789119243621826,
            "end_logit": 2.756808280944824,
            "text": "colorectal cancer.",
            "probability": 0.00020835158647969365
        },
        {
            "start_logit": -3.650895118713379,
            "end_logit": 4.148892879486084,
            "text": "sis",
            "probability": 0.00019235219224356115
        },
        {
            "start_logit": 4.517669677734375,
            "end_logit": -4.145167350769043,
            "text": "metasta",
            "probability": 0.00016966623661573976
        },
        {
            "start_logit": 4.517669677734375,
            "end_logit": -4.181334018707275,
            "text": "meta",
            "probability": 0.00016363969189114869
        },
        {
            "start_logit": -3.8189125061035156,
            "end_logit": 4.148892879486084,
            "text": "PTBP1 is associated with metastasis",
            "probability": 0.0001626029988983646
        },
        {
            "start_logit": -3.840540885925293,
            "end_logit": 4.148892879486084,
            "text": "RBFOX2 and PTBP1 is associated with metastasis",
            "probability": 0.00015912378148641437
        },
        {
            "start_logit": 4.517669677734375,
            "end_logit": -4.866148948669434,
            "text": "metastasis in colorectal",
            "probability": 8.250438986578956e-05
        },
        {
            "start_logit": -3.152132034301758,
            "end_logit": 2.756808280944824,
            "text": "with metastasis in colorectal cancer.",
            "probability": 7.872864080127329e-05
        },
        {
            "start_logit": -4.553426742553711,
            "end_logit": 4.148892879486084,
            "text": "stasis",
            "probability": 7.800690218573436e-05
        },
        {
            "start_logit": -4.583099842071533,
            "end_logit": 4.148892879486084,
            "text": "microexon splicing by RBFOX2 and PTBP1 is associated with metastasis",
            "probability": 7.572617323603481e-05
        },
        {
            "start_logit": 2.692502975463867,
            "end_logit": -3.3954813480377197,
            "text": "associated with metastasis in",
            "probability": 5.787888585473411e-05
        }
    ],
    "63f9cd0b33942b094c000010_0003": [
        {
            "start_logit": 2.2017481327056885,
            "end_logit": 0.23765891790390015,
            "text": "Differential microexon splicing",
            "probability": 0.612751841545105
        },
        {
            "start_logit": 0.36298537254333496,
            "end_logit": -0.03189717233181,
            "text": "microexon splicing",
            "probability": 0.07441378384828568
        },
        {
            "start_logit": 2.2017481327056885,
            "end_logit": -2.4536938667297363,
            "text": "Differential microexon splicing was shown to be due, at least in part, to altered expression of RBFOX2",
            "probability": 0.04153793677687645
        },
        {
            "start_logit": -0.44992125034332275,
            "end_logit": -0.03189717233181,
            "text": "PTBP1, as regulators of microexon splicing",
            "probability": 0.033007487654685974
        },
        {
            "start_logit": 0.36298537254333496,
            "end_logit": -0.9993665218353271,
            "text": "microexon splicing in CRC cells.",
            "probability": 0.028280477970838547
        },
        {
            "start_logit": -0.7089895009994507,
            "end_logit": -0.03189717233181,
            "text": "RBFOX2 and PTBP1, as regulators of microexon splicing",
            "probability": 0.025474200025200844
        },
        {
            "start_logit": -0.44992125034332275,
            "end_logit": -0.3358745574951172,
            "text": "PTBP1",
            "probability": 0.024355480447411537
        },
        {
            "start_logit": 2.2017481327056885,
            "end_logit": -3.1295809745788574,
            "text": "Differential",
            "probability": 0.021130552515387535
        },
        {
            "start_logit": -0.6928179264068604,
            "end_logit": -0.3358745574951172,
            "text": "RNA interference-mediated knockdown experiments identified two splicing factors, RBFOX2 and PTBP1",
            "probability": 0.019103286787867546
        },
        {
            "start_logit": -0.7089895009994507,
            "end_logit": -0.3358745574951172,
            "text": "RBFOX2 and PTBP1",
            "probability": 0.01879684254527092
        },
        {
            "start_logit": -1.577193021774292,
            "end_logit": 0.23765891790390015,
            "text": "microexon-containing pre-mRNAs and to control their splicing in such cells. Differential microexon splicing",
            "probability": 0.013999460265040398
        },
        {
            "start_logit": -0.6928179264068604,
            "end_logit": -0.6603089570999146,
            "text": "RNA interference-mediated knockdown experiments identified two splicing factors, RBFOX2",
            "probability": 0.013810456730425358
        },
        {
            "start_logit": -0.7089895009994507,
            "end_logit": -0.6603089570999146,
            "text": "RBFOX2",
            "probability": 0.013588914647698402
        },
        {
            "start_logit": -0.44992125034332275,
            "end_logit": -0.9993665218353271,
            "text": "PTBP1, as regulators of microexon splicing in CRC cells.",
            "probability": 0.012544285506010056
        },
        {
            "start_logit": -0.7089895009994507,
            "end_logit": -0.9993665218353271,
            "text": "RBFOX2 and PTBP1, as regulators of microexon splicing in CRC cells.",
            "probability": 0.009681305848062038
        },
        {
            "start_logit": 0.36298537254333496,
            "end_logit": -2.0770280361175537,
            "text": "microexon splicing in CRC cells. RBFOX2",
            "probability": 0.009626406244933605
        },
        {
            "start_logit": 0.36298537254333496,
            "end_logit": -2.167588472366333,
            "text": "microexon splicing in CRC cells. RBFOX2 and PTBP1",
            "probability": 0.008792947046458721
        },
        {
            "start_logit": -2.0597994327545166,
            "end_logit": 0.23765891790390015,
            "text": "microexon splicing",
            "probability": 0.008640085346996784
        },
        {
            "start_logit": 0.36298537254333496,
            "end_logit": -2.5179033279418945,
            "text": "microexon splicing in CRC cells",
            "probability": 0.006194334011524916
        },
        {
            "start_logit": -0.44992125034332275,
            "end_logit": -2.0770280361175537,
            "text": "PTBP1, as regulators of microexon splicing in CRC cells. RBFOX2",
            "probability": 0.004269956611096859
        }
    ],
    "63f9cd0b33942b094c000010_0004": [
        {
            "start_logit": 0.3502635955810547,
            "end_logit": 1.2782995700836182,
            "text": "CRC metastasis",
            "probability": 0.40781083703041077
        },
        {
            "start_logit": -0.13173943758010864,
            "end_logit": 1.2782995700836182,
            "text": "influence CRC metastasis",
            "probability": 0.25184163451194763
        },
        {
            "start_logit": 0.3502635955810547,
            "end_logit": -0.41537681221961975,
            "text": "CRC metastasis through the regulation of microexon splicing",
            "probability": 0.07497292757034302
        },
        {
            "start_logit": -0.13173943758010864,
            "end_logit": -0.41537681221961975,
            "text": "influence CRC metastasis through the regulation of microexon splicing",
            "probability": 0.04629917070269585
        },
        {
            "start_logit": -0.14677761495113373,
            "end_logit": -0.41537681221961975,
            "text": "regulation of microexon splicing",
            "probability": 0.045608118176460266
        },
        {
            "start_logit": -1.9386883974075317,
            "end_logit": 1.2782995700836182,
            "text": "metastasis",
            "probability": 0.041340868920087814
        },
        {
            "start_logit": 0.3502635955810547,
            "end_logit": -1.2381184101104736,
            "text": "CRC metastasis through the regulation of microexon splicing.",
            "probability": 0.03293004259467125
        },
        {
            "start_logit": -0.13173943758010864,
            "end_logit": -1.2381184101104736,
            "text": "influence CRC metastasis through the regulation of microexon splicing.",
            "probability": 0.020335789769887924
        },
        {
            "start_logit": -0.14677761495113373,
            "end_logit": -1.2381184101104736,
            "text": "regulation of microexon splicing.",
            "probability": 0.020032264292240143
        },
        {
            "start_logit": 0.3502635955810547,
            "end_logit": -2.454528331756592,
            "text": "CRC",
            "probability": 0.009756907820701599
        },
        {
            "start_logit": -1.9386883974075317,
            "end_logit": -0.41537681221961975,
            "text": "metastasis through the regulation of microexon splicing",
            "probability": 0.007600205019116402
        },
        {
            "start_logit": -0.13173943758010864,
            "end_logit": -2.454528331756592,
            "text": "influence CRC",
            "probability": 0.0060253324918448925
        },
        {
            "start_logit": -3.8779830932617188,
            "end_logit": 1.2782995700836182,
            "text": "altered expression of RBFOX2 and PTBP1 might influence CRC metastasis",
            "probability": 0.005945037119090557
        },
        {
            "start_logit": -2.275815010070801,
            "end_logit": -0.41537681221961975,
            "text": "microexon splicing",
            "probability": 0.0054251654073596
        },
        {
            "start_logit": -4.015101909637451,
            "end_logit": 1.2782995700836182,
            "text": "PTBP1 might influence CRC metastasis",
            "probability": 0.005183279514312744
        },
        {
            "start_logit": -4.094478130340576,
            "end_logit": 1.2782995700836182,
            "text": "Our data thus suggest that altered expression of RBFOX2 and PTBP1 might influence CRC metastasis",
            "probability": 0.004787755664438009
        },
        {
            "start_logit": -4.189825057983398,
            "end_logit": 1.2782995700836182,
            "text": "RBFOX2 and PTBP1 might influence CRC metastasis",
            "probability": 0.004352345131337643
        },
        {
            "start_logit": -4.299864292144775,
            "end_logit": 1.2782995700836182,
            "text": "might influence CRC metastasis",
            "probability": 0.00389882642775774
        },
        {
            "start_logit": -1.9386883974075317,
            "end_logit": -1.2381184101104736,
            "text": "metastasis through the regulation of microexon splicing.",
            "probability": 0.003338204463943839
        },
        {
            "start_logit": -3.0444843769073486,
            "end_logit": -0.41537681221961975,
            "text": "the regulation of microexon splicing",
            "probability": 0.002515266416594386
        }
    ],
    "63f56f7533942b094c000002_0001": [
        {
            "start_logit": 7.8008646965026855,
            "end_logit": 7.032981872558594,
            "text": "aspartoacylase Gene",
            "probability": 0.9783993363380432
        },
        {
            "start_logit": 7.8008646965026855,
            "end_logit": 3.0490269660949707,
            "text": "aspartoacylase",
            "probability": 0.018209846690297127
        },
        {
            "start_logit": 7.8008646965026855,
            "end_logit": 0.618466317653656,
            "text": "aspartoacylase Gene.",
            "probability": 0.001602238044142723
        },
        {
            "start_logit": 1.3404759168624878,
            "end_logit": 7.032981872558594,
            "text": "Cribriform Appearance of White Matter in Canavan Disease Associated with Novel Mutations of aspartoacylase Gene",
            "probability": 0.0015303994296118617
        },
        {
            "start_logit": 7.8008646965026855,
            "end_logit": -2.3191542625427246,
            "text": "as",
            "probability": 8.490529580740258e-05
        },
        {
            "start_logit": -1.902965784072876,
            "end_logit": 7.032981872558594,
            "text": "White Matter in Canavan Disease Associated with Novel Mutations of aspartoacylase Gene",
            "probability": 5.973048246232793e-05
        },
        {
            "start_logit": 1.3404759168624878,
            "end_logit": 3.0490269660949707,
            "text": "Cribriform Appearance of White Matter in Canavan Disease Associated with Novel Mutations of aspartoacylase",
            "probability": 2.8483631467679515e-05
        },
        {
            "start_logit": -2.972426414489746,
            "end_logit": 7.032981872558594,
            "text": "Gene",
            "probability": 2.049911199719645e-05
        },
        {
            "start_logit": -3.7663631439208984,
            "end_logit": 7.032981872558594,
            "text": "Mutations of aspartoacylase Gene",
            "probability": 9.266862434742507e-06
        },
        {
            "start_logit": -3.78566312789917,
            "end_logit": 7.032981872558594,
            "text": "Novel Mutations of aspartoacylase Gene",
            "probability": 9.089722880162299e-06
        },
        {
            "start_logit": -3.8945136070251465,
            "end_logit": 7.032981872558594,
            "text": "Canavan Disease Associated with Novel Mutations of aspartoacylase Gene",
            "probability": 8.152250302373432e-06
        },
        {
            "start_logit": 7.8008646965026855,
            "end_logit": -4.940629959106445,
            "text": "aspartoacy",
            "probability": 6.172236680868082e-06
        },
        {
            "start_logit": -4.1743927001953125,
            "end_logit": 7.032981872558594,
            "text": "ribriform Appearance of White Matter in Canavan Disease Associated with Novel Mutations of aspartoacylase Gene",
            "probability": 6.162085810501594e-06
        },
        {
            "start_logit": -4.301054954528809,
            "end_logit": 7.032981872558594,
            "text": "Appearance of White Matter in Canavan Disease Associated with Novel Mutations of aspartoacylase Gene",
            "probability": 5.428989425126929e-06
        },
        {
            "start_logit": -4.393065929412842,
            "end_logit": 7.032981872558594,
            "text": "acylase Gene",
            "probability": 4.951752544002375e-06
        },
        {
            "start_logit": 7.8008646965026855,
            "end_logit": -5.232924938201904,
            "text": "aspar",
            "probability": 4.607870778272627e-06
        },
        {
            "start_logit": -4.50120735168457,
            "end_logit": 7.032981872558594,
            "text": "partoacylase Gene",
            "probability": 4.444203568709781e-06
        },
        {
            "start_logit": 1.3404759168624878,
            "end_logit": 0.618466317653656,
            "text": "Cribriform Appearance of White Matter in Canavan Disease Associated with Novel Mutations of aspartoacylase Gene.",
            "probability": 2.506202008589753e-06
        },
        {
            "start_logit": -5.299803733825684,
            "end_logit": 7.032981872558594,
            "text": "lase Gene",
            "probability": 1.9997141862404533e-06
        },
        {
            "start_logit": -5.314339637756348,
            "end_logit": 7.032981872558594,
            "text": "of White Matter in Canavan Disease Associated with Novel Mutations of aspartoacylase Gene",
            "probability": 1.9708566014742246e-06
        }
    ],
    "63f56f7533942b094c000002_0002": [
        {
            "start_logit": 4.754194259643555,
            "end_logit": 4.047701835632324,
            "text": "aspartoacylase or aspartoacylase gene",
            "probability": 0.714258074760437
        },
        {
            "start_logit": 3.155600070953369,
            "end_logit": 4.047701835632324,
            "text": "aspartoacylase gene",
            "probability": 0.14440909028053284
        },
        {
            "start_logit": 4.754194259643555,
            "end_logit": 2.028846025466919,
            "text": "aspartoacylase",
            "probability": 0.09485868364572525
        },
        {
            "start_logit": 4.754194259643555,
            "end_logit": 0.9616860151290894,
            "text": "aspartoacylase or aspartoacylase",
            "probability": 0.03262988477945328
        },
        {
            "start_logit": 3.155600070953369,
            "end_logit": 0.9616860151290894,
            "text": "aspartoacylase",
            "probability": 0.006597127765417099
        },
        {
            "start_logit": 4.754194259643555,
            "end_logit": -1.7027159929275513,
            "text": "aspartoacylase or aspartoacylase gene that",
            "probability": 0.0022723774891346693
        },
        {
            "start_logit": 4.754194259643555,
            "end_logit": -1.9582079648971558,
            "text": "aspartoacylase or aspartoacylase gene that possibly accounts for the severe form of Canavan disease,",
            "probability": 0.0017600362189114094
        },
        {
            "start_logit": 3.155600070953369,
            "end_logit": -0.9721093773841858,
            "text": "aspartoacylase gene that possibly accounts for the severe form of Canavan disease, which probably explains the imaging findings.",
            "probability": 0.0009539338061586022
        },
        {
            "start_logit": -2.4237141609191895,
            "end_logit": 4.047701835632324,
            "text": "Genetic analysis revealed novel mutations in the aspartoacylase or aspartoacylase gene",
            "probability": 0.0005451664328575134
        },
        {
            "start_logit": 3.155600070953369,
            "end_logit": -1.7027159929275513,
            "text": "aspartoacylase gene that",
            "probability": 0.00045943050645291805
        },
        {
            "start_logit": 3.155600070953369,
            "end_logit": -1.9582079648971558,
            "text": "aspartoacylase gene that possibly accounts for the severe form of Canavan disease,",
            "probability": 0.00035584508441388607
        },
        {
            "start_logit": -3.456496000289917,
            "end_logit": 4.047701835632324,
            "text": "novel mutations in the aspartoacylase or aspartoacylase gene",
            "probability": 0.0001940875081345439
        },
        {
            "start_logit": -3.585630178451538,
            "end_logit": 4.047701835632324,
            "text": "the aspartoacylase or aspartoacylase gene",
            "probability": 0.00017057497461792082
        },
        {
            "start_logit": 4.754194259643555,
            "end_logit": -4.596136569976807,
            "text": "aspartoacylase or aspartoacylase gene that possibly accounts for the severe form of Canavan disease, which probably explains the imaging findings",
            "probability": 0.0001258588017662987
        },
        {
            "start_logit": 4.754194259643555,
            "end_logit": -4.8998212814331055,
            "text": "as",
            "probability": 9.289562149206176e-05
        },
        {
            "start_logit": -2.4237141609191895,
            "end_logit": 2.028846025466919,
            "text": "Genetic analysis revealed novel mutations in the aspartoacylase",
            "probability": 7.240211562020704e-05
        },
        {
            "start_logit": -4.544473171234131,
            "end_logit": 4.047701835632324,
            "text": "or aspartoacylase gene",
            "probability": 6.538753950735554e-05
        },
        {
            "start_logit": 4.754194259643555,
            "end_logit": -5.2756805419921875,
            "text": "aspar",
            "probability": 6.379132537404075e-05
        },
        {
            "start_logit": 4.754194259643555,
            "end_logit": -5.30338716506958,
            "text": "aspartoacylase or aspartoacylase gene that possibly accounts for the severe form of Canavan disease",
            "probability": 6.2048107793089e-05
        },
        {
            "start_logit": 4.754194259643555,
            "end_logit": -5.454988479614258,
            "text": "aspartoacylase or aspartoacylase gene that possibly accounts for the severe form",
            "probability": 5.331988359102979e-05
        }
    ],
    "63f56f7533942b094c000002_0003": [
        {
            "start_logit": 4.5284318923950195,
            "end_logit": 4.292309284210205,
            "text": "aspartoacylase",
            "probability": 0.5253611207008362
        },
        {
            "start_logit": 4.5284318923950195,
            "end_logit": 3.8880743980407715,
            "text": "aspartoacylase (aspartoacylase)",
            "probability": 0.35067158937454224
        },
        {
            "start_logit": 4.5284318923950195,
            "end_logit": 2.12721848487854,
            "text": "aspartoacylase (aspartoacylase).",
            "probability": 0.06027964502573013
        },
        {
            "start_logit": 4.5284318923950195,
            "end_logit": 1.8051350116729736,
            "text": "aspartoacylase (aspartoacylase",
            "probability": 0.04368089884519577
        },
        {
            "start_logit": -0.22435127198696136,
            "end_logit": 4.292309284210205,
            "text": "gene encoding aspartoacylase",
            "probability": 0.004532628692686558
        },
        {
            "start_logit": 0.07527637481689453,
            "end_logit": 3.8880743980407715,
            "text": "aspartoacylase)",
            "probability": 0.004082440864294767
        },
        {
            "start_logit": -0.22435127198696136,
            "end_logit": 3.8880743980407715,
            "text": "gene encoding aspartoacylase (aspartoacylase)",
            "probability": 0.00302547262981534
        },
        {
            "start_logit": -1.1102763414382935,
            "end_logit": 4.292309284210205,
            "text": "mutations in the gene encoding aspartoacylase",
            "probability": 0.0018689511343836784
        },
        {
            "start_logit": -1.1102763414382935,
            "end_logit": 3.8880743980407715,
            "text": "mutations in the gene encoding aspartoacylase (aspartoacylase)",
            "probability": 0.0012475011171773076
        },
        {
            "start_logit": -1.6155916452407837,
            "end_logit": 4.292309284210205,
            "text": "Canavan disease (Canavan disease) is an inherited leukodystrophy resulting from mutations in the gene encoding aspartoacylase",
            "probability": 0.0011275667930021882
        },
        {
            "start_logit": 0.07527637481689453,
            "end_logit": 2.12721848487854,
            "text": "aspartoacylase).",
            "probability": 0.0007017618627287447
        },
        {
            "start_logit": -2.109675407409668,
            "end_logit": 4.292309284210205,
            "text": "leukodystrophy resulting from mutations in the gene encoding aspartoacylase",
            "probability": 0.0006879618740640581
        },
        {
            "start_logit": -0.22435127198696136,
            "end_logit": 2.12721848487854,
            "text": "gene encoding aspartoacylase (aspartoacylase).",
            "probability": 0.0005200717714615166
        },
        {
            "start_logit": 0.07527637481689453,
            "end_logit": 1.8051350116729736,
            "text": "aspartoacylase",
            "probability": 0.000508523138705641
        },
        {
            "start_logit": -2.109675407409668,
            "end_logit": 3.8880743980407715,
            "text": "leukodystrophy resulting from mutations in the gene encoding aspartoacylase (aspartoacylase)",
            "probability": 0.00045920582488179207
        },
        {
            "start_logit": 4.5284318923950195,
            "end_logit": -2.9109511375427246,
            "text": "aspartoacylase (",
            "probability": 0.00039095021202228963
        },
        {
            "start_logit": -0.22435127198696136,
            "end_logit": 1.8051350116729736,
            "text": "gene encoding aspartoacylase (aspartoacylase",
            "probability": 0.0003768636379390955
        },
        {
            "start_logit": -1.1102763414382935,
            "end_logit": 2.12721848487854,
            "text": "mutations in the gene encoding aspartoacylase (aspartoacylase).",
            "probability": 0.00021444247977342457
        },
        {
            "start_logit": -1.1102763414382935,
            "end_logit": 1.8051350116729736,
            "text": "mutations in the gene encoding aspartoacylase (aspartoacylase",
            "probability": 0.00015539310697931796
        },
        {
            "start_logit": -3.970597743988037,
            "end_logit": 4.292309284210205,
            "text": "acylase",
            "probability": 0.00010699809354264289
        }
    ],
    "63f56f7533942b094c000002_0004": [
        {
            "start_logit": 5.6609320640563965,
            "end_logit": 4.226588249206543,
            "text": "aspartoacylase (aspartoacylase) gene",
            "probability": 0.4350184202194214
        },
        {
            "start_logit": 5.6609320640563965,
            "end_logit": 3.966933012008667,
            "text": "aspartoacylase (aspartoacylase)",
            "probability": 0.3355373442173004
        },
        {
            "start_logit": 5.6609320640563965,
            "end_logit": 3.188616991043091,
            "text": "aspartoacylase",
            "probability": 0.1540716588497162
        },
        {
            "start_logit": 5.6609320640563965,
            "end_logit": 1.9586637020111084,
            "text": "aspartoacylase (aspartoacylase) gene, we introduced the wild-type (wild-type) aspartoacylase",
            "probability": 0.045036088675260544
        },
        {
            "start_logit": 5.6609320640563965,
            "end_logit": 0.7761937379837036,
            "text": "aspartoacylase (aspartoacylase",
            "probability": 0.013804493471980095
        },
        {
            "start_logit": 1.1999685764312744,
            "end_logit": 4.226588249206543,
            "text": "aspartoacylase) gene",
            "probability": 0.00502499844878912
        },
        {
            "start_logit": 1.1999685764312744,
            "end_logit": 3.966933012008667,
            "text": "aspartoacylase)",
            "probability": 0.0038758700247853994
        },
        {
            "start_logit": 2.6534628868103027,
            "end_logit": 1.9586637020111084,
            "text": "aspartoacylase",
            "probability": 0.0022255294024944305
        },
        {
            "start_logit": 2.6534628868103027,
            "end_logit": 1.6289124488830566,
            "text": "aspartoacylase gene",
            "probability": 0.0016003844793885946
        },
        {
            "start_logit": -0.7354100346565247,
            "end_logit": 4.226588249206543,
            "text": "Canavan disease is caused by mutations of the aspartoacylase (aspartoacylase) gene",
            "probability": 0.0007254573865793645
        },
        {
            "start_logit": -0.7354100346565247,
            "end_logit": 3.966933012008667,
            "text": "Canavan disease is caused by mutations of the aspartoacylase (aspartoacylase)",
            "probability": 0.0005595578113570809
        },
        {
            "start_logit": 1.1999685764312744,
            "end_logit": 1.9586637020111084,
            "text": "aspartoacylase) gene, we introduced the wild-type (wild-type) aspartoacylase",
            "probability": 0.0005202222382649779
        },
        {
            "start_logit": 1.1999685764312744,
            "end_logit": 1.6289124488830566,
            "text": "aspartoacylase) gene, we introduced the wild-type (wild-type) aspartoacylase gene",
            "probability": 0.000374093244317919
        },
        {
            "start_logit": -1.5313141345977783,
            "end_logit": 4.226588249206543,
            "text": "mutations of the aspartoacylase (aspartoacylase) gene",
            "probability": 0.00032730685779824853
        },
        {
            "start_logit": 5.6609320640563965,
            "end_logit": -3.0031557083129883,
            "text": "aspartoacylase (aspartoacylase) gene, we introduced the wild-type (wild-type)",
            "probability": 0.000315260753268376
        },
        {
            "start_logit": -0.7354100346565247,
            "end_logit": 3.188616991043091,
            "text": "Canavan disease is caused by mutations of the aspartoacylase",
            "probability": 0.0002569369971752167
        },
        {
            "start_logit": -1.5313141345977783,
            "end_logit": 3.966933012008667,
            "text": "mutations of the aspartoacylase (aspartoacylase)",
            "probability": 0.00025245745200663805
        },
        {
            "start_logit": 5.6609320640563965,
            "end_logit": -3.4650516510009766,
            "text": "aspartoacylase (aspartoacylase) gene, we introduced the wild-type",
            "probability": 0.0001986419956665486
        },
        {
            "start_logit": 1.1999685764312744,
            "end_logit": 0.7761937379837036,
            "text": "aspartoacylase",
            "probability": 0.00015945889754220843
        },
        {
            "start_logit": -1.5313141345977783,
            "end_logit": 3.188616991043091,
            "text": "mutations of the aspartoacylase",
            "probability": 0.00011592304508667439
        }
    ],
    "63f56f7533942b094c000002_0005": [
        {
            "start_logit": 7.5342607498168945,
            "end_logit": 5.327215671539307,
            "text": "aspartoacylase",
            "probability": 0.5992738008499146
        },
        {
            "start_logit": 7.5342607498168945,
            "end_logit": 4.918577194213867,
            "text": "aspartoacylase gene",
            "probability": 0.39824986457824707
        },
        {
            "start_logit": 7.5342607498168945,
            "end_logit": -1.5189294815063477,
            "text": "aspartoacylase gene probably underlay the Canavan disease in this patient, and the result has enabled prenatal diagnosis for this family.",
            "probability": 0.0006373559008352458
        },
        {
            "start_logit": 0.3626389503479004,
            "end_logit": 5.327215671539307,
            "text": "The compound heterozygous variants of the aspartoacylase",
            "probability": 0.0004602875851560384
        },
        {
            "start_logit": 0.1248016208410263,
            "end_logit": 5.327215671539307,
            "text": "compound heterozygous variants of the aspartoacylase",
            "probability": 0.0003628589620348066
        },
        {
            "start_logit": 0.3626389503479004,
            "end_logit": 4.918577194213867,
            "text": "The compound heterozygous variants of the aspartoacylase gene",
            "probability": 0.0003058861766476184
        },
        {
            "start_logit": 7.5342607498168945,
            "end_logit": -2.472212314605713,
            "text": "as",
            "probability": 0.0002456837974023074
        },
        {
            "start_logit": 0.1248016208410263,
            "end_logit": 4.918577194213867,
            "text": "compound heterozygous variants of the aspartoacylase gene",
            "probability": 0.00024113953986670822
        },
        {
            "start_logit": 7.5342607498168945,
            "end_logit": -3.9637451171875,
            "text": "aspartoacylase gene probably underlay the Canavan disease in this patient,",
            "probability": 5.528560359380208e-05
        },
        {
            "start_logit": 7.5342607498168945,
            "end_logit": -4.434052467346191,
            "text": "aspartoacylase gene probably underlay the Canavan disease in this patient",
            "probability": 3.4543008951004595e-05
        },
        {
            "start_logit": 7.5342607498168945,
            "end_logit": -4.731398105621338,
            "text": "aspartoacylase gene probably underlay the Canavan disease in this patient, and the result has enabled prenatal diagnosis for this family",
            "probability": 2.565809518273454e-05
        },
        {
            "start_logit": -2.813455104827881,
            "end_logit": 5.327215671539307,
            "text": "heterozygous variants of the aspartoacylase",
            "probability": 1.9216273358324543e-05
        },
        {
            "start_logit": 7.5342607498168945,
            "end_logit": -5.150161266326904,
            "text": "aspartoacy",
            "probability": 1.687944859440904e-05
        },
        {
            "start_logit": 7.5342607498168945,
            "end_logit": -5.17848539352417,
            "text": "aspartoacylase gene probably underlay the Canavan disease",
            "probability": 1.640806112845894e-05
        },
        {
            "start_logit": 7.5342607498168945,
            "end_logit": -5.259608268737793,
            "text": "aspartoacylase gene probably underlay the Canavan disease in this patient, and the result has enabled prenatal diagnosis",
            "probability": 1.5129543498915154e-05
        },
        {
            "start_logit": 7.5342607498168945,
            "end_logit": -5.314323425292969,
            "text": "aspar",
            "probability": 1.4323967661766801e-05
        },
        {
            "start_logit": -2.813455104827881,
            "end_logit": 4.918577194213867,
            "text": "heterozygous variants of the aspartoacylase gene",
            "probability": 1.277025330637116e-05
        },
        {
            "start_logit": -4.233020305633545,
            "end_logit": 5.327215671539307,
            "text": "acylase",
            "probability": 4.646862635127036e-06
        },
        {
            "start_logit": -4.297127723693848,
            "end_logit": 5.327215671539307,
            "text": "partoacylase",
            "probability": 4.358314527053153e-06
        },
        {
            "start_logit": -4.415499687194824,
            "end_logit": 5.327215671539307,
            "text": "lase",
            "probability": 3.871776243613567e-06
        }
    ],
    "63eeeb70f36125a426000005_0001": [
        {
            "start_logit": 3.2841920852661133,
            "end_logit": 2.9564414024353027,
            "text": "Relapsed or Refractory DLBCL",
            "probability": 0.33994099497795105
        },
        {
            "start_logit": 3.1323792934417725,
            "end_logit": 2.9564414024353027,
            "text": "Refractory DLBCL",
            "probability": 0.2920599579811096
        },
        {
            "start_logit": 2.455040454864502,
            "end_logit": 2.9564414024353027,
            "text": "DLBCL",
            "probability": 0.1483568251132965
        },
        {
            "start_logit": 3.2841920852661133,
            "end_logit": 0.8028236031532288,
            "text": "Relapsed or Refractory DLBCL after CAR T-Cell Therapy.",
            "probability": 0.03945473954081535
        },
        {
            "start_logit": 3.2841920852661133,
            "end_logit": 0.7262546420097351,
            "text": "Relapsed",
            "probability": 0.0365464873611927
        },
        {
            "start_logit": 3.1323792934417725,
            "end_logit": 0.8028236031532288,
            "text": "Refractory DLBCL after CAR T-Cell Therapy.",
            "probability": 0.03389750421047211
        },
        {
            "start_logit": 3.2841920852661133,
            "end_logit": 0.5553354620933533,
            "text": "Relapsed or Refractory DLBCL after CAR T-Cell Therapy",
            "probability": 0.030804665759205818
        },
        {
            "start_logit": 3.1323792934417725,
            "end_logit": 0.5553354620933533,
            "text": "Refractory DLBCL after CAR T-Cell Therapy",
            "probability": 0.026465805247426033
        },
        {
            "start_logit": 2.455040454864502,
            "end_logit": 0.8028236031532288,
            "text": "DLBCL after CAR T-Cell Therapy.",
            "probability": 0.01721881330013275
        },
        {
            "start_logit": 2.455040454864502,
            "end_logit": 0.5553354620933533,
            "text": "DLBCL after CAR T-Cell Therapy",
            "probability": 0.013443753123283386
        },
        {
            "start_logit": 3.2841920852661133,
            "end_logit": -0.8169485330581665,
            "text": "Relapsed or Refractory",
            "probability": 0.0078098224475979805
        },
        {
            "start_logit": 3.1323792934417725,
            "end_logit": -0.8169485330581665,
            "text": "Refractory",
            "probability": 0.0067098005674779415
        },
        {
            "start_logit": -1.1646127700805664,
            "end_logit": 2.9564414024353027,
            "text": "Glofitamab Treatment in Relapsed or Refractory DLBCL",
            "probability": 0.003974771127104759
        },
        {
            "start_logit": 3.2841920852661133,
            "end_logit": -3.127457857131958,
            "text": "Relap",
            "probability": 0.0007748177158646286
        },
        {
            "start_logit": -3.140535593032837,
            "end_logit": 2.9564414024353027,
            "text": "or Refractory DLBCL",
            "probability": 0.0005510359187610447
        },
        {
            "start_logit": -1.1646127700805664,
            "end_logit": 0.8028236031532288,
            "text": "Glofitamab Treatment in Relapsed or Refractory DLBCL after CAR T-Cell Therapy.",
            "probability": 0.0004613258643075824
        },
        {
            "start_logit": -1.1646127700805664,
            "end_logit": 0.7262546420097351,
            "text": "Glofitamab Treatment in Relapsed",
            "probability": 0.00042732106521725655
        },
        {
            "start_logit": 3.2841920852661133,
            "end_logit": -3.791762113571167,
            "text": "Relapsed or Refractory DLBC",
            "probability": 0.00039874581852927804
        },
        {
            "start_logit": -1.1646127700805664,
            "end_logit": 0.5553354620933533,
            "text": "Glofitamab Treatment in Relapsed or Refractory DLBCL after CAR T-Cell Therapy",
            "probability": 0.00036018455284647644
        },
        {
            "start_logit": 3.1323792934417725,
            "end_logit": -3.791762113571167,
            "text": "Refractory DLBC",
            "probability": 0.00034258203231729567
        }
    ],
    "63eeeb70f36125a426000005_0002": [
        {
            "start_logit": -0.10449643433094025,
            "end_logit": 0.19606022536754608,
            "text": "progressed after CAR T treatment. We report nine consecutive patients with progressive DLBCL",
            "probability": 0.37761348485946655
        },
        {
            "start_logit": -0.10449643433094025,
            "end_logit": -0.7098733186721802,
            "text": "progressed after CAR T treatment",
            "probability": 0.1526179313659668
        },
        {
            "start_logit": -1.0119776725769043,
            "end_logit": 0.19606022536754608,
            "text": "DLBCL",
            "probability": 0.15238191187381744
        },
        {
            "start_logit": -1.7886803150177002,
            "end_logit": 0.19606022536754608,
            "text": "CAR T treatment. We report nine consecutive patients with progressive DLBCL",
            "probability": 0.07008348405361176
        },
        {
            "start_logit": -2.503438949584961,
            "end_logit": 0.19606022536754608,
            "text": "progressive DLBCL",
            "probability": 0.034292567521333694
        },
        {
            "start_logit": -2.640368700027466,
            "end_logit": 0.19606022536754608,
            "text": "patients who progressed after CAR T treatment. We report nine consecutive patients with progressive DLBCL",
            "probability": 0.0299041960388422
        },
        {
            "start_logit": -1.7886803150177002,
            "end_logit": -0.7098733186721802,
            "text": "CAR T treatment",
            "probability": 0.02832525223493576
        },
        {
            "start_logit": -0.10449643433094025,
            "end_logit": -2.7034788131713867,
            "text": "progressed after CAR T treatment. We report nine consecutive patients with progressive DLBCL after preceding CAR T-cell therapy",
            "probability": 0.020787090063095093
        },
        {
            "start_logit": -0.10449643433094025,
            "end_logit": -2.7452919483184814,
            "text": "progressed after CAR T treatment.",
            "probability": 0.019935838878154755
        },
        {
            "start_logit": -0.10449643433094025,
            "end_logit": -2.752880811691284,
            "text": "progressed after CAR T treatment. We report nine consecutive patients with progressive DLBCL after preceding CAR T-cell therapy.",
            "probability": 0.019785121083259583
        },
        {
            "start_logit": -0.10449643433094025,
            "end_logit": -2.844491958618164,
            "text": "progressed",
            "probability": 0.018053127452731133
        },
        {
            "start_logit": -2.359543800354004,
            "end_logit": -0.7098733186721802,
            "text": "CD20xCD3 antibody glofitamab in patients who progressed after CAR T treatment",
            "probability": 0.01600482687354088
        },
        {
            "start_logit": -2.640368700027466,
            "end_logit": -0.7098733186721802,
            "text": "patients who progressed after CAR T treatment",
            "probability": 0.012086211703717709
        },
        {
            "start_logit": -0.10449643433094025,
            "end_logit": -3.264345407485962,
            "text": "progressed after CAR T",
            "probability": 0.01186349056661129
        },
        {
            "start_logit": -1.0119776725769043,
            "end_logit": -2.7034788131713867,
            "text": "DLBCL after preceding CAR T-cell therapy",
            "probability": 0.00838840939104557
        },
        {
            "start_logit": -1.0119776725769043,
            "end_logit": -2.752880811691284,
            "text": "DLBCL after preceding CAR T-cell therapy.",
            "probability": 0.007984074763953686
        },
        {
            "start_logit": -3.3990676403045654,
            "end_logit": -0.7098733186721802,
            "text": "bispecific CD20xCD3 antibody glofitamab in patients who progressed after CAR T treatment",
            "probability": 0.005659674294292927
        },
        {
            "start_logit": -2.359543800354004,
            "end_logit": -1.750901460647583,
            "text": "CD20xCD3",
            "probability": 0.005651168525218964
        },
        {
            "start_logit": -4.569107532501221,
            "end_logit": 0.19606022536754608,
            "text": "who progressed after CAR T treatment. We report nine consecutive patients with progressive DLBCL",
            "probability": 0.004346018191426992
        },
        {
            "start_logit": -0.10449643433094025,
            "end_logit": -4.294144153594971,
            "text": "progressed after CAR T treatment. We report nine consecutive patients with progressive DLBC",
            "probability": 0.004236200358718634
        }
    ],
    "63eeeb70f36125a426000005_0003": [
        {
            "start_logit": 1.106645107269287,
            "end_logit": 0.08217839896678925,
            "text": "DLBCL relapsing after CAR T-cell therapy",
            "probability": 0.33990007638931274
        },
        {
            "start_logit": 1.106645107269287,
            "end_logit": -0.22361940145492554,
            "text": "DLBCL",
            "probability": 0.2503484785556793
        },
        {
            "start_logit": 1.106645107269287,
            "end_logit": -0.3917858600616455,
            "text": "DLBCL relapsing",
            "probability": 0.21159783005714417
        },
        {
            "start_logit": -1.1779077053070068,
            "end_logit": 0.08217839896678925,
            "text": "CAR T-cell therapy",
            "probability": 0.03460848331451416
        },
        {
            "start_logit": -1.3029917478561401,
            "end_logit": 0.08217839896678925,
            "text": "relapsing after CAR T-cell therapy",
            "probability": 0.03053930774331093
        },
        {
            "start_logit": 1.106645107269287,
            "end_logit": -2.4841396808624268,
            "text": "DLBCL relapsing after CAR T-cell therapy and can enhance residual CAR T-cell activity",
            "probability": 0.026110397651791573
        },
        {
            "start_logit": 1.106645107269287,
            "end_logit": -2.5663304328918457,
            "text": "DLBCL relapsing after CAR T-cell therapy and can enhance residual CAR T-cell activity.",
            "probability": 0.024050191044807434
        },
        {
            "start_logit": -1.3029917478561401,
            "end_logit": -0.3917858600616455,
            "text": "relapsing",
            "probability": 0.019011622294783592
        },
        {
            "start_logit": 1.106645107269287,
            "end_logit": -3.3814408779144287,
            "text": "DLBCL relapsing after CAR T-cell",
            "probability": 0.010644384659826756
        },
        {
            "start_logit": -2.3967440128326416,
            "end_logit": 0.08217839896678925,
            "text": "patients with DLBCL relapsing after CAR T-cell therapy",
            "probability": 0.010229364968836308
        },
        {
            "start_logit": 1.106645107269287,
            "end_logit": -3.4727988243103027,
            "text": "DLBCL relap",
            "probability": 0.009715032763779163
        },
        {
            "start_logit": -2.3967440128326416,
            "end_logit": -0.22361940145492554,
            "text": "patients with DLBCL",
            "probability": 0.0075342911295592785
        },
        {
            "start_logit": -2.3967440128326416,
            "end_logit": -0.3917858600616455,
            "text": "patients with DLBCL relapsing",
            "probability": 0.006368082016706467
        },
        {
            "start_logit": 1.106645107269287,
            "end_logit": -4.033252716064453,
            "text": "DLBCL relapsing after CAR T-cell therapy and",
            "probability": 0.005546797998249531
        },
        {
            "start_logit": -1.1779077053070068,
            "end_logit": -2.4841396808624268,
            "text": "CAR T-cell therapy and can enhance residual CAR T-cell activity",
            "probability": 0.002658549463376403
        },
        {
            "start_logit": 1.106645107269287,
            "end_logit": -4.769083023071289,
            "text": "DLBC",
            "probability": 0.0026575124356895685
        },
        {
            "start_logit": -1.1779077053070068,
            "end_logit": -2.5663304328918457,
            "text": "CAR T-cell therapy and can enhance residual CAR T-cell activity.",
            "probability": 0.0024487802293151617
        },
        {
            "start_logit": -1.3029917478561401,
            "end_logit": -2.4841396808624268,
            "text": "relapsing after CAR T-cell therapy and can enhance residual CAR T-cell activity",
            "probability": 0.0023459645453840494
        },
        {
            "start_logit": -1.3029917478561401,
            "end_logit": -2.5663304328918457,
            "text": "relapsing after CAR T-cell therapy and can enhance residual CAR T-cell activity.",
            "probability": 0.0021608597598969936
        },
        {
            "start_logit": -4.300683975219727,
            "end_logit": 0.08217839896678925,
            "text": "well tolerated and effective in patients with DLBCL relapsing after CAR T-cell therapy",
            "probability": 0.0015239766798913479
        }
    ],
    "63eeeb70f36125a426000005_0004": [
        {
            "start_logit": 5.88942289352417,
            "end_logit": 5.361875057220459,
            "text": "DLBCL",
            "probability": 0.9968307614326477
        },
        {
            "start_logit": 5.88942289352417,
            "end_logit": -1.4001233577728271,
            "text": "DLBC",
            "probability": 0.0011532485950738192
        },
        {
            "start_logit": 5.88942289352417,
            "end_logit": -2.2253987789154053,
            "text": "DLB",
            "probability": 0.0005052547203376889
        },
        {
            "start_logit": -1.925140380859375,
            "end_logit": 5.361875057220459,
            "text": "BCL",
            "probability": 0.00040253132465295494
        },
        {
            "start_logit": 5.88942289352417,
            "end_logit": -2.4955146312713623,
            "text": "D",
            "probability": 0.0003856563998851925
        },
        {
            "start_logit": 5.88942289352417,
            "end_logit": -2.920668601989746,
            "text": "DLBCL.",
            "probability": 0.00025209173327311873
        },
        {
            "start_logit": 5.88942289352417,
            "end_logit": -3.3115341663360596,
            "text": "DL",
            "probability": 0.00017053267220035195
        },
        {
            "start_logit": -3.2828004360198975,
            "end_logit": 5.361875057220459,
            "text": "LBCL",
            "probability": 0.00010355606355005875
        },
        {
            "start_logit": -3.5555241107940674,
            "end_logit": 5.361875057220459,
            "text": "CL",
            "probability": 7.883751823101193e-05
        },
        {
            "start_logit": -3.9683878421783447,
            "end_logit": 5.361875057220459,
            "text": "L",
            "probability": 5.217092257225886e-05
        },
        {
            "start_logit": -4.492875576019287,
            "end_logit": 5.361875057220459,
            "text": "nuclear export selinexor, and several new agents have been investigated for DLBCL",
            "probability": 3.087781078647822e-05
        },
        {
            "start_logit": -4.643083572387695,
            "end_logit": 5.361875057220459,
            "text": "oral selective inhibitor of nuclear export selinexor, and several new agents have been investigated for DLBCL",
            "probability": 2.657123695826158e-05
        },
        {
            "start_logit": -0.40184107422828674,
            "end_logit": -0.41154876351356506,
            "text": "CD19",
            "probability": 5.741087079513818e-06
        },
        {
            "start_logit": -1.925140380859375,
            "end_logit": -1.4001233577728271,
            "text": "BC",
            "probability": 4.656944270209351e-07
        },
        {
            "start_logit": -3.117528200149536,
            "end_logit": -0.41154876351356506,
            "text": "mosunetuzumab, and glofitamab, anti-CD19",
            "probability": 3.798274690325343e-07
        },
        {
            "start_logit": -0.40184107422828674,
            "end_logit": -3.2389068603515625,
            "text": "CD19 antibody drug tafasitamab",
            "probability": 3.39694111062272e-07
        },
        {
            "start_logit": -3.4439520835876465,
            "end_logit": -0.41154876351356506,
            "text": "epcoritamab, mosunetuzumab, and glofitamab, anti-CD19",
            "probability": 2.7404504976402677e-07
        },
        {
            "start_logit": -0.40184107422828674,
            "end_logit": -3.543067216873169,
            "text": "CD19 antibody",
            "probability": 2.506068881302781e-07
        },
        {
            "start_logit": -3.6129133701324463,
            "end_logit": -0.41154876351356506,
            "text": "anti-CD19",
            "probability": 2.3144238525674155e-07
        },
        {
            "start_logit": -1.925140380859375,
            "end_logit": -2.2253987789154053,
            "text": "B",
            "probability": 2.0402737277436245e-07
        }
    ],
    "63eeeb70f36125a426000005_0005": [
        {
            "start_logit": 8.160846710205078,
            "end_logit": 7.855913162231445,
            "text": "B-cell non-Hodgkin lymphoma",
            "probability": 0.8070666790008545
        },
        {
            "start_logit": 6.032341003417969,
            "end_logit": 7.855913162231445,
            "text": "relapsed/refractory B-cell non-Hodgkin lymphoma",
            "probability": 0.09605304151773453
        },
        {
            "start_logit": 5.335598945617676,
            "end_logit": 7.855913162231445,
            "text": "refractory B-cell non-Hodgkin lymphoma",
            "probability": 0.04785418137907982
        },
        {
            "start_logit": 5.324226379394531,
            "end_logit": 7.855913162231445,
            "text": "non-Hodgkin lymphoma",
            "probability": 0.04731304198503494
        },
        {
            "start_logit": 8.160846710205078,
            "end_logit": 0.6677148938179016,
            "text": "B-cell non-Hodgkin lymph",
            "probability": 0.0006096977740526199
        },
        {
            "start_logit": 8.160846710205078,
            "end_logit": -0.4840576946735382,
            "text": "B",
            "probability": 0.0001927106932271272
        },
        {
            "start_logit": 6.032341003417969,
            "end_logit": 1.567840814590454,
            "text": "relapsed",
            "probability": 0.00017849904543254524
        },
        {
            "start_logit": 6.032341003417969,
            "end_logit": 1.2270374298095703,
            "text": "relapsed/refractory",
            "probability": 0.00012694831821136177
        },
        {
            "start_logit": 8.160846710205078,
            "end_logit": -1.286952257156372,
            "text": "B-cell non",
            "probability": 8.634029654785991e-05
        },
        {
            "start_logit": -1.003273367881775,
            "end_logit": 7.855913162231445,
            "text": "/refractory B-cell non-Hodgkin lymphoma",
            "probability": 8.452453039353713e-05
        },
        {
            "start_logit": 6.032341003417969,
            "end_logit": 0.6677148938179016,
            "text": "relapsed/refractory B-cell non-Hodgkin lymph",
            "probability": 7.256318349391222e-05
        },
        {
            "start_logit": 5.335598945617676,
            "end_logit": 1.2270374298095703,
            "text": "refractory",
            "probability": 6.324639252852648e-05
        },
        {
            "start_logit": 8.160846710205078,
            "end_logit": -1.676985263824463,
            "text": "B-cell non-Hodgkin l",
            "probability": 5.845537089044228e-05
        },
        {
            "start_logit": 8.160846710205078,
            "end_logit": -1.961617350578308,
            "text": "B-cell non-Hodgkin",
            "probability": 4.397542215883732e-05
        },
        {
            "start_logit": 8.160846710205078,
            "end_logit": -2.1027984619140625,
            "text": "B-cell non-Hod",
            "probability": 3.818527329713106e-05
        },
        {
            "start_logit": 5.335598945617676,
            "end_logit": 0.6677148938179016,
            "text": "refractory B-cell non-Hodgkin lymph",
            "probability": 3.615139576140791e-05
        },
        {
            "start_logit": 5.324226379394531,
            "end_logit": 0.6677148938179016,
            "text": "non-Hodgkin lymph",
            "probability": 3.57425888068974e-05
        },
        {
            "start_logit": 8.160846710205078,
            "end_logit": -2.2267746925354004,
            "text": "B-cell",
            "probability": 3.373291474417783e-05
        },
        {
            "start_logit": -2.091618776321411,
            "end_logit": 7.855913162231445,
            "text": "oma",
            "probability": 2.846559618774336e-05
        },
        {
            "start_logit": 8.160846710205078,
            "end_logit": -2.578876256942749,
            "text": "B-cell non-Hodgkin lymphoma.",
            "probability": 2.372126436966937e-05
        }
    ]
}
